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Inflammation is a response of the immune and vascular systems to the stimuli perceived 
as harmful to the host. Inflammation can be acute or chronic, and the recruitment of 
leukocytes to the affected tissues is a fundamental process during the course of both 
these events. Leukocytes are recruited in a process known as the multi-step adhesion 
cascade, which is a highly co-ordinated series of adhesive events mediated by the cell 
adhesion molecules (CAMs) on both leukocytes and endothelial cells. L-selectin is a 
CAM involved in the initial stages of the cascade, i.e. tethering and rolling, although there 
is a mounting body of evidence that points towards its role at later stages of the cascade, 
such as chemotaxis beyond transendothelial migration (TEM). The work outlined in this 
thesis explores the possibility that L-selectin actively contributes to TEM in monocytes. 
There are two important and measurable properties of L-selectin: (i) its rapid proteolysis 
(or “shedding”) upon cell activation, and (ii) its transition from being monomeric in the 
plasma membrane to being clustered, following ligand binding, which is a hallmark of 
downstream signalling. By expressing C-terminally green fluorescent protein (GFP)-
tagged L-selectin in THP-1 monocytes, it was possible for the first time to monitor and 
analyse the spatio-temporal distribution of L-selectin and its shedding during TEM. In 
addition, co-expressing L-selectin-GFP with L-selectin tagged to red fluorescent protein 
(RFP) enabled measurement of L-selectin clustering during TEM via the use of 
fluorescence lifetime imaging microscopy (FLIM) to monitor Forster resonance energy 
transfer (FRET) between the GFP and RFP-tags. Interestingly, the majority of L-selectin 
was found to be clustered exclusively in pseudopods protruding beneath the endothelial 
monolayer, where L-selectin ligands are known to exist. L-selectin clustering was also 
found to occur following cross-linking of either CD43 or PECAM-1, suggesting inside-out 
signalling is an important factor in modulating L-selectin function. Moreover, both the 
extracellular cleavage domain and two cytoplasmic tail serine residues were involved in 
fundamentally regulating L-selectin clustering. Finally, the sub-cellular distribution of L-
selectin clustering correlated tightly with the dynamics of the pseudopods that protruded 
beneath the endothelial monolayer during TEM. This thesis aims to understand the 
contribution that L-selectin has during the later stages of the adhesion cascade, and will 
re-shape the currently held perspective that this cell adhesion molecule’s role is solely 
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CHAPTER 1. INTRODUCTION 
1.1 INFLAMMATION 
Inflammation is believed to have evolved as an adaptive response of the immune system 
to homeostatic imbalance. The most common causes of such imbalances are infections 
and tissue injuries. A pathogen or injury triggers an acute inflammatory response, which 
is a controlled physiological reaction of a healthy organism that serves to protect the 
host. However, inflammation underlies not only physiological, but also a variety of 
pathological processes. The majority of cases where inflammation is detrimental to the 
host are the chronic inflammation states that ensue when the acute phase is not 
resolved.  
Inflammation was first described in the 1st century A.D. by a Roman medical writer 
Celsius, who identified its four cardinal signs: redness, swelling, fever and pain. Two 
hundred years later another accomplished medical researcher of antiquity, Galen of 
Pergamon, added the fifth sign to the list – loss of function. In other words, any 
organ/tissue afflicted with inflammation loses it’s ability to function normally. 
Inflammation of a certain organ/tissue is denoted by the addition of the suffix “-itis” (from 
ancient Greek, initially meaning “pertaining to”, now has come to mean “inflammation 
of”), e.g. inflammation of peritoneum is known as peritonitis, inflammation of the tonsils 
is called tonsillitis, etc. There are two components of an inflammatory response: the 
vascular arm and the cellular arm. The vascular arm is the vascular tissue that reacts 
immediately to the harmful stimuli by vasodilation (widening of the blood vessels) and an 
increase in the vascular permeability. The vascular arm is especially important for acute 
inflammation. The cellular arm is composed of the cells of the immune system – 
leukocytes. There are several subsets of leukocytes: lymphocytes (T cells, B cells, NK 
cells), monocytes, dendritic cells, mast cells and “granulocytes” – neutrophils, basophils 
and eosinophils, (also collectively known as polymorphonuclear leukocytes, PMN). 
Majority of leukocytes originate in the bone marrow, however yolk sac-derived 
macrophages have been recently identified [1], suggesting a greater complexity of 
leukocyte origin than previously anticipated. Leukocytes guard the peripheral tissues 
through circulation in the blood and the lymphatic system. All leukocytes contribute to a 
successful outcome of an inflammatory response through integration of innate and 
adaptive immune responses. In broad terms, innate responses (killing and engulfing of 
the pathogens) are mediated by granulocytes and monocytes, whereas the adaptive 
responses (production of antigen-specific antibodies) depend on lymphocytes.  
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1.1.1 Acute inflammation 
Acute inflammation is initiated by the vascular arm, which also involve the contribution 
of tissue-resident macrophages and mast cells of the cellular arm that respond directly 
to the pathogen/injury. Various inflammatory mediators are responsible for different 
aspects of a successful inflammatory response. Platelet activating factor (PAF), 
prostaglandins (PGEs) as well as vasoactive amines and peptides cause vasodilation 
and increased endothelial permeability of the capillaries. Additionally, PAF and various 
cytokines mediate leukocyte recruitment to the sites of inflammation. As a result 
leukocytes, predominantly neutrophils, extravasate from the blood vessels and in to the 
affected tissues. Hence, vasodilation and leukocyte emigration in to the tissues are 
responsible for heat (because the blood core temperature is brought more readily to the 
skin surface), redness and swelling. Pain is mainly a result of the activity of bradykinin 
and prostaglandin 2 (PGE2), and the latter is also pyrogenic (causes fever) [2, 3]. 
A successful acute inflammatory response results in the elimination of the infectious 
agent and is followed by a tissue healing phase. If the immune system fails to eliminate 
the pathogen, inflammation persists and develops into a “chronic inflammation” (section 
1.1.2). 
1.1.2 Chronic inflammation 
A hallmark of acute-to-chronic inflammation transition is a decrease in infiltrating 
neutrophils and a profound increase in the influx of mononuclear cells (monocytes and 
lymphocytes). Trafficking of monocytes in both acute and chronic inflammation is 
discussed in more detail in section 1.6 of this thesis.   
Apart from persistent pathogens, chronic inflammation can result from other causes of 
tissue damage like undegradable foreign objects, e.g. silica [4] or asbestos [5] particles, 
or autoimmune responses (due to persistence of self-antigens), e.g. multiple sclerosis 
(MS) or systemic lupus erythematosus (SLE). Perhaps the most notorious example of 
chronic inflammation is atherosclerosis, the main driver of cardiovascular disease (CVD). 
CVD includes myocardial infarction, heart failure and stroke, and is a leading cause of 
death worldwide. Monocyte-driven mechanisms underlying atherosclerosis are 
described in more detail in section 1.6.2. The involvement of L-selectin in 
atherosclerosis is discussed in section 1.13.1. 
1.2 THE LEUKOCYTE ADHESION CASCADE 
Migration of leukocytes out of the blood vessels and into the inflamed tissues depends 
on a highly co-ordinated, multistep process termed the “Multi-step leukocyte adhesion 
cascade”. The leukocyte adhesion cascade is also utilised by naïve lymphocytes during 
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their recirculation (homing) to the peripheral lymph nodes (PLNs). This is a dynamic 
process that requires the synchronised activity of various cell adhesion molecules 
(CAMs) on both the leukocyte and the endothelium. In general, leukocyte recruitment is 
initiated by tethering and rolling of leukocytes on inflamed endothelium due to the 
interaction between the selectin family of glycoproteins and their ligands [6] (figure 1.1). 
Next, activation and arrest of leukocytes takes place as a result of chemokine-induced 
integrin activity, which leads to arrest of leukocytes on the endothelium. This step is 
followed by intravascular crawling and transmigration of leukocytes through the 
endothelium, via the paracellular or transcellular route [6]. The stages of the cascade 
and the CAMs involved are discussed more thoroughly in the following sections. 
 
 
Figure 1.1 The leukocyte adhesion cascade. Homing of naïve lymphocytes to LN or recruitment 
of leukocytes to sites of inflammation is a strictly defined and dynamic process, which requires 
the co-ordinated activity of both leukocyte and endothelial cell adhesion molecules. Initially, 
capture of leukocytes (tethering) from free blood flow occurs through interaction between the 
selectins and their ligands, e.g. PSGL-1. Subsequent tethering, rolling and slow rolling is also 
selectin-mediated, however, LFA-1, VLA-4 and α4β7 integrins and their counter-receptors 
contribute to these steps as well. Chemokine-mediated inside-out activation of integrins and 
resultant outside-in integrin signalling leads to leukocyte arrest and firm adhesion onto ECs. Next, 
integrin-mediated adhesion strengthening and leukocyte spreading as well as MAC-1/ICAM-1-
dependent intravascular crawling act collectively as prerequisites to promote transendothelial 
migration (TEM). TEM can occur through a paracellular or a transcellular route. Both transcellular 
and paracellular routes are dependent on PECAM-1, CD99 and JAMs. Additionally, paracellular 
route utilises ESAM and transcellular route employs ICAM-1. For abbreviations used see 























1.2.1. Leukocyte tethering  
In the absence of inflammation, leukocytes in flowing blood pass over the endothelium. 
The wall shear stress, which is a parallel force applied to the endothelium by the shear 
force of the flowing blood, ensures that no inappropriate contacts between the leukocytes 
and the endothelium can be made. However, vasodilation of blood vessels at sites of 
inflammation (section 1.1.1) slows the blood flow, thereby reducing the shear stress. 
Additionally, the red blood cells that are more flexible and flow faster than the leukocytes, 
displace the leukocytes towards the walls of the venules [7, 8]. Collectively, this allows 
the leukocytes to form contacts with the endothelium. The initial contact between the 
flowing leukocytes and the endothelium is established through the formation of transient 
“tethers”. Tethering (also known as leukocyte capture) is facilitated by the microvilli – thin 
actin-rich projections that protrude from the leukocyte body. A tether is formed when 
parts of microvillar plasma membrane are taken apart from the underlying cytoskeleton 
and are stretched into a less rigid structure [9]. Tethers act like “elastic bands” that help 
to decrease the pulling force of the blood flow imposed on the bonds forming between 
the leukocyte and endothelium [9, 10]. Tethering of leukocytes is mediated by the 
selectins (section 1.7) and their ligands, most important being P-selectin glycoprotein 
ligand 1 (PSGL-1) (figure 1.2). Whilst all members of the selectin family recruit 
leukocytes at sites of inflammation, L-selectin is almost single-handedly responsible for 
the recirculation of naïve lymphocytes to the PLNs [11-13]. Leukocyte α4 integrins, 
namely α4β1 (very late antigen 4, VLA-4) [14] and α4β7 [15], have also been reported to 
mediate tethering (figure 1.2). Leukocyte CAMs involved in the formation of tethers are 
localised to the tips of leukocyte microvilli [15-18]. Microvillar localisation of these CAMs 
provides a spatial advantage over the cell body localisation, and is ideal for the initiation 
of contacts with the endothelium. 
The significance of L-selectin-mediated tethering for leukocyte recruitment in vivo has 
been demonstrated by Stein et al. (1999) [19] and Eriksson et al. (2001) [20]. These 
studies showed that vessel diameter plays a key role in this particular phase of the 
adhesion cascade. Specifically, tethering is important for recruitment of leukocytes in the 
vessels that are larger than 20 μm in diameter, [19]. In contrast, the recruitment of 
leukocytes in venules with diameters less than 20 μM commences by initiation of rolling, 
and tethering is not required [19]. It was postulated that his is because in such narrow 
venules (<20 µm), the leukocytes are already in close contact with the vessel walls, and 
the initial capture is not needed [19]. Additionally, in vessels that have a diameter of more 
than 45 µm, L-selectin plays a prominent role in the initiation of secondary tethers, in the 




Figure 1.2 Cell adhesion molecules mediating tethering and rolling. The leukocyte adhesion 
cascade is a multistep process that involves synchronised interactions of CAMs on both the 
leukocyte and the endothelium. This schematic depicts CAMs involved in the first two stages of 
the cascade: leukocyte tethering and leukocyte rolling. Full names of the CAMs can be found in 
the Abbreviations section.   
 
1.2.2 Leukocyte rolling 
After the initial tethering is established, if there is sufficient ligand presented on the 
surface of the endothelium, then leukocytes will begin to “roll”. Rolling of lymphocytes on 
non-inflamed high endothelial venules (HEV) in PLN occurs constitutively [11, 21, 22]. 
However, rolling of leukocytes on other vascular beds is only triggered when the 
endothelium becomes inflamed. Rolling of leukocytes from P-, E- and L-selectin null mice 
[11, 23-25] or upon antibody-mediated blocking of selectins [26-31] is dramatically 
reduced. Thus, the selectins are the primary mediators of the leukocyte rolling. 
Additionally, leukocyte integrins VLA-4, lymphocyte function-associated antigen 1 (LFA-






























this process [14, 15, 32-35] (figure 1.2). Integrins that mediate rolling are thought to be 
in their “intermediate” state of activation (intermediate-affinity), which unlike the “high” 
activation state (high-affinity) does not promote adhesion [36, 37].  
Rolling is a continuous movement of the leukocytes along the endothelial cells (ECs) that 
lasts from seconds to minutes, depending on the vascular bed [38-40]. This movement 
depends on the formation and breakage of bonds formed between CAMs and their 
respective ligands on both leukocytes and the endothelial cells. The forces exerted on 
the leukocyte by the flowing blood, collectively known as the hydrodynamic drag, and 
the bonds formed between the selectins and their ligands counter-balance each other 
and result in leukocyte rolling [10, 41-43]. The hydrodynamic drag increases with the 
increasing wall shear stress [41]. In fact, selectin-mediated rolling requires a minimum 
shear stress for the formation of the so-called “catch-slip” bonds, and the cells do not 
adhere below the critical shear stress of 0.1 dynes/cm2 [44-48]. The bonds formed by 
the selectins are called “catch-slip” bonds due to their biphasic responses to the applied 
force [49]. The strength of those bonds increases with the increasing force (catch), but 
then deceases when further force is applied (slip) [49, 50]. During rolling, shear stress 
acting on the rear of the cell is stronger than that acting at its front. Hence, the catch-slip 
bond phenomenon allows formation of new bonds at the front edge and dissociation of 
the preexisting bonds at the rear edge, promoting the cell to roll in the general direction 
of blood flow [48]. 
The three selectins have both overlapping and distinctive functions and each of the 
selectins mediates rolling at an individual velocity [24, 51, 52]. It has been suggested 
that L-selectin is most efficient in capturing leukocytes from flow [53, 54], and mediates 
the fastest type of rolling [52, 55]. P-selectin can both initiate [56] and maintain [27] 
rolling, whereas E-selectin mediates stable rolling that has the lowest velocity [51]. As 
rolling progresses, the strength of the catch bonds increase and the selectins and 
integrins mediate rolling at progressively lower velocities [24, 57]. This “slow rolling” 
enables the leukocytes to sample for chemokines presented by the inflamed endothelium 
[51, 58, 59]. Eventually, the transition from leukocyte rolling to arrest takes place as a 
result of leukocyte activation (section 1.2.4). Therefore, the role of leukocyte rolling 
appears to be to slow the leukocytes down and prolong their passage through the 
venules. This allows the leukocytes to survey the endothelium for chemoattractants and 
gives them time to become activated and employ the integrin-based adhesion 
machinery.    
1.2.3 Secondary leukocyte capture 
Leukocyte tethering and rolling can be augmented by a phenomenon known as 
“secondary capture”. Secondary capture takes place when free flowing leukocytes tether 
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to and roll on the adherent leukocytes and it has been observed both in vitro and in vivo 
[20, 54, 60, 61]. Additionally, adherent leukocyte fragments have been proposed to 
participate in the capture of circulating leukocytes [62]. Secondary leukocyte capture is 
mediated by L-selectin on free-flowing leukocytes [60], and freely available PSGL-1, 
belonging to the leukocytes already interacting with the endothelium [62]. Depending on 
the vessel size and flow rate, the homotypic leukocyte-leukocyte interactions can 
account for 25-70% of the total leukocyte accumulation [20, 54]. This demonstrates the 
importance of the secondary capture for amplification of the leukocyte accumulation at 
sites of inflammation. Leukocytes engage secondary capture mechanisms more as 
vessel size increases, raising the possibility that secondary capture may play a role 
during inflammation of large blood vessels, and in diseases such as atherosclerosis [20].  
It has been reported that secondary capture of leukocytes can be seen as formation of 
characteristic “strings” or grape-shaped “clusters” (both hereafter referred to as strings) 
[20, 53, 54, 63, 64]. The formation of the strings occurs when a newly captured leukocyte 
binds upstream of the already adherent one. However, it has been reported that strings 
can form in the absence of L-selectin – the primary secondary capture mediator [65].  
Additionally, it has also been shown that formation of the strings can occur without the 
initial leukocyte-leukocyte interactions in a process called “hydrodynamic recruitment” 
[66]. Hydrodynamic recruitment theory postulates that the perturbations in the fluid 
surrounding an adherent leukocyte may play a critical role in bringing the apposing 
leukocytes within binding distance [66].  It has been suggested that formation of these 
strings could be a result of a synergistic action of L-selectin-mediated secondary capture 
and random leukocyte collisions resulting from the hydrodynamic recruitment [64].   
1.2.4 Transition from leukocyte rolling to arrest 
The transition from leukocyte rolling to firm adhesion (arrest) is a key element of the 
inflammatory response. During decelerated rolling, when leukocytes are able to survey 
the endothelium for the inflammatory cues [59, 67], the cells need to “decide” whether to 
arrest or to detach and leave the site. This “decision-making” process involves at least 
two main mechanisms: the chemokine-mediated “inside-out” integrin activation and the 
“outside-in” signalling evoked by CAMs binding to their respective ligands during rolling. 
If signalling triggered by the chemokines and CAMs reach a certain threshold, then the 
rolling leukocyte becomes “activated”. Activated leukocytes arrest on the ECs.  
Chemokines are important for both homing of naïve lymphocytes to PLNs and for the 
recruitment of leukocytes to the sites of inflammation. However, specific expression and 
regulation of each chemokine, as well as chemokine receptor expression patterns on the 
leukocytes, create a functional diversity that allows the chemokines to direct different 
leukocyte subsets to different vascular beds. Chemokines bind to seven-pass 
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transmembrane G-protein coupled receptors (GPCRs) on leukocytes, which triggers 
complex signalling pathways inside the cell that eventually lead to integrin activation [59, 
68-74]. This is known as ‘inside-out’ signalling because signals generated intracellularly 
are transmitted out to the extracellular domain of the integrin. Integrin activation occurs 
through their transition from a bent low-affinity form to a high-affinity (extended) form [68, 
75-77]. High-affinity integrins mediate firm leukocyte adhesion through binding to their 
endothelial ligands, such as ICAM-1 and VCAM-1 (section 1.2.5) [75, 78-80]. 
Additionally, chemokines promote lateral mobility of the integrins, which results in 
formation of integrin clusters that enhance the integrin/ligand encounter frequency [80]. 
Irrespective of their ability to activate the integrins, chemokines have also been shown 
to cause microvillar collapse [81]. Loss of microvilli is beneficial during the transition from 
rolling to arrest as it enlarges the region of contact between the leukocyte and the ECs. 
Apart from the chemokines, transition from leukocyte rolling to arrest is also mediated by 
CAMs. Binding to E-selectin [82] or P-selectin [83], or engagement of L-selectin [84-89], 
is known to cause upregulation and activation of leukocyte integrins, and thus promote 
leukocyte adhesion. Additionally, extensive studies of L-selectin-mediated signalling 
have shown that its ligation triggers leukocyte activation resulting in variety of cellular 
responses, including upregulation of chemokine receptors (section 1.11.3) [85, 86, 90]. 
Furthermore, it has been shown that L-selectin cross-linking enhances cytokine- or 
chemokine-induced adhesion through β2 integrins [85, 91], and Spertini et al. (1991) 
showed that activation of lymphocytes with physiological stimuli enhanced L-selectin-
dependent binding to HEV [92]. This suggests that an overlap and/or synergy between 
chemokine-mediated inside-out signalling and CAMs mediated outside-in signalling is 
likely to exist for successful transition from leukocyte rolling to arrest to occur (figure 
1.3). More than one “input” needed to activate and arrest the rolling leukocyte might be 
necessary to provide a few “safety levels” of activation. This would be particularly true 
for neutrophils, the first mediators of an acute inflammatory response, whose 




Figure 1.3 Transition from leukocyte rolling to arrest. To convert reversible rolling interactions 
into stable adhesion, the leukocyte must first become activated. Two main mechanisms contribute 
to leukocyte activation are depicted in this figure. The first one involves inside-out activation of 
the integrins in response to GPCR/chemokine binding. The second mechanism is initiated by 
ligation of selectins and their ligands. This leads to a variety of cellular responses, including 
upregulation, activation and adhesion through integrins as well as expression of chemokine 
receptors (not shown in the figure).   Image adapted from Totani and Evangelista, Arterioscler 
Thromb Vasc Biol, 2010 [93]. 
 
1.2.5 Leukocyte arrest 
Progressively slower leukocyte rolling and leukocyte activation described in the sections 
above result in the firm adhesion of the leukocyte on the endothelium (arrest). Leukocyte 
arrest is a result of a solid attachment through integrins and their ligands (figure 1.4). 
The integrins, therefore, are involved in mediating tethering, rolling (figure 1.2) and firm 
adhesion. This is a result of their ability to exist in multiple affinity states. As mentioned 
before, rolling interactions are mediated by the integrins activated to their intermediate-
affinity states [36]. During leukocyte activation, integrins acquire high-affinity 
conformations and thus can mediate firm adhesion [77, 94]. Activation of the integrins to 
certain affinity states is differently regulated in various leukocyte subsets by cytoplasmic 
proteins talin and kindlins1-3 [95-99]. Mutations in the kindlin-3 gene result in leukocyte 
adhesion deficiency III (LADIII) [96, 100, 101] (section 1.2.9). Integrin deactivation has 
been recently shown to occur as a result of binding of a cytosolic protein SHARPIN [102]. 
Interestingly, activation of integrins was found to be counter-balanced by an anti-
inflammatory cytokine growth differentiation factor (GDF) 15 released by the tissue 
















excessive recruitment of leukocytes to the infarcted area [103]. This suggests that 
regulation of integrin activation plays an important role in the modulation and extent of 
the inflammatory response.  
The most studied β2 integrins are LFA-1 (CD11a/CD18 or αLβ2) and Mac-1 
(CD11b/CD18 or αMβ2). Both LFA-1 and Mac-1 bind to the immunoglobulin (Ig) 
superfamily members ICAMs (inter-cellular adhesion molecules), but whilst LFA-1 binds 
both ICAM-1 [104-106] and ICAM-2 [107], Mac-1 binds ICAM-1 [108]. Additionally, 
binding of Mac-1 to the endothelial receptor for advanced glycation endoproducts 
(RAGE) has also been reported [109]. Apart from β2 integrins, β1 integrin VLA-4 (α4β1) 
mediates adhesion through binding to another Ig superfamily member VCAM-1 [110], 
and α4β7 contributes to leukocyte arrest through its interaction with mucosal addressin 
cell adhesion molecule 1 (MadCAM) [111]. 
 
Figure 1.4 CAMs involved in leukocyte arrest. This diagram shows cell surface receptors on 
both leukocyte and the endothelium that participate in the firm leukocyte adhesion (arrest). The 
leukocyte arrests through its β2 and α4 integrins that bind to their respective ligands on the 
endothelium. Full names of the CAMs can be found in the Abbreviations section.  
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1.2.6 Adhesion stabilisation and leukocyte spreading 
Adhesion stabilisation (strengthening) and leukocyte spreading were designated as 
separate to the adhesion phases of the leukocyte adhesion cascade, as they are driven 
by different mechanisms. Described above, chemokine-mediated inside-out signalling 
leads to integrin activation and firm leukocyte adhesion. Further interaction of the active 
integrins with their ligands generates outside-in signalling that drives adhesion 
stabilisation, strengthening and spreading of the already arrested leukocytes [110, 112, 
113]. Ligand-induced integrin clusters form “signalosomes”, which are clusters of 
signalling molecules that generate intracellular signals [110]. 
Inside-out and outside-in signalling define a dual regulation of the integrins in the 
adhesion of leukocytes. First of all, the integrins are responsible for leukocyte arrest and 
initial adhesion through the chemokine-mediated inside-out signalling. Secondly, they 
are important for adhesion maintenance and leukocyte spreading through the ligand 
engagement and resulting outside-in signalling. 
1.2.7 Pre-requisite steps for the leukocyte transendothelial migration 
1.2.7.1 Intraluminal crawling 
Transendothelial migration (TEM), also known as diapedesis, is the last step in the 
leukocyte adhesion cascade. Upon arrest of the rolling leukocytes, TEM is not initiated 
immediately, but is preceded by the locomotion of leukocytes on the luminal endothelial 
surface. This is known as “intraluminal crawling”, whereby leukocytes crawl on ECs 
seeking optimal transmigration sites [114, 115]. Crawling is dependent on β2 integrins 
and their ligands, and Mac-1/ICAM-1 interaction controls this process in vivo [114, 116], 
and both Mac-1/ICAM-1 and LFA-1/ICAM-2 binding have been shown to mediate 
crawling in vitro [117]. Blockade of β2 integrins results in increased rate of transcellular 
migration [114], reflecting impairment in locomotion to the EC junctions. Efficient 
crawling, TEM and subsequent migration through the ECM is dependent on the correct 
polarisation of leukocytes, which have a leading edge at the front and a single trailing 
end (or uropod) at the rear [118, 119]. Polarisation of leukocytes depends on Rho 
GTPases [118] (section 1.5), and on surface CD44 glycoprotein [120]. Additionally, 
another surface protein, namely inhibitory Ly49Q receptor, has been proposed to 
regulate neutrophil polarization and migration upon inflammation [121].  
1.2.7.2 Endothelial adhesive platforms and docking structures 
The endothelium facilitates leukocyte TEM through formation of specialised clusters 
containing integrin ligands ICAM-1 and VCAM-1. One example of such clusters are the 
endothelial adhesion platforms (EAPs) that contain ICAM-1, VCAM-1, and the 
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tetraspanin members, CD9 and CD151. [122]. EAPs exist in the membranes of the ECs 
as pre-formed pro-adhesive microdomains, thereby promoting leukocyte adhesion and 
TEM [122]. The importance of the tetraspanin-based adhesive platforms for leukocyte 
recruitment is highlighted by a study by Rohlena et al. (2009), who suggest that 
pathologically elevated levels of CD81 tetraspanin facilitate monocyte adhesion and 
promote atherosclerosis in humans [123]. Another form of endothelial pro-transmigratory 
clusters are the “docking structures” or “transmigratory cups” that form only upon 
leukocyte/endothelium engagement, and are actin-rich projections that “embrace” the 
adherent leukocyte [124-126]. These structures are rich in F-actin, actin-binding proteins, 
ICAM-1, VCAM-1, active ezrin/radixin/moesin (ERM) proteins [124, 127], and can be 
observed in vitro and in vivo during both paracellular and transcellular TEM (section 
1.2.8) [125, 128]. The existence and formation of the docking structures is however not 
completely understood, as some reports show the enrichment of ICAM-1 around the 
transmigrating leukocytes without the actin-rich projections [126, 129, 130]. It has been 
suggested that formation of the docking structures in vitro might be seen under certain 
experimental conditions, where levels of integrin activation are high [131].  On the other 
hand, it has been shown that during TEM in vivo the docking structures develop into 
“endothelial domes” that fully encapsulate transmigrating neutrophils preventing 
excessive endothelial permeability [128].   
1.2.8 Leukocyte transendothelial migration  
Leukocytes can cross the endothelium monolayer either through the junctions between 
the adjacent ECs (paracellular route, section 1.2.8.1) or by migrating directly through an 
EC (transcellular route, section 1.2.8.2). Both routes have been documented in vitro and 
in vivo, however the studies yield contradictory results, and transmigration exclusively 
through either the paracellular [132-134] or the transcellular [135-138] route has been 
reported. The contribution of the transcellular route to the total leukocyte transmigration 
ranges from 5-30% in vitro, which is dependent on the type of the ECs used and the 
presence or absence of a chemoattractant [125, 139, 140]. It has been proposed that 
leukocytes choose the route of the least resistance [141], which would differ depending 
on the vascular bed. In majority of cases this would be the “leaky” junctions of the 
permeable endothelium, but for example very tight junctions of brain/blood barrier would 
facilitate transcellular migration at sites of cerebral inflammation [142, 143]. Additionally, 
transcellular migration might be a route of choice when leukocytes are defective in 
locomotion and cannot reach the junctions [114, 144].  Interestingly, it has been shown 
that rendering of the endothelial junctions resistant to permeability through genetic 
replacement of VE-cadherin with the VE-cadherin/α-catenin fusion protein, abolished the 
majority of the neutrophil recruitment to sites of inflammation, but did not affect 
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lymphocyte trafficking to LNs [145]. This suggests that TEM of lymphocytes through HEV 
and leukocytes across the inflamed ECs might be fundamentally different.  
1.2.8.1 The paracellular route 
In the absence of inflammation, endothelial integrity is maintained by various endothelial 
junctional molecules (section 1.3). However, upon inflammatory challenge, this integrity 
is disrupted and the endothelium becomes permeable or “leaky” (section 1.1). 
Leukocytes play an important role in promoting endothelial permeability, and it has been 
shown that leukocyte binding triggers ICAM-1-dependent signalling in the ECs that 
results in phosphorylation of vascular endothelial cell–specific cadherin (VE-cadherin), 
catenin disassociation and junction disruption [146, 147]. A number of endothelial 
junctional and leukocyte CAMs are then engaged to mediate TEM (figure 1.5). 
Endothelial junctional molecules known to actively facilitate TEM include: ICAM-1, ICAM-
2, junction adhesion molecule (JAM)-A, JAM-B, JAM-C, platelet/endothelial cell 
adhesion molecule 1 (PECAM-1, CD31), CD99 and endothelial cell selective adhesion 
molecule (ESAM) [148-152]. These molecules reside at the endothelial junctional 
membrane, however,  PECAM-1 has also been shown to constitutively recycle from the 
membrane network just below the cell border, termed the lateral border recycling 
compartment (LBRC) [153]. During TEM, delivery of PECAM-1 from the LBRC is 
targeted at the sections of the junction at which the diapedesis is occurring [153], which 
is a kinesin-mediated, microtubule-dependent process [154]. The LBRC is believed to 
facilitate TEM by providing a membrane surface area that is rich in the unengaged 
PECAM-1, and that physically displaces zones of VE-cadherin [153, 154]. In addition to 
PECAM-1, JAM-A and CD99, but not VE-cadherin, have also been found in the LBRC 
[139]. During a paracellular TEM event, PECAM-1 and CD99 molecules are engaged in 
homophilic interactions, ICAM-1 and -2 interact with integrins and JAMs either bind 
integrins or are involved in homophilic interactions [148, 155, 156]. The sequence in 
which the endothelial CAMs become engaged during the paracellular TEM event is 
proposed to be as follows: (1) ICAM-2 binds to leukocyte integrins and guide the 
leukocytes in to the junctions (very early penetration step), (2) endothelial JAM-A binds 
ligands on the leukocytes (possibly JAM-A or LFA-1) facilitating further passage, (3) 
endothelial and leukocyte PECAM-1 engage in homophilic interactions mediating 
subsequent leukocyte transit between the ECs [156-159]. Additionally, homophilic 
interaction between endothelial and leukocyte CD99 has been shown to mediate the 
transmigration at a stage distant and subsequent to PECAM-1 [150, 151]. Ligation of 
PECAM-1 during the transmigration leads to expression of the leukocyte α6β1 integrin, 
which facilitate subsequent passage through the basement membrane (BM) [148, 160]. 
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As leukocytes migrate past the endothelial barrier, the homotypic interactions between 
VE-cadherin, JAMs, CD99 and PECAM-1 ensure to re-seal the junction. 
Interestingly, reverse TEM (rTEM) was recently observed during mouse ischemia-
reperfusion injury in vivo, whereby neutrophils were seen crossing the EC junction in an 
abluminal to luminal direction [161]. The process of rTEM is strongly dependent on JAM-
C and is thought to contribute to dissemination of systemic inflammation [161].  
    
 
Figure 1.5 Paracellular and transcellular transendothelial migration. Schematic image of 
leukocytes transmigrating via paracellular or transcelular routes. Leukocyte activated β1- and β2-
integrins bind to their endothelial ligands: ICAMs, VCAM1 or JAMs as well as to the ECM upon 
eventual contact between leukocyte and basement membrane (not shown in the schematic). 
During paracellular migration, engagement of ICAM-1 modifies VE-cadherin function leading to 
catenin disassociation and junction opening. PECAM-1 and CD99 form homophilic interactions 
between extravasating leukocytes and the ECs. PECAM-1, JAM-A and CD99 are recruited to 
sites of transmigration from the LBRC. During transcellular migration endothelial vesicles form 
around the leukocyte creating a transcellular pore and importance of LBRC, VVO and caveolin 1 
has been shown for this process. For the full names of the CAMs see the Abbreviations section. 
Image taken from Nourshargh et al., Nat Rev Mol Cell Biol, 2010 [162].  
. 
1.2.8.2 The transcellular route 
The transcellular route of leukocyte transmigration is still not well understood, however, 
certain mechanisms and main players have been proposed (figure 1.5). Leukocytes are 
believed to commence transcellular migration by using actin-rich protrusions, termed 
“invasive podosomes” to probe the ECs for areas of low resistance [140]. The ECs 
facilitate subsequent transmigration through the accumulation of membrane vesicles 
around the passing leukocyte that form a channel through the EC. A number of vesicle 
types have been shown to surround the transmigrating leukocyte: caveolin 1 containing 
caveolae [129], vesiculo-vacuolar organelle (VVO) [140] and, recently, the LBRC [139]. 
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Apart from the LBRC-derived PECAM-1, CD99 and JAM-A that have the same role in 
mediating leukocyte passage as in the paracellular TEM [139] (section 1.2.8.1), ICAM-
1 has also been shown to actively facilitate transcellular migration [126, 129]. Following 
ligation, ICAM-1 redistributes to the site of transcellular diapedesis and is enriched in the 
vesicles surrounding the leukocyte, where it can interact with its ligands on the passing 
leukocyte [126, 129, 139].      
1.2.9 Human leukocyte adhesion deficiencies 
Three autosomal recessive immunodeficiency disorders have been identified in humans 
that result in defective leukocyte recruitment [163]. These disorders have a collective 
name of leukocyte adhesion deficiencies (LADs) and are hereditary diseases that 
manifest themselves by recurrent infections [163]. Amongst patients with LADs, following 
abnormalities have been described: high blood leukocyte counts, recurrent skin and ear 
infections, severe bleeding, pneumonia, fungal infections and no delayed-type 
hypersensitivity reaction upon skin testing [164-167]. LADs were named LAD-I, LAD-II 
and LAD-III, which represents order in which they were discovered, as well as their 
prevalence [167].  
LAD-I was first reported in 1980 when it was found to be an X-linked disease severely 
affecting neutrophil attachment [165]. It was later identified that LAD-I is a consequence 
of various mutations in the common β2 (CD18) integrin subunit that result in a truncated 
or absent protein [163, 168]. Neutrophils isolated from LAD-I patients roll normally on 
inflamed endothelium suggesting that deficiency exclusively limits the adhesion stage of 
the leukocyte recruitment cascade, and has no influence on initial selectin-mediated 
contacts [169].  
LAD-II was described for the first time in 1992 when neutrophils isolated from two 
patients were found to be unable to interact with E-selectin due to their lack of sialyl 
Lewis X (sLex) moieties [164]. The pathology underlying LAD-II is the loss-of-function 
mutations in SLC35C1 gene, which encodes the Golgi-localised GDP-fucose transporter 
[170, 171]. Thus, LAD-II is sometimes referred to as congenital deficiency of 
glycosylation–IIc (CDG-IIc). GDP-fucose transporter is essential for posttranslational 
fucosylation of glycoproteins. Therefore, its loss affects synthesis of functional selectin 
ligands that are known to require fucosylation for successful selectin binding [172] 
(section 1.7.2). Rolling of neutrophils isolated from LAD-II patients was dramatically 
impaired, further suggesting that selectin/ligand-mediated initial contacts between the 
leukocytes and the endothelium are abolished in this immunodeficiency disorder [169]. 
Most rare of all, LAD-III (also known as LAD-I/variant) was first reported in 1997 [166]. It 
was shown that, whilst normal surface expression of integrins was found on leukocytes 
from LAD-III patients, the integrins were unable to become activated upon cellular 
38 
 
activation [166]. This was initially attributed to the loss of CalDAG-GEF1, an upstream 
regulator of small GTPase Rap1 [173, 174]. However, controversies arose, when 
patients with LAD-III were identified that had both normal CalDAG-GEF1 expression and 
Rap1 activation [96, 100]. It has now been discovered that LAD-III is caused by mutations 
in kindlin-3 [96, 100, 101], an adaptor protein that upregulates integrin affinity [95]. 
1.3 THE ENDOTHELIUM 
Endothelial cells play an important role in many vascular functions, e.g. regulation of 
vascular permeability or vascular wall remodelling. However, the nature of the 
endothelium, for example its shape and range of adhesion molecules it expresses, is 
also an important determinant in promoting efficient recruitment of leukocytes to sites of 
inflammation. It is the leukocyte/endothelial interactions that are of special interest for 
this thesis. The vascular endothelium is comprised of a monolayer of ECs, which form a 
barrier between the vessel lumen and the surrounding tissue [175]. Adhesion of adjacent 
ECs is formed by various adhesion molecules that mediate cell-cell junctions of ranging 
affinities [175]. Endothelial junctions are multifaceted arrangements formed by 
transmembrane adhesive molecules attached to a network of cytoplasmic/cytoskeletal 
proteins. There are at least four diverse types of endothelial junctions: tight junctions, 
gap junctions, adherens junctions and discontinuous adherens junctions [176, 177]. 
Endothelial junctions control the passage of various nutrients and macromolecules out 
of the blood flow as well as regulate the extravasation of leukocytes during inflammation 
[175, 177].  
1.3.1 Tight junctions 
Tight junctions (TJs) form a very close contact between neighbouring cells [177]. They 
are the most apical constituent of the junctional complex in vertebrates and are described 
as focal contacts between the plasma membranes of bordering cells in ultrathin section 
electron microscopy [178, 179]. TJs do not form an incessant seal around the cells but 
are made of discontinuities or aqueous pores that are selectively permeable to small 
molecules, such as inorganic ions, with selectivity based on the size and charge [177, 
179]. The main components of TJs as well as permeability regulators are tetraspan 
transmembrane proteins termed claudins, which co-polymerize in individual TJ strands, 
associating between adjacent cells in both a heterotypic and homotypic manner [180-
187]. Other TJ proteins include occludins [188], junctional adhesion molecules (JAMs) 
[189], ESAM [190] and Coxsackievirus and Adenovirus Receptor (CAR) [191]. JAMs are 
the only described TJ proteins active in TEM [148, 192, 193].  
39 
 
1.3.2. Gap junctions 
Gap junctions are essentially transmembrane hydrophilic channels, composed of the 
connexin family of proteins, and they permit direct exchange of ions and small molecules 
between neighbouring cells [194, 195]. Gap junctions allow establishment of homotypic 
(endothehial to endothelial) or heterotypic (e.g. endothelial-smooth muscle cells) 
interactions between cells. In vivo, the occurrence of gap junctions is related to that of 
TJs and, typically, gap junctions and TJs are intercalated [177]. As connexin proteins are 
also found on leukocytes [196-198], it has been proposed that leukocytes and ECs can 
communicate through gap junctions during the inflammatory events (“gap junction 
coupling”) [198]. Leukocyte/endothelium gap junction coupling could serve to prevent 
endothelium leaking during TEM [198].  
1.3.3. Adherens junctions 
Adherens junctions (AJs), also termed zonula adherens, form intercellular connections 
that join cytoskeletal elements, such as intermediate filaments and actin filaments of 
adjacent cells, therefore providing tissue strength [199]. Research on epithelial and ECs 
revealed that adherens junctions use cadherin-catenin complexes in order to connect to 
cortical actin filaments that lie parallel to the cell surface, and they appear linear in 
morphology along the borders between neighbouring cells [148, 176, 200]. In the 
endothelium, the major cadherin is it the vascular endothelial cadherin (VE-cadherin), 
which forms homophilic interactions with VE-cadherin expressed on adjacent EC [201-
203]. VE-cadherin/catenin interaction is disrupted during leukocyte emigration to allow 
endothelial permeability (section 1.2.8.1) [203, 204].  
1.3.4. Discontinuous adherens junctions 
Discontinuous adherens junction is the most recently identified novel type of endothelial 
cell-cell junction [176]. As the name suggests, discontinuous AJs are not linear in sub-
cellular distribution along cell borders, but are localised at the end of stress fibers, at 
points where stress fibers appear to join between adjacent cells to form stellate-like 
arrangements [176]. These have been recently characterised, and their role during the 
inflammatory response was speculated to be the resistance of the mechanical stress 
imposed by the transmigrating leukocytes [176]. 
1.3.5. Focal adhesions 
Focal adhesions (FAs) are specialized points of adhesion produced by different cell types 
grown in culture. FAs are composed of integrins that span the plasma membrane, 
interacting on the outside with constituents of the ECM, and on the inside with the actin 
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cytoskeleton. FAs are made up of many proteins, which have primarily a structural role, 
although some engage in transducing signals [205]. FAs, just like discontinuous AJs, 
anchor stress fibers in ECs, but whereas discontinuous AJs play role in attaching stress 
fibers in confluency – especially after TNF-α stimulation, FA are important for anchoring 
cells to substrate in subconufluency, for example during migration [176]. Note that 
leukocytes do not possess stress fibres, although focal adhesion-like structures have 
been observed [206]. 
1.4 MIGRATION OF LEUKOCYTES BEYOND THE ENDOTHELIUM 
Once the leukocytes cross the endothelium they must overcome the basement 
membrane (BM) and the pericyte sheath, and then migrate through the interstitium 
towards the source of inflammation. BM is an extracellular matrix (ECM)-like material, 
composed of collagens, laminins and heparan sulfate proteoglycans (HSPG) [207]. 
Pericytes are embedded in the BM forming a discontinuous cellular layer within the 
vessel wall [208]. Leukocytes cross the BMs using β1 and β2 integrins that act as 
receptors for BM components [209, 210], e.g. integrin α6β1 is a receptor for BM laminin 
[160, 211, 212]. Additionally, leukocytes utilise proteases to degrade the BMs to aid their 
way through, for example neutrophils use elastase [213-215] and lymphocytes employ 
gelatinases [216]. Furthermore, it is known that BMs contain areas of low resistance, 
termed low expression regions (LER), which contain ≤ 60% protein deposition as 
compared to other BM sites, and are the preferred points of leukocyte emigration [217]. 
It has been shown that whilst neutrophils enlarge the LER size during passage – most 
probably a result of proteolysis - monocytes do not modify LERs, possibly due to their 
higher degree of flexibility that allows them to squeeze through the pre-existing areas 
[218]. Pericytes actively support leukocyte emigration in the process of “abluminal 
crawling”, whereby neutrophils crawl along pericyte processes for relatively long time 
and distance (~30 minutes, ~54 µm), until they reach gaps between adjacent pericytes 
[219]. Abluminal crawling is mediated by interactions between pericyte ICAM-1 and 
neutrophil LFA-1 and Mac-1 [219]. Gaps between pericytes co-localise with LERs, and 
so the leukocytes preferably migrate between the pericytes [220], however, migration 
directly through the pericytes (transcellular route) has also been reported [137].  
Heparan sulfates form a fundamental part of BMs, are deposited within the interstitium, 
are known to bind chemokines, and thus can form stable chemokine gradients that guide 
leukocyte emigration [221, 222]. Migration through the interstitium follows a 
chemoattractant (cytokines, chemokines, hydrogen peroxide) gradient and towards the 
source of the inflammation, and is known as chemotaxis or directed cell migration. 
Chemotaxis requires engagement of chemokine receptors on leukocytes, and 
interestingly, L-selectin ligation has been shown to result in chemokine receptor 
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upregulation and enhanced chemotaxis in vitro (see section 1.11.3). Furthermore, 
establishment of cell polarity (extended leading edge at the cell front and rounded back), 
gradient-sensing and motility are crucial for successful chemotaxis and are mainly 
controlled by small Rho GTPases (for the role of the Rho GTPases in leukocyte migration 
see section 1.5 below). In contrast to migration on two-dimensional (2D) substrates, i.e. 
endothelial monolayers, pericytes or ligand-coated surfaces, leukocyte migration through 
the interstitium or in three-dimensional (3D) composites can occur without integrins [223, 
224]. This opens up the possibility that other cell adhesion molecules (non-integrin 
receptors) may play a role in facilitating leukocyte locomotion in 3D environments. In fact, 
leukocyte chemotaxis in vivo has been shown to be dependent on L-selectin and this is 
discussed in more detail in section 1.7.5.1.2 of this thesis. Leukocytes arrest locally 
when they reach the source of inflammation, which confines their motility to the areas, in 
which their function is needed. It has been reported that the interstitial arrest is an active 
process that depends on specific chemokines and calcium signalling [225, 226]. 
1.5 REGULATION OF LEUKOCYTE MIGRATION BY SMALL RHO GTPASES 
The Rho family of small (~21 kDa) GTPases regulate cytoskeletal dynamics, thereby 
affecting multiple cellular functions including cell shape, polarity and motility [227, 228]. 
The Rho GTPases are GTP hydrolases that act as molecular binary switches that cycle 
between GTP-bound (active) and GDP-bound (inactive) forms [229]. The activity of Rho 
GTPases is modulated by guanine nucleotide exchange factors (GEFs), GTPase 
activating proteins (GAPs) and GDP dissociation inhibitors (GDIs). GEFs catalyse the 
exchange of GDP into GTP, thereby activating the GTPases [230], whereas GAPs 
stimulate intrinsic GTPase activity, which leads to hydrolysis of GTP to GDP and 
inactivation [231]. GDIs maintain the Rho GTPases in a GDP-bound, inactive state [232]. 
The active Rho GTPases interact with a variety of downstream targets to induce cellular 
responses [233]. The most extensively studied family members are RhoA, Rac1, Rac2 
and Cdc42, which have all been shown to control leukocyte migration (see summary in 
table 1.1). Ectopic expression of either dominant negative or dominant constitutively 
active forms of RhoA, Rac1 or Cdc42 have all been found to impair leukocyte polarisation 
and migration [118, 234-239]. This suggests that a tightly regulated, fine balance must 
exist between activation and deactivation of the Rho GTPases for successful leukocyte 
locomotion. 
The significance of RhoA activity for leukocyte migration has been shown by expression 
of dominant constitutively active RhoA or expression of dominant negative RhoA or 
inhibition of RhoA signalling, which affects migration on 2D substrates and across filters, 
crawling on HUVEC, TEM and chemotaxis [118, 234, 236, 240]. RhoA has been shown 
to be responsible for tail retraction in migrating monocytes, neutrophils and lymphocytes 
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[118, 238, 241]. Lack of RhoA activity does not impair gradient sensing but leads to 
formation of multiple competing lamellipodia, whereas expression of its dominant active 
form results in a rounded cell that does not protrude [238, 240, 241]. Hence, it has been 
proposed that RhoA must be actively inhibited at the leading edge to allow lamellipodial 
protrusions but must be active at the rear to confer rounded “backness” [240, 241]. 
However, a recent study by Heasman et al. (2010) has demonstrated that RhoA activity 
is also important at the front of migrating lymphocytes (2D substrates and TEM), where 
it controls both membrane protrusion and retraction, thereby contributing to the formation 
of a leading edge [118]. RhoA exerts its activity through activating RhoA kinase (ROCK) 
[236, 240], and ROCK has been shown to mediate monocyte tail retraction during 
diapedesis through negatively regulating integrin adhesion at the back [241]. 
Additionally, RhoA/ROCK signalling pathway is known to control myosin 
phosphorylation, and myosin-based contractility has previously been implicated in the 
tail retraction of migrating neutrophils [242].     
Ectopic expression of either dominant negative Rac1 or dominant constitutively active 
Rac1 have both been found to impair chemotaxis of mouse macrophage-like cell line 
and both human and mouse neutrophils [234, 238]. This was due to a polarisation defect 
that took the neutrophil migration speed down to basal levels (as seen with no 
chemoattractant present) [234]. In keeping with this, it has been found that Rac1 plays 
an essential role in stimulating actin polymerization at the leading edge, and controls 
pseudopod formation in migrating neutrophils [237]. Interestingly, it has also been 
reported that neutrophils lacking Rac1 activity were still able to develop oriented leading 
edge and sense the chemoattractant gradient, but much like RhoA deficient leukocytes, 
presented with a uropod retraction defect [238]. This was found to be a result of a positive 
role of Rac1 in stimulating uropod-localized Rho activity [238]. Further investigations 
found that migrating neutrophils establish dual communication from front to back with 
Rac1 and/or Rac2 locally inhibiting, and Rac1 globally activating, Rho-mediated 
backness [238]. Rac2 deficiency results in reduced actin polymerisation, impaired cell 
polarisation and overall decrease in chemotaxis in mouse neutrophils and T cells [243, 
244]. Interestingly Rac2 null neutrophils have reduced emigration in to the inflamed 
peritoneum as well as decreased rolling on GlyCAM-1, but not on P-selectin [243]. As 
GlyCAM-1 is a ligand for L-selectin during rolling, this suggests that Rac2 might act 
downstream of L-selectin to facilitate leukocyte emigration. In line with this, activation of 
Rac2 upon L-selectin ligation has been previously reported (section 1.11.4) [245, 246].  
Transmigration of monocytic cell lines across bare filters and HUVEC monolayers is 
impaired when dominant negative or dominant constitutively active Cdc42 constructs are 
expressed [235, 236]. Interestingly, neutrophils expressing dominant negative Cdc42 are 
able to retract their tails and migrate at a speed seen in WT cells [247]. However, the 
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cells do not establish polarity and migrate only short distances in a disorganised, 
vacillating manner [234, 237]. Cdc42 has been shown to control the number, stability 
and directionality of pseudopods but, unlike Rac, is neither necessary nor sufficient for 
actin polymerization [237].  Additionally, Cdc42 was shown to regulate CD11b 
distribution and functioning and it was proposed that in turn CD11b is required for proper 
MLC-based contractility to suppress inappropriate protrusions [247]. Therefore, Cdc42 







Leukocyte type Role Citation 
RhoA Monocytes and 
monocytic cell lines, 
lymphocytes and 
lymphocytic cell lines, 
primary human 
neutrophils 
Active mainly at the back but activity at the front has been reported, promotes migration through 
limiting membrane protrusions and retraction of the leukocyte tail (via p160ROCK, during TEM this 
allows to complete diapedesis) 
Constitutively active: promotes TEM (via p160ROCK), impairs chemotaxis 
Constitutively inactive or inhibited:  reduced and slower TEM, responds to chemotactic gradient but 









Controls actin polymerisation at the front, responsible for extension of the protrusions, regulates 
local and global RhoA activity 
Constitutively active: impaired chemotaxis 
Constitutively inactive: able to sense the chemoattractant gradient but decrease in chemotaxis due to 
polarisation defect, fails to retract uropod due to the lack of RhoA stimulation at the back 
[234, 236-
238] 
Rac2 Mouse neutrophils and 
T cells 
Plays a role in actin polymerisation, cell polarisation and chemotaxis 
Deficiency: decreased neutrophil numbers in peritoneal exudate upon peritonitis, reduced tethering 
on GlyCAM-1 under flow, impaired polarisation, loss of directional movement, decreased chemotaxis  
[243, 244] 




Controls the stability, number, and directionality of the protrusions, role in regulating CD11b activity 
reported 
Constitutively active: impaired chemotaxis and TEM (across stimulated ECs or towards MCP-1), does 
not stimulate formation of actin-rich filopodia 
Constitutively inactive or inhibited: decreased TEM towards MCP-1, unable to polarise and loss of 




Table 1.1 Role of the Rho GTPases in leukocyte migration. This table shows summary information about the role of RhoA, Rac1/2 and Cdc42 in the migration of 
leukocytes. The role of each GTPase is accompanied by the information about effects of its inactivation (expression of constitutively inactive construct or GTPase 
inhibition) or over-activation (expression of constitutively active construct). 
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1.6 MIGRATION OF MONOCYTES 
Monocytes are important players in both acute and chronic inflammation as well as in 
immune surveillance. Monocytes originate in bone marrow, where they derive from a 
common myeloid progenitor that they share with granulocytes [248]. Circulating 
monocytes have a half-life of 1 and 3 days in mice and humans, respectively [249, 250], 
comprise from 4% (mice) to 10% (humans) of all circulating leukocytes and can 
differentiate into macrophages or dendritic cells (DCs) once in tissues [251-254]. A large 
reservoir of monocytes have also been discovered in the spleen in mice, and these 
monocytes can be rapidly mobilised upon myocardial infarction (MI) [255].  In broad 
terms, monocyte subsets are known as “classical” (or “inflammatory”) and “non-classical” 
(also known as “patrolling” or “resident”), and the two subsets can be distinguished by 
their cell surface receptors (markers). Classical monocytes in humans express high 
levels of CD14, C-C chemokine receptor 2 (CCR2) and L-selectin (CD62), low levels of 
CX3C chemokine receptor 1 (CX3CR1) and do not express CD16 (CD14HiCD16-
CCR2+CX3CR1LowCD62+); in mice classical monocytes express high levels of 
lymphocyte antigen Ly6C (Ly6C), CCR2 and L-selectin, and low levels of CXC3R1 
(Ly6CHiCCR2+CX3CR1LowCD62+); non-classical monocytes are known as 
CD14DimCD16+CCR2-CX3CR1HiCD62- in humans and Ly6CLowCCR2-CX3CR1HiCD62- in 
mouse [254, 256-259]. Because monocyte subsets are defined by the expression of 
surface markers, it is currently unclear whether they can interconvert [253, 254]. 
However, it is known that classical monocytes specialise in phagocytosis and reactive 
oxygen species (ROS) production, whereas non-classical monocytes are weak 
phagocytes, do not generate ROS and, following activation, produce a different set of 
cytokines to classical monocytes [260]. Both classical and non-classical monocytes 
maintain tissue homeostasis in health (section 1.6.1), but can also drive disease 
(section 1.6.2).  
1.6.1 Migration of monocytes in health 
In a healthy organism, monocytes are important components of an acute inflammatory 
response (section 1.1.1), where their infiltration at sites of inflammation follows that of 
the neutrophils, and can sustain for days. The majority of studies have shown that it is 
the classical monocyte subset that dominates early on during monocyte infiltration, 
however, non-classical monocytes have also been reported to be the first ones to arrive 
at the sites of the tissue insult (see below). Monocyte behaviour, in the context of acute 
inflammation, is best characterised in a model of Listeria monocytogenes infection, and 
elevated numbers of monocytes in tissues of rabbits infected with this pathogen were 
first reported in 1926, hence the current species name “monocytogenes” [261]. During a 
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challenge with L. monocytogenes, infiltration of monocytes is dependent on the CCR2 
receptor and its ligands (C-C motif) ligand 2 (CCL2, also known as MCP-1, monocyte 
chemoattractant protein-1) and CCL7, and absence of either CCR2 or CCL2/7 results in 
profound reduction in the numbers of recruited monocytes and increased bacterial 
burden [262-264]. Monocyte egress from bone marrow during infection is dependent on 
CCR2-mediated signalling [265], and it has been shown that inflammation evoked by L. 
monocytogenes infection specifically promotes monopoiesis in bone marrow to sustain 
delivery of monocytes to peripheral sites of infection [266]. CCR2/CCL2-mediated 
recruitment of monocytes have also been shown to drive monocyte migration to lung 
during Mycobacterium tuberculosis infection [267, 268], to the small intestine during 
Toxoplasma gondii infection [269] and during an acute ischemic-reperfusion injury in 
kidney [270]. Once at the site of inflammation, monocytes differentiate into scavenging 
macrophages or DCs depending on the cytokines present in the local environment [271, 
272], and antigen-loaded monocyte-derived DCs subsequently travel to PLNs via 
afferent lymphatics [273]. Interestingly, direct entry of monocytes through HEV of PLNs 
that drain the local site of inflammation has also been reported to occur in an MCP-1 and 
MIG (monokine induced by gamma interferon, CXCL9) dependent manner [274, 275].  
Non-classical monocytes constitutively migrate into non-inflamed tissues in a CX3CR1-
dependent manner, and give rise to resident tissue macrophages and dendritic cells 
[254]. Non-classical monocytes also scan the resting endothelium in a long-range 
crawling manner in a search of infected or damaged cells, and their activity has been so 
far detected in the skin, mesentery, central nervous system and heart in mice [276-278]. 
Additionally, human non-classical monocytes adoptively transferred into mice were 
shown to crawl in the skin microvasculature in the same manner [260]. Due to their 
patrolling behaviour, these monocytes are also known as “patrolling monocytes” and, 
upon MI or detection of infection or an injury, they can rapidly infiltrate affected tissues, 
well before the arrival of the classical monocytes or even neutrophils [276, 278]. During 
this early infiltration stage, patrolling monocytes produce pro-inflammatory cytokines that 
serve to induce the inflammatory response [254, 276].    
A co-ordination in homeostasis maintenance between the classical and non-classical 
monocytes has been elegantly demonstrated in a study by Nahrendorf et al. (2007), who 
showed that upon MI, sequential recruitment of classical and non-classical monocytes is 
responsible for digestion of damaged tissue and tissue healing phase, respectively [258].  
1.6.2 Migration of monocytes in disease 
Monocyte trafficking in chronic inflammation (section 1.1.2) has been mainly studied in 
atherosclerosis, a chronic inflammatory disease of the arterial wall, characterised by the 
formation of lipid-laden lesions. Heart attack and stroke induced by atherosclerosis 
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accounts for nearly three quaters of all deaths from CVD worldwide, and hence 
recognition of the detailed pathological processes underlying atherosclerosis is needed 
to improve existing therapeutic strategies. Murine models of atherosclerosis have been 
established, whereby apolipoprotein E (apoE) deficient mice develop atherosclerotic 
lesions when placed on high fat diet. Those mice have an altered plasma lipid profile and 
marked monocytosis [279-282]. The number of circulating monocytes directly correlates 
with the atherosclerotic plaque size in mice and also is thought to be a CVD risk factor 
in humans [281]. Atherosclerotic lesions first develop when low-density lipoprotein (LDL) 
starts to accumulate in the arterial walls. LDL accumulation occurs preferentially in the 
areas of disturbed laminar flow, such as the branching points of the arterial tree [283-
285]. Once trapped in the vessel wall, LDL can undergo oxidation (giving rise to oxidised 
LDL, oxLDL) [286]. It has been shown that exposure of human ECs to oxLDL induces 
them to express a plethora of genes, many of them associated with cell adhesion [287]. 
In line with this, endothelial adhesion molecules P-selectin, VCAM-1 and ICAM-1 have 
been shown to be involved in atherosclerotic lesion development [288-291], and 
leukocyte recruitment in atherosclerosis has been also reported [292, 293]. Interestingly, 
L-selectin has been implicated in the recruitment of leukocytes at sites of atherosclerotic 
lesion formation, and this is discussed in more detail in section 1.13.1. Multiple reports 
have shown that monocytes are involved in the early steps atherosclerogenesis [294-
297]. Monocytes have been mainly observed to be recruited from the arterial lumen [294, 
298], however, infiltration from vasa-vasorum has been reported at later stages of the 
atherosclerotic plaque development [299]. Although the majority of reports describing 
atherosclerosis formation in mice point towards the recruitment of classical monocytes 
[279, 280, 300], recruitment of non-classical monocytes has also been shown to 
contribute to plaque formation [301]. It is possible that the contribution of the two 
monocyte subsets varies accordingly to the anatomical location of the plaque, i.e. arterial 
arch versus arterial sinuses [302]. During the development of atherosclerosis monocytes 
undergo so-called “vicious cycle” of recruitment, whereby monocyte-derived 
macrophages at sites of the lesion produce cytokines and chemokines, which in turn 
serve to recruit more monocytes. Monocyte-derived macrophages can take up LDL, 
oxLDL and other lipids and become lipid-loaded “foam cells” [303-305]. Aggregations of 
foam cells form the atheromatous core and as this process progresses, the 
atheromatous core of the plaque converts into a necrotic one, which consists of lipids, 
cholesterol crystals and cell debris [306]. Plaques having necrotic cores are vulnerable 
and prone to rupture [307]. Ruptured plaques invariably occlude the blood vessels that 




As this thesis is dedicated to the adhesive and signalling function of L-selectin, the 
following sections are dedicated to molecular details surrounding this cell adhesion 
molecule.      
1.7 THE SELECTINS 
The selectins are a family of cell adhesion molecules that mediate many critical 
interactions within the vasculature. The selectins and their carbohydrate ligands are 
expressed on ECs, platelets and leukocytes (figure 1.6). Therefore, they can facilitate 
the contact between the blood and vascular cells, whenever such contact is needed. The 
family of selectin proteins consists of three members, P-selectin, E-selectin and L-
selectin, which were all discovered in the 1980s. All three members were discovered as 
part of a concerted effort to identify all possible epitopes that existed in the mouse 
circulation through the generation of monoclonal antibodies. The approach was to 
identify all the “clusters of differentiation” recognised by mAbs raised against the 
unknown epitopes on the surface of the leukocytes, and hence the identified epitopes 
were given the CD name followed by a number. P-selectin (CD62P) (section 1.7.3) was 
identified, when in 1986 its expression was found on human activated platelets (hence 
P- for platelet) [308] and human ECs [309]. In resting cells, P-selectin is stored in α-
granules of platelets and Weibel-Palade bodies of ECs, and is translocated to the 
platelet/EC surface upon activation [308-310]. The discovery of E-selectin (CD62E, 
section 1.7.4) followed a year later, where it was identified as a cell surface adhesion 
molecule expressed on activated ECs (hence E- for endothelium) [311]. L-selectin 
(CD62L, section 1.7.5) was first observed in 1983 as a cell surface protein responsible 
for murine lymphocyte (L- for lymphocyte) recirculation to the LNs [12], and is thus also 
known as the “lymphocyte homing receptor”.   
 
Figure 1.6 Location of the selectins and their ligands. The selectin family comprises three 
members: E-selectin, P-selectin and L-selectin. Upon cell activation, P-selectin is translocated to 
the surface of platelets and ECs, and E-selectin is expressed on ECs. L-selectin is constitutively 
expressed on virtually all circulating leukocytes. Selectins recognise carbohydrate ligands 














1.7.1 Selectin structure and function 
All selectins are highly related type I, single-pass transmembrane glycoproteins [312]. 
Each selectin is composed of: (i) an amino (N)-terminal calcium-dependent (C-type) 
lectin ectodomain that interacts with carbohydrate motifs presented by selectin counter-
receptors, (ii) a single epidermal growth factor (EGF)-like domain, (iii) two to nine 
sequence consensus repeat (SCR) domains, (iv) a single transmembrane region and (v) 
a C-terminal cytoplasmic tail [16, 313, 314] (figure 1.7).  
 
Figure 1.7 The protein structure of the selectins. The selectin proteins have conserved protein 
structure within their extracellular domain. The common structure is comprised of an N-terminal 
calcium-dependent C-type lectin, which binds to carbohydrate-bearing ligands. Lectin domain is 
followed by the epidermal growth factor (EGF)-like domain and several sequence consensus 
repeats (SCR), that share homology with complement proteins. Nine, six and two SCRs are 
present in P-, E- and L-selectin respectively. SCRs in L-selectin proteins are followed by a 
membrane-proximal extracellular cleavage site, which has not been identified in the other two 
family members.  Each selectin has a single-pass transmembrane domain and a COOH-terminal 
cytoplasmic tail. The tails are not conserved between the selectins, which allows for their unique 
regulation and signalling.   
 
The homology of the lectin domain differs between selectin members within the same 
species is around 52%, however, this increases to around 72% between the same 
selectins from different species [16]. Such high homology represents the importance of 
the lectin domain. The lectin domain possesses two high affinity binding sites for calcium 
ions and interacts with its ligands in a Ca2+-dependent manner [315, 316]. It has been 
shown that upon calcium binding, the L-selectin lectin domain undergoes a 
conformational change, which leads to the exposure of an epitope responsible for 
interacting with the ligand [316]. It is this property that signifies the C-type lectin domain. 
The sequence identity of the EGF-like domains of one selectin between different species 
is around 60% [16]. This sequence conservation suggests a significant role for the EGF-











and EGF-like domains are needed for optimal ligand recognition and binding of P-
selectin [317, 318]. The L-selectin EGF-like domain was also found to regulate binding 
of the lectin domain to its ligand [319, 320]. Resolution of the crystal structures of E- and 
P-selectin lectin and EGF domains co-complexed with their ligands revealed existence 
of extended and bent conformations of the EGF-like domain [321]. It was subsequently 
shown that the region at the junction of the lectin and EGF-like domains of L-selectin 
acts like a hinge allowing closed- and open-angle protein conformations, thereby 
regulating bond formation between the lectin domain and its ligands [47]. Open-angle 
(extended) conformation was further shown to have greater affinity for ligand and 
mediated rolling with increased efficiency [322]. The hinge is likely to explain the “catch-
slip” bond phenomenon that occurs during selectin-dependent rolling (section 1.2.2). 
Additionally, EGF-like domain has been shown to regulate cleavage of L-selectin 
ectodomain in a proteolytic process termed “shedding” (section 1.9.2) [323].  
SCRs show a lower degree of sequence conservation than the lectin and EGF-like 
domains [16].  Human E- and P-selectin contain 6 [324] and 9 [325] SCRs, respectively, 
but their number can vary from 4 to 9 in other species [16]. Human L-selectin has two 
SCRs, the number of which is conserved across species [16]. The variable number of 
SCRs between the selectins may be explained by their different cellular locations. 
Although L-selectin possesses only two SCRs, it is expressed at the tips of the leukocyte 
microvilli [18], therefore its exposure to the potential ligands is relatively high during 
tethering. Nine and six SCRs in P- and E-selectin, respectively suggest that P-selectin 
would be more exposed to the leukocyte ligands than E-selectin. This corresponds to 
the timeline of when these two molecules become engaged during rolling (sections 
1.2.2, 1.7.3 and 1.7.4).    
Unlike E- and P-selectin, SCRs in L-selectin are followed by a membrane proximal 
cleavage site [326]. This site allows L-selectin shedding [327] (see section 1.9.2), which 
is associated with cell activation [328]. Although soluble forms of E- [329] and P-selectin 
[330] have been found in the sera of patients suffering from chronic inflammatory 
diseases, no discernable cleavage site has been identified. 
The transmembrane and cytoplasmic domains of the selectins do not show any 
sequence conservations between family members, although the sequence conservation 
of one selectin member across different species is considerably high [16]. The sequence 
conservation across various species is logical as the selectins are expected to perform 
the same functions in all species. The lack of sequence conservation between the 
selectins of one species is likely to reflect the specific functions each of the selectin has. 
Varied amino acid sequences within the cytoplasmic tails of the selectins are understood 
to provide binding motifs for different cytoplasmic proteins. This in turn would control the 
unique signalling generated downstream of each of the selectins and explain their 
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functional differences. The cytoplasmic tail of L-selectin and its binding partners are 
described in more detail in section 1.10.  
1.7.2 Common selectin ligands  
The selectins recognise ligands that are glycosylated [314, 331-336]. Modifications 
include sulfation, fucosylation and sialylation [337] and a minimal recognition motif for P-
, E- and L-selectin is the sialyl-Lewis X (sLex) tetrasaccharide that is built of sialic acid 
α2-3-linked to galactose, which is further β1-4-connected to N-acetylglucosoamine, and 
α1-3-links to fucose [334, 335, 338] (figure 1.8 A). Glycosylation modifications are 
performed by the enzyme fucosyltransferase VII [339], sialyltransferases such as 
ST3Gal-IV [340, 341], and sulfotransferases such as HEC-GlcNAc6ST [342] or 
GlcNAc6ST-1 [343]. The absolute requirement for glycosylation of selectin ligands is 
demonstrated by the loss of leukocyte rolling in mouse models lacking certain 
glycosylation enzymes, e.g. ST3Gal-IV or HEC-GlcNAc6ST [341, 342], and in LAD-II 
immunodeficiency syndrome in humans, where fucosylation is abolished (section 1.2.9). 
The sulfated/sialylated/fucosylated structures are found on the non-reducing termini of 
both O- and N-linked glycoconjugates [344-347], with an exception of PSGL-1 – a ligand 
for all three selectins – which is sulfated on a tyrosine residue within its protein backbone 
[348]. O-linked glycans are sugar moieties linked to the proteins via oxygen molecule of 
either serine or threonine side chains [349]. N-glycans represent another type of linkage, 
where the sugar moieties are connected to the proteins via a nitrogen atom of the amine 
group in the asparagine side chain [349]. Anchorage mode of the canonical selectin 




Figure 1.8 Presentation of sialyl-Lewisx on O- and N-glycans. Canonical selectin ligand sLex  
(A) can be presented to the selectins by both O- and N-linked glycans (B). Note that the sulfation 
(red S) on PSGL-1 is not present on the carbohydrate motif but occurs on the tyrosine residue 
within the protein. Meca-79 is a mAb reactive with PNAd L-selectin ligands (section 1.8.1). Image 
in B taken from Hirakawa et al., Journal of Biological Chemistry, 2010 [345]. 
 
Although sLex binds to all three selectins, the affinity of such binding is relatively low and 
it is likely that selectins recognise multiple motifs presented by their ligands [16]. 
Furthermore, differences exist in the requirements for sugar modifications between the 
selectins, for example ligand sulfation is needed for P- and L-selectin, but not E-selectin 
binding [350]. To this date, multiple ligands for the selectins have been identified. P-
selectin can bind to PSGL-1 [351], variant of CD44 (CD44v) [352], endoglycan [353] and 
versican [354].  E-selectin binds to PSGL-1 [351], L-selectin [355], CD43 [356, 357], 
CD44 [358-360], CD44v [361], E-selectin ligand-1 (ESL-1) [362, 363], carcinoembryonic 
antigen (CEA) [361], podocalyxin [364] and endoglycan [353]. L-selectin binds to a 
variety of ligands expressed both inside and outside of the vasculature. L-selectin ligands 
are described in more detail in section 1.8 (see summary in table 1.2). 
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1.7.3  P-selectin and its role in the leukocyte adhesion cascade 
P-selectin (CD62P, GMP-140, PADGEM) is expressed by activated platelets and ECs 
[308, 309]. P-selectin null mice have elevated counts of circulating granulocytes, which 
reflects a defect in leukocyte extravasation [25]. Additionally, baseline leukocyte rolling 
in mouse mesentery microcirculation is completely abolished, and leukocyte recruitment 
is delayed in both trauma and thioglycollate-induced models of inflammation [25, 365]. 
Upon inflammatory challenge, endothelial P-selectin, which is synthesised constitutively 
and stored in intracellular vesicles of endothelial Weibel-Palade bodies, is translocated 
to the plasma membrane, where it can bind to its leukocyte ligand PSGL-1 [310, 366, 
367]. In murine, but not primate ECs, stimulation with TNF-α additionally induces P-
selectin gene expression [368]. Owing to its rapid translocation from the intracellular 
pool, P-selectin mediates most leukocyte rolling during the first phase (<2 hours) after 
the inflammatory challenge [25, 365]. This explains the delays in leukocyte recruitment 
seen in P-selectin deficient mice. It is possible that E-selectin can mediate rolling in the 
absence of P-selectin [369], however E-selectin cannot mediate tethering [24]. On the 
other hand, in the absence of P-selectin, it appears that tethering can be compensated 
for by L-selectin [24]. However, L-selectin mediates much more rapid rolling (above 100 
µm/s) than P-selectin (below 50 µm/s), and also it cannot compensate for the initial (<1 
hour) rolling absent in P-selectin deficient mice during trauma-induced model of 
inflammation [52, 365]. Thus, it seems that P-selectin co-operates with L-selectin to 
maintain the rolling at a speed of 20-70 µm/s [52], however, under certain inflammatory 
conditions (trauma), the very initial rolling is unique to P-selectin [52, 365].   
As described in section 1.2.4, engagement of the selectins leads to the activation of 
integrins, which contributes to leukocyte activation and arrest. In vitro and in vivo 
experiments with mouse and in vitro experiments with human neutrophils as well as 
precipitation studies of transfected HEK 293T cell line revealed that engagement of P-
selectin by PSGL-1 leads to activation of Src kinases which phosphorylate Nef 
associated factor 1 (Naf-1) at Tyr552 [366]. Subsequently, activated Naf-1 recruits 
phosphoinositide 3-kinase (PI3K) (p85-p110δ heterodimer) to this complex, which 
eventually triggers activation of β2 integrins Mac-1 and LFA-1 [366]. 
Apart from its role in the recruitment of leukocytes to the activated endothelium, P-
selectin also mediates certain platelet interactions. Upon activation, platelet P-selectin is 
translocated from the intracellular α-granules to the platelet surface [308], where it 
mediates contacts with leukocytes [370] through interaction with leukocyte PSGL-1 
[371]. Platelet-leukocyte aggregates have been reported to circulate in bloodstream of 
patients with coronary artery disease [372] and Helicobacter pylori infection [373], and 
have been suggested to contribute to atherosclerosis development in a mouse model 
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[374]. Additionally, P-selectin facilitates platelet-platelet interactions and formation of 
platelet aggregates [375]. Formation of platelet aggregates is an important step during 
blood coagulation at the site of an injury.  
1.7.4 E-selectin and its role in the leukocyte adhesion cascade  
E-selectin (CD62E, ELAM-1) expression is induced upon stimulation with TNF-α, LPS or 
interleukin-1β (IL-1β), and is a result of de novo protein production [51, 368, 376, 377]. 
E-selectin expression on the surface of the endothelium can be seen 2 hours after 
stimulation with a pro-inflammatory agent and peaks after 4 hours [378]. Upon its 
expression on the endothelial surface, E-selectin joins P-selectin in mediating leukocyte 
rolling. E-selectin is different to the other two family members in that it is not able to 
mediate tethering [24, 53, 56]. After some time, the co-operation between E- and P-
selectin in rolling maintenance is discontinued and rolling becomes dependent only on 
E-selectin and its ligands [379]. E-selectin is known as a mediator of “slow rolling” (3-5 
µm/s), and its absence significantly increases rolling velocities of leukocytes as well as 
promotes their ‘skipping’ behaviour [51, 379, 380]. Skipping behaviour of leukocytes in 
the absence of E-selectin is characterised by cycles of short steady rolling episodes 
followed by detachment and re-tethering further downstream [379]. This results in sharp 
and transient changes in velocity and leukocytes moving in this manner fail to engage in 
steady rolling [379]. It was established that E-selectin mediates slow and stable rolling 
through interaction with CD44 and ESL-1, respectively [379].  
It should be noted that human L-selectin from neutrophils can interact with E-selectin 
[355, 381]. This is because neutrophil L-selectin is modified with sLex moieties and thus 
becomes a ligand for E-selectin [355]. This is neutrophil specific as L-selectin from 
lymphocytes does not bear sLex epitopes [355]. This represents glycosylation-dependent 
specificity of selectins and their ligands, which in this case allows trafficking of naïve 
lymphocytes to LNs and neutrophils to the sites of inflammation. However, L-selectin 
from mouse neutrophils cannot bind E-selectin [381], revealing a species-specific 
interaction. It should therefore be made clear that much of our current understanding of 
how L-selectin contributes to leukocyte rolling comes from studying murine models, and 
little is known how this may reflect the human system where E-selectin/L-selectin 
interaction can occur.   
Much like P-selectin, binding of E-selectin to its counter-receptors leads to integrin 
activation, which supports transition from leukocyte rolling to arrest (section 1.2.4). Both 
in vitro and in vivo experiments on murine neutrophils revealed that interaction of PSGL-
1 or CD44 with endothelial E-selectin triggers a signalling pathway in leukocytes that 
starts with Src family kinases (SFKs) [382, 383]. This is followed by activation of spleen 
tyrosine kinase (Syk) and Burton’s tyrosine kinase (Btk), which in turn leads, through 
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phospholipase C (PLC) γ2, to the activation of p38 mitogen-activated protein kinase 
(MAPK); this pathway triggers the β2 integrin-mediated slow rolling of leukocytes [382, 
383]. Additionally, Mueller et al. (2010) reports the involvement of PI3K gamma (PI3Kγ) 
in this signalling pathway [383] and Yago et al. (2010) stress the importance of lipid rafts 
for efficient PSGL-1 and CD44 signalling (2010) [382]. The cytoplasmic domain of PSGL-
1 is crucial for signalling to downstream components of this particular signalling pathway 
as deletion of this domain in PSGL-1 prevents phosphorylation of Src family kinases 
(SFKs) and reduces E-selectin-triggered neutrophil slow rolling on immobilised ICAM-1 
[382]. Conversely, Hidalgo et al. (2007) claim that in murine leukocytes transition from 
rolling to arrest in vivo is mediated by E-selectin interacting with CD44 and ESL-1, 
whereas there is no role for PSGL-1 in this process [379]. The controversies described 
could be due to the experimental techniques and/or the inflammatory models used in the 
respective studies. 
1.7.5 L-selectin 
L-selectin (CD62L, TQ1, Leu-8, LAM-1, LECAM-1) is expressed on all circulating 
leukocytes, with an exception of activated T and B cells [384-386] and a subset of 
memory T cells [387]. As mentioned earlier, L-selectin was discovered through screening 
of leukocytes with antibodies raised against unknown antigens. The antigen on mouse 
lymphocytes was recognised by MEL-14 mAb [12] and its human homolog was identified 
in 1990 by raising mAbs against molecules shed from human leukocytes following their 
activation [388]. There were 5 mAbs raised:  DREG-55, -56, -110, -152 and -200, out of 
which DREG-56 showed specific >90% inhibition of binding of human lymphocytes to 
PLN HEV [388]. L-selectin was established to be responsible for the migration of 
lymphocytes to PLN, Peyer's patches (specialised lymph nodes in the gut), mesenteric 
lymph nodes (MLNs) and spleen as well as for leukocyte recruitment to sites of 
inflammation [11, 12, 389-398]. L-selectin was found to play a prominent role in skin 
inflammation, and its absence or blocking results in decreased leukocyte recruitment, 
reduced delayed-type and immediate-type hypersensitivity responses and delayed 
allograft rejection [391, 392, 399-401]. Its predicted molecular weight (MW) is 30 kDa but 
the actual MWs have been reported to be 74 kDa for lymphocytes [402] and 90-120 kDa 
for neutrophils [381]. This increase in the MW is a result of L-selectin protein 
glycosylation, which is thought to occur differently in various leukocyte subsets [313].  
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1.7.5.1 The role of L-selectin during leukocyte recruitment 
1.7.5.1.1 Roles for L-selectin within the vasculature 
Although mainly known for its ability to mediate tethering and rolling, L-selectin takes part 
in other stages of the leukocyte adhesion cascade (figure 1.9).  
 
Figure 1.9 The role of L-selectin during the leukocyte adhesion cascade. L-selectin is best 
known for its ability to mediate leukocyte tethering and rolling. In addition, L-selectin also mediates 
leukocyte activation and transition from rolling to arrest as well as modulates adhesion through β 
integrins. L-selectin has been shown to regulate TEM during lymphocyte homing to PLN, and 
there are some indications pointing at its possible role during TEM at sites of inflammation. For 
abbreviations used see the Abbreviations section.   
 
L-selectin mediates leukocyte recruitment through both its adhesive and signalling 
properties. The adhesive interactions are important for mediating tethering and rolling. 
L-selectin-mediated tethering is facilitated by its microvillar localisation [18, 19, 403] and 
the unique kinetic properties of L-selectin/ligand bonds that allow shear-dependent 
tethering [46, 404, 405]. Out of the three selectins L-selectin mediates the fastest type of 
rolling (>100 µm/s) [52, 405, 406], and is the only selectin that can mediate secondary 
capture of free flowing leukocytes (section 1.2.3). L-selectin co-operates with P-selectin 
in mediating rolling (section 1.7.3), however its distinct contribution can be seen at later 
time-points (>1-2 hours) in cytokine-stimulated venules [365, 398, 407]. L-selectin-
deficient mice have been shown to have a dramatic reduction in lymphocyte rolling 
and/or accumulation on PLN HEV, which resulted in 70-90% decrease of lymphocyte 
numbers in PLNs and corresponding elevated numbers of lymphocytes in circulation and 
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rolling in exteriorised mesenteric [11, 28, 29, 409] and cremasteric muscle venules [52, 
365], and L-selectin deficient mice present with monocytosis (elevated levels of 
circulating monocytes), suggesting impaired monocyte emigration [389]. The importance 
of L-selectin-dependent recruitment at sites of inflammation was demonstrated through 
thioglycollate-induced peritonitis model, where 40-80% reduction of leukocyte 
(lymphocyte, neutrophil and monocyte) emigration in to the inflamed peritoneum was 
seen [11, 392]. L-selectin has also been shown to mediate rolling on activated ECs in 
vitro [410]. Vascular ligands for L-selectin are induced on activated endothelium (section 
1.8.2) and presumably are important for mediating rolling. L-selectin was shown to 
mediate rolling (together with α4 integrin) in rat mesenteric venules 12 days after 
immunisation with Mycobacterium butyricum, suggesting a role for L-selectin in chronic 
inflammation [411]. The role of L-selectin in atherosclerosis, the chronic inflammation of 
the arteries, is discussed in more detail in section 1.13.1. Furthermore, L-selectin was 
shown to mediate neutrophil recruitment in myocardial ischemia/reperfusion model in 
cats, where anti-L-selectin mAb significantly decreased neutrophil accumulation on 
ischemic/reperfused coronary endothelium [412].  
Apart from mediating tethering and rolling through the virtue of its lectin domain and 
catch-slip bond phenomenon, L-selectin generates intracellular signalling that results in 
leukocyte adhesion. As described in section 1.2.4, one of the prominent events driving 
the transition from leukocyte rolling to arrest is outside-in signalling triggered by L-
selectin engagement, which results in integrin activation. Rolling of neutrophils on L-cells 
transfected with E-selectin and ICAM-1 have been shown to induce co-clustering of L-
selectin and PSGL-1, which is necessary for the rolling cells to adhere (arrest) [413]. 
Furthermore, cross-linking of L-selectin has been shown to induce the transition from 
neutrophil rolling to LFA-1- and Mac-1-dependent arrest during perfusion of cells over 
monolayers of E-selectin and ICAM-1 [414]. A number of studies have now established 
the role of outside-in L-selectin signalling in mediating leukocyte adhesion through β1 
and β2 integrins, and these reports are discussed in more detail in section 1.11.2. In 
addition to its direct role in the integrin-mediated arrest, L-selectin engagement has also 
been shown to act in synergy with various chemokines and cytokines to enhance 
adhesion (section 1.2.4). In concert with its role in synergising outside-in signalling and 
chemokine-mediated adhesion, engagement of L-selectin has been shown to regulate 
expression levels of the chemokine receptors present on the leukocyte surface (section 
1.11.3).  
L-selectin, and specifically its shedding, regulates TEM across HEV during lymphocyte 
homing to PLN (section 1.9.2). It is thus possible that L-selectin might also be involved 
in leukocyte TEM at sites of inflammation. This is currently unclear, although stimulation 
through L-selectin was found to enhance leukocyte transmigration to various 
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chemokines (e.g. SDF-1, IL-8, SLC) in vitro [85, 91, 415]. L-selectin has been shown to 
mediate leukocyte chemotaxis in extravascular tissues in vivo (section 1.7.5.1.2), and 
perhaps it is the relationship between L-selectin and certain chemokines that drives 
leukocyte emigration and influence TEM in inflammation.  
1.7.5.1.2 Roles for L-selectin outside the vasculature 
Much of the current literature on L-selectin is centred mainly on its role in tethering and 
rolling during the leukocyte adhesion cascade. Interestingly however, reports can be 
found that point towards a prominent role L-selectin might play in leukocyte migration 
beyond the vasculature both during homing of lymphocytes to PLNs and during 
inflammation. There is a number of reports suggesting that engagement of L-selectin 
enhances leukocyte chemotaxis in vitro (section 1.11.3), and a role for L-selectin in 
directed cell migration in vivo has also been proposed. For example, in L-selectin 
deficient mice defects were seen in the interstitial migration away from the venules, both 
during trafficking of lymphocytes to MLN [415], and during the antigen-induced leukocyte 
recruitment in the cremasteric muscle model of inflammation [416]. Likewise, in a mouse 
model of multiple sclerosis (MS), emigrated L-selectin deficient leukocytes were found 
to be located perivascularly and did not infiltrate the brain tissue, which in turn limited the 
demyelinating pathology [417]. Interestingly, screening with L-selectin-IgG chimera 
showed that L-selectin ligands are present on myelin sheaths of axons [418], suggesting 
L-selectin dependent leukocyte infiltration results in myelin destruction during MS 
progression. In all of the above-described studies, the emigrated leukocytes were not 
able to disseminate in to the surrounding tissues and remained closely associated with 
the venules. This would suggest an impairment in chemotaxis that was caused by L-
selectin knock-out. Interestingly, another report demonstrated that chemotaxis in vivo 
was indeed abolished in L-selectin null mice [398]. Hickey et al. (2000) found that 50% 
of the emigrated leukocytes had a profound decrease in their ability to migrate towards 
a KC (keratinocyte chemokine)-soaked agarose block and remained closely associated 
with the cremasteric microvessels [398]. Similarly, the path length of extravascular 
locomotion was 40-50% decreased in L-selectin null leukocytes as compared to WT ones 
during emigration upon cremaster superfusion with PAF or KC [398]. Interestingly, 
leukocytes from mice expressing a sheddase-resistant form of L-selectin (i.e. a mutant 
resistant to shedding) were also found to have impaired chemotaxis as measured by the 
distance they travelled away from the KC-perfused cremaster microvessel [419]. These 
two different scenarios, first, where L-selectin is lacking and second, where it is 
constitutively expressed in its non-cleavable form on the leukocyte surface, seem to exert 
the same effect on chemotaxis.  Therefore, it can be speculated that the L-selectin’s 
involvement in migration through the ECM may rely on its ability to undergo shedding 
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and subsequent re-expression. Alternatively signalling involving the cleaved L-selectin 
(“stump”) may be possible.  Furthermore, the migration defect of leukocytes expressing 
sheddase-resistant L-selectin was true for KC, but not TNF-α superfusion [419], 
suggesting that L-selectin dependent chemotaxis has preference towards certain 
chemokines and is insensitive to or overridden by others. In keeping with this, it has been 
shown in vitro that engagement of L-selectin on murine T and B cells enhanced their 
chemotaxis to secondary lymphoid tissue chemokine (SLC), but not to SDF-1 or EBV-
induced molecule 1 ligand chemokine (ELC) [415].          
In addition to a defect in chemotaxis, L-selectin-null mice have been shown to have 
greatly (50-60%) reduced total number of emigrated leukocytes at various sites of 
inflammation [11, 392, 398, 420]. Interestingly, Hickey et al. (2000) saw no gross defects 
in leukocyte rolling, suggesting that at least in certain cases reduced emigration was not 
due to a decrease in L-selectin-dependent rolling [398]. As all of these studies were 
performed in vivo, it can be assumed that a great abundance of cytokines and 
chemokines were present to elicit L-selectin-dependent cellular responses. Perhaps it is 
the chemokines and the ECM environment that synergise to drive L-selectin dependent 
migration beyond the vessel lumen. The nature of L-selectin signalling occurring outside 
the vasculature is expected to be different from the signalling that takes place during the 
leukocyte recruitment inside the venules. During tethering and rolling, L-selectin engages 
transiently with its ligands, which is a result of the disruptive forces imposed by blood 
flow. However, it can be assumed that once the leukocyte is in the ECM, much slower 
movement of the cell will prolong L-selectin/ligand interactions and therefore enhance 
and/or modify L-selectin signalling. In line with this, the capability of L-selectin to bind 
components of the ECM has been reported on numerous occasions (section 1.8.3). 
Taken together, L-selectin plays a vital role in leukocyte trafficking both during 
interactions of leukocytes with ECs and during interstitial migration outside the vessel 
wall (and in the absence of shear stress). It is currently unknown how inta- and extra-
vascular activity of L-selectin is linked, although shedding of the extracellular domain is 
likely to play a role (for the physiological relevance of L-selectin shedding see section 
1.9.2). 
1.7.5.2 Current methods used to study L-selectin-dependent phenomena 
Current in vivo and in vitro methods used to study the role of L-selectin in the leukocyte 
adhesion cascade involve intravital microscopy of various tissues and organs, analysis 
of cell exudates following thiglycollate-induced peritonitis, parallel plate flow chamber 
assays and transwell assays. The majority of these studies concentrate on the effects of 
L-selectin on total numbers of recruited leukocytes and do not investigate the sub-cellular 
distribution of L-selectin. In the studies where visualisation of cell-associated L-selectin 
60 
 
was performed, the leukocytes were first labelled using an anti-L-selectin mAb, and then 
perfused over immobilised ligand [379, 421]. Such reports ignore the fact that using 
antibodies causes, firstly, L-selectin clustering and signalling in an “outside-in” manner 
(section 1.11), and secondly, blocks the lectin (ligand binding) domain. Hence, treatment 
of leukocytes with anti-L-selectin antibodies prior to the flow experiments might pose 
serious risks to correct data interpretation. Therefore, the current methods of visualising 
L-selectin cannot be classified as “non-invasive”, and other approaches are needed for 
reliable tracking of L-selectin’s fate during the leukocyte adhesion cascade. For example, 
tagging of L-selectin with a fluorescent protein would help to address the aforementioned 
visualisation issues, providing a non-invasive way of monitoring L-selectin by not 
interfering with its function (i.e. provided the tag itself would not affect L-selectin’s form 
and function). 
1.8 LIGANDS FOR L-SELECTIN 
L-selectin was firstly recognised to bind carbohydrate ligands on PLN HEV (section 
1.8.1), however it is now known that many other L-selectin ligands, distinct from the 
“classical” HEV ligands exist. For example, numerous L-selectin ligands have been 
reported at sites of inflammation (section 1.8.2), in the ECM (section 1.8.3) and on a 
variety of other cells and tissues (section 1.8.4). A summary of all L-selectin ligands 
identified to date is shown in table 1.2 and the ligands are discussed in more detail in 
the sections below.   
1.8.1 L-selectin ligands on high endothelial venules (HEV) 
Initial work showed that L-selectin recognises carbohydrate ligands on PLN HEV in a 
calcium dependent manner [11, 422-424]. Early attempts on identifying carbohydrate-
based ligands for L-selectin suggested that sugar moieties were mainly O-linked glycans 
[337], and despite their prevalence, L-selectin-dependent rolling can also occur on N-
linked glycans [346, 347]. L-selectin recognises mucin (glycoprotein with multiple O-
linked glycans) ligands on HEV that have a collective term of peripheral lymph node 
addressins (PNAd) and are reactive with MECA-79 mAb [425]. MECA-79 is routinely 
used to detect L-selectin reactive vessels and it has been shown to block lymphocyte 
tethering and rolling on HEV [426], as well as immunoprecipitate the same set of proteins 
from mouse PLNs and human tonsils as the L-selectin-IgG chimera [427]. The reason 
for this is that MECA-79 mAb recognises an epitope that overlaps with the basic L-
selectin recognition determinant – the 6-sulpho-sLex motif (figure 1.8). Sulfation of the 
sLex moiety is necessary for efficient interaction with L-selectin, as sulfation greatly 
enhances L-selectin binding in cell-free assays and during binding of L-selectin-IgG 
chimera or L-selectin expressing cells to ECs transfected with relevant sulfotransferases 
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[428-431]. A number of 6-sulpho-sLex-bearing PNAd sialomucins have been identified to 
date. The first ones to be recognised were glycosylation-dependent cell adhesion 
molecule 1 (GlyCAM-1) [337, 432, 433], CD34 [434, 435] and a CD34 family member 
podocalyxin-like protein [436]. Subsequent studies identified further L-selectin ligands 
expressed on PLN HEV: sgp200 protein [427], endomucin [437], nepmucin (not 
expressed on Peyer’s patches HEV) [438] and mucosal vascular addressin cell adhesion 
molecule 1 (MadCAM-1) (expressed only on MLN HEV) [439]. Interestingly, CD34 [440] 
or GlyCAM-1 [428] null mice did not present with any abnormalities in lymphocyte homing 
to PLNs, suggesting that HEV mucins might be functionally redundant, and can 
compensate for each other to mediate all rolling. On the other hand, HEC-GlcNAc6ST 
sulfotransferase deficiency resulted in greatly diminished lymphocyte recirculation to LNs 
[342]. It is therefore the specific post-translational modifications of L-selectin ligands 
rather that than the ligand protein backbone that are crucial for L-selectin mediated 
lymphocyte homing. 
Apart from the well-known mucins, non-mucin (as defined be their resistance to O-
sialoglycoprotease treatment) ligands for L-selectin have been identified on HEV in 
human PLN cryosections [441]. These ligands bear sLex and L-selectin ligand activity 
but lack MECA-79 antigen, and are capable of mediating lymphocyte binding [441]. It is 
hard to say whether similar ligands are present on HEV in mice, however it is plausible 
as blocking with MECA-79 mAb was shown to result in significant but not total inhibition 
of lymphocyte homing to PLN [442, 443]. Alternatively, differences in L-selectin HEV 
ligands might exist between species, as it has been shown that e.g. MECA-79 mAb 
weakly stains Peyer’s patches HEV in mice but strongly in sheep, rabbit and pig [443, 
444]. Therefore, the complexity of L-selectin HEV ligands is likely to be higher than 
currently anticipated. Additionally, it is noteworthy that MECA-79-reactive HEV-like 
venules are commonly found at sites of chronic inflammation, implying the role of the 
“classical” L-selectin HEV ligands in inflammation (section 1.8.2).   
1.8.2 Ligands for L-selectin on the endothelium at sites of inflammation 
 As mentioned at the end of the section above, venules resembeling HEV are often found 
at sites of chronic inflammation. MECA-79-reactive HEV-like vessels together with 
dendritic cells and zones of B and T cells populate tissues at sites of persistent 
inflammation in a process known as lymphoid organ neogenesis [445, 446]. PNAd, 
MadCAM and/or CD34 expressing HEV-like venules have been identified in various 
inflammatory diseases (the diseases are listed in table 1.2) [442, 447-453]. Additionally, 
HEV-like structures have also been identified in gastric lymphoma that lacked MECA-79 
reactivity, but nevertheless could bind L-selectin through 6-sulfo-sLex [454]. This 
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suggests that much like in the case of PLN HEV, other ligands than PNAd are involved 
in binding L-selectin at sites of chronic inflammation.  
MECA-79 staining of acutely inflamed vessels has not been reported to date, and the 
existence of other L-selectin ligands at sites of inflammation in vivo is controversial. For 
example, no L-selectin ligand activity during leukocyte recruitment in the exteriorised 
cremaster muscle venules was found by Eriksson (2008) [455]. On the other hand, an 
unidentified ligand has been observed during neutrophil recruitment to the inflamed 
peritoneum and in the cremaster muscle model of inflammation in a different study [456]. 
In vitro, the situation seems to be clearer as several studies found L-selectin ligand 
activity on activated ECs. As mentioned in section 1.7.4, human but not mouse L-
selectin from neutrophils binds E-selectin, as identified by cell-free binding experiments 
and neutrophil recruitment in parallel-plate flow chamber assay [355, 381]. 
Sulfoglucuronosyl paragloboside (SGPG) has been identified as L-selectin ligand during 
interaction of PBL with IL-1β stimulated bovine brain microvascular endothelial cells 
(BMEC) in a static binding assay [457]. Additionally, unidentified ligands were seen 
during leukocyte recruitment to TNF-α activated bovine kidney microvascular glomerular 
endothelial cells (BKMGEC) or human cardiac microvascular ECs (HCMEC) in static and 
non-static (rotation or flow) in vitro [458, 459]. These ligands were synthetized de novo, 
required sialylation or sulfation and mediated interaction for prolonged period of time (24-
48 hours) [458, 459]. Furthermore, inducible L-selectin ligand has been seen on IL-4 
stimulated HUVEC, and this ligand supported L-selectin-mediated monocyte recruitment 
for at least 48 hours under rotating conditions [410]. Given that rolling has been observed 
to be dependent on L-selectin at later time-points (> 1-2 h) [52, 365, 411], it is plausible 
that it is these unidentified ligands, which persist on the endothelium for long periods of 
time that bind L-selectin to support leukocyte rolling at later stages of the recruitment. 
Additionally, it seems that the vascular bed specificity for these ligands exists as 
demonstrated by the study by Zakrzewicz et al. (1997), who observed L-selectin ligands 
on HCMEC but not on the ECs derived from the macrovessels [459]. 
Interestigly, L-selectin ligand(s) were also detected on resting bovine aortic endothelial 
cells (BAEC), and their expression increased after TNF-α stimulation [460]. These 
ligands supported monocyte recruitment to BAEC under rotating conditions [460], 
suggesting a role for L-selectin/ligand binding in the recruitment of monocytes to the 
aortic endothelium and in development of atherosclerosis. The role of monocytes and L-




1.8.3  L-selectin ligands in the extravascular tissues 
A substantial number of reports have identified components of the extracellular matrix 
(ECM) as ligands for L-selectin. The majority of these ligands belong to the family of 
sulfated proteoglycans (PGs), and binding of heparan sulfate (HS), dermatan sulfate 
(DS) and chondroitin sulfate (CS) PGs derived from rodent and human tissues to L-
selectin has been shown [461-463]. The proteoglycans involved in L-selectin binding 
have been identified as HSPG collagen XVIII, CS/DS PG versican and DSPG biglycan, 
and all bind L-selectin via their sulfated glycosamicoglycan (GAG) chains [221, 354, 463-
466]. PGs are well-known for their involvement in tissue architecture maintenance, 
however emerging body of evidence suggests that they also act as signalling molecules 
actively participating in the inflammatory response [467]. In keeping with this, 
accumulation of versican and biglycan is associated with development of atherosclerotic 
lesions in humans and mice [468-475], and loss of collagen XVIII has been shown to 
promote atherosclerosis in mice [476]. Interestingly, lubricin, a mucin-like protein isolated 
from the synovial fluid of patients with rheumatoid arthritis, has also been shown to bind 
L-selectin via its sialylated and sulfated oligosaccharides [477]. These reports suggest 
that L-selectin and its ECM ligands could mediate leukocyte emigration during chronic 
inflammatory diseases. A role for ECM components in leukocyte tissue infiltration has 
been suggested by Ogawa et al. (2004), who found that monocytes from L-selectin null 
mice and sulfatide null mice display the same extent of emigration defect in murine 
unilateral ureteral obstruction (UUO) model [420]. Sulfatide is an ECM glycolipid, which 
also has been shown to bind L-selectin via its long sulfated sugar chains [478]. Notably, 
distribution of sulfatide and L-selectin ligands in both normal and ureteric obstructed 
kidneys is very similar, and 24 hours after UUO both relocate from distal renal tubules to 
vascular bundles, where subsequent infiltration of monocytes is seen [420, 479]. The 
same staining pattern has been observed for versican, although examination of 
leukocyte emigration was not performed in this study [465]. Interestingly, interstitial 
infiltration of L-selectin-positive cells has been seen in kidney biopsy sections from 
patients with immunoglobulin A (IgA) nephropathy [480], suggesting a role for L-selectin 
in pathogenesis of kidney disease in humans. 
Heparan sulfates are commonly present on the luminal surface of ECs, where they are 
involved in chemokine presentation [481, 482]. Interestingly however it is unlikely that 
these heparan sulfate moieties mediate L-selectin binding. L-selectin has been shown to 
have a pH-dependent preference for its ligands, and whilst 6-sulfo-sLex binding occurs 
at the blood pH of 7.4, binding of HS and CS chains was observed at pH of 5.6 [483]. In 
line with this, L-selectin dependent rolling was seen at the pH range between 6.8 and 
7.4 and no rolling was detected below pH 5.6 [483]. A very recent report found that in 
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acidic conditions, the carbohydrate binding domain of L-selectin becomes protonated 
and shares more bonds with sulfated GAG chains, which increases binding affinity [484]. 
Acidic pH is often found at sites of inflammation [485, 486] and perhaps it is an important 
factor in modulating L-selectin’s affinity for its intra- versus- extravascular ligands.     
1.8.4 Various L-selectin ligands on other cells 
Apart from ECs and ECM components L-selectin can bind variety other cells. The best 
known non-vascular ligand for L-selectin is PSGL-1, which binds L-selectin through a 
sLex moiety and sulfated tyrosine residues within its protein backbone [62]. L-
selectin/PSGL-1 interactions are responsible for secondary capture of leukocytes at sites 
of inflammation (section 1.2.3). Interestingly PSGL-1 has been discovered on the 
endothelium of microvessels induced in advanced atherosclerotic plaques, where it 
supports leukocyte infiltration [299]. This yet again points towards a role for L-selectin in 
atherosclerosis (section 1.13.1).  Another cell surface leukocyte protein endoglycan has 
been reported to bind L-selectin [487]. Like podocalyxin and CD34, endoglycan is a 
member of the CD34 family and is also expressed on the vascular endothelium, smooth 
muscle cells and hematopoietic precursor populations [487]. Despite being a mucin, 
endoglycan shows similarities to PSGL-1 in that it binds L-selectin via sLex and sulfated 
tyrosine residues [487]. However, a relevant contribution of endoglycan to L-selectin-
dependent recruitment has not yet been established. L-selectin has been shown to bind 
a variety of ligands on cancer cells (table 1.2) [352, 361, 488], suggesting a role for L-
selectin in cancer metastasis. Indeed, it has been shown that L-selectin-dependent 
interactions of leukocytes at the sites of tumour cells embolization facilitate initiation of 
tumour cell extravasation [489]. MECA-79 reactive ligands for L-selectin have also been 
found on human endometrium during the window of implantation [490]. In agreement 
with this, a role for L-selectin in trophoblast implantation has been reported [491]. 
Taken together L-selectin has the ability to bind a variety of ligands, in both health and 









Localisation L-selectin ligand Notes Citation 








1Belongs to CD43 family 
2Not expressed in PP HEV 
3Not expressed in PLN  
(Mesenteric LN only) 





at sites of 
inflammation 
 MECA-79  reactive antigens1 
 E-selectin2 
 Unidentified, seen in vivo 
 Unidentified, induced on HUVEC by IL-4 
 Sulfoglucuronosyl paragloboside (SGPG), induced on BMEC 
by IL-1β 
 Unidentified, induced by TNF-α on HCMEC3, BKMGEC4 and 
BAEC 
1Expressed on HEV-like vessels induced in certain chronic 
inflammatory diseases: ulcerative colitis, Crohn’s disease, asthma, 
diabetis, cutaneous inflammation and lymphoma, Grave’s disease, 
rheumatoid arthritis 
2On human, but not mouse neutrophils 
3Sulfation but not  sialylation required 





ECM  Versican (CS/DS PG)1 
 Biglycan(DSPG)1 
 Collagen VXIII(HSPG)1 
 Sulfatide (sulphated glycolipid)2 
 Lubricin (mucin-like glycoprotein)1  
1Bind L-selectin through long sulfatated GAGs 





Various  PSGL-11 
 Endoglycan1  
 Podocalyxin-like protein (Non-MECA-79 reactive)2 
 MECA-79 reactive3 
 Carcinoembryonic antigen (CEA)4 
 CD445 and CD44v6 
 Human complement factor H 
 Nucleolin 
1Binding through sLex and Tyr-SO3 
2On colon carcinoma cells 
3On human endometrium during the window of implantation 
4Expressed by CLS174T colon carcinoma cell line 
5Expressed by hematopoietic-progenitor cells 





Table 1.2 L-selectin ligands. This is a current list of identified L-selectin ligands. This table shows known L-selectin ligands alongside the details about the location 
of their expression and ligand nature. Note that the list may not be exhaustive. For the abbreviations used see Abbreviations section.
PNAd mucins 
(MECA-79 reactive) 
Bind L-selectin through 6-sulfo-sLex 
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1.9 REGULATION OF L-SELECTIN EXPRESSION 
L-selectin levels on circulating leukocytes are fairly constant, however, under certain cell 
activating conditions, cell surface L-selectin is rapidly downregulated in a process known 
as “shedding” (section 1.9.2) [495, 496]. Additionally, upon T cell activation, L-selectin 
shedding is accompanied by modulations in L-selectin messenger RNA (mRNA) levels 
and stability [386, 497]. Certain T cell subsets (central memory T cells) subsequently 
upregulate surface L-selectin expression, which enables recirculation to PLN [387, 498]. 
Furthermore, human leukemic cells freshly isolated from patients were shown to sustain 
high L-selectin mRNA levels, which was associated with increased leukocyte infiltration 
into various organs [499]. Thus, L-selectin expression levels can be actively regulated 
both transcriptionally (section 1.9.1) and post-translationally (through shedding), and 
deviations in these balances are often seen in disease. 
1.9.1 Transcriptional regulation of L-selectin expression 
Human L-selectin from all leukocyte subsets is encoded by the lam-1 gene 
(Chromosome 1) containing at least 10 exons that produce single L-selectin mRNA, and 
9 of these exons are translated in to L-selectin protein [313]. Post-translational 
glycosylation accounts for differences in L-selectin MW seen between the leukocyte 
subsets [381, 402]. No reports exist about alternative L-selectin protein variants, 
however, three different L-selectin isoforms were discovered in mice (L-selectin-v1-3) 
[500]. Mouse L-selectin-v1-3 comprise only 3-5% of the total L-selectin protein [500], and 
it is currently unclear how these splice variants may affect L-selectin-dependent 
recruitment.   
The positioning of the L-selectin gene promoter is located immediately upstream (-288/-
1 bp) of the START codon, and can be activated by a number of transcription factors 
(TFs), e.g. Krupper-like factor 2(Klf2), Forkhead box protein O1 (FOXO-1), E-twenty six 
(Ets1), myeloid zinc finger 1 (Mzf1), specificity protein 1 (Sp1), and to a lesser extent, 
interferon regulatory TF (Irf1) [501-504]. It has been shown that FOXO-1 and another TF 
– Elf4 (Ets-related transcription factor) – regulate the expression of Klf2 [505-507]. 
Therefore, FOXO-1 appears to regulate L-selectin expression by at least two 
mechanisms: by activating Klf2 and by directly binding to the FOXO-1 motif identified 
within the L-selectin promoter region [503]. Deficiency in FOXO-1, Klf2 or Elf1 result in 
decreased L-selectin expression, reduced lymphocyte homing to PLNs and increased T 
cell accumulation in non-lymphoid tissues [504-510]. In line with this, Klf2 over-
expression leads to increased L-selectin expression and augments lymphocyte 
recruitment to PLN [501]. It has been shown that upon T cell receptor (TCR) ligation, Klf2 
mRNA levels are reduced, which results in decreased L-selectin gene transcription [511]. 
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Klf2 expression was shown to be downregulated by the phosphatidylinositol-3-OH kinase 
(PI(3)K) that mediated its effects through the mammalian target of Rapamycin (mTOR) 
[511]. This signalling pathway is not active in naïve T cells and thus L-selectin 
transcription is maintained on T cells that home to PLN and becomes quenched in 
activated T cells [511]. Interestingly, another TF, Forkhead Box M1 (FOXM-1) was 
recently shown to control L-selectin levels on monocytes but not neutrophils [512]. 
FOXM-1 deficient mice showed impaired accumulation of monocytes during acute liver 
injury [512], implying a role for this TF in the L-selectin-dependent monocyte homing to 
sites of inflammation. Hence, it seems that transcriptional regulation of L-selectin 
expression depends on both leukocyte subset and the cell activation status. Interestingly, 
genetic variations in the proximal 5´ flanking region of the L-selectin promoter have been 
identified in Chinese and Japanese populations, and have been proposed to be the risk 
factors for Grave’s autoimmune disease and the immunoglobulin A nephropathy  [480, 
513]. One of the variations (–642A>G substitution) was subsequently shown to impair 
the transcription efficiency of the L-selectin gene [514]. 
1.9.2 Regulation of L-selectin expression by proteolytic cleavage (shedding) 
Endoproteolytic cleavage of L-selectin, termed “shedding”, occurs at an extracellular site 
proximal to the cell membrane (figure 1.7) and results in the formation of a 68 kDa 
soluble form of L-selectin (sL-selectin) and retention of a 6 kDa transmembrane fragment 
(and will be referred to interchangably as “stump”) [326, 515]. The proteolytic activity is 
membrane-associated [516, 517] and can be inhibited by hydroxamic acid-based 
metalloprotease inhibitors, which are often employed to study L-selectin shedding [313, 
517-520].  Upon cell activation, L-selectin is cleaved between lysine-283 and serine-284 
by A Disintegrin and Metalproteinase 17 (ADAM17) (also known as TNF-α converting 
enzyme, TACE) [326, 521-523]. Additionally, ADAM8 and ADAM10 have been reported 
to have the ability to shed L-selectin [524, 525]. ADAM10 is most closely related to 
ADAM17 [526], and in vitro studies showed that it can be activated to cleave L-selectin, 
when ADAM17 is chronically absent [525]. Notably, emigrated ADAM17 null neutrophils 
were shown to be able to shed their L-selectin in the model of murine peritonitis [527]. It 
is possible that this was due to ADAM8 activity, as ADAM8 has been shown to be 
upregulated on human neutrophils upon adhesion to ECs [524]. Additionally, ADAM8 
has also been implicated in L-selectin cleavage during chronic inflammatory disease, i.e. 
rheumatoid arthritis [524]. Interestingly, neither point mutations nor mutations of multiple 
conserved amino acids within the cleavage site were found to affect L-selectin shedding 
[522, 528]. However, deletions of several amino acids within the L-selectin cleavage 
domain – which brought the cleavage site closer to the plasma membrane – abolished 
L-selectin shedding [323, 522, 528]. Therefore, metalloproteases that cleave L-selectin 
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seem to target a “relaxed” sequence specificity, but are more sensitive to the physical 
distance of the cleavage site from the plasma membrane, and possibly other structural 
features of the cleavage site.  
L-selectin is shed upon stimulation with various cell activating factors, e.g. phorbol 12-
myristate 13-acetate (PMA), N-formyl-methionyl-leucyl-phenylalanine (fMLP), thrombin, 
IgE receptor agonists, a peptide component of complement activation (C5a), IL-8, 
lipopolysaccharide (LPS), TNF-α, PAF, H2O2, phosphatase inhibitors, as a result of 
mechanical force imposed during rolling, upon B- or T cell receptor (BCR and TCR, 
respectively) engagement, or upon ectodomain cross-linking [419, 421, 495, 496, 529-
538]. Protein kinase C (PKC) and various mitogen activated protein kinases (MAPK) 
have been implicated in mediating L-selectin shedding [495, 496, 511, 531, 539-541]. 
The interaction between PKC, L-selectin, and contribution of sequences within the tail to 
shedding are discussed in more detail in section 1.10.2.  
The shed extracellular domain of L-selectin remains functionally active and can prevent 
leukocyte attachment to ECs in vitro [542] and in vivo [543], possibly acting like an 
“adhesion buffer” limiting excess leukocyte recruitment at sites of inflammation. In 
addition to cell-activation induced shedding, L-selectin is constitutively cleaved from the 
cell surface, which is known as “basal shedding” [521, 544]. The plasma of healthy 
humans contains 1.6±0.8 µg/mL of sL-selectin [542, 545], and such high concentration 
suggests that basal shedding is a physiologically relevant process. In keeping with this, 
plasma sL-selectin levels are affected in certain inflammatory diseases, e.g. elevated sL-
selectin is seen in patients with SLE [546, 547] or type I diabetes [548], and low levels 
were observed in patients suffering from adult respiratory distress syndrome (ARDS) 
[549]. Not much is currently known about basal shedding. It is dependent on 
metalloprotease activity and utilizes the same cleavage site as the activation-induced 
shedding, however the exact metalloprotease has not been identified [521, 544]. 
ADAM17 null mice have been reported to produce sL-selectin and “stump”, implying that 
other than ADAM17 metalloprotease mediates basal shedding [521, 544]. At the same 
time, increased surface levels of L-selectin were seen on neutrophils from ADAM17 null 
mice, suggesting that this enzyme does control L-selectin surface density under resting 
conditions [521, 527]. It is possible that two mechanisms of basal L-selectin turnover 
exist, one that is independent and the other that is dependent on ADAM17. The first one 
controls homeostatic sL-selectin plasma levels and the latter controls L-selectin surface 
density. Interestingly, in 1996 it was shown that a protease-independent mechanism of 
L-selectin shedding could also occur [529]. Seven years later, generation of mice 
expressing sheddase-resistant mutant of L-selectin showed that very low (<5% of wild 
type) sL-selectin levels were present in plasma of these mice, suggesting that the 
protease-independent mechanism could contribute to basal L-selectin shedding [22]. Of 
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note, L-selectin shedding during neutrophil apoptosis has been shown to be dependent 
and independent on ADAM17 at early and later stages, respectively [550]. 
Although the physiological significance of L-selectin shedding is not entirely understood, 
a few definite and putative roles have been identified. As mentioned above, shedding 
maintains physiological sL-selectin levels in plasma. Several studies using hydroxamic 
acid-based metalloprotease inhibitors or mice expressing sheddase-resistant L-selectin 
suggested a role of shedding at various stages of the leukocyte adhesion cascade. Some 
reports implicate shedding as a mechanism limiting leukocyte rolling at sites of 
inflammation [519, 551, 552], however others find no influence of L-selectin cleavage on 
leukocyte rolling velocity or flux [419, 520]. Shedding was found to play an important role 
during T cell recirculation to PLN. It has been shown that during TEM across PLN HEV 
naïve T cells downregulate their surface L-selectin to 30% of the blood levels, and then 
re-express the protein upon the exit [553]. In line with this, blocking L-selectin shedding 
results in reduced TEM of naïve T cells across HEV [22, 518]. Furthermore, L-selectin 
shedding occurs in activated T lymphocytes and this prevents them from re-entering the 
PLNs [22, 419]. Shedding is also thought to occur during TEM at sites of inflammation 
as surface levels of L-selectin on emigrated leukocytes are low compared to “resting” 
levels seen on cells in the circulation or in culture [520, 554-556]. However, the exact 
timing or spatial distribution of L-selectin shedding on transmigrating leukocytes has not 
been investigated so far. Interestingly, L-selectin shedding has also been proposed to 
be important in leukocyte migration beyond vessel walls and possibly controls 
chemotaxis in vivo (section 1.7.5.1.2) [419]. Finally, it is likely that L-selectin shedding 
is regulated differently depending on the leukocyte subset. ADAM17 null mice showed 
increased adhesion and early emigration of neutrophils but not monocytes at sites of 
inflammation [527]. Additionally, ADAM17 null neutrophils did, and monocytes did not 
shed their L-selectin upon emigration in the thioglycollate-induced peritonitis mouse 
model of inflammation [527]. 
1.10 THE CYTOPLASMIC TAIL OF L-SELECTIN 
The cytoplasmic tail of L-selectin is only 17 amino acid-long, however it is known to 
interact with a number of cytoplasmic proteins. These interactions are important for L-
selectin function, sub-cellular distribution and signalling [90, 496, 515, 557-561]. The 
main players involved in the interactions at the tail of L-selectin are the actin binding 
proteins α-actinin and the ERM proteins, ezrin and moesin, as well as the calcium-
sensing protein calmodulin. Another important feature of the L-selectin tail are the two 
serine residues, of which phosphorylation is likely to regulate L-selectin shedding 
amongst other aspects of L-selectin [495, 496]. Figure 1.10 shows a schematic summary 
of the interactions between the L-selectin tail and its main cytosolic binding partners, and 
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these interactions are described in more detail in the following sections. Of note, L-
selectin has also been shown to bind the p56Lck kinase, SOS/Grb2 [245], c-Abl [562] and 
high mobility group 1 (HMG1) [563]. No information is currently available about the 
functional implications of L-selectin interaction with HMG1. The involvement of p56Lck 
and c-Abl is described in the subsequent sections with respect to signalling downstream 
of the L-selectin tail (section 1.11.4).    
 
Figure 1.10 The cytoplasmic tail of L-selectin. The short, 17 amino acid cytoplasmic tail of L-
selectin interacts simultaneously with CaM (L358 and K359), ERM proteins (R357 and K362) and 
α-actinin (K363 to Y372). Phosphorylation of the L-selectin tail occurs at S364 and S367. The 
outcomes of each of the interaction as well as the results of the phosphorylation are depicted on 
the diagram and discussed in the text. For abbreviations used see Abbreviations section. Image 
adapted from Ivetic and Ridley, Biochem. Soc. Trans., 2004 [564]. 
1.10.1 Interaction with α-actinin 
The first molecule identified to bind to the cytoplasmic tail of L-selectin was the 
cytoplasmic actin-binding protein α-actinin [565]. L-selectin/α-actinin interaction was 
shown through a solid-phase binding assay and co-immunoprecipitation studies in L-
selectin transfectants and Jurkat T lymphocytes [565, 566]. Interaction with α-actinin is 
mediated by the 11 amino acid COOH-terminal domain of the L-selectin tail [565] (figure 
1.10). Deletion of this sequence was earlier reported to abolish in vitro binding of 
lymphocytes to HEV in frozen LN sections as well as in vivo rolling of leukocytes in 
exteriorized rat mesenteric venules [557]. Therefore, α-actinin-mediated linkage of L-
selectin to the actin cytoskeleton is critical for the L-selectin-dependent adhesion of 
leukocytes to the endothelium. On the other hand, L-selectin lacking the 11 terminal 
amino acids correctly localised to microvilli, suggesting that α-actinin is not important for 











L-selectin microvillar positioning [565]. Two other cytoskeletal proteins, vinculin and talin, 
are also thought to associate with the L-selectin/α-actinin complex [565]. 
1.10.2 Cytoplasmic serine residues and interaction with PKC isoforms 
Two serine residues at position 364 (S364) and 367 (S367) of L-selectin have been 
shown to be important for ectodomain shedding (figure 1.10). Phosphorylation of S364 
and S367 within the L-selectin cytoplasmic tail mediates PKC-dependent shedding in 
response to PMA, IL-8, thrombin, IgE agonists, C5a, PAF and fMLP [495]. In line with 
this, mutation of S364 or S367 into non-phosphorylatable alanines desensitizes L-
selectin to PKC-dependent shedding, and mutation of S367 into a phospho-mimicking 
aspartate sensitizes shedding [534]. Strangely, mutation of S364 into aspartate was 
found to reduce rather that promote shedding [496]. It is possible that this substitution is 
not a successful phosphomimic or perhaps a complex relationship between the two 
serines exist, where S364 needs not to be phosphorylated to drive S367 phosphorylation 
and shedding. Studies by Kilian et al. (2004) showed that PKC isozymes θ and  
transiently interact with the cytoplasmic tail of L-selectin and are involved in the 
phosphorylation of S364 and S367, with a preference to the former [567]. Once 
phosphorylated, the cytoplasmic domain of L-selectin increases binding of PKCθ and 
promotes binding of PKCα [567]. This suggests that serine phosphorylation and L-
selectin shedding could promote formation of a signalling complex at the tail of L-selectin. 
However, it is currently unknown which event occurs first, serine phosphorylation or 
shedding, and it is possible that the PKC isoforms could bind the L-selectin “stump”. 
Shedding is linked to the disassociation of calmodulin (CaM, section 1.10.4) from the L-
selectin tail, and CaM does not co-immunoprecipitate with the “stump” [559]. Perhaps a 
change-over of binding partners – from CaM to PKC isoenzymes – is involved in 
signalling downstream of L-selectin tail upon PKC-mediated shedding. In support of this 
theory, L-selectin is a well-known signalling molecule and phosphorylation of its single 
cytoplasmic tyrosine residue has been associated with intracellular signalling events 
(section 1.11.4). On the other hand, shedding induced by the phosphatase inhibitors 
(cantharidin and calyculin A, the PP2A-type phosphatase inhibitors) is independent of 
both PKC and phosphorylation of the L-selectin serine residues, but is driven by p38 
MAPK, phosphorylation of ADAM17 cytoplasmic tail and upregulation of surface 
ADAM17 levels [496]. Further differences between PKC- and p38 MAPK-dependent 
shedding is demonstrated by the fact that the PKC-mediated shedding requires 
interaction of the L-selectin tail with the ERM proteins, whereas p38 MAPK-mediated 
shedding occurs independently of the ERMs  (section 1.10.3) [496]. In conclusion, 
protease-sensitive site-dependent L-selectin shedding can be regulated by PKC, ERM 
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and modulation of L-selectin cytoplasmic tail, or by p38 MAPK and regulation of ADAM17 
phosphorylation and surface expression.  
1.10.3 Interaction with the exrin/radixin/moesin (ERM) family members 
The family of ERM proteins consists of three members, exrin, radixin and moesin, which 
have an approximate MW of 75-82 kDa. Inactive ERM proteins reside in the cytosol in 
an auto-inhibited conformation, where N- and C-termini interact with each other [568]. 
Upon activation, the ERM proteins switch into an extended form, where the N-terminal 
FERM (band Four point one Ezrin Radixin Moesin) domain binds the integral 
transmembrane proteins and the C-terminal domain binds F-actin [569, 570]. Thus, the 
active ERM proteins serve to link the transmembrane proteins to the actin cytoskeleton. 
Apart from their structural purpose, the ERM proteins can modulate leukocyte function, 
and especially motility, by acting both upstream and downstream of the Rho GTPases 
[571]. In murine lymphocytes, the cytoplasmic tail of L-selectin was shown to bind ezrin 
and moesin as radixin expression is absent in leukocytes [563]. L-selectin arginine-357 
(R357) and lysine-362 (K362) were shown to contribute to binding ERM (R357 having a 
predominant role), and both are located within a 6 amino acid, membrane proximal 
cytoplasmic tail domain [558] (figure 1.10). Cell lines expressing alanine swap mutations 
of L-selectin at positions R357 or K362, which abrogate ERM binding, showed impaired 
microvillar positioning, reduced PMA-induced shedding, as well as decreased tethering 
efficiency [496, 558]. Interestingly, L-selectin/ERM interaction was shown to be 
dispensable for the phosphatase inhibitor-mediated shedding [496]. Thus, L-
selectin/ERM interaction is important for PKC-mediated shedding and localisation of L-
selectin to leukocyte microvilli, which in turn is likely to positively influence tethering. Both 
R357 and K362 are juxtaposed to L358 and K359, which are amino acid residues 
responsible for calmodulin (CaM) binding (section 1.10.4) [559]. A detailed study by 
Killock et al. (2009), involving molecular modelling, in vitro binding assays and in vivo 
protein-protein interaction studies showed that, despite close proximity of their putative 
binding sites, CaM and ERM interact with the L-selectin tail in a non-competitive way 
[572]. Moreover, the same report predicted that ERM, L-selectin and CaM can form a 
1:1:1 ternary complex in resting leukocytes, which was confirmed by other recent studies 
(see section 1.10.4 below) [573, 574]. Additionally, it has been proposed that CaM and 
ERM derived from adjacent L-selectin molecules interact in cis upon L-selectin 
clustering, which is likely to promote intracellular signalling, possibly involving Rap1A 
mobilisation via Ras/SOS pathway [496]. Signalling triggered by ligation of L-selectin 
domain is discussed in more detail in section 1.11 of this thesis. 
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1.10.4 Interaction with calmodulin (CaM) 
Calmodulin (CaM) is an ubiquitous 17 kDa calcium regulatory protein that associates 
with the tail of L-selectin in resting transfected cell lines and primary leukocytes [515, 
559, 572]. The amino acid residues in the L-selectin cytoplasmic tail that contribute to 
interaction with CaM are leucine-358 (L358) and lysine-359 (K359) (figure 1.10) [515, 
559]. Inhibition of CaM promotes protease-dependent shedding of the L-selectin 
ectodomain (section 1.9.2) in human neutrophils, and significantly reduces adhesion of 
pre-B lymphocytic cells to HEV as well as their rolling on MECA-79 antigen [515]. Direct 
proof for the involvement of CaM in the ectodomain shedding was provided by Matala et 
al. (2001) who showed, through L-selectin tail mutational analysis, that disassociation of 
CaM from L-selectin increases shedding [559]. Through biophysical studies it has been 
suggested that CaM binds L-selectin via interaction with both its cytoplasmic tail and the 
transmembrane domain (TMD) [575]. A mechanism was proposed, whereby CaM, in a 
compact conformation, wraps around L-selectin tail and reaches into the TMD [575]. This 
in turn pulls the L-selectin molecule down, thereby burying the extracellular cleavage site 
in the plasma membrane [575] (figure 1.11 A). However, it is hard to envisage the 
hydrophilic amino acids of the L-selectin membrane proximal cleavage site being 
inserted in to the hydrophobic plasma membrane. Interestingly, recent studies using CLS 
(C-terminal portion of human L-selectin, comprising the entire tail and TMD) reconstituted 
in liposomes showed that CaM assumes an extended conformation when binding to the 
L-selectin tail, where only single lobe of CaM is involved in this interaction [574, 576] 
(figure 1.11 B). When the liposomes contain negatively charged lipids (i.e. 
phosphatidylserine, PS) that mimic the inner leaflet of the plasma membrane, this 
interaction is abolished [576]. This is because the basic-rich L-selectin tail interacts with 
the anionic lipid bilayer instead [576] (figure 1.11 C). Most interestingly, the FERM 
domain of moesin was shown to desorb the L-selectin tail from the anionic membrane 
surface and facilitate L-selectin/CaM interaction [573] (figure 1.11 D). These results are 
in agreement with a ternary model of L-selectin/CaM/ERM binding proposed earlier by 
Killock et al. (2009) [572], and suggest that plasma membrane environment is crucial for 






Figure 1.11 Models of association between L-selectin and calmodulin. Schematic illustration 
of L-selectin/CaM interaction modes that have been proposed most recently. A) CaM has a 
compact conformation and wraps around L-selectin tail and TMD, pulling the L-selectin molecule 
down, thereby burying the extracellular cleavage site in the plasma membrane. B) CaM has an 
extended conformation, where only one lobe interacts with the L-selectin tail (in neutral charge 
liposome environment). C) In the presence of PS, L-selectin tail has a preference for the inner 
leaflet of the plasma membrane and does not bind CaM. D) FERM domain of moesin desorbs the 
L-selectin tail from the negatively charged membrane and facilitates CaM binding. This leads to 
the formation of a ternary L-selectin/ERM/CaM complex. For abbreviations used see the 
Abbreviations section. Image adapted from Deng et al. , PLoS One, 2013 [574]. 
 
Since in many proteins phosphorylation of critical serine residues can abolish CaM 
binding [577, 578], it was proposed that serine phosphorylation of  L-selectin would 
disrupt L-selectin/CaM interaction, leading to L-selectin shedding [515]. As described 
earlier, the cytoplasmic tail of L-selectin was found to associate with protein kinase C 
(PKC) isoforms [567], and serine phosphorylation shown to be involved in the PKC-
mediated shedding of L-selectin [495, 496]. It is thus plausible that upon cell activation 
sequential changes in binding of CaM, ERM and PKC isoforms as well as modulation of 
the plasma membrane composition regulate L-selectin phosphorylation and shedding.   
1.11 L-SELECTIN OUTSIDE-IN SIGNALLING 
Outside-in signalling downstream of L-selectin has been studied through ligation of the 
ectodomain with various compounds, from primary anti-L-selectin mAb, through primary 
mAbs followed by secondary antibodies (cross-linking) to physiological and synthetic L-
selectin ligands. Various cellular responses resulting from L-selectin ectodomain ligation 










1.11.1 Changes in lateral mobility of L-selectin in the plasma membrane 
Through the generation of CLS L-selectin it has been shown that L-selectin is monomeric 
in the dodecylphosphocholine detergent micelles [579]. In other words, in resting state 
the cytoplasmic and transmembrane domains of L-selectin do not have the ability to self-
assemble, and no spontaneous oligomerisation can occur [579]. This finding has been 
confirmed in a very recent report, where the micropipette adhesion frequency assay was 
used to show that L-selectin is monomeric in the neutrophil membrane [580].  In contrast, 
PSGL-1 and P-selectin, two other CAMs actively mediating leukocyte recruitment, have 
been shown to exist in plasma membranes as homodimers [581, 582]. Expression of 
transgenic PSGL-1 and P-selectin that existed as monomers resulted in destabilised 
neutrophil rolling [583], suggesting that receptor oligomerisation is a functionally 
important process for successful leukocyte recruitment. Interestingly, dimerization of L-
selectin molecules by labelling with mAb (LAM1-118, non-function blocking antibody) 
increased L-selectin’s avidity for its ligands and enhanced tether formation under flow 
[584]. Similarly, chemically induced dimerization (CID), where two adjacent L-selectin 
molecules are artificially brought together without ectodomain engagement, resulted in 
enhanced ligand binding as well as increased rolling flux and decreased rolling velocity 
of 300.19 cells on transformed HUVEC that expressed L-selectin ligands [585]. This 
implies that upon stimulation, adjacent monomeric L-selectin molecules do come 
together, which leads to signal propagation and results in the cellular responses. An 
obvious stimulus that could elicit L-selectin oligomerisation (hereafter referred to as 
“clustering”) would be the engagement of ectodomain that could physically bring the 
adjacent molecules together. Indeed, L-selectin “patching” (a distinct strong 
immunofluorescence signal belonging to the fluorescently-conjugated secondary 
antibody used for cross-linking) has been observed upon L-selectin cross-linking or 
binding of E-selectin-IgG chimera [87, 91, 586]. In these experiments L-selectin 
clustering coincided with upregulation of and adhesion through Mac-1 (for L-selectin 
mediated integrin-dependent adhesion see section 1.11.2). In U937 monocytic cells 
triple-expressing L-selectin, ezrin-GFP and CaM-mCherry, labelling of L-selectin with 
mAb has been shown to induce CaM/ERM interaction in cis (as measured by FRET 
between ezrin-GFP and CaM-mCherry), which was potentiated after cross-linking with 
secondary antibody [572]. This suggests that a degree of L-selectin clustering regulates 
the lateral mobility of its cytosolic binding partners and could lead to the assembly of 
signalling platforms associated with two adjacent L-selectin tails [572]. Additionally, L-
selectin cross-linking, sequential stimulation of L-selectin with two mAb or ligation of L-
selectin ectodomain with GlyCAM-1 has been shown to redistribute L-selectin into 
cholesterol-rich detergent resistant membranes (DRM) [560, 587]. Movement to DRM 
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was dependent on the 11 terminal amino acids of L-selectin tail, as mutant L-selectin 
lacking this sequence failed to translocate to DRM [560]. Cholesterol-rich membrane 
microdomains, termed lipid rafts, are known to mediate immune cell signalling [382, 588], 
and hence it is plausible that upon ligand binding L-selectin clusters and translocates to 
DRMs, where it can interact with its signling partners.        
1.11.2 Activation and upregulation of the integrins 
As described in sections 1.2.4 and 1.7.5.1.1 outside-in signalling triggered by L-selectin 
ectodomain ligation is vital for the arrest of the rolling leukocytes. Antibody-mediated 
cross-linking of L-selectin, ligation with GlyCAM-1 or E-selectin-IgG chimera result in 
leukocyte adhesion through β1 and β2 integrins [86, 88, 589, 590]. Interestingly, binding 
of soluble fibronectin – which is a β1 integrin dependant process – occurred in naïve, but 
not memory, T cells upon ligation with fucoidan (a known polyvalent mimic of natural 
occurring L-selectin ligands, it is found in brown sea weed) [88]. Similarly, L-selectin 
cross-linking or GlyCAM-1 binding led to increased adhesion through or activation of β2 
integrins, respectively, that occurred in naïve but not memory T cells [86]. This suggests 
that L-selectin on certain lymphocyte subsets might transduce signalling in a functionally 
different manner to promote adhesion. Stimulation with primary antibodies was shown to 
increase activity, as measured by the expression levels of active epitopes, of β1 and β2 
integrins on neutrophil surface in the absence of increased integrin expression [591]. 
However, upregulation of Mac-1 (CD11bCD18) integrin levels on neutrophils are seen 
upon L-selectin cross-linking as well as upon simultaneous stimulation of L-selectin with 
two primary antibodies [87, 89, 91]. Perhaps L-selectin-mediated regulation of integrin-
dependent adhesion is governed by the magnitude of clustering, where initial 
engagement (i.e. elicited by single primary antibodies) causes activation of cell surface 
integrins, and further clustering (i.e. cross-linking or stimulation with two antibodies at 
once) leads to expression of new integrin molecules on the cell surface. As far as the 
signalling pathways are concerned, it has been reported that L-selectin-dependent 
adhesion through Mac-1 is a result of p38 and p42/44 MAPK (ERK1/2) phosphorylation 
[413, 589]. Interestingly, phosphorylation of p38 MAPK was seen as soon as 1 minute 
upon cross-linking, it then dropped at 2 minutes and then rose again at 3-5 minutes upon 
L-selectin cross-linking [589]. Phosphorylation of ERK1/2 had delayed kinetics with 
phosphorylation peaking at 3-5 minutes, suggesting that p38 MAPK might be the primary 
kinase responsible for L-selectin mediated Mac-1-dependent adhesion [589]. In fact, 
inhibition of p38 MAPK completely abolished L-selectin-dependent neutrophil adhesion 
to the albumin-coated latex beads (ACLB, used to test for Mac-1 dependent 
adhesiveness) [589]. However, the influence of ERK1/2 inhibitor on ACLB binding was 
not tested in this study [589], and hence the relative ERK1/2 contribution to Mac-1-
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dependent L-selectin-mediated adhesion in this system is not known. Another report has 
shown that inhibition of ERK1/2 blocks 80% of β2 integrin upregulation induced by L-
selectin cross-linking, highlighting the importance of this kinase [91].  Whether L-selectin 
signals to the integrins through co-clustering in specific membrane domains is currently 
unclear. Co-localisation of L-selectin and CD18 integrin has been reported upon L-
selectin cross-linking [87], however, such an event might be ligand-specific, as no co-
localisation was found after L-selectin/E-selectin-IgG binding [413].  
1.11.3 Regulation of chemokine receptor expression and chemotaxis 
L-selectin cross-linking or ligation with sulfatides or fucoidan have been shown to 
upregulate CXCR4 receptor on the surface of human peripheral blood lymphocytes 
(PBL), granulocytes and monocytes, murine T cells and K562 myeloid  cell line 
transfected with L-selectin [85, 90]. Notably, sulfatide-triggered CXCR4 upregulation 
occurred in CD4+, but not CD8+ T cells or B cells [90], suggesting that L-selectin 
signalling might be specific to leukocyte subtype. Enhanced surface CXCR4 expression 
was a result of pre-formed intracellular stores mobilisation, as verified by flow cytometry 
and measurement of total protein content in permeabilized cells [85]. Furthermore, L-
selectin dependent CXCR4 upregulation was selective and specific, as no enhanced 
expression of other CCR receptors, CCR5 and CCR7, was seen upon ligation with 
fucoidan or sulfatides [85]. L-selectin cytoplasmic tail was found to be important for signal 
transduction leading to CXCR4 expression, as K562 cells expressing truncated L-
selectin mutant (lacking 16 of total 17 cytoplasmic amino-acids) failed to upregulate the 
receptor as seen with L-selectin null cells [90]. Additionally, L-selectin-induced CXCR4 
upregulation was shown to be dependent on tyrosine phosphorylation, as pre-treatment 
of T cells with tyrosine kinase inhibitors prior to sulfatide stimulation resulted in 
decreased receptor expression [90]. Kinase shown to play a predominant role in CXCR4 
upregulation were shown to be the Src family kinases [90], and activation of Src kinases 
downstream of L-selectin has been repeatedly reported (section 1.11.4).  
CXCR4 is a receptor for stromal-derived factor 1 (SDF-1), a potent leukocyte 
chemoattractant and this receptor/ligand pair is known to be crucial for lymphocyte 
homing as well as recruitment to the inflammatory sites [592-595]. It is interesting that in 
addition to induction of CXCR4 surface expression, L-selectin ligation selectively 
inhibited CXCR4 internalisation induced by SDF-1, and this persistent CXCR4 
expression resulted in enhanced F-actin polymerisation  [85].  CXCR4/SDF-1 binding 
leads to firm adhesion of rolling leukocytes [59, 80], which is in keeping with a role for L-
selectin inside the vasculature during the transition from leukocyte rolling to arrest 
(sections 1.2.4 and 1.5.7.1.1). It therefore makes sense that stimulation via L-selectin 
was shown to enhance SDF-1 induced adhesion to HUVEC monolayers [85]. However, 
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it has to be noted that CXCR4 upregulation occurred two [90] or even ten [85] minutes 
after stimulation with ligands, and leukocytes arrest in seconds in vivo. This suggests 
that L-selectin-dependent CXCR4 signalling might be required in the later stages of the 
recruitment, i.e. TEM or chemotaxis. Indeed, L-selectin cross-linking or sulfatide binding 
has been shown to enhance PBL migration towards SDF-1 across both naked filters and 
HUVEC monolayers [85, 90]. L-selectin has been also shown to mediate leukocyte 
chemotaxis in vivo (see section 1.7.5.1.2). Interestingly, when primary mAb alone (no 
cross-linking) was used to cluster L-selectin, slightly decreased chemotaxis towards 
SDF-1 was observed as compared to baseline [85]. This suggests that the magnitude of 
L-selectin clustering is an important factor affecting signalling downstream of the L-
selectin tail. Furthermore, L-selectin ligation with mAb or EC-expressed ligand enhanced 
mouse T and B chemotaxis towards SLC [415]. This was not associated with CCR7 (SLC 
receptor) upregulation, but was strongly dependent on L-selectin expression levels and 
was mediated by PKC, MAPK, and Syk family kinases [415]. This suggests that L-
selectin-mediated chemotaxis occurs through more than one signalling pathway, 
dependent on the ligand, magnitude of L-selectin clustering and the type of chemokine 
involved. 
1.11.4 Activation of protein kinases, Rho GTPases, and production of secondary 
messengers 
Protein phosphorylation is a reversible post-translational modification of proteins that 
occurs through phosphate group addition by a protein kinase. The human genome 
contains 518 putative protein kinase genes, and kinases mediate majority of cellular 
signalling in eukaryotic cells by altering the activity of their substrates [596].  Mitogen-
activated protein kinases (MAPK) are serine-threonine protein kinases that become 
activated by various stimuli, and the best studied MAPKs are the p38 MAPK, extracellular 
signal-regulated kinases (ERK) and c-Jun N-terminal kinase (JNK) [597, 598]. Another 
well-known kinases are the Src family kinases (SFK) [599] and the c-Abl (Abelson murine 
leukemia viral oncogene homolog-1) kinases [600] that phosphorylate tyrosine residues 
within proteins. 
Active MAPK is itself tyrosine phosphorylated, and such phosphorylation was seen in 
human neutrophils, PBL and Jurkat T cells upon stimulation of L-selectin with sulfatides, 
fucoidan, sLex, E-selectin-IgG chimera, mAb or Fab fragments or after L-selectin cross-
linking [88, 245, 413, 589, 601]. Additionally, some of these studies found that 
ectodomain ligation resulted in tyrosine phosphorylation of L-selectin itself [88, 245]. 
Interestingly, MAP kinases (p38 and ERK) have been shown to mediate L-selectin 
shedding [511, 531, 539-541]. In the light of the fact that L-selectin ligation leads to MAPK 
activation, it can be speculated that engagement of the L-selectin ectodomain regulates 
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its own shedding through a signalling pathway involving MAPK. In support of this theory, 
multiple studies have shown that L-selectin cross-linking induces shedding [529, 533-
536]. Both MAPK and L-selectin tyrosine phosphorylation is dependent on p56lck, which 
is a member of the Src family kinases [88, 245, 598]. The involvement of MAPK, Src and 
other kinases in L-selectin-mediated integrin-dependent adhesion and chemokine 
receptor expression and chemotaxis were discussed in more detail in sections 1.11.2 
and 1.11.3 of this thesis, respectively. The kinase p56lck has been found to become 
activated (tyrosine phosphorylated) upon L-selectin stimulation in Jurkat T cells [245, 
602], and has been shown to directly associate with L-selectin tail upon stimulation with 
sulfatides, where it forms a signalling complex involving c-Abl and ZAP-70 kinases [602]. 
It has also been shown that p56lck-dependent tyrosine phosphorylation of L-selectin tail 
upon mAb binding was associated with formation of L-selectin/Grb2/SOS complex and 
activation of Rac2 activity via Ras in Jurkat T cells [245]. That the two groups found 
different p56lck-dependent signalling complexes associated with L-selectin tail suggests 
either that the signalling pathways downstream of L-selectin tail are ligand-dependent 
(i.e. mAb versus sulfatides), or that ligation can activate multiple signalling pathways 
simultaneously. Furthermore, p56lck-dependent Ras activation was also found after L-
selectin ligation with sLex or fucoidan [88, 245, 246], and L-selectin-mediated activation 
of Ras and Rac2 results in actin polymerisation [246]. In Jurkat T lymphocytes, L-selectin 
clustering with mAb or fucoidan leads to marked increase in the activity of another protein 
kinase – JNK – and this is dependent on p56lck and Rac1 [603]. Upregulation of Rac1 
activity upon L-selectin/fucoidan ligation was independently shown in another report, 
where active Rac1 was seen as soon as 1 minute after binding [566].  
Oxidative burst (superoxide, O2-, synthesis) or potentiation of TNF-α- or fMLP-induced 
oxidative burst was shown following cross-linking of L-selectin [89, 604] or upon mAb 
binding [245]. Superoxide is not the only secondary messenger produced upon ligation 
of L-selectin ectodomain. Increase in “calcium flux”, a transient increase in free cytosolic 
Ca2+, which is known to elicit various cellular responses has also been reported. 
Specifically, L-selectin cross-linking has been shown to induce calcium flux in human 
primary neutrophils [89, 601, 604], however, binding of sulfatides also lead to transient 
increase in free Ca2+ in murine CD4+ T cells [90]. Both O2- synthesis and calcium flux 
required activation of tyrosine kinases or MAPK [245, 601], which is in agreement with 
the above-described L-selectin-mediated signalling pathways. However, a distinct 
tyrosine/MAP kinase-independent signalling pathway has also been shown to be 
triggered downstream of L-selectin. Cross-linking of L-selectin has been observed to 
activate neutral  sphingomyelinase in Jurkat T cells, which resulted in hydrolysis of  
cellular sphingomyelin and in release of ceramide [605]. Ceramide is a known secondary 
messenger regulating various cellular functions, including inflammatory responses [606, 
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607]. This demonstrates that signalling downstream of L-selectin is a complex process 
that branches out into multiple signalling pathways both dependent and independent on 
tyrosine kinase or MAPK activity. 
In addition to the effects L-selectin outside-in signalling has on the leukocytes on which 
it is expressed, signalling through L-selectin might be involved in mediating the 
inflammatory response in a much broader manner. Induced expression of mRNA for IL-
8 and TNF-α has been seen in human neutrophils upon sulfatide binding [88], and an 
increase in c-Abl-dependent expression of macrophage colony stimulating factor (M-
CSF)-1 was observed upon stimulation of L-selectin with mAb in Jurkat T cells and 
neutrophils [608]. It is thus plausible that secretion of these cytokines could augment the 




Ligand Cell type Consequence of binding Notes Citation 
X-linking Human neutrophils, 
PBL, 
Jurkat T lymphocytes, 
300.19 pre-B cells, 




 Patching  
 Redistribution of L-selectin to DRM that was dependent on L-
selectin tail 
 Calcium flux, oxidative burst (O2- generation), potentiation of 
oxidative burst caused by fMLP and TNF-α , 
 Increased adhesion through β2 integrins1 
 Co-localisation with active CD18  
 Upregulation of Mac-1, adhesion via MAC-1 that was dependant 
on MAPK phosphorylation2   
 Potentiation of IL-8 or PAF induced Mac-1 dependant adhesion 
 Potentiation of SDF-1-induced adhesion to HUVEC 
 Increased transmigration through cytokine stimulated HUVEC, 
and towards SDF-1 
 Activation of neutral sphingomyelinase resulting in consumption of 
sphingomyelin and production of ceramide 
 Upregulation of CXCR4 
 CaM/ERM interaction in cis 
 L-selectin shedding 
1Occured in 
neutrophils and 
naïve, but not 
memory T cells 
2Phosphorylation of 
p38 increased at 1 




increased at 1 
minute but 













GlyCAM-1 Human neutrophils, 
PBL, 
Jurkat T lymphocytes 
 Redistribution of L-selectin to DRM (dependent on L-selectin tail)  
 Adhesion through β1 integrins 
 Activation of β2 integrins1 
1Naïve, but not 






Jurkat T lymphocytes, 
Human leukemic CEM 
cells, 
Jurkat T lymphocytes, 
Murine lymphocytes 
U937 monocytic cell 
line 
 
 MAPK phosphorylation1 
 p56lck dependent tyrosine phosphorylation of L-selectin tail and 
MAPK, formation of L-selectin/Grb2/SOS complex and activation 
of Rac2 and O2- synthesis via Ras 
 Actin filament polymerisation that was dependent on activation of 
Ras and Rac2 
 Upregulation of JNK activity that was dependent on p56lck and 
Rac1 
 Expression of M-CSF-1 that was dependent on c-Abl kinase 
 CaM/ERM interaction in cis2 
1Also Fab fragments 
to a lesser extent 




this interaction was 









 Enhanced chemotaxis towards SLC that was dependent on L-
selectin levels and was mediated by PKC, MAPK and Syk family 
kinases3 
3Also observed upon 






300.19 pre-B cells 
 Upregulation of Mac-1 
 Association with cytoskeleton in DRM 
 [87, 587] 
E-selectin Human neutrophils  Patching  
 MAPK-dependent rapid co-localization and capping of L-selectin 
and PSGL-1 on neutrophils in suspension which was critical for 
boosting CD11b/CD18 activity1  
 Co-clustering of L-selectin and PSGL-1 results in transition from 
rolling to arrest 
1CD18 clustering did 
not co-localise with 




Sulfatides Human neutrophils, 
Murine CD4+  
T cells, K562 myeloid 
cell line, human 
monocytes, 
granulocytes and PBL, 
Jurkat T lymphocytes 
 MAPK phosphorylation,  
 Calcium flux dependent on tyrosine kinases and MAPK 
 Enhanced expression of mRNAs for IL-8 and TNF-α 
 Upregulation of CXCR41  
 Tyrosine phosphorylation of p56lck itself and p56lck dependent 
tyrosine phosphorylation of L-selectin tail, formation of L-
selectin/ZAP-70/c-Abl complex  
1Murine CXCR4 
upregulation was not 
L-selectin dependent 





sLex Jurkat T lymphocytes, 
PBL 
 Tyrosine phosphorylation of L-selectin and MAPK and activation 
of Ras that was p56lck dependent 
 [245] 
Fucoidan Jurkat T lymphocytes,  
PBL 
 
 p56lck dependent tyrosine phosphorylation of L-selectin and MAPK 
and activation of Ras 
 Soluble fibronectin binding1 
 Upregulation of JNK  
 Upregulation of CXCR4 
 Upregulation of Rac1 
1Soluble fibronectin 
was bound by Jurkat 
T lymphocytes and 
naïve T cells but not 




Table 1.3 Inside-out signalling evoked by L-selectin ectodomain ligation. Ligation of L-selectin ectodomain triggers clustering and signalling downstream of L-
selectin tail. Clustering can be caused by antibodies or ligands. L-selectin-dependent signalling has been shown to affect multiple cellular functions. Consequences of 
L-selectin ligation are summarised in this table alongside the factors used for the ectodomain engagement “X-linking” indicates treatment with anti-L-selectin 
monoclonal antibody followed by cross-linking with secondary antibody. “Patching” indicates formation of large L-selectin clusters at the cell surface. For abbreviations 




1.12 REGULATION OF L-SELECTIN FUNCTION BY INSIDE-OUT SIGNALLING 
Although the majority of the current literature describes the outside-in signalling that 
follows the ligation of L-selectin ectodomain (section 1.11 above), reports can be found 
where L-selectin’s activity is modified by signals generated intracellularly (inside-out 
signalling). At this point, it has to be made clear that this section addresses changes in 
L-selectin activity other than ectodomain shedding (section 1.9.2), which occurs upon 
cell activation and is a result of intracellular signalling events. Neutrophil activation with 
granulocyte colony stimulating factor (G-CSF) or macrophage CSF (M-CSF) or T cell 
activation through CD2 or CD3 markedly enhanced the ability of these cells to bind 
PPME (polyphosphomonoester core derived from yeast, a known physiological L-
selectin ligand mimic) [92]. The stimuli did not alter surface L-selectin levels as measured 
by flow cytometry [92], suggesting that the observed effects were due to modification of 
L-selectin’s affinity for ligand. Additionally, pre-incubation of lymphocytes with lineage 
specific stimuli resulted in increased adhesion to HEV, which occurred in an L-selectin 
dependent manner [92]. Furthermore, it has been shown that exposure of PBL and 
300.19 cells expressing L-selectin to fever-range hyperthermia (40°C) caused a 
significant increase in the association of L-selectin with DRM as measured by flow 
cytometry [560]. Additionally heat-treated PBL showed 1.6- to 2-fold increase in the L-
selectin-dependent adhesion to HEV in PLN cryosections in vitro and in homing to PLN 
and Peyer’s patches in vivo [560, 610].  The hyperthermia-induced L-selectin-mediated 
effects were dependent on the cytoplasmic tail as the LDcyto L-selectin mutant (lacking 
11 terminal amino acids) did not translocate to DRM and 300.19 cells expressing LDcyto 
did not have increased adhesion to HEV in vitro [560]. Increased adhesion was 
subsequently attributed to the soluble factors secreted by heat-treated leukocytes, as 
when PBLs maintained at 37°C were incubated with supernatants from PBLs cultured at 
40°C, similar extent of increased adhesion was observed [610]. The possible 
mechanisms by which these factors could increase adhesion in L-selectin dependent 
manner were not investigated, and the factors themselves are unknown. Interestingly, 
febrile temperatures did not alter total L-selectin protein levels or surface levels, as 
analysed by Western blotting or flow cytometry, respectively, and did not increase L-
selectin’s affinity for carbohydrate ligands as measured by PPME binding [610]. 
However, PBLs cultured in 40°C showed increased immunogold labelling of L-selectin 
molecules on microvilli, without any changes in overall microvilli morphology or number 
[610]. This raises the possibility that fever-range hyperthermia causes alterations in L-
selectin’s conformation that expose epitopes for gold-labelled mAbs [610]. As high 
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temperatures are known to increase membrane fluidity [611], this could be a pre-requisite 
to or a result of L-selectin translocation to DRM.  
The studies discussed above demonstrate that, much like outside-in signalling, inside-in 
signalling can modify L-selectin function in a number of ways. Hence, L-selectin outside-
in and inside-out signalling together are likely to form a multifaceted signalling network 
that regulate numerous cellular functions during the leukocyte adhesion cascade.  
1.13 L-SELECTIN AND DISEASE 
Genetic variations are known to cause or contribute to many diseases and a number of 
genetic variations in the L-selectin gene have been identified. They are defined as single-
nucleotide polymorphisms (SNPs), where differences in single nucleotides result in the 
existence of two alternate alleles. Allele frequency, and hence genotype distribution, 
often differ between patients and controls, implying that certain alleles associate with 
disease susceptibility. SNPs within the coding sequence of L-selectin result in amino 
acid substitution and have been identified as T49S (threonine or serine at position 49 
within the lectin domain), F206L (phenyloalanine or leucine at position 206 within the 
EGF domain), P213S (proline or serine at position 213 within the SCR domain) and 
S238P (serine or proline at position 238, SCR domain). No SNPs have been found in 
the transmembrane or cytosolic domains, and T49S has not been linked to any disease 
so far. An increase in the allele frequencies of F206L SNP of the L-selectin gene, and 
the associated F/L genotype was observed in Tunisian patients with inflammatory bowel 
disease as compared to controls [612]. Additionally, the L allele in F206L SNP was linked 
to higher risk for development of brucellosis in patients of Iranian Caucasian origin [613], 
but proved protective in development of Type 1 diabetes in subjects of Polish Caucasian 
origin [614]. P213S polymorphism is thought to contribute to susceptibility to Type 2 
diabetes (T2D), insulin resistance, Grave’s disease and coronary artery disease in the 
Chinese population, and the P allele appears to be the risk factor [513, 615-617]. 
Genotype 213PP is also a genetic risk factor for the development of nephropathy during 
T2D in Japanese patients [618]. No association between P213S polymorphism and T2D 
has been found in the study on Romanian population [619], suggesting that L-selectin 
gene polymorphism is influenced by ethnicity. Interestingly, in European and North 
American white population the P213S donor-recipient incompatibility could possibly be 
associated with kidney transplant survival [620]. Generation of L-selectin constructs 
harbouring the relevant SNPs could help to understand the described above pathological 
and protective mechanisms, which in turn could fuel new therapeutic approaches. One 
such study was indeed performed, where cells transfected with 238S variant of L-selectin 
showed marked reduction in rolling on and adhesion to IL-1β-stimulated HUVEC in vitro 
[514]. The reduction in L-selectin-dependent adhesion was proposed to play a role in the 
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pathogenesis of immunoglobulin A nephropathy in patients with S238P SNP, observed 
earlier by the same group [480]. Of note, recent availability in genome wide sequencing 
resulted in great number of Ensembl (on-line genome database for vertebrates and other 
eukaryotic species) submissions, reporting other variations found in lam-1 gene. 
Identified variations include copy-number variations (CNV), duplications, inversions, 
insertions and deletions [621]. Although links between these variations and disease have 
not been identified yet, it can be expected that some, if not all, of these alterations would 
have a profound effect on L-selectin protein function. For example, CNV and duplications 
could result in elevation of L-selectin protein levels, altered leukocyte trafficking and 
disease. 
From the L-selectin SNP/disease associations and various reports mentioned in this 
chapter, it can be seen that L-selectin plays a role in the pathogenesis of the chronic 
inflammatory diseases. The most notorious of all chronic inflammatory diseases is 
atherosclerosis – the main cause of CVD and death worldwide. Recruitment of L-
selectin-positive classical monocytes during atherosclerosis progression (section 1.6.2) 
[279, 280, 300], as well as the accumulation of L-selectin ligands in the atherosclerotic 
plaques (section 1.8.3) [468-476] suggest the involvement of L-selectin in the pathology 
of this disease. In keeping with this, a role for L-selectin in atherosclerosis has been 
reported. These studies are descried in more detail in section 1.13.1 below. 
1.13.1 L-selectin and atherosclerosis 
The first report to imply L-selectin’s involvement in pathogenesis of atherosclerosis was 
published by Eriksson et al. (2001), who showed that L-selectin-mediated secondary 
capture accounts for 20-50% of all leukocyte capture on atherosclerotic lesions [20]. 
Subsequently, existence of MECA-79-nonreactive ligands on the aortic ECs and L-
selectin-dependent primary capture in atherosclerosis was proposed by Galikna et al. 
(2006) [622].  These ligands were thought to mediate 50-57% of total T and B cell homing 
to the aortic endothelium before and during development of atherosclerosis as 
established through studies on L-selectin deficient mice [622]. In line with this hypothesis, 
MECA-79-nonreactive L-selectin ligands were found on both resting and cytokine-
stimulated aortic endothelium, and supported monocyte adhesion in vitro [460]. 
Interestingly, a recent study stresses the importance of neovessels for leukocyte 
recruitment during later stages of atherosclerosis [299]. Eriksson (2011) showed that a 
network of microvessels that penetrate the advanced plaques serve as entry points for 
extravasating leukocytes [299]. Surprisingly, PSGL-1, a known leukocyte CAM, was 
found to be expressed by microvessel endothelium [299]. Primary interactions between 
the endothelial PSGL-1 and leukocyte L-selectin were established to mediate virtually all 
leukocyte recruitment that occurred via the microvessels [299]. Hence, it appears that L-
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selectin plays a dual role in the leukocyte recruitment during atherosclerosis 
development. L-selectin recruits leukocytes to the aortic ECs through both primary and 
secondary capture mechanisms, and facilitates leukocyte entry to the advanced lesions 
from the microvessels through direct binding of endothelial PSGL-1. On the other hand, 
a contradictory report showed that L-selectin null mice had a two-fold increase in the 
plaque area during the early stages of atherosclerosis progression [623]. The same 
report found no differences in the atherosclerotic burden between L-selectin null and WT 
mice during later stages of the disease, and no changes in the plaque cellular 
composition between the two mouse strains at neither of the stages [623]. This report 
suggests that L-selectin does not promote atherosclerosis, but rather has a protective 
role in the early development stages. However, this study investigated lesion formation 
through the assessment of plaques in the descending aorta, but the cellular composition 
was examined in the plaques derived from aortic sinuses [623]. Therefore it cannot be 
excluded that L-selectin-dependent recruitment contributed to the formation of lesions in 
the descending aorta. Taken together, a strong link between L-selectin and 
atherosclerosis exists, however more research is required to explain current 
controversies. For example, the generation of transgenic mice expressing L-selectin-
GFP chimera could help to directly visualise trafficking and distribution of L-selectin-
positive leukocytes during development of atherosclerosis.   
1.13.2 Therapeutic implications of L-selectin 
Due to its prominent role in mediating the inflammatory response in both acute and 
chronic inflammation, as well as its association with many chronic diseases, L-selectin 
is an attractive target for therapy. L-selectin has been shown to be modulated by non-
steroidal anti-inflammatory drugs (NSAIDs). NSAIDs are commonly known to exert their 
action through inhibition of cyclooxygenase (COX), however it now becomes clear that 
a group of NSAID also stimulate cell surface NADPH-oxidase to generate superoxide 
anion, which in turns activate ADAM17 on neutrophils [624]. This causes L-selectin 
shedding and thus prevents neutrophil attachment to ECs in vitro [624-626]. Anti-L-
selectin compounds are continually being tested at various stages of pre-clinical and 
clinical trials. For example, aselizumab, a humanised anti-L-selectin antibody, was tested 
for its ability to decrease posttraumatic inflammatory response in the multiple injured 
patients [627]. However, despite being well tolerated by the study subjects, it did not 
outperform the placebo [627]. Some hopes are presently attached with the L- and P-
selectin ligand PSGL-1-IgG chimera (drug name YSPSL) that has shown no adverse 
effects in Phase II trial, and is currently undergoing further tests in trials on renal allograft 
rejection [628].  
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Academic research plays a central role in discoveries that drive novel therapeutic ideas. 
An exciting report, published last year by Bernal et al. (2012), demonstrates that transient 
transfection of cardiac mesoangioblasts with L-selectin greatly improves the ability of 
these cells to home to the damaged heart tissue in a mouse model of myocardial 
infarction [629]. Cardiac mesoangioblasts are mesenchymal stem cells that can 
differentiate into cardiomyocytes [630]. Augmented recruitment of L-selectin 
transfectants resulted in much better heart tissue regeneration as compared to 
unmodified cardiac mesoangioblasts [629]. This report opens up a new opportunity for 






















1.14 ORIGINAL HYPOTHESIS 
The role of L-selectin in leukocyte tissue infiltration has been currently allocated mainly 
to mediating leukocyte tethering and rolling as well as to the activation of integrin-
dependent adhesion. However, an emerging body of evidence suggests that L-selectin 
plays a prominent role during migration of leukocytes beyond the vessel wall. The event 
of transendothelial migration links intra- and extra-vascular locomotion of leukocytes. It 
is therefore proposed that L-selectin might be directly involved in the exit of leukocytes 
from the vasculature and in to the surrounding space. Furthermore, it is postulated that 
shedding of L-selectin is likely to play a role in regulating TEM. L-selectin-dependent 
migration of monocytes is of particular interest given the strong association of both L-
selectin and monocytes with chronic inflammatory disease. Hence, the ultimate goal of 
this PhD project is to establish the role that L-selectin and its shedding may play during 
monocyte TEM. 
1.15 AIMS OF THE PROJECT  
To test the hypothesis produced in section 1.14, a number of aims were established for 
this project: 
1. To generate and characterise monocytic cell line expressing WT L-selectin-GFP 
to visualise the sub-cellular distribution of L-selectin without the use of 
monoclonal antibody. 
2. With the use of sheddase-resistant and cytoplasmic serine mutants of L-selectin, 
determine its spatio-temporal distribution during TEM, which would provide clues 
to: 
a) When and where in the cell shedding of L-selectin occurs. 
b) What the relative contribution of the intracellular and extracellular 
domains are in this process. 
3. To investigate whether other molecules known to act during the adhesion 
cascade have an effect on L-selectin clustering, which would give insight in to 
outside-in and inside-out signalling mechanisms.  
4. To determine how L-selectin shedding and clustering may influence monocyte 








CHAPTER 2. MATERIALS AND METHODS 
2.1 CELL CULTURE REAGENTS, CHEMICALS, BUFFERS AND SOLUTIONS 
Tabulated list of cell culture media, reagents, buffers and solutions used in this thesis is presented in table 2.1. 
 Product/Material Supplier Ingredients (Recipe)/Stock Storage 
Cell 
Culture 
RPMI (Roswell Park Memorial 
Institute)-1640 + 5 mM L-glutamine 
Gibco® Invitrogen, U.K. Manufacturers Recipe +4°C 
Foetal Calf Serum Gibco® Invitrogen, U.K. N/A -20°C 
EGM-2 Media BulletKit Lonza Walkersville Endothelial Growth 
Medium supplemented with hEGF, 
Hydrocortisone, FBS (Fetal Bovine 
Serum), GA-1000 (Gentamicin, 
Amphotericin-B),VEGF, hFGF-B, R3-
IGF-1, Ascorbic Acid, Heparin 
+4°C 
Fibronectin Sigma-Aldrich®, Germany 1 mg/mL  
HBSS (Hank’s Buffered Saline 
Solution)  
Gibco® Invitrogen, U.K. 1.26 mM Calcium-, 0.493 mM 
magnesium-, 5.33 mM potassium- and 
137.93 mM sodim chloride, 0.407 mM 
magnesium sulfate, 0.441 mM 
potassium phosphate monobasic, 4.17 
mM sodium bicarbonate, 0.338 mM 
sodium phosphate dibasic (Na2HPO4) 
anhydrous, 5.56 mM D-Glucose, 0.026 
mM phenol red 
+4°C 
OPTIMEM® Gibco® Invitrogen, U.K. Manufacturers Recipe (complete 
formulation is confidential) 
+4°C 





Luria Bertani (LB) media Sigma-Aldrich®, Germany 20 g in 1 litre ddH20 RT 





Cytobuster™ Protein Extraction 
Reagent 
Novagen®, Germany N/A RT 
Poly-L-lysine (PLL) Sigma-Aldrich®, Germany 0.1% (w/v) manufacturers solution +4°C 
STE buffer Made in house 10 mM Tris-HCl, pH 8.0, 150 mM NaCl, 
1 mM 
EDTA 
On ice upon 
preparation 
GFP-Trap® Wash/Dilution Buffer Made in house 10 mM Tris/Cl pH 7.5, 150 mM NaCl, 
o.5 mM EDTA, 25 nM calyculin A, 5 µM 
bisindolylmaleimide 
On ice upon 
preparation 
GFP-Trap® Lysis Buffer Made in house 10 mM Tris/Cl pH 7.5, 150 mM NaCl, 
o.5 mM EDTA, 0,5% NP-40, 25 nM 
calyculin A, 5 µM bisindolylmaleimide 




Sigma-Aldrich®, Germany 1M +4°C 
PBS (Phosphate Buffered Saline), pH 
7.4 
Severn Biotech® Ltd, U.K. 0.8% sodium chloride (w/v), <0.1 % 
potassium chloride (w/v), <0.2% 
monosodium phosphate (w/v), <0.1% 
potassium phosphate (w/v), 0.1% 
sodium azide (w/v)  
RT 
Coomassie Blue R350 Staining 
Solution 
Fluka®, Sigma-Aldrich, Germany 0.25 g of powder in 500 mL, 50% 
methanol, 40% ddH20, 10% acetic acid 
(v/v) 
RT 
Coomassie Blue De-stain solution Made in house 50% methanol, 40% ddH20, 10% acetic 
acid (v/v) 
RT 
GelCode™ Blue Stain reagent Thermo Scientific, U.K. N/A RT 
6x DNA loading buffer Made in house 30% glycerol (v/v), 0.25% (w/v) 
bromophenol blue (w/v), 0.25% xylene 




4x Protein Loading Buffer Made in house 200 mM Tris-HCl pH 6.8, 8 % SDS 
(v/v), 20%  glycerol (v/v), 0.4 
bromphenol-blue % (w/v), 3.6% β-
mercaptoethanol (v/v) 
RT 
2x Protein Loading Buffer Made in house 100 mM Tris-HCl pH 6.8, 4 % SDS 
(v/v), 10%  glycerol (v/v), 0.2 
bromphenol-blue % (w/v), 1.8% β-
mercaptoethanol (v/v) 
RT 
30% bovine serum albumin (BSA) 
(sterile 
filtered) 
Sigma-Aldrich®, Germany N/A  +4°C 
Tris-buffered saline (TBS) solution Made in house 150 mM NaCl/15 mM Tris-HCl, pH 7.4 
in ddH20 
RT 
10x TAE (400 mM Tris-Acetate and 
10 mM EDTA) buffer 
Invitrogen®, U.K. N/A RT 
20x MES (2-morpholinoethanesulfonic 
acid, 
monohydrate)-SDS Buffer (Running 
Buffer) 
Invitrogen®, U.K. N/A RT 
20x Novex® NuPAGE® transfer buffer Invitrogen®, U.K. N/A RT 
Novex® NuPAGE® Sharp® Ladder 
protein standard solution 
Invitrogen®, U.K. N/A -20°C 




Perkin-Elmer LAS, inc. U.S.A. N/A +4°C 
Milk buffer High Street Supermarket 5% dry milk powder, w/v in TBS with 
0.1% NP-40 substitute 
+4°C 
Western blotting “stripping buffer” Made in house 62.5 mM Tris-HCl pH 6.7, 2% SDS 
(v/v), 100 mM β-mercaptoethanol 
RT 





Buffer P1 at 
+4°C 
QIAprep® Maxiprep DNA isolation kit Qiagen, U.K. As per manufacturer’s instructions RT, upon 
RNAse A 
addition 
Buffer P1 at 
+4°C 
QIAquick Gel Extraction Kit Qiagen, U.K. As per manufacturer’s instructions RT 
Ampicillin Sigma-Aldrich®, Germany 100 mg/mL -20°C 
Methanol Fisher Scientific, U.S.A. N/A RT 
Isopropanol Fisher Scientific, U.S.A. N/A RT 
Glutaraldehyde GPR™ N/A +4°C 
β-mercaptoethanol Sigma-Aldrich®, Germany N/A RT 
Di-methyl-sulphoxide 
(DMSO; cell culture 
tested) 
Sigma-Aldrich®, Germany N/A RT 
TRIZMA® base Sigma-Aldrich®, Germany Used to make 1 M Tris.HCl (pH 6.8, 7.4 
or 8,0) in ddH20 
RT 
Sodium Chloride (NaCl) Sigma-Aldrich®, Germany 1 M in ddH20 RT 
Glycerol Sigma-Aldrich®, Germany N/A RT 
Triton-X100 Sigma-Aldrich®, Germany N/A RT 
Nonidet P-40 substitute (NP-40) Fluka®, Sigma-Aldrich, Germany N/A RT 
Tween-20 Sigma-Aldrich®, Germany N/A RT 
SDS Sigma-Aldrich®, Germany 20% in H2O manufacturer’s solution RT 
Glutathione Sepharose 
4B® beads 
GE Healthcare®, U.K. 50% ethanol/beads slurry +4°C 
GFP-Trap®  A Chromotek, Germany Small GFP-binding protein coupled 
to agarose beads (Manufacturers 
composition) 
+4°C 
Ethylene Diamine-tetraacetic acid 
(EDTA) 









0.1 M in ddH20  -20°C 
Phenyl-methyl-sulfonylfluoride 
(PMSF) 
BioChemica, Germany 200 mM in methanol -20°C 
1,4-Dithio-DL-threitol (DTT) Sigma- 
Aldrich®, Germany 





Calyculin A Sigma- 
Aldrich®, Germany 
20 μM in DMSO -80°C 
Bisindolylmaleimide Calbiochem® 1mM -20°C 
Protease Inhibitor Cocktail Sigma- 
Aldrich®, Germany 
N/A -20°C 
Novex® NuPAGE® Bis-Tris 4-12 % 
gradient gels, 10 wells, thickness: 1.0 
or 1.5 mm 





32.5 μM in ethanol -20°C 
Sodium Fluoride (NaF) Sigma- 
Aldrich®, Germany 
powder RT 
Sodium ortho-vanadate (Na3VO4) Sigma- 
Aldrich®, Germany 
0.5 M in ddH20 RT 
Recombinant Human Tumor Necrosis 
Factor alpha (TNF-α) 
R&D systems 100 µg/mL -80°C 
Recombinant Human Monocyte 
Chemoattractant protein 1 (MCP-
1)/CCL2/JE 
R&D systems 100 µg/mL -20°C 
Recombinant Human CXCL1/GRO 
alpha 
R&D systems 100 µg/mL -20°C 
Ro-31-9790 Kind Gift from Ann Ager, 30 mM in DMSO -20°C 
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University of Cardiff, Cardiff, U.K. 
LY-374973, N-[N-(3,5-
Difluorophenacetyl)-L-alanyl]-S-
phenylglycine t-butyl ester (DAPT) 
Sigma- 
Aldrich®, Germany 
18 mg/mL in DMSO -20°C 
Ro-31-8220 Calbiochem®, Merck KGaA, 
Germany 
500 μM in ddH20 -20°C 
Paraformaldehyde (PFA) BDH Laboratory 
Supplies, U.K. 






0.2 mg/mL in methanol -20°C 
Table 2.1 Reagents used during this research project. Other chemical/reagents used may be noted in the text, and the supplier was Sigma-Aldrich®, 




Tabulated list of primary antibodies used in this thesis is presented in table 2.2., and 
secondary antibodies in table 2.3. 










GFP Rabbit Polyclonal IgG 200 Santa Cruz 
Biotechnology 










Rat Monoclonal IgG2B 100 Santa Cruz 
Biotechnology 
Anti-CD43 CD43 Mouse Monoclonal IgG1 200 Santa Cruz 
Biotechnology 












PECAM-1 Mouse Monoclonal IgG1 205 Dako 
Anti-EEA1 EEA1 Mouse Monoclonal IgG1 250 BD 
Transduction 
Laboratories™ 








564 (R) and 
558 (M) 
Rabbit Polyclonal ? ? Cell Signaling 
Technology® 
Anti-RhoA RhoA Mouse Monoclonal IgG1 200 Santa Cruz 
Biotechnology 
Anti-Rac1 Rac1 Mouse Monoclonal IgG2b 1000 Merck Millipore 
Anti-
Cdc42 
Cdc42 Mouse Monoclonal IgG1 1000 Abcam 
Anti-actin Beta-actin Goat Polyclonal IgG 200 Santa Cruz 
Biotechnology 
Anti-CCR2 CCR2 Rabbit Monoclonal IgG 1000 Abcam 
IgG1 N/A Mouse Monoclonal IgG1 200 Santa Cruz 
Biotechnology 
IgG N/A Rabbit Polyclonal IgG 200 Abcam 
Table 2.2 List of primary antibodies used in this thesis. Dilutions at which the antibodies 
were used are described in specific sections of “Materials and Methods” or within 
results chapters. All antibodies were purchased from the indicated supplier, apart from 
DREG56, which was purified from hybridomas in house. ‘?’ indicates unavailable 
information. See Abbreviations section for description of abbreviations. 
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Mouse Immunoglobulins Rabbit 970 Dako 
Goat anti-
mouse-RPE 
Mouse Immunoglobulins Goat 1000 Dako 
Goat anti-
mouse-HRP 
Mouse Immunoglobulins Goat 1000 Dako 
Goat anti- 
rabbit-HRP 
Rabbit Immunoglobulins Goat 250 Dako 
Rabbit anti- 
goat-HRP 















Goat Immunoglobulins Donkey 2000 Moleccular 
Probes® 
Invitrogen® 
Table 2.3 List of secondary antibodies used in this thesis. Dilutions at which the antibodies 
were used are described in specific sections of “Materials and Methods” or within 
results chapters. See Abbreviations section for description of abbreviations. 
 
2.3 CLONING 
Human L-selectin cDNA was amplified by PCR (see section 2.4) from pCMV6-AC-GFP 
vector (OriGene). PCR primers were designed with BamHI and XhoI restriction sites 
engineered at 5’ and 3’ ends, respectively (forward primer: 5’-
GAGAGAGGATCCGGTACCGAGGAGA-3’; reverse primer 5’-
GAGAGACTCGAGATATGGGTCATTCATACTTCTC-3’). PCR products amplified by 
Pfu DNA polymerase (Stratagene) were excised from 0.8 % agarose gels and purified 
using QIAquick Gel Extraction kit (Qiagen) according to manufacturer’s protocol. The 
pHR’SIN-SEW  lentiviral backbone vectors were provided by Prof. Adrian Thrasher 
(Institute of Child Health, UCL) and were carrying either enhanced green fluorescent 
protein (eGFP, from now on referred to as GFP) or red fluorescent protein (RFP) C-
terminal tags. The vectors were named pHR’SIN-SEW-GFP or pHR’SIN-SEW-RFP 
according to the fluorescent tag they were bearing.  The vectors were linearised by 
double digestion with BamHI and XhoI restriction enzymes (New England Biolabs, NEB) 
according to manufacturer’s protocol (NEB). Digests were resolved on a 0.8% agarose 
gel and the vector was purified with a QIAquick Gel Extraction kit according to 
manufacturer’s protocol. Purified vectors were dephosphorylated with calf intestinal 
alkaline phosphatase (CIP, from NEB) for 1 hour at 37ºC and cleaned from the reaction 
mixture using QIAquick Gel Extraction Kit according to manufacturer’s protocol.  The 
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vectors were then ligated with the insert with a molar vector to insert ratio of 1:3. Ligation 
was performed by T4 DNA ligase (Promega) in a 10 µL reaction at 4ºC overnight prior to 
transformation (see section 2.7). Colonies were selected and grown overnight to 
generate plasmid preps using a QIAprep® Miniprep DNA isolation kit (Qiagen, U.K.) and 
following manufacturer’s protocol. The open reading frames were subsequently 
sequenced by Geneservice using primers targeting sequences approximately 100 bp 
upstream of the L-selectin start codon (primer Frd1: 5’- 
GCGCTTCTGCTTCCCGAGCTCTAT-3’), approximately 300 bp into the ORF (primer 
Frd2: 5’- GACGTGGGTGGGAACCAACAAATCT-3’) and approximately 700 bp into the 
ORF (primer Frd3: 5’ CCACCTGTGGACCATTTGGAAACTG-3’). Collectively, the design 
of these primers ensured that the entire open reading frame was sequenced. 
2.4 POLYMERASE CHAIN REACTION (PCR) 
PCR amplifications were performed using 1 μL (10 μM) of each primer (synthetized by 
Sigma-Aldrich) and 100 ng of DNA template.  PCR reactions were performed in a 50 μL 
reaction volume, using thin walled PCR tubes in a thermo cycler (Perkin Elmer, 
GeneAmp PCR System 2400) using the following conditions:  hot-start denaturation 
95C 5 min, denaturation 95C 30 seconds*, annealing 55C 40 seconds*, elongation 
72C (30 seconds per 500 bp)*, end 72C 2 min.   (*Repeated for 25 cycles). 
PCR reactions were mixed with 6x DNA loading buffer (table 2.1) and separated by gel 
electrophoresis on agarose gels supplemented with ethidium bromide or SafeView™ dye 
as described in section 2.6.  PCR products were visualized using UV detection of before 
being purified, cloned and dispatched for sequencing. 
2.5 IN VITRO PCR MUTAGENESIS AND SEQUENCING OF THE MUTANTS 
The pHR’SIN-SEW plasmid containing the cDNA of human WT L-selectin fused with 
GFP or RFP (pHR’SIN-SEW-L-selectinWT-GFP or pHR’SIN-SEW-L-selectinWT-RFP (for 
cloning method see section 2.3) was used as a template for generating mutations.  A 
QuickChange™ (Stratagene) PCR in vitro mutagenesis protocol was employed in order 
to generate the S364A, S367A, SSAA, ΔM-N, ΔM-N SSAA S364D, S367D, SSDD and 
R357A mutants (single amino acid names for Serine [S], Aspartate [D] and Arginine [R]) 
using the pHR’SIN-SEW-L-selectinWT-GFP plasmid and SSAA, ΔM-N and ΔM-N SSAA 
using the pHR’SIN-SEW-L-selectinWT-RFP plasmid. Briefly, polymerase chain reaction 
(PCR) mutagenesis reaction was followed by 1 hour digestion with DpnI restriction 
enzyme (NEB). This step involves the cleavage of methylated, but not unmethylated 
DNA. Note that methylated DNA is derived from bacterially synthesised DNA, and not 
PCR synthesised DNA (where the mutation has been generated). DpnI restriction 
enzyme (1 µL) was added to 50 µL PCR mutagenesis reaction at 37ºC, and then 1 µL of 
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the mixture was used to transform competent bacteria (section 2.7). The open reading 
frames of all the mutants were subsequently sequenced by Geneservice using primer 
Frd3 (see section 2.3) to ensure insertion of the desired mutations into the L-selectin tail 
and once this was confirmed, the ORFs were sequenced with primers Frd1 and Frd2 to 
ensure no spontaneous mutations appeared within the insert during the mutagenesis 
procedure.  Two-step mutagenesis was applied when obtaining ΔM-N mutant as deletion 
of eight amino acid codons in single PCR reaction was not considered likely. Therefore 
two sets of primers were designed: ΔMIKE and ΔMIKEGDYN. Once the ΔMIKE pair of 
primers was successfully used – as confirmed by sequencing – to delete MIKE amino 
acid sequence, ΔMIKEGDYN pair of primers was used to further delete GDYN amino 
acid sequence. When generating ΔM-N SSAA mutants, pHR’SIN-SEW-L-selectinΔM-N-
GFP/RFP plasmid was used as a template for the SSAA primers.  All the primers used 
for in vitro PCR mutagenesis during this thesis are shown in table 2.4.  
Mutation Primer Sequence 
S364A Frd GATTAAAAAAAGGCAAGAAAGCCAAGAGAAGTATGAATGA
CC 
 Rev GGTCATTCATACTTCTCTTGGCTTTCTTGCCTTTTTTTAATC 
S367A Frd GGCAAGAAATCCAAGAGAGCTATGAATGACCCATATCAC 
 Rev GTGATATGGGTCATTCATAGCTCTCTTGGATTTCTTGCC 
SSAA Frd GGCAAGAAAGCCAAGAGAGCTATGAATGACCCATATCAC 
 Rev GTGATATGGGTCATTCATAGCTCTCTTGGCTTTCTTGCC 
ΔMIKE Frd CAAAAGTTTCTCACCCCTCTTCATTC 
 Rev GAATGAAGAGGGGTGAGAAACTTTTG 
ΔMIKEGDYN Frd GACAAAAGTTTCTCAGGTGATTATAACCCC 





S367D Frd GGCAAGAAATCCAAGAGAGATATGAATGACCCATATCAC 
 Rev GTGATATGGGTCATTCATATCTCTCTTGGATTTCTTGCC 
SSDD Frd GGCAAGAAAGACAAGAGAGATATGAATGACCCATATCAC 







Table 2.4 Sequences of the mutagenesis primers. This table outlines all the mutagenesis 
primers that were used during this project. The primers are all written in the direction of 
5’ to 3’.Frd, forward primer; Rev, reverse primer.   
 
2.6 AGAROSE GEL ELECTROPHORESIS 
PCR products were mixed with 6x gel loading buffer (table 2.1) and resolved by 
electrophoresis on a 0.8% 1x tris-acetate-EDTA (TAE) (Invitrogen) agarose gels with 
ethidium bromide (1:10 000) or SafeView™ (1:500).  Gels were resolved at 120V until 
the bands had been adequately separated (normally, when the dye front had reached 
the bottom of the gel.  Gels were visualized by UV transillumination and digital images 
were acquired.  Product sizes were determined by using DNA ladders (GeneRuler™ or 
NEB).   
2.7 TRANSFORMATION OF ESCHERICHIA COLI BL-21 AND PLASMID 
PURIFICATION 
For every transformation, 50 l of competent BL-21 Escherichia coli (E. coli) (kindly 
provided by Alison Brewer) were slowly thawed on ice and allowed to mix with 200-1000 
ng of plasmid or 1 l of PCR mutagenesis reaction for 1 hour on ice. Alternatively, 2 l 
of ligation reaction were added to 50 l One Shot® TOP10 Chemically Competent E. coli 
(Invitrogen). The genotype of TOP10 cell is similar to DH10B™ strain.  Following 30 
minute-long incubation on ice, bacteria were heat-shocked by submerging tubes into a 
water bath pre-heated at 42C for 45 seconds, and then rapidly cooled on ice for a further 
10 minutes.  LB (200 l) was added to each transformation reaction and incubated 
shaking in a 37C for 1 hour. The transformation (200 µL) was plated out onto a pre-
warmed appropriate antibiotic treated LB agar plates and allowed to culture at 37C 
overnight for colony formation.  The following morning colonies were picked and cultured 
in 3 mL of LB supplemented with the appropriate antibiotic for around 8 hours. Bacteria 
were subsequently harvested for plasmid isolation using QIAprep® Miniprep DNA 
isolation kit (Qiagen, U.K.) according to manufacturer’s protocol (see below). 
Alternatively 1 mL was inoculated in to 100 mL of LB supplemented with the appropriate 
antibiotic and bacteria were cultured overnight. Following day bacteria were harvested 
by centrifugation at 4,000 rpm (SORVALL® Legend RT, U.K.) for 45 minutes at 4°C and 
plasmid isolation was performed using QIAprep® Maxiprep DNA isolation kit (Qiagen, 
U.K.) according to manufacturer’s protocol. Briefly, both QIAprep® Mini- and Maxiprep 
DNA isolation kits are based on alkaline lysis of bacterial cells. The lysis if followed lysate 
preparation, clearing and immobilisation of liberated DNA onto silica membranes within 
a spin column under high salt conditions. The DNA pellets obtained after washing and 
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elution from the spin column were dissolved in ddH2O and the concentration determined 
by measuring the OD260 using NanoDrop spectrophotometer (Thermo Scientific, U.K.). 
The quality of the DNA was assessed by monitoring OD260/OD280 ratio and was 
deemed acceptable if determined to be close to the value of 1.8 absorbance units.  
2.8 PROTEIN ANALYSIS 
2.8.1 SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE) of extracts derived 
from THP-1 cells and HUVEC. 
Cells were harvested by centrifugation at 1200 rpm (SORVALL® Legend RT, U.K.), 
samples were lysed in appropriate volume of CytoBuster™ Protein Extraction Reagent 
(Novagen, U.K.) supplemented with 1x protease inhibitor cocktail (Sigma-Aldrich®, 
Germany) and four times concentrated protein loading buffer (PLB) was added. Samples 
were incubated at 95 ºC for 5 minutes and the denatured proteins were then resolved by 
polyacrylamide gel electrophoresis on pre-cast Novex® NuPAGE® 4-12% Bis-Tris 
gradient gels (Invitrogen®, U.K.) in MES-SDS buffer at constant 100-200 V until the dye 
front left the gel. Novex® sharp pre-stained protein standard molecular weight markers 
(Invitrogen) were used for all gels. 
2.8.2 Protein gel staining  
Proteins resolved on polyacrylamide gels as described in section 2.8.1 were often 
directly stained using Coomassie Blue R350® staining solution or GelCode® Blue Safe 
Protein Stain (Thermo Scientific, US) (table 2.1). For the Coomassie Blue staining, the 
gels were incubated with 20-30 mL of Coomassie staining solution for 15-30 min in a 
plastic 14-cm diameter dish. Gels were subsequently incubated with Coomassie destain 
solution (table 2.1) (until the protein bands were clearly visible over the background 
staining. For GelCode® staining, the gels were first prefixed with a 50% methanol (v/v) 
and 7% acetic acid (v/v) solution for 15 minutes at room temperature (RT) and then 
washed three times for five minutes with approximately 100 ml of ultrapure water.  
Further incubation with ultrapure water was continued until the protein bands became 
clearly visible. Gels were stored in sterile water at 4 °C and scanned in with a 
commercially available scanner (LI-COR®). 
2.8.3 Immunoblotting (Western blotting) 
Polyacrylamide gels were transferred to polyvinylidene fluoride (PVDF) Immobilon-P® 
(Millipore®, U.K.) transfer membranes that had been pre-wetted with 100% methanol 
and then equilibrated in transfer buffer, using the NuPAGE® transfer module (Invitrogen, 
U.K.). Transfer was carried out at 25 V for two hours. Subsequently, membranes were 
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blocked in 5% milk in TBS (Tris-buffered saline) supplemented with 0.1% NP40 (TBSN) 
for 1 h at RT. Immunodetection of proteins of interest was performed with the use of 
appropriate primary antibody at a dilution of 1:500 in blocking solution at 4ºC with 
continuous agitation overnight. The next day, membranes were washed in TBS for five 
minutes, then in TBSN for ten minutes, then in TBS for 5 minutes and finally blocked in 
5% milk in TBSN for 60 min at RT. Subsequently, horseradish peroxidase (HRP)-
conjugated secondary antibody was added at a dilution of 1:3,000 for another hour and 
then membranes were washed again as described above. For detection of CaM, the 
PVDF membranes were rinsed with PBS once for 5 minutes, incubated for 15 minutes 
at RT in 20 mL of 0.25% glutaraldehyde in PBS and washed with TBS before the first 
blocking step. The TBS wash step serves to quench any excess reactive glutaraldehyde 
carried over from the initial fixation step. Treatment with glutaraldehyde prevented CaM 
protein from being washed from the membrane during the labelling procedure. After 
thorough washing in TBS, the membrane was blocked, and labelled as described above. 
Protein detection was performed using Western Lightning™ chemiluminescent reagent 
(Perkin Elmer®, U.S.A) as directed by manufacturer, followed by exposure of 
membranes to SuperRX X-ray films (Fuji®, Japan). Films were developed using a 
Compact X4 automatic X-ray film developer (X-ograph imaging Systems, U.K.). When 
detectin MCP-1 whose molecular weight was similar to the MW of beta-actin used as a 
loading control, the primary and secondary antibodies used to detect MCP-1 were 
removed and membrane re-probed with anti-actin antibody. This was achieved by 
incubation of the membrane with “stripping buffer” (Table 2.1) at 60°C for 30 minutes.  
The membrane was then washed in TBSN for 10 min at RT and probed with the 
secondary antibody to confirm the removal of the previous signal. Once this was verified, 
the membrane was blocked with 5% milk in TBSN for 60 min at RT and detection of actin 
was performed according to the protocol described above. 
2.8.4 GFP-Trap® Immunoprecipitation 
Immunoprecipitation of wild type and mutant forms of L-selectin-GFP fusion protein and 
GFP protein were performed using commercially available GFP-binding protein 
covalently conjugated to agarose beads (GFP-Trap®_A, Chromotek, Germany).In brief, 
GFP-Trap® is a high quality GFP-binding protein coupled to agarose beads.  The 
manufacturer’s protocol was used with minor adjustments. Briefly, 30 million THP-1 cells 
expressing wild type or mutant forms of L-selectin-GFP fusion protein or just GFP protein 
were harvested and washed with 10 mL PBS (to remove any traces of albumin from 
tissue culture). Each cell pellet was then resuspended in 200 µL of lysis buffer (10 mM 
Tris/Cl pH 7.5, 150 mM NaCl, 0.5 mM EDTA, 0.5% NP40, 25 nM calyculin A, 5 µM 
bisindolylmaleimide) supplemented with 1x protease inhibitor cocktail (Sigma-Aldrich®, 
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Germany) and the samples were incubated on ice for 30 minutes with extensive pipetting 
performed every 10 minutes. Phosphatase inhibitor calyculin A and kinase inhibitor 
bisindolylmaleimide were added to ensure that protein phosphorylation status was 
preserved in the immunoprecipitation assay. The lysates were centrifuged at 20,000 x g 
(eppendorf centrifuge 5417R, Eppendorf®, Hannover, Germany) for 10 minutes at 4 °C 
and obtained supernatant was transferred to a fresh pre-cooled eppendorf tube and 550 
µL of dilution/wash buffer (10 mM Tris/Cl pH 7.5, 150 mM NaCl, 0.5 mM EDTA, 25 nM 
calyculin A, 5 µM bisindolylmaleimide) was added per sample. The lysate (50 µL) was 
then mixed with 50 µL of 2x protein loading buffer (PLB) and the samples were boiled at 
95 °C for 5 min. These were later used to determine the total levels of protein within a 
given cell lysate (input). The remaining cell lysate was then added to 25 µL of GFP-
Trap® beads that had been pre-equilibrated with the dilution/wash buffer (three washes), 
and beads/lysate mixture was incubated overnight at 4 °C under rotation. The bead 
pellets were subsequently washed three times with dilution/wash buffer and then 100 µL 
2x PLB was added per sample. Finally, the resuspended beads were boiled at 95 °C for 
10 min in order to free the immunocomplexes from the beads. The beads were collected 
by centrifugation at 2,700 x g (eppendorf centrifuge 5417R, Eppendorf®, Hannover, 
Germany) for 2 minutes at 4 °C, and the supernatant loaded and resolved on 
polyacrylamide gels (see section 2.8.1). 
2.8.5 Densitometry analysis 
Conventional scanner (EPSON® Perfection 2400) was used to scan developed X-ray 
films. Scanned images were quantified by using ImageJ® software version 1.43 
(National Institutes of Health, U.S.A.). Fold-changes were determined on the basis of the 
signal intensities amongst all the selected bands. These intensities were then normalised 
against the signal intensity of a protein deemed as “loading control”, for example, actin. 
The results were expressed as a “fold change” against the control in any given 
experiment. 
2.9 PURIFICATION OF GST FUSION PROTEINS  
Glutathione-S-transferase (GST)-fusion proteins of Rho GTPase effector domains were 
kindly provided by John G. Collard, Netherlands Cancer Institute, Amsterdam, the 
Netherlands. Three different GST-fusion proteins were used: p21-binding domain of PAK 
(PAK-PBD), Cdc42/Rac interacting domain (cassette) of the Wiskott-Aldrich syndrome 
protein (WASP-CRIB-C) and the Rho-binding domain of Rhotekin (Rhotekin-C21). All 
GST-fusion proteins were expressed in E. coli BL-21, which were grown in LB-medium 
containing 0.1 mg/mL ampicillin over night at 37 °C under aerobic agitation. On the 
following day, cultures were diluted 1:20 in fresh LB-medium and incubated at 37 °C 
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under agitation.  Once the approximate OD600 of 0.8 was reached, expression of GST-
fusion proteins was induced with 0.5 mM IPTG (table 2.1) for 2.5 hours at 30 °C. Cultures 
were subsequently centrifuged for 45 min at 3,000 rpm at 4 °C (SORVALL® Legend RT, 
U.K.) and the bacterial cell pellets frozen at -80 °C. The frozen pellet from a 150-mL-
culture was thawed on ice and resuspended in 2.25 mL of ice-cold STE buffer (10 mM 
Tris-HCl, pH 8.0, 150 mM NaCl, 1 mM EDTA) supplemented with 1 mM PMSF (table 
2.1). The suspension was then homogenised finally with a 19G hyperdermic needle 
(Kendall, U.K.). Subsequently, 100 μg/mL of lysozyme (Sigma-Aldrich®, Germany) was 
added to the suspension and the mixture incubated on ice for 15 minutes. Consequent 
addition of 5 mM DTT, 1% Tween-20 (v/v) and 0.03% SDS (v/v) led to a change in 
viscosity upon mixing, which indicated that lysis of the bacteria had occurred. The lysate 
was then centrifuged (eppendorf centrifuge 5417R, Eppendorf®, Hannover, Germany) 
for 20 min at 14,000 rpm at 4 °C. The supernatant was then added to 100 μL of 
glutathione Sepharose 4B® beads (GE Healthcare®, U.K.), which had been pre-
equilibrated in STE buffer (three washes), and incubated for 1 h at 4 °C under rotating 
conditions. After the binding of the purified GST-proteins to the beads had occurred, 
beads were centrifuged and washed three times with STE buffer for three minutes at 
1,200 rpm (eppendorf centrifuge 5417R, Eppendorf®, Hannover, Germany) at 4 °C. The 
yield was determined by comparison to a linear BSA calibration standard by protein 
electrophoresis. Representative Commassie-stained gel is shown in figure 2.1. Beads 
were best used within 24 h of production. 
 
Figure 2.1 Determining protein concentration of GST-fused effector domain bound to 
glutathione sepharose beads.  Increasing amounts of BSA (3, 12, 18, 24, 27 and 30 μg) are 
resolved in the first six lanes of the polyacrylamide gel. The concentration range normally loaded 
is between 3- and 30-μg BSA. M = molecular weight standards (from bottom to top: 10, 15, 20, 
30, 40, 50, 60, 80, 110, 160 and 260 kDa). B = 5 μL of glutathione beads boiled and loaded onto 
the last lane of the gel. Coomassie staining of the polyacrylamide gel reveals that 5 μL of beads 





prepared in this example carries the equivalent of approximately 10 μg of protein. This particular 
example shows yield of PAK-PBD. 
 
2.10 RHO GTPASE ACTIVATION ASSAYS 
Ten million THP-1 cells expressing wild type or mutant forms of L-selectin-GFP or just 
GFP were harvested from cell suspension, washed with 5 mL PBS and resuspended in 
1 mL of ice cold lysis buffer (10 mM MgCl2, 1 mM EDTA, pH 8.0, 25 mM HEPES pH 7.0, 
150 mM NaCl, 2% glycerol (v/v), 1% Triton X-100 (v/v), 1 mM Na3VO4, 50 nM NaF, 25 
nM calyculin A) supplemented with 1x protease inhibitor cocktail (Sigma-Aldrich®, 
Germany). Immediately after resuspension, the samples were span down at 14,000 rpm 
(eppendorf centrifuge 5417R, Eppendorf®, Hannover, Germany) for 10 min, which 
incorporated both lysis and centrifugation. The lysate (50 µL) was then mixed with 50 µL 
of 2x protein loading buffer (PLB) and the samples were boiled at 95 °C for 5 min. These 
were later used to determine the total levels of RhoGTPase within a given cell lysate. 
The remaining part of the lysate was mixed with approximately 40 µg of GST-fusion 
RhoGTPase bait protein conjugated to the glutathione sepharose beads (see section 
2.9) and the beads/lysate mixture was incubated for 1 hour at 4 °C under rotation. After 
the incubation step was completed, the beads were washed three times with 1 mL of the 
cell lysis buffer and then 20 µL of 2x PLB was added per sample. The samples were 
boiled at 95 °C for 10 min and allowed to cool down. Finally, the samples were loaded 
and resolved on polyacrylamide gels (see section 2.8.1). 
2.11 LENTIVIRAL GENE DELIVERY AND GENERATION OF STABLE CELL LINES 
2.11.1 Lentiviral production in HEK 293T packaging cell line 
Lentiviral particles carrying C-terminally GFP- or RFP-tagged L-selectin were produced 
using HEK 293T packaging cell line and pCMVΔR8.91 or psPAX2 (envelope) and 
pMD.G (packaging) helper vectors. HEK 293T cells were plated one day prior to 
transfection at a density of 10 - 15 x 106 cells per dish (diameter of 14 cm). On the day 
of transfection 30 µg pCMVΔR8.91 or psPAX2, 10 µg pMD and 40 µg pHR’SIN-SEW-L-
selectin-GFP (or –RFP) or pLenti CMV Puro DEST (w118-1) carrying sequences for Rho 
GTPase Raichu probes, were added to 4 mL OPTIMEM (GIBCO®, Invitrogen) in one 
tube and 1 µL of 10 mM polyethylene imine (PEI) was added to 4 mL of OPTIMEM in a 
second tube (the amounts of DNA and volumes of OPTIMEM and PEI described were 
for 1 dish of HEK 293T cells, and if more dishes were used, the reagents were adjusted 
accordingly). The tubes were mixed together and incubated in RT for 15 minutes. Culture 
media was aspirated off HEK 293T cells and the transfection mixture was added onto 
105 
 
the packaging cells in a dropwise manner (8 mL per dish). After 4 hours of incubation 
transfection media was aspirated and fresh media was added. Cell supernatants 
containing lentivirus particles were collected 48 hours after transfection (1st harvest), 
new media was added and then supernatant was collected again after 72 hours post-
transfection (2nd harvest). Supernatants form both harvests were pooled and 
subsequently filtered with 0.45 µm filter (MILLEX® GP) and either frozen in -80ºC or 
concentrated by ultracentrifugation. 
2.11.2 Lentivirus concentration 
Lentiviral particles produced as described in section 2.11.1 were concentrated by 
ultracentrifugation. Ultracentrifugation was performed in 11.5 mL tubes in TH641 rotor at 
50, 000 xg (SORVALL® Discovery ultracentrifuge) for two hours at 4ºC. After 
ultracentrifugation, supernatant was decanted and 50 µL of RPMI (supplemented with 
10% FCS (v/v) and 1% penicillin/streptomycin (v/v)) was added to a small yellowish pellet 
residing at the bottom of each tube and incubated on ice for 40 minutes. The pellets were 
then resuspended in the added volume, the volumes pooled together, aliquoted in 50 µL 
and stored in -80ºC until used. Concentrated virus was subsequently titrated before 
transduction of THP-1 cells took place. 
2.11.3 Measuring lentiviral titres 
In order to establish lentiviral titres, HEK 293T cells were plated in 24-well plates, at a 
density of 1 x 105 cells/well (day 0). On the day of transduction, HEK 293T cells were 
counted and serial dilutions of the concentrated lentivirus (10-6 to 10-1) were added onto 
the cells (day 1). On day 2, media was changed and on the day 4 media was removed, 
cells taken off with trypsin/EDTA, resuspended in PBS and analysed in duplicates by 
flow cytometry. When lentiviral particles carrying L-selectin-GFP or Raichu CFP/YFP 
construct were titrated, percentage of positive cells was determined by obtaining direct 
FACS data of either GFP or YFP expression levels, respectively. When lentiviral particles 
carrying L-selectin-RFP were titrated, cells were first stained with mouse anti-L-selectin 
DREG56 antibody and then α-mouse secondary RPE-conjugated antibody and L-
selectin expression was determined by obtaining flow cytometry data of the RPE 
fluorescence. Virus titre was established from cells that were ideally 1-30% transduced 
to ensure that multiple integrations were avoided and calculations were done within the 
linear range. Titres were calculated according to the following equation: T= PxN/DxV, 
where T = titre, P = GFP/YFP/RFP positive cells, D  = dilution and V = volume. Titres for 
all the lentiviral particles generated throughout this project are shown in Table 2.5.        
Lentiviral vector plasmid Gene of interest Titre (x 108 i.u./mL) 
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pHR´SIN-SEW WT L-selectin-GFP 2.128 
pHR´SIN-SEW GFP 2.56 
pHR´SIN-SEW S364A L-selectin-GFP 2.18 
pHR´SIN-SEW S367A L-selectin-GFP 2.56 
pHR´SIN-SEW SSAA L-selectin-GFP 6.3 
pHR´SIN-SEW ΔM-N L-selectin-GFP 2.84 
pHR´SIN-SEW ΔM-N SSAA L-selectin-
GFP 
13.3 
pHR´SIN-SEW WT L-selectin-RFP 12.56 
pHR´SIN-SEW SSAA L-selectin-RFP 2.71 
pHR´SIN-SEW ΔM-N L-selectin-RFP 1.87 
pHR´SIN-SEW ΔM-N SSAA L-selectin-
RFP 
4.4 
pLenti CMV Puro DEST 
(w118-1) 
CFP/YFP RhoA Raichu 
probe 
10.56 
pLenti CMV Puro DEST 
(w118-1) 
CFP/YFP Rac1 Raichu 
probe 
9.2 
pLenti CMV Puro DEST 
(w118-1) 
CFP/YFP Cdc42 Raichu 
probe 
9.1 
Table 2.5 Lentivirus titres. The table shows titres in infection units (i.u.) per mL of all 
concentrated lentivirus suspensions generated throughout this research project. See 
Abbreviations section for abbreviations used. 
 
2.11.4 Transduction of THP-1 cells 
THP-1 cells were resuspended at the density of 0.4 x 106 cells/mL on a day prior to the 
transductions. The next day, 1 x 106 cells were harvested, centrifuged and resuspended 
in fresh media into which lentivirus suspension was added (total volume of media and 
lentivirus suspension was 1 mL). Volume of concentrated virus that was added per 
transduction was found on the basis of the titre and desired multiplicity of infection (MOI) 
accordingly to the following equation: (Number of cells transduced) x (MOI)/(Titre) = (mL 
of virus). The MOIs used were that of 5, 7 or 20. The cells were then placed in the CO2 
incubator at 37 °C and fed fresh media two days after the transduction. Four days after 
the transduction the entire media was replaced with fresh media.  
2.12 CELLS AND CELL CULTURE 
All cells were cultured in a 5% CO2 incubator at 37°C. 
2.12.1 THP-1 cells (Acute Monocytic Leukemia, human) 
THP-1 cell line was purchased from American Type Culture Collection (ATCC). Cells 
were maintained in RPMI-1640 (GIBCO®, Invitrogen) medium supplemented with 10% 
FCS, 1% antibiotics (penicillin/streptomycin) and 0.05 mM β-mercaptoethanol (BME), 
referred to as “THP-1 media”. For cell line maintenance, cells were seeded at a density 
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of 0.3-0.5 x 106 cells/mL and split every 2-3 days when the density reached 0.7-0.9 x 
10x6 cells/mL. Cells were seeded at 0.4 x 106 cells/mL one day prior to any given 
experiment.  
2.12.2 HEK 293T cells (Human Epithelial Kidney cells) 
HEK 293T cells were a kind gift from Dr Yolanda Calle (Cancer Division, King’s College 
London). Cells were maintained in RPMI-1640 medium supplemented with 10% FCS 
and 1% antibiotics (penicillin/streptomycin). Medium was renewed every 2-3 days and 
cells were passaged with a subcultivation ratio of 1:3 to 1:6.  
2.12.3 Human umbilical vein endothelial cells (HUVEC) 
HUVEC were purchased from Lonza and were maintained in EGM-2 growth media 
supplemented with appropriate growth factors (Lonza) (Table 2.1), 10% FCS and 1% 
antibiotics (penicillin/streptomycin) in fibronectin-coated (10 µg/mL) tissue culture dishes 
(14 cm diameter). Cells were initially expanded for 6 passages. For passaging, media 
was aspirated and cells washed once with sterile PBS. Two millilitres of trypsin-EDTA 
(Sigma-Aldrich®, Germany) was added on to cells and the cells were incubated in a 5% 
CO2 incubator at 37°C until all HUVEC cells detached from the plates. EGM-2 media 
was then added (8 mL) to neutralise the action of trypsin and the cells were centrifuged 
(SORVALL® Legend RT, U.K.) for 5 minutes at RT. Cell pellets were then resuspended 
in fresh EGM-2 media and seeded in to plastic tissue culture dishes. After 6 passages, 
HUVEC were cryopreserved (section 2.12.4) and were again re-cultured prior to the 
experiments. Media was changed in to fresh every second day,  and cultures were used 
for experiments when reached confluence (3–5 days).   
2.12.4 Cryopreservation of cells 
Cells destined for cryopreservation were grown in log phase for a couple of days before 
freezing. Approximately 10 million cells were harvested, and the cell pellet was 
resuspended in 10% DMSO and 90% FCS (v/v) and placed in a single pre-cooled 
Corning® freezing vial. The vials were immediately placed on ice and transferred to -80 
°C freezer. After 24 hours, vials were transferred to liquid nitrogen for long-term storage. 
For re-culturing, frozen cells were rapidly thawed in a water-bath at 37 °C and thawed 
suspension added to 9 mL of fresh cultivation media. After 5 minutes of centrifugation 
(SORVALL® Legend RT, U.K.), the cell pellets were resuspended in fresh media, placed 
into tissue culture flasks and flasks placed in the incubator for culturing.  
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2.13 FLOW CYTOMETRY 
2.13.1 Technical equipment 
All samples were analysed on a FACSCalibur flow cytometer (BD Biosciences). All 
fluorophores were excited at λ 488 nm and GFP and FITC fluorescence was detected at 
λ 530 nm (FL-1 channel) and RPE fluorescence was detected at λ 588 nm (FL-2 
channel). Direct detection of RFP was not possible as the available flow cytometer was 
not equipped a laser capable of exciting RFP. Therefore, L-selectin-RFP-expressing 
cells were analysed by labelling with mouse anti-L-selectin DREG56 and then anti-
mouse-FITC conjugated secondary antibody. Data were acquired and analysed with 
CellQuest™Pro Version 4.0.2 (BD Biosciences) acquisition and analysis software.  
2.13.2 Antibody labelling procedure 
All cells were labelled on ice in 96-well plates. Primary and secondary antibody 
incubations were 30 and 15 minutes in duration, respectively. All centrifugation was 
performed at 4°C and at 1200 rpm (SORVALL® Legend RT, U.K.) for 1 minute. All 
washes were performed using 10% FCS in HBSS (GIBCO®, Invitrogen) or THP-1 media 
(RPMI-1640 medium supplemented with 10% FCS, 1% penicillin/streptomycin and 0.05 
mM BME) supplemented with 25mM HEPES to ensure Fc receptors blockage by FCS. 
After approximately 100,000 cells per sample were harvested, the cells were 
centrifugated, supernatant discarded, and cells were washed. THP-1 cells were 
subsequently labelled with either primary antibodies or appropriate IgG isotype control 
antibodies, all at 1:80 dilution in 50 μL. The cells were then washed three times and 
incubated with anti-mouse-RPE/FITC-conjugated secondary antibodies at 1:20 dilution 
in a 50 μL volume. After incubation with secondary antibodies, cells were washed three 
times, each sample resuspended in 150 μL of washing buffer/media and then added to 
200 μL of PBS that had been pre-added to glass FACS tubes (BD Falcon™). The 
samples prepared in this way were subsequently analysed by flow cytometry. Analysis 
of cells were performed exclusively on the “live gate”. These were determined based on 
their distinctive scatter pattern. A minimum of 10,000 cells were counted for each sample 
in every experiment and samples were performed in triplicate. Data from shedding 
experiments are represented as percentage of L-selectin surface expression relative to 
untreated cells after adjustment for background fluorescence with control isotype-
matched antibody-stained cells. 
2.14 PARALLEL PLATE FLOW CHAMBER ASSAY 
All cells were resuspended in THP-1 media (RPMI-1640 medium with 10% FCS, 1% 
penicillin/streptomycin and 0.05 mM BME)  supplemented with 25 nM HEPES buffer prior 
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to the perfusion assays, referred to as “perfusion media”. HEPES is a CO2-independent 
buffering system and its addition ensured that media pH was maintained at physiological 
levels during the perfusion assays where no CO2 supply was present. 
When interaction of THP-1 cells with HUVEC was analysed, HUVEC monolayer was 
grown to confluency and stimulated with 10 ng/mL TNF-α overnight. 
2.14.1 Technical equipment 
All experiments were performed in 37°C, 5% CO2 incubator (SolentScientific) and 
visualized using Olympus IX81 time-lapse inverted fluorescence microscope connected 
to a Hamamatsu C10600 ORCA-R2 digital video camera. A Harvard syringe pump 
(Harvard Apparatus®, U.S.A) was used to generate a flow rate of 0.25 mL/min 
(corresponding to 1.24 dyn/cm2, which is a physiological shear stress of the blood flow). 
Images were acquired into a video file (Volocity® Imaging software, Perkin Eelmer). 
Schematic of the parallel plate flow chamber as well as a photograph of assembled 





Figure 2.2 Parallel plate flow chamber system. A) Three steps of parallel plate flow assembly. 
Step 1: top part of the chamber containing inlet/outlet ports as well as a vacuum port was attached 
to the silicon gasket. Step 2: inlet, outlet and vacuum tubes were attached to their respective 
ports. Step 3: Vacuum force was applied and the apparatus was “sucked” onto a glass coverslip 
on which HUVEC cells were grown. B) Diagram illustrating the complete system used for the 
parallel plate flow chamber assay. In brief, the assembled chamber was placed over the objective 
of an inverted microscope in an environmental chamber heated to 37°C. A syringe pump applied 
suction force that drew the cell suspension through the chamber with a set flow rate (set by a 
syringe refill rate). The flow through waste was collected in the syringe. Video footage of the 
microscope image was recorded by a CCD (charge-coupled device) camera with video recorder 
connected to the computer acquired with Volocity visualisation and analysis software.   
 
2.14.2 Cell co-perfusion experiments 
Experiments were performed as co-perfusions where two THP-1 cell lines were co-
perfused at 1:1 ratio.  Prior to the flow chamber assays, one of the cell lines was labelled 
with 10 nM Cell Tracker® Green (Molecular Probes®, Invitrogen®, Paisley, U.K.) and 



















HBSS (without serum) for 10 minutes in 37 °C. The cells were then harvested by 
centrifugation (SORVALL® Legend RT, U.K.), washed and resuspended in perfusion 
media at total density of 0.5 x 106 cells/mL. The cells were perfused over TNF-α activated 
HUVEC, grown in 6-well plastic dishes, for ten minutes. The footage was recorded from 
the moment the pump was switched on using a x4 objective, and four separate fields of 
view were acquired per experiment. Three frame-views per minute were acquired for the 
phase contrast, the GFP channel (to visualise Cell Tracker® Green) and the RFP 
channel (to visualise Cell Tracker® Orange).  The footage was analysed using Volocity 
software (PerkinElemer, U.S.A). Number of recruited cells was counted manually.   
2.14.3 Perfusion of cells for confocal microscopy, FLIM/FRET and pseudopod 
dynamics analysis 
For these experiments HUVEC were grown on 35 mm diameter sterile glass coverslips 
(ThermoScientific, Germany) that were pre-coated with 10 µg/mL fibronectin. Cells in the 
perfusion media were perfused over TNF-α activated HUVEC at a density of 0.25 x 106 
cells/mL and the footage was acquired for 15 minutes for three separate fields of view 
using x10 objective. Four frame-views per minute were acquired for the phase contrast 
and the GFP channel. In experiments where cells were pre-incubated with R0-31-9790 
metalloprotease inhibitor, the inhibitor was added at a working concentration of 30 µM 
30 minutes prior to the assay. After recording was completed, the coverslips were fixed 
with 4% paraformaldehyde (PFA) (w/v) for 20 minutes at room temperature, washed 
three times with PBS and processed either for analysis using confocal microscopy 
(section 2.16) or for FLIM analysis of FRET (section 2.18). The acquired footage was 
analysed using Volocity software (PerkinElemer, U.S.A). Analysis included manual 
counting of cells having one, two or multiple pseudopods. Additionally, still images were 
exported for the purpose of cell spreading area analysis using ImageJ® software 
(section 2.15).      
2.15 CELL SPREADING AREA ANALYSIS 
Video footage from time-lapse parallel-plate flow chamber experiments (section 2.14.3) 
was used to generate still images using Volocity software (PerkinElemer, U.S.A). Two 
stills were generated per field of view, corresponding to early and late time point of 
perfusion, respectively. Three fields of view were acquired per experiment and all 
experiments were repeated on three independent occasions. The images were loaded 
in to ImageJ® software (N.I.H., U.S.A.) and the scale was adjusted. At least 30 cells per 
one still image were analysed. Analysis was performed by outlining the cell shape with 
a drawing tool cursor, and the cell area measurements (in µm2) were automatically 
generated by the ImageJ® software.  
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2.16 CONFOCAL MICROSCOPY 
2.16.1 Technical equipment 
Leica TCS SP5 confocal microscope (Leica Microsystems, Germany) was used to 
acquire all images.  GFP was excited at λ = 488 nm with an Argon laser, whereas TRITC-
phalloidin and Alexafluor®633 were excited with Helium-Neon lasers at λ = 543/568 and 
633 nm, respectively. Images were acquired as single Z-planes or as series of Z-stacks.   
2.16.2 Cell labelling procedure 
For L-selectin-GFP visualisation, cells were perfused over TNF-α activated HUVEC as 
described in section 2.14.3. For biglycan visualisation HUVEC were grown to confluence 
and stimulated with TNF-α or left untreated. Cells were then fixed with 4% PFA in PBS 
(w/v) for 10 minutes at RT and washed 3 times with PBS. Nonident P-40 (NP40) (Fluka 
BioChemika) was then added at a concentration of 0.1% in PBS (v/v) for no more than 
3 minutes in order to permeabilise the cells. Cells were subsequently washed three times 
in PBS and blocked with 5% BSA in PBS (v/v) for 40 minutes at room temperature. For 
early endosome antigen 1 (EEA1) and biglycan staining, samples were incubated with 
anti-EEA1 or anti-biglycan antibody in the blocking solution at 1:500 or 1:300 dilution, 
respectively, for 1 hour at room temperature. Samples were subsequently washed three 
times with PBS and TRITC-phalloidin (1:300 dilution) and appropriate Alexafluor®633-
conjugated secondary antibodies (1:250 dilution) were added in a blocking solution. 
When no additional staining was performed, TRITC-phalloidin (1:300 in blocking 
solution) was added straight after the blocking step. Coverslips were stained at 4°C 
overnight.  Following day, coverslips were washed three times with PBS and mounted 
on a microscopic slide with a use of fluorescent mounting media (DAKO).  
2.16.3 Three-dimensional (3D) rendering 
Z-stacks were acquired with Leica TCS SP5 confocal microscope with the scan speed 
of 200 Hz and 3 line averages per scan. Acquired z-stacks were saved as series of TIFF 
files and imported into Imaris imaging software (Bitplane AG, Switzerland). Three-
dimensional (3D) reconstruction was performed manually using “Volume rendering” task 
for both green and red channels, which corresponded to L-selectin-GFP and TRITC-
phalloidin-stained actin, respectively. Snapshot of the generated 3D image was taken 
and saved as a JPG photograph.   
2.16.4 Analysis of L-selectin-GFP “spots”, “spikes” and “clusters” 
THP-1 cells expressing either wild type or mutant L-selectin-GFP were perfused over 
TNF-α activated HUVEC as described in section 2.14.3. TRITC-phalloidin labelling 
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enabled visualisation of HUVEC actin cables and THP-1 cell protrusions positioned 
underneath the endothelial cells could therefore be identified. Single z-plane images 
were acquired with Leica TCS SP5 confocal microscope. To improve image quality, 
clarity, and accuracy and to reduce noise for single z-plane scans, the scan speed was 
reduced to 100 Hz and line averages were increased to 4 as compared to microscope 
settings used for z-stacks acquisition (section 2.16.3). One image per cell was acquired 
in order to obtain maximal possible magnification. Darkfield images of the GFP channel 
were loaded in to Volocity imaging software and only the protrusions were selected for 
analysis. Analysis was performed using “Find Spots” task, where manual adjustment of 
local fluorescence intensity minima were applied for each image. Clusters were identified 
as large bright L-selectin-GFP agglomerations. Spikes were counted manually. Fifteen 
cells were analysed per experiment and experiments were repeated three times for each 
cell line.     
2.17 L-SELECTIN SHEDDING ASSAYS 
2.17.1 Shedding in response to PMA and TNF-α stimulation 
Cell stimulation with either PMA or TNF-α was followed by analysis of cell surface 
expression of L-selectin. In each case, approximately 100,000 cells were treated in 200 
μL of medium. The medium used was either 10% FCS (v/v) in HBSS or the THP-1 media 
(RPMI-1640 medium supplemented with 10% FCS, 1% penicillin/streptomycin and 0.05 
mM BME), and medium was supplemented with 25 mM HEPES. The stimulation was 
performed at 37ºC and 5% CO2 for 30 minutes (PMA) or 1 hour (TNF-α ). Levels of cell 
surface L-selectin were subsequently determined by flow cytometry as described in 
section 2.13. Experiments were performed in triplicate on at least three independent 
occasions.  
2.17.2 Shedding during static transmigration assay 
HUVEC monolayers were grown to confluence in 6-well plastic dishes and stimulated 
with 10 ng/mL TNF-α overnight. (2 x 105) were added in 1 mL of media per one well of 
HUVEC and incubated for 0, 5, 10, 20, 30 or 60 minutes. The supernatant (unbound 
THP-1 fraction) and HUVEC fraction (bound THP-1 fraction) were then harvested, 
washed once with PBS and lysed in appropriate volume of Cytobuster™ Protein 
Extraction Reagent supplemented with protease inhibitors cocktail (Sigma-Aldrich®, 
Germany). After x4 protein loading buffer addition and sample boiling at 95 °C (5 
minutes), the samples were resolved on polyacrylamide gels as described in section 
2.8.1 and L-selectin-GFP was detected by Western blotting using anti–GFP antibody as 
described in section 2.8.3. 
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2.18 FLIM ANALYSIS OF FRET 
2.18.1 Preparation and labelling of cells  
In order to study clustering of L-selectin, THP-1 cells were double transduced with 
lentivirus carrying WT or mutant L-selectin-GFP followed by the lentivirus carrying WT 
or corresponding mutant L-selectin-RFP. These cells were referred to as GFP/RFP. GFP 
is an excellent donor molecule for FLIM is it exhibits mono-exponential decay kinetics. 
RFP acts as suitable acceptor for GFP as the excitation spectra overlaps with the 
emission spectra of GFP. When investigating clustering of L-selectin during TEM, 
HUVEC were seeded on to 35 mm diameter fibronectin-coated glass coverslips 
(ThermoScientific, Germany) and grown to confluency. Once confluent HUVEC were 
stimulated with 10 ng/mL TNF-α overnight. The GFP/RFP “double expressors” were 
perfused over TNF-α activated HUVECs for 15 minutes (for parallel flow chamber assays 
protocol see section 2.14.3) and then fixed with 4% PFA for 20 minutes at RT. For 
antibody-mediated “Inside-out” L-selectin clustering assays (see section 2.19), poly-L-
lysine (PLL)-coated coverslips were prepared by applying neat PLL to the coverslip (100 
μL) for 20 minutes at room temperature. Excess PLL was aspirated and the coverslips 
were left to dry overnight at room temperature. After antibody labelling, GFP/RFP cells 
were resuspended in PBS and plated on PLL-coated glass coverslips. Binding of cells to 
PLL were performed at RT for 5 minutes. Cells were then fixed with 4% PFA for 20 
minutes at RT. After PFA fixation, the cells were washed 3 times with PBS. Subsequent 
permeabilisation of cells was perfomed with 0.1% NP40 in PBS (v/v) for no more than 3 
minutes the cells were then washed three times with PBS. Sample was subsequently 
treated with 1 mg/mL of sodium boryhydride for 10 minutes. Sodium boryhydride is a 
reducing agent that decreases the background fluorescence, minimising “noise” during 
detection. Samples were subsequently blocked with 5% BSA (v/v) in PBS for 40 minutes 
at room temperature. For experiments investigating L-selectin clustering during TEM, 
Alexafluor®633-phalloidin in at 1:300 dilution in the blocking solution was added. Actin 
staining with Alexafluor®633-phalloidin enabled visualisation of HUVEC actin cables. 
This allowed identification of the z-planes at which THP-1 cells were positioned in respect 
to the endothelial cells (i.e. on top or underneath the HUVEC monolayer). For 
experiments investigating “Inside-out” L-selectin clustering, donkey anti-goat 
Alexafluor®633-conjugated tertiary antibody was added in blocking solution at 1:100 
dilution. Samples were stained at 4°C overnight. The glass coverslips were washed three 
times with PBS and then mounted on the microscopic slides (ThermoScientific, 
Germany) with a use of fluorescent mounting medium (DAKO). Mounted slides were 
dried at 37°C for one hour and then placed in a dark box and stored at +4ºC until analysis 
of protein interactions by fluorescence lifetime imaging microscopy (FLIM) measurement 
115 
 
of FRET was performed. All image collection and data analysis were performed by Dr 
Maddy Parsons (Randall Division of Cell and Molecular Biophysics, King's College 
London). 
2.18.2 Technical equipment and data analysis  
FLIM measurement of FRET was performed with a multi photon microscope system as 
described previously [153, 402]. A Nikon TE2000E inverted microscope combined with 
an in-house scanner and Chameleon Ti:Sapphire ultrafast pulsed multiphoton laser 
(Coherent) was used for excitation of GFP (at 890nm).  Fluorescence lifetime imaging 
capability was provided by time-correlated single photon counting electronics (Becker & 
Hickl, SPC 700). A 40x objective was used throughout (Nikon, CFI60 Plan Fluor N.A. 
1.3) and data were acquired at 500 ± 20 nm through a bandpass filter (Coherent Inc. 35-
5040). Acquisition times of the order of 300 s at low excitation power were used to 
achieve sufficient photon statistics for fitting, while avoiding either pulse pile-up or 
significant photobleaching. Data were analysed as previously described [153, 402]. The 
FRET efficiency is related to the molecular separation of donor and acceptor and the 
fluorescence lifetime of the interacting fraction by:  
 





Where ȠFRET is the FRET efficiency, R0 is the Förster radius, r the molecular separation, 
τFRET is the lifetime of the interacting fraction and τd the lifetime of the donor in the 
absence of acceptor. The donor only control is used as the reference against which all 
other lifetimes are calculated in each experiment. τFRET and τd can also be taken to be 
the lifetime of the interacting fraction and non-interacting fraction, respectively. 
Quantification was made from all pixels within each cell was analysed. All image 
collection and data analysis was performed by Dr Maddy Parsons (Randall Division of 
Cell and Molecular Biophysics, King's College London) using TRI2 software (developed 
by Dr Paul Barber, Gray Cancer Institute, London, U.K.). Cell line generation, staining 
and slide preparation was performed by me, Karolina Rzeniewicz. FLIM data presented 
in this thesis is shown as histograms showing mean FRET efficiency from the stated n 
number of cells from 3 independent experiments, +/- standard error of the mean (S.E.M). 




2.19 ANTIBODY-MEDIATED CROSS-LINKING ASSAYS 
For investigation of “inside-out” signalling leading to L-selectin clustering, THP-1 cells (1 
x 105) double expressing wild type or mutant forms of L-selectin-GFP/RFP were used. 
For analysis of Rho GTPase biosensor activity 1 x 105 THP-1 cells expressing WT or 
ΔM-N L-selectin-RFP and/or CFP/YFP RhoA, Rac1 or Cdc42 biosensors were used.   
Cells washed once with wash media (THP-1 media – RPMI-1640 medium with 10% FCS, 
1% penicillin/streptomycin and 0.05 mM BME –   supplemented with 25 nM HEPES) and 
incubated with antibodies against extracellular epitopes of L-selectin, PSGL-1, JAM-1, 
CD43, CD44 or PECAM-1 (1:50 dilutions in THP-1 media (v/v) supplemented with 25mM 
HEPES). All antibodies were of the same stock concentration (table 2.2). Alternatively, 
the cells were incubated with just THP-1 media. After 30 minutes at 4°C, the cells were 
washed three times with wash media and incubated with appropriate secondary 
antibodies conjugated to Alexafluor®633. After further 30 minutes incubation at 4°C, the 
cells were resuspended in 100 μL PBS and added on to glass coverslips (diameter of 13 
mm, thickness No. 0, VWR International, U.K.) pre-coated with poly-L-Lysine (PLL). PLL-
coated coverslips were prepared by applying neat PLL to the coverslip (100 μL) for 20 
minutes at room temperature. Excess PLL was aspirated and the coverslips were left to 
dry overnight at room temperature. After 5 minutes of incubation at room temperature, 
the excess cells were aspirated off the coverslips and coverslips were fixed with 4% PFA 
(w/v) and labelled for FLIM analysis of FRET as described in section 2.18.1.       
2.20 TRANSWELL MIGRATION ASSAYS 
Transwell chambers (6.5 mm with 5.0µm Pore Polycarbonate Membrane Insert, Corning) 
were used in all assays. When investigating transmigration through HUVEC, the filters 
were coated with 10 µg/mL fibronectin (FN) for 1 hour at 37°C, then excess FN was 
aspirated and 2.5 x 104 HUVEC cells were seeded per filter. HUVEC were grown to 
confluence and stimulated with 10 ng/mL TNF-α on an evening prior to the experiment. 
Appropriate concentrations of chemoattractants were prepared in 0.1% BSA in RPMI 
(v/v). Either 0.1% BSA in RPMI (v/v), 50 ng/mL MCP-1 or increasing (0,1, 3 ,50 ,100) 
ng/mL CXCL-1 chemoattractants (600 µm) were added to the lower compartments of the 
transwell. THP-1 cells were harvested and resuspended in 0.1% BSA in RPMI (v/v) at 1 
x 106 cells/mL. When investigating migration towards MCP-1, in some experiments the 
cells were resuspended in 0.1% BSA in RPMI (v/v) supplemented with 50 ng/mL MCP-
1. This created environment each in MCP-1 but devoid of gradient and was used to 
investigate if cell migration was due to cell chemokinesis (directional movement) or 
chemotaxis (random movement). This technique is known as checkboard analysis. 
Prepared cell suspension (300 µL) was mixed with 300 µL of THP-1 media (RPMI-1640 
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medium supplemented with 10% FCS, 1% penicillin/streptomycin and 0.05 mM BME) 
and kept in 37°C, 5% CO2 until the migration assay was completed. These were referred 
to as “input”. Next, the rest of the prepared cell suspension was added to the upper 
compartments (300 µL per each well)  of the transwell chamber and allowed to 
transmigrate for 2 hours and 15 minutes at 37°C, 5% CO2, and were subsequently 
analysed by flow cytometry. Briefly, 600 µL of 0.1% BSA in RPMI (v/v) (with or without 
chemoattractant), containing transmigrated cells were harvested from each lower 
compartment. Number of events was recorded for one minute and the acquired value 
divided by the value obtained for “input”. This allowed determination of the percentage 
of transmigrated cells. All the experiments were performed in triplicates on three 
independent occasions.   
2.21 STATISTICAL EVALUATION 
All quantified data were collected and processed in Microsoft® EXCEL 2007 (or higher) 
(Microsoft Corporation, U.S.A). Statistical evaluation was performed using GraphPad 
Prism® version 5.02b (or higher) for Windows (GraphPad Software, U.S.A.) with which 
bar and line graph plots were also generated. Statistical tests used to determine 
significant differences were unpaired, two-tailed t-tests and one-way ANOVA (followed 
by Dunnett’s or Tukey’s post-tests), where mentioned in text. Differences were 















CHAPTER 3. GENERATION AND CHARACTERISATION OF A 
MONOCYTE CELL LINE STABLY EXPRESSING L-SELECTIN 
TAGGED TO GREEN FLUORESCENT PROTEIN (GFP) 
3.1 INTRODUCTION 
Monocytes are cells of crucial importance in the outcome of both acute and chronic 
inflammation (section 1.6). L-selectin has been reported to play a role in monocyte 
recruitment to the inflamed venules at the site of infection [631], to the HEV of secondary 
lymphoid organs during an inflammatory response [56], to  the activated endothelium in 
vitro [410, 460] and to atherosclerotic lesions in vivo [299]. However, the molecular 
mechanisms by which L-selectin exerts its function(s) during the adhesion cascade, 
particularly in respect of signalling, remain poorly understood. The fact that L-selectin 
expression has been observed in emigrated monocytes, but not neutrophils, in a 
thioglycollate-induced model of peritonitis, strobly suggests that this cell adhesion 
molecule retains the capacity to function and signal during TEM [527]. 
As described in section 1.7.5.2, the current methods used to visualise the cellular 
distribution of L-selectin rely on labelling of L-selectin with fluorescently conjugated 
mAbs. This approach poses a serious risk to proper data interpretation as engagement 
of L-selectin with mAbs has been shown to trigger L-selectin signalling and lead to 
various cellular responses (section 1.11 and table 1.3). It was therefore decided that 
tagging L-selectin with green fluorescent protein would help address the aforementioned 
issue. In other words, it would provide a “non-invasive” method to monitor the spatio-
temporal distribution of L-selectin during the adhesion cascade.  
Two monocytic cell lines were considered for this study: THP-1 and U937. Both cell lines 
are immortalized human monocyte cell lines that are commonly utilised in leukocyte 
research. Interestingly, U937 cells have been previously used to stably express L-
selectin but the study was limited to investigating the adhesion to endothelial monolayers 
under flow conditions and transendothelial migration was not investigated [410]. It could 
be suggested that, more importantly, the U937 cell line is a monoblast leukemia cell line 
and as a result exhibits a less mature monocytic phenotype than the THP-1 cell line, 
which is a monocytic leukemia cell line [632]. As a result THP-1 cells were chosen to 
serve as a model cell line for the studies presented in this thesis. In order to express 
fluorescently tagged L-selectin in THP-1 cells, a lentiviral transgene delivery system was 
chosen and stable cell lines were generated. 
The cytoplasmic tail of L-selectin is only 17 amino acid long, and green fluorescent 
protein (GFP) is relatively large having 238 amino acids [633]. It was therefore of high 
importance to establish if GFP-tagging of L-selectin tail caused any adverse effects on 
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L-selectin expression, form and function. Hence, the hypothetical influence of the GFP 
tag on the behaviour of L-selectin was rigorously tested.  
This chapter describes the successful generation of monocyte THP-1 cell lines stably 
expressing GFP-tagged to the C-terminus of L-selectin and control THP-1 cell line 
expressing GFP alone. The results outlined in the latter sections of this chapter show 
that L-selectin-GFP chimera stably expressed by THP-1 monocytes exhibited correct 
localisation, and no overt alterations in physiological characteristics as compared with 
wild type L-selectin. 
3.2 EXPERIMENTAL DESIGN 
As described in section 3.1, in order to analyse the subcellular distribution of L-selectin 
in monocytes during the leukocyte adhesion cascade, it was decided that the THP-1 
monocyte cell line would be used to express fluorescently tagged L-selectin. THP-1 cells 
were purchased from the American Type Culture Collection (ATCC) to guarantee the 
true identity of the cell line. When choosing tags to be linked to the protein of interest, 
two options are available: C- and N-terminal tags. L-selectin is a type I transmembrane 
protein, which means N-terminal tagging would ligate GFP to the extracellular domain 
and C-terminal tagging would ligate GFP to the cytosolic tail. As described in section 
1.7.1, the very N-terminal part of L-selectin comprises the ligand-binding lectin domain 
and thus fusing a tag on this side would likely interfere with L-selectin functionality, as 
well as appropriate delivery to the plasma membrane (as the very N-terminus contains 
the pro-domain and leader sequence for membrane targeting). In conclusion, the 
favoured position for tagging L-selectin with a fluorescent tag was at the C-terminal 
cytoplasmic tail.  
Two ways of protein expression can be achieved in cells: transient and stable. The 
obvious advantage of the latter method is a long-term protein expression. The stable 
expression also prevents any adverse effects that might be caused by transiently 
transfecting cells. In addition, transient transfection is highly ‘stressful” for the cell and 
requires subjection to high voltage. Stressed cells often shed their L-selectin. Therefore 
it was decided to achieve stable expression of fluorescently tagged L-selectin in THP-1 
monocytes.       
Lentiviruses are known to infect leukocytic cell lines with high efficiency and were chosen 
as a transgene delivery method for stable cell line generation. Human L-selectin cDNA 
was cloned into the lentiviral backbone plasmid carrying open reading frames (ORF) of 
enhanced GFP (eGFP, hereafter referred to as GFP) or red fluorescent protein (RFP), 
and lentiviral particles were produced in HEK 293T cells. Transduction and subsequent 
fluorescence-associated cell sorting (FACS) of THP-1 cells were used to generate 
uniform monocytic cell lines stably expressing fluorescently-tagged L-selectin.  
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In order to test the potential influence of the GFP tag on L-selectin expression and 
biological activity, a series of experiments was designed. L-selectin-GFP expression and 
cellular localisation were tested by fluorescence microscopy, flow cytometry analysis, 
scanning electron microscopy and Western blotting. Upon cell activation, L-selectin 
undergoes proteolytic ectodomain cleavage (commonly termed “shedding”, section 
1.9.2) [326, 419, 495, 496, 515, 521, 529], and this property was tested using a number 
of known shedding activators, both artificial and physiological. The sheddase inhibitor 
was also used to assess basal L-selectin-GFP turnover that is known to occur 
physiologically under resting conditions [521, 544]. Furthermore, the interaction of the L-
selectin cytoplasmic tail with its binding partner calmodulin was analysed in “pull-down” 
assays. Finally, the ability of L-selectin-GFP to mediate interaction with its ligands under 
flow was tested in parallel-plate flow chamber assays. The tetrasaccharide, slialyl Lewis 
X (sLex), is a physiological L-selectin ligand and therefore the ability of THP-1 cells stably 
expressing L-selectin-GFP to interact with immobilised sLex under flow was examined.  
Importantly, U937 monocytic cell line and human primary monocytes are known to 
interact with cytokine-activated human umbilical endothelial cells (HUVEC) in L-selectin-
dependent manner [410]. HUVEC are used routinely in the Ivetic laboratory as a model 
to study primary vascular endothelial cells. Hence, the interaction of THP-1 cells 
expressing L-selectin-GFP with cytokine-activated HUVEC was also analysed. Overall, 
the experimental design ensured that the functionality of L-selectin-GFP fusion protein 
was thoroughly analysed.       
3.3 RESULTS 
3.3.1 Generation of cell lines stably expressing wild type L-selectin-GFP 
3.3.1.1 Cloning of human L-selectin cDNA into pHR´SIN-SEW lentiviral backbone 
vector 
Human wild type (WT) L-selectin cDNA was amplified by PCR from pCMV6-AC-GFP 
vector (OriGene) (figure 3.1 A). PCR primers were designed with BamHI and XhoI 
restriction sites engineered at 5´ and 3´ ends, respectively. Insertion of the WT L-selectin 
cDNA was obtained with pHR´SIN-SEW-GFP or pHR´SIN-SEW-RFP  lentiviral vectors 
that were acquired as a kind gift from Professor Adrian Thrasher (Institute of Child’s 
Health, UCL) (figure 3.1 B). The ORFs of generated pHR´SIN-SEW-L-selectin-GFP and 
pHR´SIN-SEW-L-selectin-RFP lentiviral vectors were subsequently sequenced (figure 
3.1 C) and the vectors were named pHR´SIN-SEW-L-selectinWT-GFP and pHR´SIN-
SEW-L-selectinWT-RFP, respectively (for the details of the cloning procedure see section 
2.3). At this stage pHR´SIN-SEW-L-selectinWT-RFP plasmid was frozen for future 
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Figure 3.1 Cloning of L-selectin cDNA into lentiviral expression vector. A) Plasmid map of 
pCMV6-AC-GFP vector, supplied by OriGene. L-selectin ORF (ORF size: 1119 bp) is present 
between SgfI and MluI cloning sites. L-selectin cDNA was amplified from pCMV6-AC-GFP vector 
using PCR primers designed with BamHI and XhoI restriction sites engineered at 5´ and 3´ends, 
respectively. Image taken from from OriGene (OriGene Technologies, I. pCMV6-AC-GFP. Vol. 
2010./ http://www.origene.com/destination_vector/PS100010.aspx). B) Map of pHR´SIN-SEW 
lentiviral vector carrying GFP C-terminal tag (pHR´SIN-SEW-GFP). Vector was double digested 
with BamHI and XhoI restriction enzymes (cleavage sites shown by red stars) and ligated with 
the PCR product amplified as described in A). Vector map was created using SnapGene® 
software on the basis of the sequence provided by Professor Adrian Thrasher (Institute of Child’s 
Health, UCL). C) Multiple cloning site of pHR´SIN-SEW vector carrying WT L-selectin-GFP. The 
sequence shows wild type L-selectin (17 amino acid C-terminal tail of L-selectin is shown in blue) 
successfully cloned into the pHR´SIN-SEW-GFP vector (termed pHR´SIN-SEW-L-selectinWT-
GFP). Sequence shown in red represents the linker between L-selectin and GFP. Sequence 
shown in green represents GFP. XhoI restriction site used for cloning is highlighted in yellow and 
KpnI and MluI restriction sites present within the linker are highlighted in blue and purple, 
respectively. An identical cloning strategy was used to insert L-selectin gene into the pHR´SIN-











3.3.1.2 Lentiviral particle generation using HEK 293T packaging cell line 
The lentiviral transgene delivery system is well known for producing stable cell lines with 
high efficiency of transduction. The main advantages of this system are long-term 
transgene expression that results from stable integration to the host genome, and little 
or no toxicity. Long-term expression enables re-using of generated cell lines and 
therefore ensures reproducibility between experiments. As a comparison, transient 
transfections of cells have generally low reproducibility and could also cause adverse 
effects. When deciding on lentiviral transgene delivery system, one needs to be aware 
of the associated risks. These are the potential of production of replication-competent 
viruses and oncogenesis. To address those health and safety issues, multiple plasmids 
are commonly used when generating lentiviruses. The very packaging system used in 
this thesis is known as a second generation packaging system. In this system the 
“transfer” vector carries the gene of interest and contains the sequences that will 
incorporate into the host genome.  Viral genes necessary for assembly of functional 
viruses are split between two “helper plasmids”. The viral particles assembled in this way 
carry only the sequences encoded by the transfer plasmid and are incapable of 
replication. This ensures that, upon transduction, the host cells are unable to produce 
functional viruses as the genes encoded by the helper plasmids are no longer present. 
Although this approach greatly improves the safety of lentivirus generation, critical care 
should still be taken when working with these vectors. A simple schematic, describing 
the steps of lentivirus generation, is shown in figure 3.2, and the method is described in 
detail in section 2.11.1 of this thesis. In brief, HEK 293T packaging cells were 
transfected with transfer pHR’SIN-SEW-L-selectinWT-GFP lentivirus backbone vector 
and two helper plasmids:  “envelope” pMD2.G (carrying genes encoding envelope 
protein VSV G) and “packaging” psPAX2 (carrying HIV gag, pol, rev, and tat genes) 
(figure 3.2 step 1). The assembled lentiviral particles released in to the supernatant of 
293T HEK cells were harvested 48 hours and then again 72 hours post-transfection 
(figure 3.2 step 2), pooled, and the concentrated lentivirus of a known titre was used to 
transduce target THP-1 cells (figure 3.2 step 3). A detailed protocol describing lentivirus 




Figure 3.2 Lentiviral transgene delivery system. Lentiviral vectors were generated by 
cotransfection of a packaging cell line (HEK 293T) with the  pHR´SIN-SEW transfer plasmid 
carrying L-selectin-GFP or –RFP transgene, and  two helper  plasmids (1). Helper plasmids 
psPAX2 and pMD2.G encode structural and envelope proteins, respectively. Genome of a 
lentiviral particle produced by HEK 293T cells encoded sequences from the pHR´SIN-SEW 
transfer plasmid only. After the incubation period (48 and 72 hours), the lentiviral particles 
released into HEK 293T cells supernatant were harvested (2), concentrated by ultracetrifugation 
and used to transduce target THP-1 cells (3). VSV-G, the vesicular stomatitis virus G protein; HIV, 
human immunodeficiency virus, Gag, gene encoding group specific antigen; Pol, viral 
polymerase; Rev, regulator of expression of virion proteins.   
 
The lentivirus titre, defined as the number of infectious units per mL (i.u./mL), was 
established by serial dilution (0, 10-6, 10-5, 10-4, 10-3, 10-2, 10-1) of the concentrated lentivirus 
stock to infect a given number of HEK 293T cells. The titre was determined by analysis 
of GFP-tag expression by flow cytometry. Figure 3.3 shows the steps that were 
undertaken to calculate the lentivirus titre and the titration method is described in more 
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dilution of the lentivirus stock was plotted (figure 3.3 i). This was then used to determine 
the dilutions resulting in no more than 30% of transduction efficiency, and those dilutions 
were further used to determine the linear range of transduction (figure 3.3 ii). Using the 
dilutions placed within the linear range assured that multiple lentiviral integrations were 
avoided when calculating the titre. Equation 1 (figure 3.3 iii) was used to calculate the 
titre of the lentivirus carrying WT L-selectin-GFP transgene, which was established to be 
2.128 x 108 i.u./mL.   
 
Figure 3.3 Titration of lentiviral particles containing pHR´SIN-SEW vector carrying WT L-
selectin-GFP construct. (i) HEK 293T cells were transduced with serial dilutions (0, 10-6, 10-5, 
10-4, 10-3, 10-2, 10-1) of the concentrated lentivirus suspension and the percentage of GFP positive 
(GFP+) cells was established by flow cytometry. (ii) Lower-end dilutions were used to determine 
linear range in order to avoid multiple integrations. (iii) Lentiviral titre was calculated using the 




















T Titer (infection units per millilitre, i.u./mL)
P Per-cent of transduced cells
N Number of cells at the day of transduction
D Lentivirus dilution 
V Volume of lentivirus added (mL) 
Average titer:



































3.3.1.3 Lentivirus mediated transduction of THP-1 cells 
In order to achieve reproducible levels of protein expression, the “multiplicity of infection” 
(MOI) is used as a quantitative unit of measure when transducing cells with lentiviral 
particles. MOI defines the number of infectious units (lentiviral particles) delivered per 
target cell. It was decided that 5 and 20 would be used to represent low and high, 
respectively, MOIs when transducing THP-1 cells with lentiviral particles carrying the WT 
L-selectin-GFP transgene.  
To achieve MOI of 5 and MOI of 20, volumes of lentivirus stock were calculated according 
to the Equation 2 (figure 3.4) where 1 x 106 THP-1 cells were inoculated with the 
lentivirus stock of a titre of 2.128 x 108 i.u./mL (as calculated in section 3.3.1.2.). The 
detailed method of THP-1 cell transduction is described in section 2.11.4. 
Transduced THP-1 cells were termed low expressor “THP-1 WT L-selectin-GFP MOI 5” 
and high expressor “THP-1 WT L-selectin-GFP MOI 20”. Generated cell lines were 
maintained in culture until a sufficient number had expanded which allowed sorting of 
the cells into uniform-expressing populations. This was performed to enrich the cell 
populations expressing the transgene, and also to ensure consistency and reproducibility 
of future experiments.  Unsorted parental cell populations would exhibit variations in the 
percentage of L-selectin positive cells and unmatched expression levels. This could 
severely impair interpretation of any future results as L-selectin expression levels is an 
important factor for its adhesiveness [634]. Thus, unsorted low and high expressors were 
taken to a core-funded FACS sorting facility, and were sorted in to uniform populations 
termed THP-1 WT L-selectin-GFP Lo5 and THP-1 WT L-selectin-GFP Hi20, respectively. 
Four cell lines: low expressors: unsorted THP-1 WT L-selectin-GFP MOI 5 and sorted 
THP-1 WT L-selectin-GFP Lo5, and high expressors: unsorted THP-1 WT L-selectin-
GFP MOI 20 and sorted THP-1 WT L-selectin-GFP Hi20, were then examined by 
fluorescence microscopy to assess L-selectin-GFP expression. Images of both phase 
contrast and GFP channel were acquired and representative images of each cell type 
are shown in figure 3.4. No GFP signal could be detected in control untransduced THP-
1 cells (figure 3.4 A), suggesting THP-1 cells have negligible autofluorescence in the 
FL1 channel (that detects GFP). In transduced cells, the average percentage of green 
cells per field of view was determined by analysing images acquired for five different 
fields of view per cell line. As expected, transduction with MOI of 20 resulted in higher 
average percentage (67%) of green cells (figure 3.4 D) than transduction with MOI of 5 




Figure 3.4 Generation of THP-1 cell lines expressing L-selectin-GFP.  Equation 2 was used 
to calculate volume of lentivirus suspension that would transduce 1 x 106 THP-1 cells. Low and 
high multiplicities of infection (MOI), MOI 5 and MOI 20, respectively, were used to transduce 
THP-1 cells with lentiviral particles carrying pHR´SIN-SEW-L-selectinWT-GFP. THP-1 WT L-
selectin-GFP MOI 5 and THP-1 WT L-selectin GFP MOI 20 cell lines were obtained as low and 
high L-selectin-GFP expressors, and FACS was used to sort them into uniform populations 
termed THP-1 WT L-selectin-GFP Lo5 and THP-1 WT L-selectin-GFP Hi20 , respectively.  
Fluorescence microscopy was used to detect GFP and establish the extent of transduction as a 
percentage of GFP positive (GFP+) cells. A) No GFP signal in untransduced THP-1 cells. B) 
Unsorted low expressor cell line where average 38% GFP+ cells were detected. C) Sorted, 
uniform low expressor cell line having average 97% GFP+ cells. D) Unsorted high expressor cell 
line with average 67% GFP+ cells. E) Sorted, uniform high expressor cell line where average 96% 
GFP+ cells were detected. Percentage of GFP+ cells was calculated as an average obtained from 
five different fields of view. Arrows in B-E show localisation of L-selectin to the plasma membrane. 
Scale bar 30 µm.  
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Enrichment in the green cell populations was seen in sorted cell populations to average 
97% for THP-1 WT L-selectin-GFP Lo5 (figure 3.4 C) and 96% for WT L-selectin-GFP 
Hi20 (figure 3.4 E).  
Furthermore, fluorescence microscopy also revealed peripheral localisation of L-
selectin-GFP (figure 3.4 B-E arrows), which served as the initial indication that GFP 
tagging of L-selectin was not interfering with its traffic through the “secretory pathway” 
towards the plasma membrane.  
To further determine L-selectin-GFP expression levels, the generated THP-1 cell lines 
were subjected to flow cytometry analysis. This approach enabled examination of many 
more cells (approximately 10,000) than fluorescence microscopy. Five cell lines were 
analysed: control untransduced THP-1 cells, low expressors: unsorted THP-1 WT L-
selectin-GFP MOI 5 and sorted, uniform THP-1 WT L-selectin-GFP Lo5 and high 
expressors: unsorted THP-1 WT L-selectin-GFP MOI 20 and sorted, uniform THP-1 WT 
L-selectin-GFP Hi 20. Two methods of analysis were employed: analysis of GFP levels 
and analysis of surface L-selectin levels. GFP levels were analysed by simply measuring 
the GFP fluorescence and analysis of surface L-selectin levels was by labelling THP-1 
cells with mouse anti-L-selectin DREG56 antibody, followed by anti-mouse secondary 
antibody conjugated to fluorescent dye R-phycoerythrin (RPE). DREG56 is an antibody 
that recognises an extracellular N-terminal epitope of L-selectin [635], and as a result all 
the RPE signal specifically corresponded to surface-expressed L-selectin. Viable and 
single cell population was selected for analysis (figure 3.5 A, Gate R1). Histograms were 
generated for GFP (figure 3.5 B and C, left panels) and RPE fluorescence intensities 
(figure 3.5 B and C, right panels) and the percentage of GFP or RPE positive cells within 
fluorescent positive gate M1 (shown on the histograms) was determined. Sorting of THP-
1 WT L-selectin-GFP MOI 5 cells into THP-1 WT L-selectin-GFP Lo5 uniform cell 
population resulted in the enrichment of GFP positive cells from 42.04% to 95.89% 
(figure 3.5 B, left panel) and in the enrichment of surface L-selectin positive cells (as 
measured by RPE signal) from 47.8% to 94.78% (figure 3.5 B, right panel). This was 
also true when analysing GFP and RPE levels of THP-1 WT L-selectin-GFP MOI 20 and 
THP-1 WT L-selectin-GFP Hi 20 cells, where the percentage of GFP positive cells rose 
from 77.84% to 98%, respectively, (figure 3.5 C, left panel) and the percentage of RPE 
positive cells increased from 80.85% to 96.6%, respectively (figure 3.5 C, right panel). 
These values were in line with those obtained by utilisation of the fluorescence 
microscopy (figure 3.4), and DREG56/RPE labelling confirmed that L-selectin was 




Figure 3.5 Flow cytometry analysis of L-selectin expression in THP-1 cells expressing low 
or high levels of L-selectin-GFP.  THP-1 cells were transduced with pHR’SIN-SEW-L-
selectinWT-GFP carrying lentivirus and sorted into uniform populations of low (Lo5) and high 
expressors (Hi20) as described in figure 3.4. Cells were stained with either mouse anti-L-selectin 
DREG56 or mouse IgG isotype control antibodies followed by α-mouse secondary antibody 
conjugated to RPE fluorescent dye and compared to their unsorted parental cell lines. The 
DREG56 antibody recognises the extracellular epitope of L-selectin and is an indicator of surface 




















































case of both Lo5 (B) and Hi20 (C) cell lines, enrichment in both GFP (left histograms) and RPE 
(right histograms) gated cells (gate M1) was observed within sorted populations as compared to 
unsorted populations (Lo5:MOI5 = 95.89%:42.04% for GFP signal and 94.78 %:47.8% for RPE 
signal; Hi20:MOI20 = 98%:77.84% for GFP signal and 96.6%:80.85% for RPE signal). Bar graphs 
in D) show significantly higher mean fluorescence intensities (MFIs) of both GFP (left graph) and 
RPE (right graph) of Hi20 cell line as compared to Lo5 cell line. Analysis was performed in 
duplicates on three independent occasions. Data represent mean ± S.E.M. Statistical analysis: 
two tailed unpaired t-test. **= p<0.01. MFI, mean fluorescence intensity. 
 
Importantly, flow cytometry analysis additionally showed that THP-1 cells did not express 
endogenous L-selectin (figure 3.5 B and D, right panel, compare dotted line – IgG isotype 
control and black line - untransduced cells stained with Dreg56). This would mean that 
any potential L-selectin-dependent effects would be a direct result of the ectopic L-
selectin-GFP chimera expression, which would be most useful should any mutated L-
selectin-GFP was to be introduced to the THP-1 cells in the further studies. Of note, 
ATCC-obtained THP-1 cells have been shown previously not to express endogenous L-
selectin [636], however L-selectin-positive THP-1 cells have also been reported [637]. 
This discrepancy highlights the importance of accurate cell line characterisation before 
any experiments are commenced. 
At this stage the parental unsorted THP-1 WT L-selectin-GFP MOI 5 cells and THP-1 
WT L-selectin-GFP MOI 20 cells were excluded from any further analysis and 
experiments, and only sorted, uniform populations of THP-1 WT L-selectin-GFP Lo5 and 
THP-1 WT L-selectin-GFP Hi20 cells were taken forward. Bar graphs of the mean 
fluorescence intensities (MFIs) shown in figure 3.5 D depict the increase in surface L-
selectin levels and a corresponding increase in GFP levels of THP-1 WT L-selectin-GFP 
Hi20 cells as compared to THP-1 WT L-selectin-GFP Lo5 cells. Due to their high levels 
of both GFP and surface L-selectin, the THP-1 WT L-selectin-GFP Hi20 cells were 
chosen for further characterisation and experimentation. If the high L-selectin-GFP 
expression levels proved to cause adverse effects on THP-1 monocyte cell biology, low 
expressors would be tested. 
Having generated THP-1 cells stably expressing L-selectin tagged to GFP protein, it was 
deemed necessary to generate a control THP-1 cell line expressing just GFP alone. 
Since THP-1 WT L-selectin-GFP Hi20 cells were chosen for further studies, it was 
considered appropriate to generate THP-1 cells expressing matching levels of GFP. To 
this end, lentiviral particles were generated as described in section 3.3.1.2, using 
original pHR´SIN-SEW-GFP lentiviral backbone vector. The titre of this virus was 
established as described in section 3.3.1.2, and was calculated to be of 2.56 x 108 
i.u./mL. THP-1 cells were transduced with MOI 20 and seven days post-infection, GFP 
expression in those cells, termed THP-1 GFP MOI 20, was monitored by fluorescence 
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microscopy and compared to untransduced cells (figure 3.6 A and B). Scoring of GFP 
positive cells per field of view (five fields of view analysed) was used to establish the 
average number of cells expressing GFP, which was 62%. To obtain uniform GFP-
expressing cell lines, THP-1 GFP MOI 20 cells were sorted with a use of FACS sorting 
facility, and the uniform cell population was termed THP-1 GFP Hi20 (figure  3.6 C). WT 
L-selectin-GFP Hi20 cells were used as a reference population to set the GFP gate 
during cell sorting. This allowed GFP levels to be a close match to L-selectin-GFP levels. 
As analysed by flow cytometry, the sorting enriched the GFP positive cells from 57,92% 
in THP-1 GFP MOI 20 to 96,87% in THP-1 GFP Hi20 (figure 3.6 D). 
 
Figure 3.6 Generation of THP-1 cell line expressing uniform levels of GFP.  THP-1 cells (A) 
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subsequently sorted into a uniform population termed THP-1 GFP Hi20 (C).  D) Sorting led to an 
increase in the percentage of GFP positive cells from 57.92% to 96.87% (right histogram) as 
analysed by flow cytometry. Dot plot on the left shows gate used to analyse singe and viable cells 
only. Scale bar in A, B and C: 30 µm. 
 
3.3.2 Monitoring L-selectin-GFP expression levels during THP-1 cell line 
maintenance in tissue culture 
Previous work in the Ivetic laboratory, performed by David Killock (a then PhD student in 
the Ivetic lab), revealed a strong correlation between cell density and L-selectin shedding 
in the 300.19 murine pre-B cell line. This has also been reported by others in the field 
[638, 639]. Therefore, THP-1 WT L-selectin-GFP Hi20 cells were monitored over a period 
of days to establish any potential changes in L-selectin expression. As presented in 
figure 3.7, L-selectin surface expression was inversely proportional to the cell culture 
density as measured by flow cytometry. On day one, cell culture density and both GFP 
and surface L-selectin levels of a 3-day culture were noted and cells were split to 0.4 x 
106 cells/mL. On the following day (day two) levels of both surface L-selectin and GFP 
were recorded and those were treated as 100% expression. This allowed for back-
calculation that the levels of GFP and surface L-selectin were 83% and 89%, respectively 
in the initial 3-day culture. On day three a decrease in GFP and surface L-selectin levels 
to 87% and 88%, respectively, was seen. On day four L-selectin surface levels further 
decreased to 86%, whereas GFP-tag levels started to climb up reaching 90% of the 
levels observed on day two. When the cells were left unpassaged on the day 1, the levels 
of GFP and surface L-selectin reached 58% and 50%, respectively, on day four of the 
experiment. This corresponded to an overgrown 7-day culture. Having established a 
significant effect of cell culture density on L-selectin-GFP levels it was considered 
necessary to maintain stable cell densities during cell culture. Therefore, the cells were 
split every two or three days when in culture, and seeded overnight at a density of 0.4 x 
106 cells/mL before each experiment. This was thought to ensure that cells had matched 




Figure 3.7 Maintanance of THP-1 cells expressing L-selectin-GFP in tissue culture.  THP-1 
cells expressing WT L-selectin-GFP Hi20 were monitored for their surface L-selectin expression 
and GFP levels across 4 days, with respect to cell culture density. Cells were split (arrow) on day 
one to 0.4 x 106 cells/mL (black line) or were left unpassaged (green line). A) Graph showing cell 
culture density on the monitored days. Flow cytometry was used to assess GFP (B) and surface 
L-selectin (C) expression. Acquired MFI values were used to calculate average percentages of 
expression. GFP and surface L-selectin levels on day two (first measurement after splitting) were 
treated as 100%. Experiment was performed on three independent occasions. Error bars 
represent standard error. MFI, mean fluorescence intensity. 
 
3.3.3 Characterisation of THP-1 L-selectin-GFP Hi20 stable cell line 
As explained in sections 3.1. and 3.2., it was considered crucial to establish whether 
tagging of the short cytoplasmic tail of L-selectin with a bulky GFP protein of a molecular 
weight of 27 kDa had any effect on L-selectin expression and L-selectin function. A 
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number of experiments were performed in order to establish that fluorescently tagged L-
selectin is correctly localised and functions properly in THP-1 monocytes. The 
experiments were performed on THP-1 WT L-selectin-GFP Hi20 cells and included 
monitoring of L-selectin expression at the plasma membrane, its localisation to microvilli, 
ability to undergo proteolytic cleavage, its interaction with endogenous calmodulin, its 
ability to recognise its physiological ligand under flow and to tether and adhere to 
endothelial cells under flow. 
3.3.3.1 L-selectin expression 
L-selectin is a single-pass type I transmembrane protein and is known to localise to the 
tips of leukocyte microvilli [16]. Labelling of cells with DREG56, and subsequent flow 
cytometry used when generating stable cell lines revealed that L-selectin-GFP was 
expressed at the plasma membrane (figure 3.5). This proved that addition of the GFP-
tag was not affecting L-selectin traffic from the endoplasmic reticulum to the plasma 
membrane. Additionally, L-selectin-GFP localisation to the plasma membrane of THP-1 
monocytes was confirmed by fluorescence microscopy. Initial peripheral localisation of 
L-selectin-GFP was noted during cell line generation (figure 3.4 B-E). This was now 
further confirmed using an objective of higher magnification and THP-1 cells expressing 
GFP alone as a control.  A distinct membrane staining could be seen in THP-1 WT L-
selectin-GFP Hi20, but not in THP-1 GFP Hi20 cells (figure 3.8 A arrows). Additionally, 
in each cell a high-intensity GFP fluorescence signal was seen, which was likely to 
represent the Golgi apparatus, where L-selectin-GFP expression was also expected to 
be high due to the ongoing glycosylation of newly translated proteins (figure 3.8 A stars). 
Next, immunogold labelling of DREG56-decorated THP-1 cells, performed by Dr 
Aleksandar Ivetic, and scanning electron microscopy (SEM) revealed that L-selectin-
GFP was localised to the microvilli of the THP-1 cells (figure 3.8 B).  
Commercially available anti-GFP antibody was then used to examine L-selectin-GFP 
expression by Western blotting. The results presented in figure 3.8 C show that the 
antibody was indeed GFP specific as it recognised 27 kDa protein derived from THP-1 
GFP Hi20 cells (middle lane) but did not detect any signal in the lane corresponding to 
untransduced THP-1 cells (first lane). Furthermore, three different bands were detected 
that were L-selectin-specific (last lane), as they did not appear in the lanes corresponding 
to the untransduced THP-1 cells and THP-1 GFP Hi20 cells. The heaviest form, 
migrating at 90-110 kDa was considered to be the full-length surface form of L-selectin. 
After subtraction of 27 kDa (the MW of GFP) the obtained MW for L-selectin would be 
60-90 kDa, which is in accordance with the reported molecular weights. The predicted 
molecular weight (MW) of L-selectin is approximately 30 kDa, but the actual MW varies 
between 74 kDa in lymphocytes [402] and 90-120 kDa in neutrophils [381]. This is 
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thought to be the result of extensive glygosylation modifications [313]. In keeping with 
this, the fuzzy appearance of the band suggested that the protein was highly 
glycosylated, which is seen in primary leukocytes. 
 
Figure 3.8 GFP-tagging does not influence expression of L-selectin by THP-1 cells. A) 
Upper panel: L-selectin-GFP is successfully localised to the plasma membrane (arrows) of THP-
1 cells. Distinctive high-intensity fluorescence signal (stars) is thought to represent Golgi 
apparatus compartment where L-selectin-GFP undergoes glycosylation.  Bottom panel: Diffused 
distribution and lack of distinctive membrane localisation of the GFP protein in control THP-1 cells. 

























































selectin-GFP show that microvilli (MV, arrows) were formed in THP-1 monocytes expressing L-
selectin-GFP (i). Scale bar: 2 µm. Immunogold staining of L-selectin further demonstrated that L-
selectin-GFP (white arrows) was mainly localised to the microvilli (appearing as phase dark) and 
not to the cell body (appearing as phase light) (ii). Scale bar: 325 nm. C) Biochemical 
characterisation of L-selectin-GFP expression in stably transduced THP-1 cells. THP-1 cells were 
grown under resting conditions, harvested prior to the experiment and analysed by Western 
blotting as described in section 2.8.3. Representative Western blotting showing three forms of L-
selectin-GFP present in the lysates of THP-1 cells expressing wild type L-selectin-GFP Hi 20.  
Anti-GFP antibody was used to detect GFP-tag in the lysates from cells expressing L-selectin-
GFP (WT) and GFP protein in control cells expressing GFP alone (GFP). Fuzzy 90-110 kilo Dalton 
(kDa) band (blue arrow) corresponds to the surface fully-glycosylated L-selectin-GFP, 80 kDa 
band is thought to be the non-glycosylated intracellular form of L-selectin-GFP (associated with 
Golgi apparatus and endoplasmic reticulum, green arrow) and the two bands detected at around 
35 kDa are thought to be forms of L-selectin-GFP cleavage product (“stump”, yellow arrow), which 
is formed upon L-selectin extracellular domain cleavage. Specificity of the anti-GFP antibody is 
shown when analysing lysates from untransduced THP-1 cells (THP-1), where no bands can be 
detected. D) Further characterisation of L-selectin-GFP and GFP expression. Lysates from THP-
1 cells expressing GFP Hi20 alone (GFP) or wild type L-selectin-GFP Hi20 (WT) were used to 
perform GFP-Trap® immunoprecipitation (IP) as described in section 2.8.4. Left panel shows 
representative GelCode staining of the total protein present in the cell lysates. Surface (blue 
arrow), intracellular (green arrow) and “stump” (red arrow) forms of L-selectin-GFP as well as 
GFP protein (yellow arrow) can be seen in the GelCode staining of the pull-down fraction (middle 
panel). Representative anti-GFP Western blotting (WB) performed on the pulled-down protein 
shows expression of all of the proteins (right panel). Note: Immunogold labelling of L-selectin-
GFP shown in B was performed by Dr Aleksandar Ivetic.  
 
The second largest molecular weight species of L-selectin, migrating at 80 kDa was 
thought to be an intracellular L-selectin-GFP form, localised to the trans Golgi network. 
This form of L-selectin was thought not to have undergone the full complement of 
glycosylation events, hence the lack of fuzzy band appearance. Partial glycosylation was 
thought to occur as the form was still larger than the predicted MW of the non-
glycosylated L-selectin-GFP. Third and the smallest form migrated at approximately 33-
35 kDa in the form of two bands. Subtraction of the molecular weight of GFP left MW 
that corresponded to the L-selectin cleavage product (“stump”) that is generated upon L-
selectin ectodomain cleavage and has been reported to migrate at around 6 kDa [326, 
515]. Further confirmation of L-selectin-GFP expression was performed using GFP-
Trap® immunoprecipitation beads (figure 3.8 D). GFP-Trap® is a commercially available 
pull-down system, where a GFP-binding protein (which is also able to detect eGFP) is 
covalently linked to the sepharose beads and is therefore a very useful method for 
detecting GFP-fused proteins. The beads were incubated with cell lysates from THP-1 
cells expressing either GFP Hi20 or WT L-selectin-GFP Hi20, which allowed for pull-
down of either GFP or the L-selectin-GFP chimera. The three L-selectin-GFP forms could 
already be seen in the pull-down fractions of the protein gels stained with GelCode 
protein gel stain, and were even more prominent when Western blotting using an anti-
GFP antibody was performed on the pulled-down protein. This additionally confirmed 
136 
 
that L-selectin-GFP was successfully expressed in THP-1 cells, and also formulated a 
ground for future co-precipitation experiments as an easy and clean method for L-
selectin-GFP pull-down was established. 
3.3.3.2 Shedding of L-selectin-GFP in THP-1 cells  
Numerous stimuli have been used to promote the rapid endoproteolytic cleavage of L-
selectin, or L-selectin shedding, which results in production of soluble L-selectin (sL-
selectin) and a cleavage product (“stump”) (section 1.9.2) [326, 515]. Examples of cell-
activating stimuli include the potent leukocyte activator phorbol 12-myristate 13-acetate 
(PMA) [495, 496, 529, 640], TNF-α [496] and the phosphatase inhibitor Calyculin A [496]. 
Sequences within the tail of L-selectin are known to influence L-selectin shedding [323, 
558], and therefore it was crucial to establish whether the fusion of GFP protein to the 
tail of L-selectin had any adverse effects on L-selectin shedding. THP-1 WT L-selectin-
GFP Hi20 cells were stimulated with Calyculin A, TNF-α or PMA and processing of L-
selectin-GFP was analysed by Western blotting of whole cell lysates. As shown in figure 
3.9, treatment with all three stimuli resulted in a significant loss of full-length surface-
expressed L-selectin-GFP, and Calyculin A and PMA triggered ectodomain shedding to 
a much higher extent than TNF-α (figure 3.9 A and B). Moreover, the L-selectin “stump” 
was detected in the extracts from non-stimulated cells (figure 3.9 A control lane), 
suggesting that constitutive L-selectin-GFP shedding was occurring in the THP-1 WT L-
selectin-GFP Hi20 cell line. Although no statistical difference could be seen when 
analysing changes in the levels of L-selectin cleavage product, a clear trend could be 
seen, where the “stump” levels increased following stimulation with all three stimuli 
(figure 3.9 A and C). This indicated that GFP-tagging of the cytoplasmic tail of L-selectin 
did not hinder the ability of the ectodomain to undergo proteolytic cleavage. Additionally, 
no loss of the 80 kDa form of L-selectin-GFP was observed upon cell activation (figure 





Figure 3.9 The GFP-tag does not interfere with L-selectin’s ability to undergo proteolytic 
cleavage.  THP-1 cells expressing WT L-selectin-GFP Hi20 were stimulated with PMA, caliculin 
A, TNF-α, left untreated (control) or treated with vehicle control (DMSO control), and subjected to 
Western blotting analysis as described in section 2.8.3. A) Representative Western blotting 
showing that loss of the fully-glycosylated surface L-selectin-GFP (red arrow) can be seen with 
all three stimuli. B) Fold-change in the surface L-selectin expression following all three treatments, 
where TNF-α-caused downregulation of surface L-selectin was not as severe as with the other 
two stimuli. C) Fold-change in the “stump” L-selectin levels following cell-activation. No significant 
changes were found by statistical analysis however, a trend can be seen, where cell activation 
leads to upregulation of the L-selectin cleavage product. No influence of DMSO control was seen 
on L-selectin shedding. Fold-change data was obtained by densitometric analysis (section 2.8.5) 
of the bands corresponding to full length L-selectin or L-selectin “stump”, and normalised against 
actin. The experiment was repeated on three independent occasions. Data represent mean ± 
standard error. Statistical analysis: One-way ANOVA followed by Tukey’s post-test. * = p < 0.05, 
*** = p < 0.001.  
 
The ADAM17 metalloprotease is known to cleave L-selectin from the leukocyte surface 




















































































































31-9790 is a hydroxamate-based broad-spectrum zinc-metalloprotease inhibitor and has 
been shown to inhibit L-selectin shedding under various cell-activating conditions [520, 
641]. Flow cytometry analysis revealed that the profound loss of surface L-selectin-GFP 
seen following PMA stimulation was blocked by pre-incubating the cells with Ro-31-9790 
(figure 3.10 A). Additionally, incubation of the cells with Ro-31-9790 alone resulted in 
the upregulation of surface L-selectin-GFP levels above the levels exhibited by non-
treated cells (figure 3.10 A), suggesting that metalloproteases are involved in basal 
turnover of L-selectin-GFP that occurs under resting conditions. This further confirmed 
that GFP did not influence normal L-selectin function as basal turnover of L-selectin is 
known to occur physiologically and is dependent on metalloprotease activity [521, 544]. 
Interestingly, although not statistically significant, a trend could be seen in the GFP 
levels, which followed that of surface L-selectin levels (figure 3.10 B). A slight decrease 
in GFP-tag expression was seen following PMA stimulation and this was rescued when 
unstimulated cells were pre-incubated with Ro-31-9790. Treatment with Ro-31-9790 
alone resulted in slight increase in GFP-tag levels, which again paralleled with changes 
to surface L-selectin. These results suggest a very dynamic turnover of WT L-selectin-
GFP chimera at the plasma membrane of unstimulated THP-1 cells, and this process is 





Figure 3.10 L-selectin-GFP is subjected to basal shedding.  THP-1 WT L-selectin-GFP Hi20 
cells were stimulated with PMA, ADAM17 inhibitor Ro-31-9790 or both and analysed for both 
GFP-tag and surface L-selectin levels by flow cytometry (section 2.13). A) Surface L-selectin 
levels measured by using mouse anti-L-selectin DREG56 antibody and following anti-mouse-RPE 
conjugated secondary antibody. L-selectin expression was downregulated following PMA 
stimulation, which could be prevented by pre-incubation with Ro-31-9790. Inhibition of basal 
metalloprotease activity by Ro-31-9790 treatment led to increased surface L-selectin expression.  
M1 on the histogram shows gate for RPE positive THP-1 cell population. B) GFP-tag levels, where 
M1 (histogram) shows gate for GFP positive cells, followed pattern observed with surface L-
selectin but changes in MFI values were not significant. C) Gate R1 in the dot plot contains 
population of viable THP-1 cells and was applied to all samples.  Histograms in A, B and C 
represent the changes seen in a typical experiment  and fold-changes of L-selectin surface levels 
shown on corresponding graphs were established on the basis of MFI values acquired in 
triplicates for 3 independent experiments. Data represent mean ± S.E.M. and significance was 


















































3.3.3.3 Interaction of endogenous calmodulin with L-selectin-GFP 
The cytoplasmic calcium-sensing protein calmodulin (CaM) is known to interact with the 
L-selectin tail (section 1.10.4). Importantly, calmodulin is known to negatively regulate 
L-selectin shedding [559]. In vitro, calmodulin inhibitors severely decrease binding of 
lymphocytes to HEV and rolling of neutrophils on MECA-79 antigen, a physiological L-
selectin ligand [515]. Thus, it was important to establish whether tagging of GFP to the 
cytoplasmic tail of L-selectin had any detrimental effects on CaM binding. 
Immunoprecipitation has been used in the past to detect L-selectin-CaM interaction 
[515]. GFP-Trap® was successfully used to pull-down L-selectin-GFP (figure 3.8 D), 
and it was now employed to test whether CaM co-precipitated with L-selectin-GFP. To 
this end, resting THP-1 WT L-selectin-GFP Hi20 cells and control THP-1 GFP Hi20 cells 
were harvested and lysates were added to GFP-Trap® beads slurry. The data presented 
in figure 3.11 A and C show significant increase of pulled-down CaM when L-selectin-
GFP interacted with the GFP-Trap® as compared to just GFP. Binding of CaM to GFP 
alone was thought to be a result of non-specific binding caused by a great abundance of 
GFP (figure 3.11 B). This suggested that L-selectin indeed had the ability to interact with 
endogenous calmodulin, eliminating the possibility of detrimental effects of the GFP-tag 
on L-selectin/CaM interaction. 
 
 
Figure 3.11 WT L-selectin-GFP associates with endogenous calmodulin (CaM). GFP-
Trap®  (section 2.8.4)/Western blotting (WB, section 2.8.3) analysis of interaction between L-
selectin-GFP and CaM in resting THP-1 WT L-selectin-GFP Hi20 cells. A) Representative 
























in the pull-down fraction can be seen when L-selectin-GFP is used as compared to just GFP. 
Protein input lysate is shown on the bottom blot. B)  Representative anti-GFP Western blotting 
showing immunoprecipitating L-selectin-GFP and GFP proteins. C) Densitometric analysis of 
three independent Western blottings shown in A. Mean values ± standard error are shown. 
Statistical analysis: two-tailed, unpaired Student’s t-test. *= P<0.05.   
 
L-selectin tail is also known to interact with ezrin/radixin/moesin (ERM) proteins (section 
1.10.3) and the attempts were made to investigate this interaction in THP-1 cells 
expressing WT L-selectin-GFP. Unfortunately however, attempts to immunoprecipitate 
ERM proteins using GFP-Trap® proved unsuccessful.  
3.3.3.4 Interaction of L-selectin-GFP on THP-1 cells with physiological ligands under 
flow conditions 
3.3.3.4.1 L-selectin recognises sialyl Lewis X (sLex) 
In order to determine whether L-selectin-GFP expressing THP-1 cells were capable of 
rolling on L-selectin ligands, THP-1 WT L-selectin-GFP Hi20 cells were perfused over 
immobilised sialyl Lewis X (sLex). Sialyl Lewis X tetrasaccharide was chosen as it is a 
known physiological L-selectin ligand (section 1.7.2) and has been reported to mediate 
L-selectin-dependent rolling of leukocytes under flow in the parallel plate flow chamber 
assays [642].  
The experiments were performed by Dr Aleksandar Ivetic and Mr Ahmed Ahmed (during 
his MSc research project in the Ivetic lab), using the aforementioned THP-1 WT L-
selectin-GFP Hi20 cells. Briefly, excess sLex-biotin (1 µg/mL) was added to increasing 
amounts of immobilised neutravidin, which approach achieved increasing concentration 
of sLex available for L-selectin binding (figure 3.12 A). The cells were subsequently 
perfused over the immobilised ligand under a shear stress parallel to the physiological 
stress of a blood flow (shear stress defined as a force imparted by the flow parallel to the 
vessel wall), and analysed for rolling. The mean rolling velocity of cells perfused over 2 
µg/mL of neutravidin co-immobilised with sLex was 43.6 µm/s (figure 3.12 B). This 
velocity decreased to 34.9 µm/s when 3 µg/mL of neutravidin was used, and no further 
decrease was seen with 4 µg/mL (mean cell velocity was recorded as 35.2 µm/s) (figure 
3.12 B), suggesting that the L-selectin/sLex interaction per monocyte reached saturation. 
Analysis of the rolling flux (figure 3.12 C) revealed that the flux was directly proportional 
to the concentration of neutravidin immobilised, and therefore to the amount of sLex 
available for L-selectin binding. These results indicate that transgenic L-selectin-GFP 
chimera was able to recognise its ligand and mediate cell rolling, and that the rolling flux 






Figure 3.12 Interaction of THP-1 cells expressing WT L-selectin-GFP with sialyl Lewis X 
(sLex) ligand under conditions of flow.  THP-1 cells expressing L-selectin-GFP were subjected 
to a parallel-plate flow chamber assay where the interaction with L-selectin physiological ligand, 
sLex tetrasaccharide was monitored. A) Schematic describing immobilisation of sLex ligand. 
Surface of the plastic well dishes was coated with poly-L-lysine and then increasing amounts of 
neutravidin were immobilised on to plastic wells. This was followed by the addition of an excess 
amount of biotinylated sLex. Binding of biotin on sLex to neutravidin achieved an increasing 
surface density of sLex. B) Slight decrease in the mean rolling velocity was observed with 3 µg/mL 
and 4 µg/mL neutravidin concentration. C) Increased rolling flux was observed to be directly 
proportional to the amount of neutravidin immobilised. Error bars represent S.E.M. All flow assays 
were performed at a shear stress of 2.5 dynes per cm2.Unpublished data obtained by Dr 










































































3.3.3.4.2 L-selectin mediates interactions of THP-1 cells with TNF-α-activated 
endothelium 
Initial attachment of primary human monocytes to interleukin 4 (IL-4) or TNF-α activated 
HUVEC was shown to be dependent on L-selectin [410, 575]. In addition, stable 
expression of L-selectin in the U937 monocytic cell line grants the ability to roll on and 
attach to IL-4 activated HUVEC under flow, which is thought to be a result of direct 
binding of L-selectin to its endothelial-expressed ligands [410]. To establish whether 
expression of L-selectin-GFP by THP-1 monocytic cells conferred the ability to attach to 
TNF-α activated HUVEC, a set of co-perfusion experiments was performed using the 
parallel plate flow chamber assay. The chamber that was used throughout this thesis is 
described in section 2.14.1, and the detailed method of the co-perfusion experiments is 
outlined in section 2.14.2. Firstly, THP-1 WT L-selectin-GFP Hi20 cells were compared 
against untransduced THP-1 cells to analyse the effect the ectopic expression of L-
selectin-GFP on the interactions between the THP-1 monocytes and the HUVEC 
monolayer (figure 3.13 A). Next, THP-1 WT L-selectin-GFP Hi20 were compared 
against THP-1 GFP Hi 20 cells to examine the influence of the GFP expression on THP-
1 cell recruitment in the absence of L-selectin (figure 3.13 B). Finally, untransduced 
THP-1 cells and THP-1 GFP Hi 20 cells were compared against each other to assess 
the influence of the lentiviral gene delivery on THP-1 cell recruitment (figure 3.13 C). All 
the perfusions were performed as co-perfusions, comparing one cell line directly against 
another, over a 10 minute period. Orange and Green Cell Tracker® dyes were used to 
differentially label each cell line under investigation. Additionally, the dyes were swapped 
between the experiments to exclude any effects the dyes could have had on the 
behaviour of the cells.  Panels A and B in figure 3.13 show that an average of 10% 
increase in the number of recruited cells occurred when THP-1 cells were expressing L-
selectin-GFP as compared to control (L-selectin negative) cells. No difference in the 
recruitment numbers was found between untransduced THP-1 cells and cells expressing 
GFP alone (figure 3.13 C), further confirming that the augmented recruitment was a 





Figure 3.13 Expression of L-selectin augments recruitment of THP-1 monocytes to TNF-α-
activated HUVEC. Confluent HUVEC monolayers were stimulated overnight with 10 ng/mL TNF-
α and THP-1 cells expressing WT L-selectin-GFP (WT), GFP alone (GFP) or THP-1 cells that 
had not been transduced (UT, untransduced) were perfused over the monolayer in the parallel-
plate flow chamber as described in section 2.14.2. The experiments were performed as co-
perfusions, where two types of cells at ratio 1:1 were perfused at the same time for 10 minutes. 
Prior to perfusion, cells were labelled with cell tracker dyes (one cell line with Cell Tracker® Green 
and one with Cell Tracker® Orange). The dyes were swapped between the experiments to ensure 
the results were not influenced by the dyes themselves. A) Significantly more WT THP-1 cells 
bound to TNF-α activated HUVEC than UT THP-1 cells. B) Significantly more WT THP-1 cells 
bound to TNF-α activated HUVEC than GFP THP-1 cells. C) No difference in recruitment numbers 
was seen when UT and GFP THP-1 cells were co-perfused.  Three independent co-perfusions 
were performed for each pair of cell lines. Error bars represent S.E.M. Statistical analysis: two-
tailed, unpaired Student’s t-test. ***= p<0.001.   
 
3.4 DISCUSSION 
3.4.1 Stable expression of L-selectin-GFP in THP-1 cells using lentiviral vectors 
The ultimate aim of the studies presented in this thesis is to gain new insights into the 
role of monocyte L-selectin during the leukocyte adhesion cascade and particularly its 
contribution to TEM. Using cell lines is generally considered advantageous due to the 
convenient supply of a large number of cells without dependency on a donor [643]. What 
is more, cell lines provide a simplified model of the biology of a certain cell type, which 
UT, untransduced THP-1 cells
WT, THP-1 cells expressing WT L-selectin-GFP Hi20











































































is extremely important when studying novel cellular processes. Furthermore, cell lines 
are in principle uniform and immortal, which again provides a simple and convenient 
model for the study of basic cellular processes. Additionally, a recent review suggests 
that THP-1 monocytic cell line is specifically well suited for studying function of 
monocytes in the vascular system, as the interaction between THP-1 cells and 
endothelial cells is comparable to that of human primary monocytes and endothelial cells 
[644].   
Lentiviral vectors are commonly employed tools for gene delivery and have successfully 
been used to express proteins of interest in various cell types of hematopoietic origin 
[645-650]. More specifically, human monocytic cell lines, including THP-1 cells, have 
been reported to become stably transduced using lentiviral vectors [651-654]. It was 
therefore decided to create lentiviral particles carrying the L-selectin transgene fused to 
fluorescent tags and use the viruses to transduce THP-1 cells. Human L-selectin cDNA 
was successfully cloned into C-terminal GFP- and RFP-tagging lentiviral backbone 
vectors, pHR´SIN-SEW-GFP and pHR´SIN-SEW-RFP, respectively (section 3.3.1.1, 
figure 3.1). At this stage pHR´SIN-SEW-L-selectinWT-RFP vector was frozen for future 
experiments and pHR´SIN-SEW-L-selectinWT-GFP was used to generate the lentiviral 
particles (figure 3.2). Two MOIs were used to overexpress L-selectin in THP-1 cells: low 
(MOI 5) and high (MOI 20). Obtaining high levels of L-selectin-GFP expression would be 
more desirable, however it could potentially have some adverse effects on cell function. 
If this was the case, it was hoped that the low expressors could be used to overcome 
this issue. Both MOIs were able to transduce THP-1 cells as confirmed by fluorescence 
microscopy of GFP channel and flow cytometry analysis of both GFP-tag and surface L-
selectin expression; however, as expected, a MOI of 20 resulted in higher transduction 
efficiency than a MOI of 5 (figure 3.4 and figure 3.5). The THP-1 WT L-selectin-GFP 
MOI 5 and THP-1 WT L-selectin-GFP MOI 20 were then FACS sorted into uniform 
populations, low expressor THP-1 WT L-selectin-GFP Lo5 and high expressor THP-1 
WT L-selectin-GFP Hi20, respectively. In sorted, uniform populations, each cell within a 
population was expressing matched levels of L-selectin-GFP. This was an important to 
ensure consistency and repeatability for future experiments as the parental unsorted cell 
populations included L-selectin-negative cells and cells of variable L-selectin expression 
levels. Flow cytometric analysis of uniform cell lines showed that THP-1 WT L-selectin-
GFP Hi20 cells had significantly higher levels of both GFP-tag and surface L-selectin 
levels than THP-1 WT L-selectin-GFP Lo5 cells as determined by MFI values (figure 
3.5), and this cell line was chosen for further characterisation. If any adverse effects of 
high L-selectin-GFP expression were found, low expressor THP-1 WT L-selectin-GFP 
Lo5 cells would be then tested. 
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In order to control for any effects lentiviral transduction might have had on the THP-1 
cells, a cell line was generated, where GFP protein was expressed on its own. To this 
end, the original pHR´SIN-SEW-SEW-GFP vector was used to produce lentiviral 
particles that were subsequently employed to transduce THP-1 cells with the MOI of 20. 
The THP-1 GFP MOI 20 cell line was subjected to FACS sorting in order to achieve 
uniform cell population (figure 3.6), where GFP levels would resemble those of GFP tag 
levels in THP-1 WT L-selectin-GFP Hi20 cells as closely as possible. 
Additionally, it was established that the levels of L-selectin-GFP expression in the THP-
1 cells was highly dependent on the cell culture density (figure 3.7), and it was decided 
that prior to the experiments, the cells would be seeded overnight at a strictly defined 
density of 0.4 x 106 cells/mL. This would ensure that the L-selectin-GFP levels would be 
matched between experiments.   
In conclusion, lentiviral gene delivery was successfully used to stably express L-selectin-
GFP in THP-1 monocytic cells. Two sorted, uniformly-expressing cell lines, low and high 
L-selectin-GFP expressors were created. High L-selectin expressor THP-1 WT L-
selectin-GFP Hi20 was chosen for further characterisation alongside control high GFP 
expressor THP-1 GFP Hi20. 
3.4.2 Tagging of the L-selectin cytoplasmic tail with GFP does not influence L-
selectin expression, localisation and function 
Fusing of proteins of interest to fluorescent tags is a well-known method used in cellular 
biology that enables non-invasive monitoring of protein localisation over time. Although 
generally considered useful, this approach has been reported to cause some adverse 
effects on the biology of the target protein under investigation [655, 656]. In this particular 
study, where a relatively large, 27 kDa protein (GFP) was fused to a short 17 amino acid 
L-selectin cytoplasmic tail, the possibility of the tag negatively affecting L-selectin 
function had to be taken in to consideration. A set of experiments was therefore designed 
that would test for characteristic features of L-selectin, including its expression at the cell 
plasma membrane, its localisation to microvilli, its ability to undergo shedding in 
response to cell stimulation, its capacity to interact with endogenous cytosolic binding 
partners and its ability to recognise its ligands under flow. 
Biochemical analysis of L-selectin expression revealed three separate protein forms of 
approximately 90-110, 80 and 35 kDa (figure 3.8 C and D). After substraction of 27 kDa 
belonging to the GFP, the obtained MWs (60-90, 53 and 5-8 kDa) correspond to those 
reported for endogenous L-selectin [381, 402, 515], suggesting that successful 
production of L-selectin-GFP chimera in the THP-1 cells had occurred. The fuzzy 
appearance of the heaviest band (90-110 kDa) suggested the full-length protein was 
heavily glycosylated, which was a further indicative of its mature form. The smallest form 
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(35 kDa) was identified as L-selectin cleavage product that is retained upon shedding 
(“stump”). The L-selectin-GFP “stump” appeared as a doublet, which was not entirely 
clear but it was thought that further cleavage might occur in the cell after L-selectin 
ectodomain was shed. The 80 kDa band was recognised as the intracellular form of L-
selectin that was associated with endoplasmic reticulum and Golgi apparatus structures. 
The evidence for intracellular L-selectin-GFP was also found when analysing 
fluorescence microscopy data, where distinct high-fluorescence L-selectin-GFP signal 
was seen within each cell (figure 3.8 A). The abundance of such form was expected as 
the lentiviral gene delivery system is based on the constitutively active promoter, and 
hence constitutive protein production was understood to take place.   
The initial evidence for L-selectin-GFP fusion protein expression at the cell surface was 
obtained by flow cytometry analysis during the cell line generation process (figure 3.5). 
Further investigation using fluorescence microscope revealed a distinct plasma 
membrane localisation of L-selectin-GFP chimera that could not be seen when only GFP 
was expressed in THP-1 cells (figure 3.8 A). More specifically, L-selectin is known to be 
localised to microvilli, and immunogold labelling followed by scanning electron 
microscopy (SEM) has been used before to assess this property in monocytes [18]. A 
study by Bruehl et al. [18] found that an average 72% of surface L-selectin is localised 
to the tips of monocyte microvilli and the rest of the protein is found on the cell body. 
Although quantification of the gold particles was not executed in the study performed in 
our laboratory, the SEM photographs clearly show that the majority of L-selectin-GFP 
was localised to the microvilli of the THP-1 monocytes (figure 3.8 B). 
ADAM17 is known to be the main metalloprotease that cleaves L-selectin following cell 
activation (section 1.9.2), and it has been reported that two distinct ways of ADAM17 
activation exist depending on the nature of the stimulus [496]. Killock and Ivetic (2010) 
showed that PKC-dependent L-selectin cleavage occurs upon stimulation with potent 
cell activator PMA, whereas p38-dependent shedding occurs after treatment with 
phosphatase inhibitors [496]. Examination of shedding in response to stimulation with 
PMA and protease inhibitor calyculin A would help to assess whether these two modes 
of L-selectin cleavage were functioning properly in the THP-1 WT L-selectin-GFP Hi20 
cells. Additionally, TNF-α, which was reported to cause L-selectin shedding in monocytes 
in a mechanism similar to that of protease inhibitors [496], was also used as a 
physiological stimulus. All three stimuli caused shedding of L-selectin as examined by 
Western blotting (figure 3.9), and shedding in response to PMA stimulation was 
addiotionally confirmed by flow cytometry (figure 3.10 A blue bar). While analysing the 
Westrn blottings, an inversely proportional relationship between surface L-selectin and 
“stump” levels was observed (figure 3.9 A and C). This was expected, as it is known 
that cleavage of L-selectin ectodomain leads to accumulation of the “stump” [657]. The 
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fact that the increase in the “stump” levels was not statistically significant could be due 
to its rapid turnover following the cleavage. Furthermore, pre-treatment of the cells with 
metalloprotease inhibitor Ro-31-9790 prevented PMA-induced shedding of L-selectin, 
indicating that cleavage was mediated by a metalloprotease (figure 3.10 A). 
Treatment with metalloprotease inhibitor on its own (in the absence of shedding stimulus) 
resulted in increased surface L-selectin expression (figure 3.10 A). This suggested that 
L-selectin was being constitutively cleaved in resting THP-1 WT L-selectin-GFP Hi20 
cells, a phenomenon known as basal L-selectin shedding (section 1.9.2). In keeping 
with this, Western blotting analysis revealed that L-selectin-GFP “stump” could be 
detected under resting conditions (figure 3.9 A control lane and figure 3.8 C and D). 
Little is currently known about the mechanism regulating basal shedding of L-selectin, 
but it has been reported that it occurs in both primary cells [521] and cell lines [544]. 
Although the same cleavage site seems to be involved as in the activation-induced 
shedding, the metalloprotease that cleaves L-selectin under resting conditions is not 
known [544]. ADAM17-dependent and ADAM17-independent basal L-selectin turnover 
has been shown [521, 544], and thus it appears that more than one mechanism 
regulating basal L-selectin shedding exists. It is possible that other metalloproteases like 
ADAM8 [524] or ADAM10 [525], which are known to have the ability to cleave L-selectin, 
can take part in basal L-selectin turnover. Since Ro-31-9790 is a broad-spectrum 
metalloprotease inhibitor, it is capable of inhibiting not only ADAM17, but also other 
metalloproteases. Therefore, it could not be discerned from this experiment which 
metalloprotease was responsible for basal L-selectin turnover in this particular system. 
Nevertheless, the ability of L-selectin-GFP to undergo cleavage under both cell-
activating and basal conditions was confirmed.  
Shedding of L-selectin is modified by calmodulin and ERM, which are cytosolic proteins 
that bind to the L-selectin tail (sections 1.10.3 and 1.10.4) [496, 558, 559]. Interactions 
between cytosolic proteins and the L-selectin tail have also been shown to be important 
for L-selectin adhesiveness and surface expression [515, 557, 558], as well as in the 
signalling induced downstream of L-selectin clustering [245, 562]. Even though no issues 
with L-selectin-GFP shedding were found in the THP-1 cells, this data did not provide 
any direct evidence as to L-selectin/CaM or L-selectin/ERM interaction. Direct proof for 
L-selectin/CaM interaction was obtained using GFP-Trap®/Western blotting analysis 
(figure 3.11), and this suggested that the GFP-tag did not impair the ability of the L-
selectin tail to bind CaM. GFP-Trap® was also used to attempt co-precipitation of L-
selectin-GFP and ERM proteins, unfortunately however, this proved unsuccessful. This 
is not thought to be a result of a lack of actual interaction, since ERM-dependent 
localisation of L-selectin-GFP to the microvilli [558] has been confirmed for these cells 
(figure 3.8 B). Furthermore, L-selectin, CaM and ERM were proposed to exist as a 1:1:1 
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ternary complex [572], and a very recent research performed by Deng et al. (2013) 
suggests sequential ERM and CaM binding to L-selectin tail [573]. In this model, moesin 
desorbs L-selectin from the anionic lipids within the inner leaflet of the plasma 
membrane, which is a prerequisite for subsequent CaM association (section 1.10.4 and 
figure 1.11) [573]. Since L-selectin-CaM interaction was detected for THP-1 WT L-
selectin-GFP Hi20 cells (figure 3.11), it strongly implies that ERM interaction had also 
occurred. Additionally, no apparent cell shape alterations could be observed, which 
would most probably be the case if the ERM proteins failed to link L-selectin-GFP 
cytoplasmic tail to the cytoskeletal network.  Previous work in the Ivetic laboratory came 
across similar ERM immunoprecipitation problems, however L-selectin-ERM interaction 
has been seen using other approaches (Dr Aleksandar Ivetic and Dr Maddy Parsons, 
King’s College London, personal communication).   
Functional L-selectin mediates leukocyte rolling (sections 1.2.2 and 1.7.5.1) [11, 52, 
365, 407], and so rolling of the THP-1 WT L-selectin-GFP Hi20 cells on immobilised sLex 
was examined (Dr Aleksandar Ivetic and Mr Ahmed Ahmed during his MSc research 
project in the Ivetic laboratory). An increase in the amount of immobilised sLex caused a 
reduction in the mean rolling velocity of L-selectin-GFP expressing cells (figure 3.12 B), 
suggesting that the cells started to roll slower when more tethers between L-selectin and 
sLex were formed. This was thought to be an indication of L-selectin-GFP successfully 
recognising its ligand. The increase of rolling flux that was directly proportional to the 
increase in the immobilised sLex (figure 3.12 C), further served to prove that L-selectin-
GFP mediated rolling of the THP-1 monocytes. In order to fully control for the L-selectin-
GFP interaction with sLex, these experiments should be complimented with appropriate 
controls. For example, analysis of mean rolling velocities and rolling flux of untransduced 
THP-1 cells or cells expressing GFP alone could be performed. Nevertheless, changes 
in the rolling behaviour of the cells that corresponded directly to the amount of sLex 
available, suggested that tagging of the L-selectin cytoplasmic tail with GFP did not 
hamper the functionality of the ligand-binding lectin domain of L-selectin. Finally, 
expression of L-selectin-GFP in THP-1 cells increased the recruitment of these cells to 
TNF-α-activated HUVEC as compared to untransduced THP-1 cells and THP-1 
monocytes expressing GFP alone by an average 10% (figure 3.13). L-selectin stably 
expressed by U937 monocytic cells (U937-LAM1) was also found to mediate attachment 
of those cells to IL-4 activated HUVEC; however, in this study attachment of L-selectin 
null U937 cells or U937-LAM1 cells pre-treated with anti-L-selectin antibodies was 
completely abolished [410]. The difference in the extent of L-selectin contribution 
between the study presented in this thesis (around 10%) and the study by Luscinskas et 
al (1994) (100%) [410], may lie in the monocytic cell type. Alternatively, the difference 
could be caused by the cytokine used to activate HUVEC (i.e. IL-4 versus TNF-α). Unlike 
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TNF-α, IL-4 does not induce E-selectin expression [658], and thus the observed 
contribution to recruitment in U937 cells could have been caused by L-selectin-
dependent secondary tethering and rolling (section 1.2.3). Additionally, the authors 
suggest that the inducible L-selectin ligand is present on the IL-4 activated HUVEC [410], 
and it is not known whether the same ligand is induced by TNF-α. On the other hand 
TNF-α has been shown to induce yet unidentified ligands for L-selectin on various ECs 
in vitro (section 1.8.2, summarised in table 1.2) [457-459], opening up a possibility that 
ligands for L-selectin (other than E-selectin) exist also on the TNF-α stimulated HUVEC. 
Thus, the observed L-selectin-GFP-dependent increase in recruitment of THP-1 cells to 
the TNF-α-stimulated HUVEC monolayers could be a result of secondary L-selectin 
tethering, direct L-selectin endothelial ligand binding or both. Analysis of leukocyte 
strings – formation of which is thought to be indicative of secondary leukocyte capture 
(section 1.2.3) – could prove useful in identification of L-selectin-depedent secondary 
capture, however such analysis was not formally performed in this study. 
Taken together, data presented in this section indicate that generated THP-1 WT L-
selectin GFP Hi20 cells expressed functional L-selectin-GFP chimera that exhibited 
correct localisation to plasma membrane and monocyte microvilli. High expression levels 
of L-selectin were not found to have any adverse effects and, therefore, it was concluded 
that those cells could be effectively used in further studies designed to investigate the 











CHAPTER 4. MONITORING THE SHEDDING OF L-SELECTIN-
GFP IN THP-1 CELLS  
4.1 INTRODUCTION 
The physiological significance of L-selectin shedding has been studied using two main 
approaches, the synthetic inhibitors of L-selectin shedding or mice expressing 
“sheddase-resistant” L-selectin. Certain studies showed that shedding of L-selectin 
regulate leukocyte rolling and suggested that shedding might limit leukocyte 
accumulation at sites of inflammation [519, 551, 552]. Importantly, reduced 
transendothelial migration of naive lymphocytes across PLN HEV was seen when 
shedding of L-selectin was blocked [22, 518]. Shedding was also shown to prevent 
activated T cells from re-entering the lymph nodes [22, 419]. Furthermore, impaired 
chemotaxis at sites of inflammation was observed amongst leukocytes expressing 
sheddase-resistant L-selectin [419]. These reports establish the importance of L-selectin 
shedding for the successful recruitment of leukocytes. However, just when and where 
during the leukocyte adhesion cascade the shedding occurs remains elusive. 
Transmigrated leukocytes have lost the majority of their surface L-selectin [520, 554-
556], suggesting that shedding occurs during the transendothelial migration step of the 
cascade. However, in the examples listed, studies were performed as end-point analysis 
assays. In other words, the studies monitored L-selectin expression after the 
transmigration had already occurred. For example L-selectin expression was analysed 
on neutrophils recovered from the bottom compartment of a transwell chamber [520], or 
transmigrated monocytes recovered from the abluminal side of HUVEC monolayers 
[554]. Another report measured L-selectin levels on emigrated leukocytes isolated from 
cantharidin-induced skin blisters [555, 556]. In all of these end-point assays, no 
information could be gleaned with respect to understanding the spatio-temporal 
distribution of L-selectin shedding during TEM. 
The cytoplasmic tail of L-selectin has been shown to control L-selectin shedding [323]. 
Specifically, the serine residues within the L-selectin tail were found to affect shedding 
in response to cell activating stimuli [496]. It is currently unknown whether these residues 
are also involved in L-selectin shedding during the leukocyte adhesion cascade, namely 
TEM. It is possible that those serines can modify the extent and/or timing of L-selectin 
shedding, thereby affecting leukocyte TEM. 
This chapter addresses the question of the spatio-temporal distribution of L-selectin 
shedding during monocyte TEM. The biochemistry and cell biology experiments 
performed in this chapter suggest that L-selectin shedding occurs during the early stages 
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of monocyte TEM, and that the serine residues within the L-selectin cytoplasmic tail are 
involved in regulating of this process.  
4.2 EXPERIMENTAL DESIGN 
Both full-length and cleaved (occasionally referred to as the “stump”) forms of L-selectin-
GFP can be detected on Western blots using anti-GFP antibody with high specificity 
(figures 3.8 and 3.9). This property allowed us to design a simple and reproducible 
method to detect L-selectin shedding over-time. The L-selectin-GFP expressing THP-1 
cells and activated HUVEC monolayers were co-cultured over increasing periods of time. 
Changes in full-length L-selectin and “stump” levels were assessed by Western blotting. 
The rationale behind this approach was to pin-point the time at which shedding was 
occurring during TEM. The assay was carried out under static conditions, as performing 
biochemistry studies on flowing cells is experimentally challenging, if not impossible.  
Serine residues within the cytoplasmic tail of L-selectin are important for L-selectin 
shedding [496]. This was established by generating murine pre-B 300.19 cells stably 
expressing non-phosphorylatable mutants of L-selectin [496]. Analogically, THP-1 cells 
were now used to create cell lines stably expressing serine-to-alanine cytoplasmic 
mutants of L-selectin-GFP. A lentiviral gene delivery system described in Chapter 3 was 
used to achieve mutant L-selectin expression in THP-1 monocytes. Flow cytometry was 
used to examine the surface expression to ensure that all generated cells expressed 
equivalent levels of L-selectin-GFP as compared to the THP-1 WT L-selectin-GFP Hi20 
cells described in Chapter 3. Shedding of WT and non-phosphorylatable mutants of L-
selectin in response to PMA and TNF-α was assessed by FACS. Any cells that showed 
an interesting phenotype were further analysed in co-culture assays as described in 
section 2.17.2. This would allow insights in to the role of the cytoplasmic serines in L-
selectin shedding during TEM.  
Once the static transmigration assays to monitor shedding were completed, in vitro 
parallel plate flow chamber assays were then employed. The results of the static 
transmigration assays were used to decide on the perfusion length. This was to ensure 
the cells were being monitored over a time at which shedding of L-selectin-GFP was 
occurring. THP-1 cells stably expressing “sheddase-resistant” L-selectin-GFP were 
generated to investigate whether the lack of shedding influenced the sub-cellular 
distribution of L-selectin-GFP during TEM. The cells were generated using the lentiviral 
transgene delivery system presented throughout this thesis. Flow cytometric analysis 
ensured that expression of the sheddase-resistant L-selectin-GFP matched that of WT 
L-selectin-GFP. Confocal microscopy was used to analyse L-selectin-GFP spatio-




4.3.1 Shedding of L-selectin-GFP peaks at 20 minutes in THP-1 cells undergoing 
TEM 
As described in section 4.1, transmigrated leukocytes are known to have shed L-selectin 
from the cell surface, but the exact point in time at which this occurs is not known. It is 
practically not possible to perform biochemistry on flowing cells, therefore a “static” 
transmigration assay was designed that allowed examination of L-selectin-GFP 
shedding in THP-1 cells when co-cultured with activated HUVEC (section 2.17.2). THP-
1 WT L-selectin-GFP Hi20 cells were added to TNF-α stimulated HUVEC grown on 
fibronectin-coated 6-well plastic dishes for 1, 5, 10, 20, 30 and 60 minutes. Unbound 
(supernatant) and HUVEC-bound fractions were collected, cells were lysed and 
analysed by Western blotting. Anti-GFP antibody was used to detect full-length and 
cleaved forms of L-selectin-GFP at each time point for both supernatant and HUVEC-
bound fractions. The antibody does not recognise any epitopes derived from TNF-α-
activated HUVEC (figure 4.1 A), which allows for the detection of L-selectin with great 
specificity. Figure 4.1 B shows that almost all THP-1 cells firmly bound to HUVEC by 5 
minutes as no L-selectin-GFP can be detected in the supernatant fraction at later time-
points. It was thus assumed that the 5 minute time-point represented 100% of surface L-
selectin. A decrease in surface L-selectin-GFP was seen in 10, 20, 30 and 60 minute 
time-points as compared to the 5 minute time-point. The reduction in surface L-selectin-
GFP was accompanied by an increase in cleaved L-selectin-GFP (“stump”), which 
suggested that shedding was occurring. Densitometric analysis of surface L-selectin-
GFP revealed that maximum shedding occurred at 20 minute time-point, where 44.08% 
of surface L-selectin was retained (figure 4.2 C). Although less dramatic, a further 
decrease was observed at later time points, namely 39.5% of surface L-selectin was 
present at 30 minutes and 32.12% was retained at 60 minutes (figure 4.2 C). This 
suggested that the first 20 minutes of rapid shedding was likely to be a result of THP-1 
cell activation by contact with activated HUVEC. A subsequent and gradual decline in 
the levels, seen at 30 and 60 minute time-points, could represent the ongoing basal L-
selectin shedding that continued beyond the first 20 minutes of activation induced 
shedding. The level of L-selectin-GFP “stump” increased almost two-fold at 10 minutes 
and persisted up to the 30 minute time-point (figure 4.2 D). Due to the variations between 
the experiments the changes were not significantly different. However, it could be 
suggested that the observed increase in the ”stump” levels reflected its generation during 
the proteolytic cleavage of the L-selectin-GFP ectodomain. Interestingly, at the 60 
minute-time point, the “stump” levels matched the levels observed at the 5 minute time-
point (figure 4.2 D). This suggested that between 30 and 60 minute time-points the 
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“stump” had been cleared from the cell membrane and degraded. Furthermore, it can be 
speculated that it takes around one hour for the “stump” to be turned-over after shedding 
is initiated when THP-1 cells are co-cultured with HUVEC. Overall, this data suggests 
that when THP-1 monocytes interact with TNF-α activated HUVEC under static 
conditions, L-selectin shedding starts to occur at 10 minutes (as indicated by “stump” 
generation) and peaks at 20 minutes.  
 
Figure 4.1 Time-course of WT L-selectin shedding when THP-1 cells interact with TNF-α 
activated HUVEC.  A) Specificity of the anti-GFP antibody. Cell lysates of TNF-α stimulated THP-
1 WT L-selectin-GFP Hi20 (left lane) and HUVEC cells (right lane) were analysed by Western 
blotting using anti-GFP antibody. No unspecific bands can be seen in the HUVEC lane.   B) 
Representative Western blotting showing L-selectin-GFP shedding in response to THP-1 cells 
interacting with TNF-α-activated HUVEC.  THP-1 WT L-selectin-GFP Hi20 cells were added on 
top of activated HUVECs for 1, 5, 10, 20, 30 and 60 minutes. Supernatant and HUVEC-bound 
fractions were then collected, lysed and analysed for L-selectin protein by Western blotting using 
anti-GFP antibody. C) Densitometric analysis of surface L-selectin protein derived from three 
independent Western blots shown in B. Data is represented as a percentage of L-selectin 
remaining on the surface.  As depicted by the graph, shedding of the 110 kDa form of surface L-
selectin peaks at 20 minutes, after which only a minor decrease can be observed. D) 
Densitometric analysis of L-selectin-GFP “stump” derived from three independent Western blots 
shown in B. Data is represented as a fold-change of the levels observed at 5 minute time-point. 











































































































































































Tukey’s post-test. No differences were detected in D due to the variability between the 
experiments. *=p < 0.05, **=p < 0.01.      
 
4.3.2. Generation of cell lines expressing non-phosphorylatable serine-to-alanine 
mutants of L-selectin-GFP 
By mutating the two serine residues within the cytoplasmic tail of human L-selectin into 
non-phosphorylatable alanines, Killock and Ivetic (2010) had previously shown that 
those amino acids regulate L-selectin shedding in lymphocytes. To investigate whether 
the cytoplasmic serines also affect L-selectin shedding in monocytes during TEM, it was 
decided to generate THP-1 cells expressing serine-to-alanine mutant forms of L-selectin-
GFP. THP-1 cell line is L-selectin negative (figure 3.5), hence the lack of endogenous 
L-selectin would allow direct comparisons with WT and mutant cell lines.  
The lentiviral vector pHR´SIN-SEW-L-selectinWT-GFP was used to generate various 
mutant L-selectin-GFP constructs by site-directed in vitro PCR mutagenesis as 
described in section 2.5. This allowed the generation of mutant L-selectin constructs 
with serine-364 and/or serine-367 mutated to alanine (figure 4.2 A), termed S364A, 
S367A and SSAA. All constructs were sequenced to ensure that the desired mutations 
had been achieved and no spontaneous mutations had occurred in L-selectin-GFP ORF. 
The lentivirus backbone vectors carrying mutant forms of L-selectin were then used to 
generate lentiviral particles as described in section 3.3.1.2 and section 2.12. The titres 





Figure 4.2 Generation and stable expression of L-selectin cytoplasmic tail mutants in THP-
1 cells.   A) Site directed PCR mutagenesis was performed to substitute serines at position 364 
or 367 of human WT L-selectin with non-phosphorylatable alanines. Constructs were also made 
in which both serines were replaced with alanines. THP-1 cells expressing matched levels of: 
WT-, S364A-, S367A- or SSAA-GFP L-selectin Hi20 were subjected to flow cytometry analysis 
(section 2.13) of both GFP tag levels (B) and surface L-selectin levels (C) on four different dates 
across a period of two months. MFI values show closely matched expression levels of WT and all 
mutant forms of L-selectin as One-way ANOVA detected no significant differences in the L-
selectin or GFP expression between the cell lines. Error bars represent S.E.M.  
 
Following the described method of THP-1 cell transduction outlined in section 3.3.1.3, 
THP-1 cells were transduced with lentiviruses at MOI 5 or MOI 20. As soon as a large 
enough polyclonal population of cells were established, the cells were then sorted by 
FACS into uniform-expressing populations. Table 4.1 shows all the serine-to-alanine 
mutant L-selectin-GFP expressing THP-1 cell lines that were generated in this process. 
Mutation Expressor 
Unsorted /sorted 
(uniform) Cell line name 
S364A low unsorted THP-1 S364A L-selectin-GFP MOI 5 
S364A low sorted THP-1 S364A L-selectin-GFP Lo5 
S364A high unsorted THP-1 S364A L-selectin-GFP MOI 20 
S364A high sorted THP-1 S364A L-selectin-GFP Hi20 
S367A low unsorted THP-1 S367A L-selectin-GFP MOI 5 











































S367A high unsorted THP-1 S367A L-selectin-GFP MOI 20 
S367A high sorted THP-1 S367A L-selectin-GFP Hi20 
SSAA low unsorted THP-1 SSAA L-selectin-GFP MOI 5 
SSAA low sorted THP-1 SSAA L-selectin-GFP Lo5 
SSAA high unsorted THP-1 SSAA L-selectin-GFP MOI 20 
SSAA high sorted THP-1 SSAA L-selectin-GFP Hi20 
Table 4.1 THP-1 cell lines expressing serine-to-alanine mutant forms of L-selectin-GFP.  
This table shows THP-1 cell lines expressing mutant forms of L-selectin-GFP where serine-364, 
serine-367 or both were substituted with non-phosphorylatable alanines rendering respective 
mutants: S364A, S367A and SSAA. 
 
Once sorted, THP-1 cells expressing S364A, S367A and SSAA L-selectin-GFP Hi20 
were monitored for surface L-selectin and GFP tag expression and compared to levels 
from WT L-selectin-GFP Hi20 cells. Comparable levels of both GFP tag (figure 4.2 B) 
and surface L-selectin (figure 4.2 C) were found between the cell lines as analysed by 
flow cytometry. Closely matched WT, S364A, S367A and SSAA L-selectin-GFP levels in 
THP-1 Hi20 cells ensured that any differences between the cell lines that could be 
identified during the shedding assays, would be a direct result of the introduced 
mutations and not differences in L-selectin expression.  
4.3.3 Double serine mutant within the L-selectin tail reduces TNF-α induced 
shedding 
Phosphorylation of serine residues in the L-selectin tail have been previously found to 
play a central role in regulating PMA- but not phosphatase inhibitor-induced shedding in 
murine pre-B 300.19 cells stably expressing human L-selectin [496]. Serine-to-alanine 
mutations of serine-364 (S364A) and serine-367 (S367A) resulted in decreased L-
selectin shedding at 10 nM and higher concentrations of PMA [496]. Additionally, double 
serine mutation (SSAA) resulted in reduced shedding at 100 nM and higher PMA 
concentrations (David Killock, unpublished data). To test the effect of PMA-induced 
shedding of L-selectin-GFP on THP-1 cells, WT and mutant cell lines were subjected to 
increasing doses of PMA, and surface L-selectin levels was monitored by flow cytometry. 
Treatment with 10 nM PMA resulted in almost complete loss of surface L-selectin, with 
an average of 5% of cell surface expression of WT or mutant forms of L-selectin-GFP 
(figure 4.3 A). This was rather unexpected as the study by Killock and Ivetic (2010) 
revealed that incubation with 10 nM PMA resulted in retention of 60% of surface WT L-
selectin and 20% WT L-selectin was still present on the surface when 1000 nM PMA was 
used [496]. This could be simply due to the difference in cell type (i.e. comparing murine 
pre-B cells with a human monocyte cell line). To test whether lower concentrations of 
PMA would reveal any difference in L-selectin shedding between WT and the mutants, 
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5 and 7 nM concentrations of PMA were used. Again, no differences were observed  the 
cell expressing WT or mutant forms of L-selectin-GFP (figure 4.3 A). Having found no 
effect of serine phosphorylation on PMA induced shedding of L-selectin-GFP, the effect 
of TNF-α on the shedding of WT and mutant L-selectin was next explored. Killock and 
Ivetic (2010) found that, unlike PKC-driven (i.e. PMA-induced) shedding, TNF-α- and 
phosphatase inhibitor-induced shedding are both mediated by p38 MAPK [496]. This 
means that PMA- and TNF-α-induced shedding of L-selectin are mechanistically different 
[496]. Thus, perhaps the serine residues were important for TNF-α induced L-selectin 
shedding from THP-1 monocytes. THP-1 WT, S364A, S367A or SSAA L-selectin-GFP 
Hi20 cells were therefore subjected to increasing amounts of TNF-α, and surface L-
selectin levels was again monitored by flow cytometry. As shown in figure 4.3 B, a 
decrease in shedding was seen with the double serine-to-alanine mutant SSAA at 10 
and 20 ng/mL of TNF-α. A similar trend in the loss of S364A and S367A L-selectin-GFP 
expression in response to 10 and 20 ng/mL concentration of TNF-α was observed, but 
this was not statistically significant. This suggests that both serine residues could play a 
role in TNF-α induced L-selectin-GFP shedding. No significant differences between WT 






Figure 4.3 Both S364 and S367 are required for TNF-α induced shedding. THP-1 WT, S364A, 
S367A or SSAA L-selectin-GFP Hi20 were challenged with increasing doses of either PMA (A) 
or TNF-α (B) for 30 or 60 minutes, respectively, at 37º C. L-selectin surface levels were 
subsequently monitored by flow cytometry. PMA concentrations used were 0, 5, 7 and 10 nM and 
TNF-α concentrations used were 0, 10, 20 or 50 ng/mL. All the experiments were performed at 
least three times in triplicate. Data represent mean values ± SEM. Statistical difference was 
calculated for each concentration using One-way ANOVA followed by Dunnet’s test against WT. 
*=p < 0.05.    
 
Although the results seem to contradict those of Killock and Ivetic (2010), this could 
potentially be explained by the fact that different cell lines were used for the studies. Cells 
used by Killock and Ivetic (2010) were murine pre-B lymphocytes that were stably 
expressing human L-selectin and the cells used in this study were human monocytes 
expressing human L-selectin.  The fact that 10nM PMA concentration caused around 
95% loss of surface L-selectin in THP-1 cells but only 40% loss in 300.19 cells suggests 
that monocytes are much more sensitive to this stimulus than lymphocytes. As a result, 
it cannot be excluded that at concentrations lower that 5 nM, differences in PMA-
shedding could be seen between WT and mutant forms of L-selectin-GFP. Nevertheless, 
L-selectin shedding in response to PMA
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these results show that phosphorylation of both serine-364 and serine-367 within the 
cytoplasmic tail of L-selectin is important for TNF-α induced shedding of L-selectin-GFP 
from THP-1 monocytes.  
4.3.4 SSAA mutation delays L-selectin shedding when THP-1 cells interact with 
activated HUVEC under static conditions 
Western blotting of static transmigration assays showed that WT L-selectin-GFP is shed 
when THP-1 cells are added on to activated HUVEC (figure 4.1). The data presented in 
figure 4.3 shows a reduction in TNF-α induced shedding of L-selectin-GFP when both 
cytoplasmic serine residues are mutated to non phosphorylatable alanines when cells 
are in suspension. To test whether the SSAA mutation also had an effect on L-selectin 
shedding during the static transmigration assays, THP-1 SSAA L-selectin-GFP Hi20 
cells were subjected to the assays and Western blotting analysis of the bound fraction 
as described in section 4.3.3. Western blotting showed that a loss of surface SSAA L-
selectin-GFP peaked at 30 minutes, where 44.6% of SSAA L-selectin-GFP remained cell 
associated (figure 4.4 A and B). No further decrease was seen at later time-points 
(figure 4.4 A and B). The L-selectin-GFP “stump” was first generated at the 10 minute 
time-point as seen by a 1.7 fold-increase as compared to the 5 minute time-point (figure 
4.4 A and C). The elevated “stump” levels persisted for up to 30 minutes into the assay, 
and then decreased to levels slightly above those observed at 5 minutes (1.18 fold 
change) (figure 4.4 A and C). Results were quantified and compared to the 
corresponding values obtained for WT L-selectin-GFP (presented earlier in figure 4.1). 
Statistical analysis showed that significantly more full-length SSAA L-selectin was found 
at the 20 minute time-point than WT L-selectin (74.36% versus 44.08%, respectively) 
(figure 4.4 D). Additionally, more full-length L-selectin-GFP was detected in the SSAA 
mutant (91.02%) than WT (64.8%) at 10 minutes, although this was not statistically 
significant. No differences in full-length L-selectin levels were detected at 30 minute and 
60 minute time-points, suggesting that SSAA mutation did not affect shedding at later 
time-points. Thus, it could be proposed that abrogating phosphorylation of L-selectin 
cytoplasmic serine residues leads to an approximately 10 minute delay in shedding of L-
selectin during the initial stages of monocyte TEM under static conditions. Additionally, 
analysis of the SSAA L-selectin-GFP “stump” levels showed an increase in the fold-
change at 20 minutes when compared to the WT L-selectin-GFP “stump” levels. A lack 




Figure 4.4 Serine-to-alanine mutation of the L-selectin tail delays shedding when THP-1 
cells are incubated with activated HUVEC under static conditions. THP-1 cells expressing 
SSAA L-selectin-GFP Hi20 were added on top of activated HUVEC for 1 to 60 minutes. Bound 
fractions were then collected, lysed and analysed for L-selectin protein by Western blotting using 
anti-GFP antibody. A) Representative Western blotting showing shedding of surface SSAA-L-
selectin-GFP when THP-1 cells interact with TNF-α-activated HUVEC over one hour period of 
time. Three independent Western blots were used to perform densitometric analysis of surface 
SSAA L-selectin-GFP (B) and L-selectin-GFP “stump” (C). D) Comparison of densitometric 
results of full-length WT- and SSAA-L-selectin-GFP levels on THP-1 cells interacting with TNF-α-
activated HUVEC monolayers. Significantly more surface L-selectin was found at 20 minute time-
point for SSAA mutant as compared to WT L-selectin-GFP expressing THP-1 cells. E) 
Comparison of changes in L-selectin-GFP “stump” levels between WT and SSAA mutant. 
Statistical analysis in B and C: One-way ANOVA followed by Tukey’s post-test. No differences 
were detected in C. Statistical analysis in D and E: Two-tailed, unpaired Student’s t-test for each 
time point. Error bars represent standard error. *=p<0.05. 
       


























































































































































































































4.3.5 Characterisation of interactions between THP-1 cells and TNF-α activated 
HUVEC under flow 
The results shown above indicate that, when subjected to the static transmigration assay, 
THP-1 cells bind to TNF-α-activated HUVEC within the first 5 minutes and L-selectin 
shedding peaks at 20 minutes (figure 4.1). During the optimisation phase of the in vitro 
parallel plate flow chamber experiments, it was noticed that it took two minutes for the 
first THP-1 cells to arrive from the cells reservoir, and the cells were rapidly attaching to 
the activated HUVEC monolayer. A parallel plate flow chamber assay was hence 
designed, where cells were perfused over a monolayer of TNF-α activated HUVEC over 
a 15 minute period of time. This was thought to represent the time at which L-selectin 
shedding was occurring, and it was hence important to establish what type of interactions 
were formed between THP-1 cells and activated HUVEC cells during this period. A 
detailed method of the in vitro parallel plate flow chamber assay used in these 
experiments is described in section 2.14. Few cells could be identified as “fully 
transmigrated” when the experiment was stopped after 15 minutes of flow. 
Transmigrated leukocytes can be easily identified by their phase-dark appearance [659-
662], and extremely rarely such cells could be seen (approximately 1 cell per experiment 
where three fields of view were acquired).  However, the cells appeared to have 
commenced transmigration by forming membrane extensions, termed pseudopods, 
which were thought to extend beneath the HUVEC monolayer.  Still images from a 
recorded movie clearly show that the cells started to form pseudopods as early as 3 
minutes after attachment, and that these pseudopods were very dynamic (figure 4.5, 




Figure 4.5 THP-1 cells form pseudopods just a few minutes after adhesion.   THP-1 WT L-
selectin-GFP Hi20 cells were perfused over TNF-α activated HUVEC monolayer (see section 
2.14.3) and the acquired footage was used to generate time-lapse stills.  Just a few minutes after 
adhesion (time point=0 min), THP-1 cells send processes (pseudopods) underneath the HUVEC 
monolayer. Scale bar: 30 µm.  
 
Although the phase dark appearance of the pseudopods suggested their subendothelial 
localisation, this had to be validated to ensure that THP-1 cells were indeed undergoing 
transmigration. In order to analyse this, the experiment was repeated, flow was stopped 
after 7 minutes and the cells were fixed with 4% PFA. The seven minute perfusion meant 
that the cells had been interacting with HUVEC for 5 minutes after attachment and as a 
result the fixed sample was a representative of 5 minutes, as shown in figure 4.5. Fixed 
cells were permeabilised and stained with TRITC-phalloidin and prepared for confocal 
microscopy as described in section 2.16.2. TRITC-phalloidin staining enabled 
visualisation of actin cables belonging to HUVEC and hence it was possible to identify 
the z-positions of THP-1 cells. The monocyte cell body was attached to the apical 
HUVEC surface (figure 4.6 A “Top”), and this z-plane is hereafter referred to as “Top”. 
The pseudopods were positioned underneath the HUVEC monolayer (figure 4.6 A 
“Bottom”) and this z-plane is hereafter referred to as “Bottom”.  Z-stacks of the cells were 
acquired and used to generate 3D images of the THP-1 and HUVEC cells (section 
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2.16.3). Phalloidin staining of the actin-based cytoskeleton was used as a guide to what 
was above and beneath the endothelium. Three-dimensional reconstruction of thin 
optical sections (0.75 m) obtained from laser scanning confocal microscopy revealed 
that the pseudopods of THP-1 cells were positioned underneath the actin cables 
belonging to HUVEC cells (figure 4.6 B). To test whether the pseudopods remained 
underneath the endothelium at the end of the flow experiments, 3D reconstruction was 
repeated with cells fixed after 15 minutes of perfusion. Again, it was discovered that the 
pseudopods were positioned underneath the HUVEC monolayer (figure 4.6 C). These 
results demonstrated that THP-1 WT L-selectin-GFP Hi20 cells initiated transmigration 
through TNF-α activated HUVEC by extending dynamic membrane pseudopods 
underneath the endothelial cells, and such cells are hereafter referred to as 
“transmigrating cells”. Unfortunately, the cells did not fully transmigrate underneath the 
endothelium. This was thought to be a result of the sheer size of the cell, or its nucleus; 
THP-1 cells are large and are physically unable to undergo full TEM. The drawback of 
this is that the process of complete TEM cannot be studied in our model. However, the 





Figure 4.6 THP-1 monocytes expressing L-selectin-GFP initiate transmigration through 
HUVEC by extending pseudopods underneath the endothelial cells.  THP-1 WT L-selectin-
GFP Hi20 cells were perfused over TNF-α activated HUVEC for 7 or 15 minutes (section 2.14.3), 
fixed with 4% PFA and stained with TRITC-phalloidin (section 2.16.2). Series of z-stacks were 
acquired by confocal microscope and Imaris software was used to compile the stacks, followed 
by “volume rendering” (section 2.16.3). The GFP channel was used to render THP-1 cells volume 
(shown in green) and TRITC-phalloidin was used to render actin volume (shown in red).  A) 
Schematic showing typical appearance of a THP-1 monocyte interacting with HUVEC under flow. 
Cell body is attached to the apical surface of the endothelial cells (“Top”) and the pseudopods 
extend beneath the HUVEC monolayer (“Bottom”). B) Top and Bottom view showing a 



















at 7 minute time-point. Pseudopods (blue stars) extend underneath the actin cables of endothelial 
cells (arrows). Scale bar: 10 µm. C) Representative 3D reconstruction of THP-1 cell 
transmigration at 15 minutes. In this particular example, the monocyte pseudopod (blue star) is 
positioned directly underneath the nucleus of the endothelial cell. The endothelial cell can be 
identified by characteristic actin cables (arrows). The nucleus can be detected by typical oval 
shape where phalloidin staining is absent. The large gap where the nucleus is positioned, and 
neither GFP nor actin volume is present, allows a “see-through” mode, and thus both Top and 
Bottom views can be seen in a single view. Scale bar: 5 µm.   
 
4.3.6 WT L-selectin-GFP is enriched in “spots” in the protruding pseudopods of 
transmigrating THP-1 cells under flow 
Data presented in the section above show that during 15 minute perfusion over activated 
HUVEC, THP-1 cells form dynamic pseudopods that protrude underneath the endothelial 
monolayer. This represents early transmigration stage of the leukocyte adhesion 
cascade. Additionally, based on the results obtained during static transmigration assays 
(figure 4.1), shedding of L-selectin is understood to occur during this time. It was hoped 
that detailed, high magnification images of transmigrating THP-1 monocytes could 
provide information as to the spatial distribution of L-selectin-GFP during the 15 minutes 
of perfusion. This in turn could provide clues as to where L-selectin shedding was 
occurring in any given cell. To this end, flow experiments were stopped after 7 or 15 
minutes of perfusion and the cells were fixed with 4% PFA. The seven minute time-point 
was thought to represent the time of minimal L-selectin-GFP shedding, and the 15 minute 
time-point was thought to be a representative of the time at which shedding was nearly 
at its maximum. Fixed cells were prepared for confocal microscopy (section 2.16.2), and 
confocal images were acquired of single z-planes representing Top and Bottom views 
(Top and Bottom views were as shown in figure 4.7 A). Control THP-1 GFP Hi20 cells 
exhibited a uniform, diffuse GFP distribution at 7 minutes, which did not change over 
time (figure 4.7 A). Although not abundant, high intensity GFP “spots” were found to be 
localised in the pseudopods of transmigrating THP-1 WT L-selectin-GFP Hi20 cells at 7 
minute time-point (figure 4.7 B). Interestingly, these GFP-positive spots appeared to 
accumulate more with time as seen in the images from the 15 minute time-point (figure 
4.7 C). A lack of GFP-positive spots in the control cells suggested that there were specific 
accumulations of L-selectin-GFP, and not GFP protein alone. For quantification of L-
selectin-GFP spots, only the pseudopods were selected. This was because L-selectin-
GFP was previously found to be abundant in the intracellular compartments (figure 3.8). 
It was hence assumed that the L-selectin-GFP spots present in the cell body could be 
easily confused for protein localised to the endoplasmic reticulum or the trans Golgi 
network. By excluding the cell body from the analysis one could ensure that only L-
selectin-GFP spots present in protruding and transmigrated regions of the cell were 
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being assessed. The method for analysing L-selectin-GFP spots is described in more 
detail in section 2.16.4. As shown in figure 4.8, an average 26 L-selectin-GFP spots per 
cell were seen in the pseudopods at the 7 minute time-point, and average of 62 spots 
per cell were present in the pseudopods after 15 minutes. This indicated a time-
dependent increase in the formation of these spots. No spots were seen in the 
pseudopods of the control THP-1 GFP Hi20 cells across the two time-points analysed, 
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Figure 4.7 A time-dependent accumulation of WT L-selectin-GFP “spots” in the 
pseudopods of THP-1 cells.  GFP or WT L-selectin-GFP expressing THP-1 cells were perfused 
over TNF-α activated HUVEC monolayer for 7 or 15 minutes, fixed with 4% PFA and stained with 
TRITC-phalloidin. Figures A-C show representative single z-plane (0.75 m thickness) confocal 
images of the fixed cells, where the pseudopods are outlined with dashed lines. Top and Bottom 
z-planes are as shown in figure 4.6 A. Images of the GFP channel include magnified sections of 
the areas outlined in red. For perfusion of cells in the parallel plate flow chamber assay see 
section 2.14.3. Preparation of cells for confocal microscopy and z-stack acquisition are described 
in sections 2.16.2 and 2.16.3, respectively. A) A diffuse distribution of GFP in the control THP-1 
GFP Hi20 cells at 15 minutes. Similar images for the 7 minute time-point exist, but are not shown 
in the figure. Scale bar: 5 µm. B) Low numbers of WT L-selectin-GFP spots (blue arrows) in the 
pseudopods of THP-1 WT L-selectin-GFP Hi20 cells at 7 minute time-point. Scale bar: 10 µm. C) 
At the 15 minute time-point, WT L-selectin-GFP “spots” (blue arrows) can be seen in the 
pseudopods of THP-1 WT L-selectin-GFP Hi20 cells. Scale bar: 10 µm. 
 
Figure 4.8 Quantitative analysis of L-selectin-GFP spots accumulating in the pseudopods 
of THP-1 cells over time.  The GFP-positive spots shown in figure 4.3 were scored using the 
“Find spots” feature on Volocity image analysis software (section 2.16.4). The graph shows the 
average number of spots per cell. No spots can be seen accumulating in THP-1 GFP Hi20 cells. 
At 7 minutes, an average of 26 spots are present in THP WT L-selectin-GFP Hi20 cells (WT L-
selectin-GFP), which increases to an average of 62 spots at 15 minute time-point. Fifteen cells 
were analysed per experiment and experiments were repeated three times for each cell line. 
Mean values are shown for each bar. Error bars represent S.E.M. Statistical analysis: Two-tailed, 
unpaired Student’s t-test. **=p<0.01. 
 
The results demonstrated that when THP-1 cells initiated TEM by sending pseudopods 
underneath the HUVEC monolayer, L-selectin-GFP accumulated in those pseudopods 
over-time. Yet, the nature of the L-selectin-GFP spots was unclear at this point. Since 
the scoring was performed on the GFP-tag, the spots could represent full-length L-
selectin-GFP, L-selectin-GFP “stump” or a mix of the two. It was hypothesised that, if the 
spots represented L-selectin “stump”, their accumulation could indicate L-selectin 



































shedding. On the other hand, accumulation of full-length L-selectin-GFP could mean that 
the spots represented clustered L-selectin. 
4.3.7 Generation of THP-1 cell lines expressing the sheddase-resistant (ΔM-N) 
form of L-selectin-GFP  
A sheddase-resistant form of L-selectin has been used in the past to study the role of 
shedding [22, 419, 529]. It was thus decided to generate THP-1 cell line expressing 
sheddase resistant L-selectin-GFP to further investigate the role of L-selectin shedding 
during the initial stages of TEM. L-selectin is cleaved in the extracellular region between 
lysine-321 and serine-322, which is close to the plasma membrane [326], and deletions 
within this region are known to abrogate L-selectin shedding [528]. A two-step site-
directed in vitro PCR mutagenesis was performed on wild type L-selectin cDNA in the 
lentivirus backbone vector pHR´SIN-SEW-L-selectinWT-GFP (section 2.5). Deletion of 
an 8 amino acid sequence (MIKEGDYN) within the membrane proximal site rendered L-
selectin sheddase- resistant, and this form from hereon will be termed ΔM-N L-selectin 
(figure 4.9). The ΔM-N mutant has been characterized previously and was demonstrated 
to effectively inhibit PMA-induced shedding [522]. The resulting construct, termed 
pHR´SIN-SEW-L-selectinΔM-N-GFP was sequenced to ensure that the desired deletion 
had been achieved and no spontaneous mutations had occurred within the L-selectin 
ORF. The lentiviral backbone vector carrying ΔM-N L-selectin-GFP was then used to 
generate lentiviral particles as described in section 3.3.1.2 and section 2.11. The titre 
of the concentrated lentivirus suspension is presented in table 2.5. 
   
Figure 4.9 Construction of sheddase resistant (ΔM-N) L-selectin mutant.  Amino acid 
sequence of the C-terminal portion of human L-selectin, including the entire cytoplasmic, 
transmembrane and membrane proximal (shown in red) sites. A two-step site-directed in vitro 
PCR mutagenesis (section 2.5) was used to delete sequence of eight amino acids within 
membrane proximal site to render L-selectin shedding resistant (ΔM-N). The cleavage site is 
shown with the blue arrow. SCR, sequence consensus repeats. 
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Following the established method of THP-1 cell transduction, originally outlined in 
section 3.3.1.3, THP-1 cells were infected with MOI or 5 and 20 with lentivirus carrying 
the ΔM-N L-selectin-GFP transgene. A detailed method of THP-1 cell transduction is 
described in section 2.11.4. The resultant polyclonal cell lines, termed THP-1 ΔM-N L-
selectin-GFP MOI 5 (indicating a low expressor cell line) and ΔM-N L-selectin-GFP MOI 
20 (indicating a high expressor cell line), were FACS-sorted into uniform cell populations 
expressing matched levels of L-selectin. The sorted cell lines were named THP-1 ΔM-N 
L-selectin-GFP Lo5 (low expressor) and THP-1 ΔM-N L-selectin-GFP Hi20 (high 
expressor).   
4.3.8 Characterisation of THP-1 cell lines expressing ΔM-N L-selectin-GFP  
4.3.8.1 Analysis of ΔM-N L-selectin-GFP expression levels in THP-1 cells 
The expression levels of WT and serine-to-alanine mutant forms of L-selectin-GFP have 
so far all been matched. Matched L-selectin expression was seen with high expressor 
cell lines (Hi20) (figure 4.6). However, it was the low expressor THP-1 ΔM-N L-selectin-
GFP Lo5 cells that had matched L-selectin expression levels to those of THP-1 WT L-
selectin-GFP Hi20 cells (figure 3.10 A and B). THP-1 ΔM-N L-selectin-GFP Hi20 had 
significantly higher levels of both GFP-tag and surface L-selectin than THP-1 WT L-
selectin-GFP Hi20 (figure 4.10 A and B). This was hypothesised to be due to the lack 
of basal shedding in ΔM-N L-selectin-GFP. When Ro-31-9790 is used to inhibit basal 
shedding in THP-1 WT L-selectin-GFP Hi20 cells, surface L-selectin levels increase 
significantly (figure 3.10). Therefore L-selectin expression on THP-1 ΔM-N L-selectin-
GFP Hi20 cells could mimic an outcome seen in Ro-31-9790-treated WT L-selectin-GFP 
Hi20cells. As a result, in order to ensure matched L-selectin levels between the cell lines, 
THP-1 ΔM-N L-selectin-GFP Lo5 cell line was chosen for further studies. It was noticed 
that, even though RPE MFI values, representing surface L-selectin levels, between THP-
1 WT L-selectin-GFP Hi20 and THP-1 ΔM-N L-selectin-GFP Lo5 were matched, the flow 
cytometric profiles showed slightly different distribution of the cell populations (figure 
4.10 C). The ΔM-N histogram appeared as a sharp peak at the higher end of the 
fluorescence intensity scale, whereas the WT histogram was shorter and broader 
suggesting a much broader distribution of surface L-selectin expression between the 
cells within the population (figure 4.10 C right histogram). No differences were seen in 
the histograms representing GFP-tag levels (figure 4.10 C left histogram). The reason 
for this was not clear but it was hypothesised that a lack of basal shedding in THP-1 ΔM-
N L-selectin-GFP Lo5 cells resulted in an accumulation of L-selectin at the plasma 
membrane. As such, there would be little variability in the surface L-selectin expression 
between the cells within the population. Conversely, WT L-selectin-GFP was subjected 
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to constitutive turnover (figure 3.10), and hence a slight variability in surface L-selectin 
expression within the population was likely to occur. As expected, Western blotting 
analysis revealed that THP-1 ΔM-N L-selectin-GFP Lo5 cells did not produce a L-selectin 
“stump”, suggesting that basal shedding was abolished in this cell line. This is explored 
further in the section 4.3.8.2 below. Furthermore, the intracellular (~80 kDa) band in the 
lysates from THP-1 ΔM-N L-selectin-GFP Lo5 cells was less abundant than in the lysates 
derived from the THP-1 WT L-selectin-GFP Hi20 cells (figure 4.10 D). This made sense 
given the different MOIs used (5 versus 20).  
 
Figure 4.10 Expression of ΔM-N L-selectin-GFP in THP-1 cells.  THP-1 cells expressing low 
(Lo5) or high (Hi20) levels of ΔM-N L-selectin-GFP were compared to THP-1 cells expressing WT 
L-selectin-GFP Hi20. Flow cytometry analysis (section 2.13) was performed to compare MFI 
values of both GFP-tag (A) and surface L-selectin (B). Experiments were performed in triplicates 
on three independent occasions. Error bars represent S.E.M. C) Representative histograms 
comparing GFP-tag (left histogram) and surface L-selectin (right histogram) levels of THP-1 WT 
L-selectin-GFP Hi20 and ΔM-N L-selectin-GFP Lo5. D) Representative Western blotting showing 
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from THP-1 ΔM-N L-selectin-GFP Lo5 cells as compared to the THP-1 WT L-selectin-GFP Hi20 
cells.  Statistical analysis in A and B: One-way ANOVA and Dunnett’s post-test against “WT Hi20”. 
***=p<0.001. MFI, Mean Fluorescence Intensity. 
              
4.3.8.2 Basal and activated L-selectin shedding is abrogated in THP-1 cells expressing 
ΔM-N L-selectin-GFP 
To formally test the hypothesis that ΔM-N L-selectin-GFP could not be turned over in 
THP-1 cells, the cells were treated with Ro-31-9790 metalloprotease inhibitor that can 
inhibit ADAM17 enzyme. The metalloprotease inhibitor Ro-31-9790 did not cause any 
additional increase in the surface expression of ΔM-N L-selectin-GFP (figure 4.11 A red 
bar), confirming that ΔM-N mutation abrogates basal shedding of L-selectin in THP-1 
cells. As expected, PMA stimulation did not promote shedding in this cell line (figure 
4.11 A blue bar). Interestingly, surface levels of ΔM-N L-selectin increased slightly upon 
PMA stimulation, although this was not statistically significant. Whether this finding was 
a coincidence or whether there was an actual influence of PMA stimulation on surface 
ΔM-N L-selectin levels was not clear. It may be that PMA stimulation increased trafficking 
of ΔM-N L-selectin-GFP to the plasma membrane via activation of the secretory pathway. 
PMA has been shown previously to stimulate secretory pathways [663] and elevate cell 
surface protein levels [664]. No change in GFP-tag levels upon PMA stimulation (figure 
4.11 B blue bar) would support this hypothesis. The GFP-tag would provide the same 




Figure 4.11 No shedding occurs in THP-1 cells expressing ΔM-N L-selectin.   THP-1 cells 
expressing ΔM-N L-selectin-GFP Lo 5 were stimulated with PMA, ADAM17 inhibitor Ro-31-9790 
or both and analysed for both GFP-tag and surface L-selectin levels as described in figure 3.10. 
A) Surface L-selectin expression was not modified by any of the stimuli used. Slight increase in 
the expression was seen in MFI values upon PMA stimulation but this was not statistically 
significant. M1 on the histogram shows gate for RPE positive THP-1 cell population. B) GFP-tag 
levels, where M1 (histogram) shows gate for GFP positive cells did not change upon treatment 
with any of the stimuli. C) Gate R1 in the scatter profile contains population of viable THP-1 cells 
and was applied to all samples.  Histograms in A, B and C represent the changes seen in a typical 
experiment and fold-changes of L-selectin surface levels shown on corresponding graphs were 
established on the basis of MFI values acquired  for 3 independent experiments. Data represent 
mean ± SEM and no significance were found by One-way ANOVA. 
 
4.3.9. Shedding of L-selectin-GFP directly correlates with an accumulation of GFP-
positive “spots” in the transmigrating pseudopods of THP-1 cells 
As described in section 4.3.5 and 4.3.6, mutating both serines in the L-selectin tail to 
















































addition, a corresponding delay in shedding of L-selectin-GFP was observed in the static 
transmigration assays (figure 4.4). Following the hypothesis that accumulation of WT L-
selectin-GFP spots in the pseudopods of transmigrating THP-1 cells could indicate 
shedding (section 4.3.2), it would be of interest to determine if the accumulation of SSAA 
L-selectin-GFP spots was also decreased. Additionally, analysis of the ΔM-N L-selectin-
GFP accumulation could directly answer the question whether shedding and GFP-
positive spots accumulation were linked. Flow cytometric analysis revealed that THP-1 
SSAA L-selectin-GFP Hi20 and ΔM-N L-selectin-GFP Lo5 cells had matched L-selectin-
GFP expression to that of THP-1 WT L-selectin-GFP Hi20 cells (figure 4.2 and figure 
4.10). These cell lines were therefore employed in this study. Accumulation of WT L-
selectin-GFP spots was observed after 15 minutes of flow (figure 4.8), and this time-
point corresponds to the period just before the peak of shedding is seen in the static 
transmigration assays (figure 4.1). It was hence anticipated that if any differences were 
to be seen between WT, SSAA and ΔM-N L-selectin-GFP accumulation, this would be 
most prominent after 15 minutes of perfusion. The cells were therefore subjected to a 15 
minute-long flow assay and then numbers of spots were compared to THP-1 WT L-
selectin-GFP Hi20 cells. Figure 4.12 shows that after 15 minute perfusion, both SSAA 
L-selectin-GFP and ΔM-N L-selectin-GFP appeared to accumulate less spots than WT 
L-selectin-GFP. Additionally, very prominent long and thin membrane extensions, 
termed spikes, were seen extending from some of the cells. To analyse possible 
differences between the cell lines against WT L-selectin-GFP, spots were analysed as 
described earlier in section 4.3.2. Spikes were manually counted for each cell, and 
average number per cell was calculated (see section 2.16.4). As shown in figure 4.13 
A, the average number of SSAA L-selectin-GFP spots was significantly lower than that 
observed for WT L-selectin-GFP (35 versus 62). The ΔM-N L-selectin-GFP spots 
accumulated even less, as the average number of spots per cell was calculated to be 
only 17. This was below the number of WT L-selectin-GFP spots seen accumulating at 
7 minutes (average 26 spots per cell) (figure 4.8). Hence, it appeared that ΔM-N L-
selectin-GFP spots did not accumulate at all. Although an increase in spikes was seen 
in THP-1 cells expressing SSAA L-selectin-GFP, it was not considered to be statistically 
significant (figure 4.13 B). Additionally, a great variability of number of spikes was seen 




























Figure 4.12 Relationship between shedding and accumulation of L-selectin-GFP spots in 
the protruding pseudopods of THP-1 cells.  THP-1 cells expressing SSAA or ΔM-N L-selectin 
were perfused over TNF-α activated HUVEC for 15 minutes, fixed with 4% PFA, stained with 
TRITC-phalloidin and analysed by confocal microscopy. For detailed methods describing parallel 
plate flow chamber assay and the confocal microscopy analysis see sections 2.14.3 and 2.16, 
respectively. Representative single z-plane confocal images of Top and Bottom views (see figure 
4.6 A) of transmigrating THP-1 cells at a 15 minute time-point are shown. L-selectin-GFP spots 
are shown with blue arrows. Magnified sections of selected areas are shown in red. Spikes 
extending from the pseudopods are indicated with red arrows. The dashed lines encircle the 
protruded areas that were analysed to measure spots. A) WT L-selectin-GFP accumulates in the 
pseudopods of THP-1 cells. This particular cell does not have any spikes. Scale bar: 10 µm. B) 
SSAA L-selectin-GFP accumulates in the pseudopods, although less spots seem to be formed. 
This particular cell presents with a high number of spikes. Scale bar: 7.5 µm. C) ΔM-N L-selectin-
GFP spots does not accumulate in the pseudopods. A few spikes can be seen in this example 
cell. Scale bar: 10 µm. 
     
 
 
Figure 4.13 Monitoring the accumulation of spots and spikes in the protruding pseudopods 
of transmigrating THP-1 cells expressing WT, SSAA or ΔM-N L-selectin-GFP.  L-selectin-
GFP spots and spikes shown in the representative images in figure 4.12 were quantified. Each 

















































































analysed as described in figure 4.8.  Accumulation of ΔM-N L-selectin-GFP spots did not occur 
and accumulation of SSAA L-selectin-GFP spots was less than that of WT L-selectin-GFP. B) 
Spikes were counted manually. Fifteen cells were analysed per experiment and experiments were 
repeated three times for each cell line. Mean values are shown for each bar. Error bars represent 
S.E.M. Statistical analysis: One-way ANOVA followed by Tukey’s post-test. *=p<0.05 **=p<0.01, 
***=p<0.001. 
  
Since ΔM-N L-selectin-GFP does not undergo shedding and SSAA L-selectin-GFP 
sheds much slower that WT L-selectin-GFP in the static transmigration assays (figure 
4.4), these results suggested a correlation existed between L-selectin shedding and the 
accumulation of spots. Although this work has not fully concluded that the spots signify 
shed L-selectin, it remains a strong possibility.  
4.3.10 Investigating the fate of the L-selectin “stump” following shedding during 
transendothelial migration of THP-1 cells  
Examination of the L-selectin-GFP spots in the pseudopods of transmigrating THP-1 
monocytes suggested that WT L-selectin-GFP might be shed and accumulation of 
“stump” might occur in the pseudopods (section 4.3.6 and 4.3.9). When analysing L-
selectin-GFP by confocal microscopy, it is not possible to distinguish between full-length 
L-selectin-GFP and L-selectin-GFP “stump” as both of the forms are attached to GFP. 
One way to address this issue would be to stain the fixed cells with DREG56 antibody 
and perform co-localisation analysis between GFP and DREG56. Unfortunately, 
DREG56 antibody does not recognise L-selectin from fixed specimens and this approach 
was not feasible.  
The fate of the cleaved L-selectin is currently not known. It has been proposed that once 
the L-selectin ectodomain is shed, the “stump” is internalised and degraded [563]. When 
lymphocytes are stimulated with PMA over 60 minute period of time, Western blotting 
analysis shows that “stump” levels peak at 15 minutes and then gradually decrease 
[323]. Static transmigration assay used in this study showed that WT L-selectin-GFP 
“stump” is rapidly generated at 10 minutes and the levels persist up to 30 minutes after 
which “stump” is also being cleared (figure 4.1 D). Cells internalise membrane proteins 
by endocytosis and hence the observed clearance of the “stump” could be a result of 
endosomal uptake. If this was the case, L-selectin-GFP spots observed in the 
pseudopods after 15 minutes of flow could represent L-selectin-GFP “stump”-loaded 
endosomes. Two endosomal markers, early endosomal antigen 1 (EEA1) and late 
endosomal-lysosomal marker CD63 antigen are commonly used to detect early and late 
endosomes, respectively [665, 666]. Early endosomes can recycle back to the plasma 
membrane or mature into late endosomes [667]. Late endosomes proceed down the 
lysosomal route of protein degradation [667].  To test whether L-selectin-GFP spots co-
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localised with any of the endosomal markers, THP-1 WT L-selectin-GFP cells were 
subjected to a 15 minute-long parallel plate flow chamber assay, fixed with 4% PFA and 
prepared for confocal microscopy as described in section 2.16.2. No co-localisation of 
WT L-selectin-GFP with CD63 was found (Dr A. Ivetic, unpublished data) suggesting that 
L-selectin-GFP “stump” did not undergo degradation through this pathway. Similarly, no 
co-localisation was found between WT L-selectin-GFP spots and EEA1 (figure 4.14). 
However, this result is hard to interpret as the EEA1 staining was clearly seen in the 
HUVEC cells suggesting that antibody did not recognise its antigen in THP-1 cells. 
Although EEA1 has been used previously to detect early endosomes in THP-1 cells, the 
staining was performed after three days of PMA treatment [665]. It is thus possible that 
undifferentiated THP-1 cells have a relatively low capacity to phagocytose and on that 
basis, it is possible that they express low levels of EEA1. It has also been observed that 
primary smooth muscle cells lose EEA1 expression upon immortalisation (Aleksander 
Kapustin, King’s College London, personal communication) and perhaps THP-1 cell line 
does not express EEA1 antigen.  
 
Figure 4.14  WT L-selectin-GFP in the pseudopods of transmigrating THP-1 cells does not 
co-localise with early endosome marker.  THP-1 cells expressing WT L-selectin-GFP Hi20 
were perfused over TNF-α activated HUVEC for 15 minutes (section 2.14.3), fixed with 4% PFA, 
stained with TRITC-phalloidin and early endosomes marker EEA1 and analysed by confocal 





4.6 A. Representative image shows L-selectin-GFP spots (blue arrows) in THP-1 cells and EEA1 
staining (yellow arrows) in the HUVEC cells. No co-localisation between the two could be 
detected. Scale bar: 7.5 µm.       
 
4.4 DISCUSSION 
Leukocytes have been observed to shed their L-selectin during transendothelial 
migration [554-556], and blocking shedding results in abnormal emigration in to the 
surrounding tissue [22, 419, 518, 668]. This chapter attempts to determine the spatio-
temporal resolution of L-selectin shedding during TEM and whether the serine residues 
in the cytoplasmic tail are involved in this regulation. Finally, this chapter embarked on 
experiments that were set out to explore the fate of the L-selectin “stump” following 
shedding. 
4.4.1 L-selectin shedding is likely to occur during the early stages of TEM and is 
dependent on cytoplasmic serine residues 
The results presented in this chapter demonstrate that when THP-1 cells are perfused 
over TNF-α activated HUVEC, the cells form dynamic pseudopods (figure 4.5). The 
pseudopods extend underneath the endothelial monolayer as early as 7 minutes in to 
the flow experiment and remain underneath the endothelium for the duration of the 15 
minute-long flow assay (figure 4.6). However, THP-1 cells never fully complete 
transmigration across the HUVEC monolayer, which has been described by others [153, 
643]. As a result this model of transendothelial migration is used to monitor L-selectin as 
cells are undergoing transmigration – in other words the early stages of TEM (see 
diagram in figure 4.6 A). Western blotting analysis of surface L-selectin revealed that 
shedding peaks at 20 minutes in the static transmigration assays (figure 4.1). Although 
this data did not provide any information as to the part of the cell at which shedding 
occurred, it clearly demonstrated that interaction of THP-1 cells with TNF-α activated 
HUVEC triggers L-selectin ectodomain shedding. This, alongside the results discussed 
above, suggests that L-selectin shedding and pseudopods extension could occur 
concomitantly. However, it is difficult to directly relate these events as the timing of TEM 
in static assays might not be an exact match of the timing seen under flow conditions. It 
should be noted that the static assay is devoid of flow and this may in itself influence the 
outcome of the observations.   
To test the function played by L-selectin tail serine phosphorylation, non-
phosphorylatable mutants of L-selectin were created. Stable cell lines expressing each 
serine mutant were generated successfully in THP-1 cells. The fact that all serine mutant 
constructs could be expressed to similar levels in these cells suggests that tail 
181 
 
phosphorylation is neither required for nor detrimental to, L-selectin-GFP expression and 
does not affect basal L-selectin shedding as assessed by flow cytometry (figure 4.2). 
However, it can be hypothesised that phosphorylation of the serines plays a role in TNF-
α induced shedding of L-selectin from THP-1 monocytes, as introduction of the SSAA 
mutation resulted in reduced shedding (figure 4.3). Thus it could be suggested that the 
above described shedding of L-selectin-GFP induced by interaction of THP-1 monocytes 
with TNF-α activated HUVEC monolayers, could also be influenced by the 
phosphorylation of the serine residues. To test this possibility, THP-1 SSAA L-selectin-
GFP Hi20 cells were subjected to the static transmigration assays and the changes in 
surface L-selectin-GFP occurring over time were compared to that of WT L-selectin-GFP. 
Figure 4.4 shows that significantly more SSAA than WT L-selectin-GFP was retained at 
the cell surface at 20 minutes, and a similar trend was observed at a 10 minute time-
point. No changes were seen at later time-points, suggesting that the SSAA mutation 
caused a delay in L-selectin ectodomain cleavage during the static transmigration assay. 
Hence, it is tempting to speculate that phosphorylation of the tail serines plays a role in 
L-selectin shedding during THP-1 monocyte TEM. Interestingly, Tsubota et al. (2013) 
showed that treatment of monocytes with a broad spectrum metalloprotease inhibitor 
GM6001 caused a delay in their transmigration through HUVEC monolayers under both 
static and flow conditions [669]. Although the authors attributed this result to inhibition of 
Mac-1 integrin cleavage, GM6001 – within the concentration range employed by Tsubota 
et al., 2013 [669] – is also used to prevent L-selectin shedding [670-673], and thus it 
seems that the contribution of L-selectin to the observed effect cannot be formally 
excluded. Surprisingly, however, this was not at all investigated in this study [669]. Since 
THP-1 cells do not fully transmigrate in the system used in this thesis, it was not possible 
to compare the number of transmigrated cells between THP-1 WT and SSAA L-selectin-
GFP Hi20 cell lines. A modified system is currently being developed in the Ivetic 
laboratory, where HUVEC monolayers are grown on a mixture of collagen/matrigel 
substrates, and it is hoped that this will generate sufficient subendothelial space for THP-
1 cells to undergo full transmigration under both static and flow conditions. In light of the 
results discussed above, it would be interesting to see whether delayed shedding of the 
SSAA mutant will also delay THP-1 transmigration. If this was the case, additional 
studies could be designed to analyse relative contribution of Mac-1 – which is expressed 
by THP-1 cell line [674] – and L-selectin cleavage to monocyte TEM.    
4.4.2 Accumulation of GFP-positive “spots” occurs in the protruding pseudopods 
of transmigrating THP-1 cells and correlates directly with L-selectin shedding 
The main reason for tagging L-selectin with GFP was to “non-invasively” monitor its 
spatio-temporal distribution during transendothelial migration. The results presented in 
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section 4.3.6 show that WT L-selectin-GFP accumulate over time in the pseudopods of 
transmigrating THP-1 cells. This is seen as the appearance of characteristic GFP-
positive “spots” that are not observed in control cells expressing matched levels of GFP 
protein (figure 4.7). However, the caveat of this analysis lies in the fact that by following 
the GFP-tag it is not possible to distinguish between full-length surface L-selectin-GFP 
and L-selectin-GFP “stump”. It was hoped that by analysing the mutant forms of L-
selectin-GFP some insights could be gained pertaining to the nature of the spots. As 
discussed above SSAA mutation results in delayed shedding of L-selectin-GFP when 
THP-1 cells interact with TNF-α activated HUVEC. Additionally, a “severe” shedding 
mutant, namely ΔM-N L-selectin-GFP, was generated and stably expressed in THP-1 
cells (section 4.3.7). Apart from activation-induced, basal shedding is also abrogated in 
the ΔM-N L-selectin mutant (figure 4.11). A lack of basal shedding was thought to be a 
reason behind the extremely high surface L-selectin-GFP levels in THP-1 ΔM-N L-
selectin-GFP Hi20 cells that were exceeding those of THP-1 WT L-selectin-GFP Hi20 
cells (figure 4.10). As a result, low expressor THP-1 ΔM-N L-selectin-GFP Lo5 was a 
closer match to the THP-1 WT L-selectin-GFP Hi20 cells and was employed in all further 
studies. Examination of WT SSAA and ΔM-N L-selectin-GFP spots formed in the 
pseudopods of the respective cell lines after 15 minutes of flow revealed interesting 
differences. Both SSAA and ΔM-N L-selectin-GFP presented fewer GFP-positive spots 
when compared to WT L-selectin-GFP (figure 4.13). These results demonstrate a strong 
correlation with the extent of shedding and the formation of the GFP-positive spots in 
transmigrating monocytes. It is tempting to speculate that the GFP-positive spots 
represent the L-selectin-GFP “stump” accumulating in the pseudopods of THP-1 cells 
during TEM. However, the nature of the spots still remains unclear and accumulation of 
full length L-selectin-GFP cannot be formally excluded. For example, spots could 
represent aggregates of full-length L-selectin that form as pre-requisite for shedding. 
Additionally, L-selectin is known to cluster upon ligand binding and extracellular matrix 
L-selectin ligands have been identified (section 1.8.3). Therefore, it is possible that full 
length L-selectin-GFP clusters in the pseudopods of transmigrating THP-1 cells upon 
binding of ECM ligand(s) deposited by TNF-α activated HUVEC. Pre-treating THP-1 cells 
expressing WT L-selectin-GFP with Ro31-9790 may result in a reduction of spots, 
lending further weight to the possibility that the spots are due to shedding.  
4.4.3 Investigating the fate of L-selectin-GFP “stump”      
The fate of the L-selectin “stump” is currently unknown.  Zhao et al. (2001) showed that 
a gradual decrease in the L-selectin cleavage product generated upon PMA treatment 
starts 15 minutes after stimulation, and it is entirely cleared from the membrane by 60 
minutes [323]. Likewise, results showed in this chapter demonstrate that WT L-selectin-
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GFP “stump” generated during static transmigration assays is turned-over within a 1 hour 
period (figure 4.1). When investigating the influence of cytoplasmic serine residues on 
shedding of L-selectin-GFP during TEM, it was noticed that the SSAA L-selectin-GFP 
“stump” was more abundant than WT L-selectin-GFP “stump” at 20 minutes (figure 4.4). 
A statistical test did not find this change significant and this result could just be a 
coincidence. However, it can be speculated that rapid protein turnover is hard to measure 
by Western blotting where time-points are at least 5 minutes apart and saturation of the 
bands can be an issue when quantifying the results. Perhaps using antibodies directly 
labelled with near-infrared dyes that do not reach saturation upon development would 
prove more informative in future. 
The clearance of the L-selectin-GFP “stump” from the membrane could be a result of its 
internalisation. It was proposed that L-selectin-GFP spots accumulating in the 
pseudopods of transmigrating THP-1 cells could represent vesicles containing the 
internalised “stump”. Attempts were made to investigate whether the L-selectin-GFP 
spots co-localised with the endosomal markers CD63 and EEA1. No co-localisation 
between the GFP-positive spots and CD63 was seen (Dr A. Ivetic, unpublished data), 
suggesting that the “stump” was not targeted for degradation through the 
endosomal/lysosomal pathway. Investigation of co-localisation of the GFP-positive spots 
and EEA1 staining proved unsuccessful. Further optimisation of the method would be 
needed to analyse possible association of L-selectin-GFP spots with the early endosome 
compartments. Alternatively, the small GTPase Rab5 is another known early endosome 
marker [675], and it would be of interest to determine if Rab5 can be detected in THP-1 
cells, and if so, if it would co-localise with the L-selectin-GFP spots. 
It has been suggested that L-selectin “stump” can be further cleaved by a gamma-
secretase complex (Ann Ager, Cardiff University, personal communication). Indeed, 
membrane secretases have been proposed to have the ability to cleave any surface 
protein that lack a bulky membrane-proximal globular domain [676]. Two bands migrating 
at the molecular weight of the L-selectin-GFP “stump” have been detected in Western 
blots (figure 3.8), suggesting that further cleavage of “stump” might indeed occur in THP-
1 WT L-selectin-GFP Hi20 cells. Interestingly, the ADAM17 substrate, Notch receptor, is 
known to be internalised and further cleaved by gamma-secretase complex [677]. 
Gamma-secretase dependent cleavage depends on monoubiquitination and clathrin-
dependent endocytosis of cleaved Notch product [677]. Additionally, is was suggested 
that Notch receptor monoubiquitination  occurs on a juxtamembrane lysine residue [677]. 
L-selectin tail contains five lysine residues (K359, K360, K362, K363 and K365) and 
therefore it is highly likely that ubiquitination could occur on one of them. It is hence 
possible that ADAM17 induced L-selectin cleavage is followed by endocytosis and 
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further cleavage in a manner similar to that of the Notch receptor. Finally, clathrin-























CHAPTER 5. CLUSTERING OF L-SELECTIN DURING 
TRANSENDOTHELIAL MIGRATION 
5.1 INTRODUCTION 
Previous studies have suggested that L-selectin might play a role beyond the vasculature 
[221, 354, 398, 416, 419, 420, 465, 479]. Specifically, L-selectin null leukocytes have 
been shown to have reduced infiltration into the tissue interstitium at various sites of 
inflammation [11, 392, 398, 420], and impaired locomotion away from the venule and 
towards the inflammatory source [398, 416]. Additionally, aberrant chemotaxis in vivo 
has also been reported for leukocytes expressing the sheddase-resistant L-selectin 
[419].  However, this area has never been researched at the molecular level, and no 
mechanism for L-selectin-dependent TEM or interstitial migration has been suggested. 
It is likely that L-selectin-dependent emigration may vary between the leukocyte subsets, 
as it has been shown that L-selectin levels on murine neutrophils and monocytes are 
regulated differently upon emigration into the inflamed peritoneum [527]. The results 
presented in Chapter 4 of this thesis show that L-selectin-GFP spots accumulate in the 
pseudopods of transmigrating THP-1 monocytes (figure 4.4), and this appears to be 
dependent on cytoplasmic serine residues as well as L-selectin’s ability to be shed 
(figure 4.13). In the previous chapter, the spots of L-selectin-GFP were hypothesised to 
be internalised vesicles containing the “stump” of L-selectin-GFP but this was never 
formally addressed. However, biochemical assessment using anti-GFP Western blotting 
of the whole cell lysates derived from THP-1 cells stably expressing either WT or M-N-
L-selectin, revealed the only difference between these cell lines to be the stump. This 
would strongly support the theory that the observed GFP-positive spots were the 
“stump”. One other possibility is that the accumulation of L-selectin-GFP spots could 
represent clusters of full-length L-selectin-GFP that form as pre-requisite to shedding. 
Indeed, a recent paper has shown that high-density sulphated ligands (such as those 
derived from the ECM) can drive L-selectin clustering and subsequent shedding [678]. 
Additionally, a number of ECM ligands for L-selectin have now been described (section 
1.8.3, summarised in table 1.2), and binding of L-selectin with a subendothelial ligand 
could serve to drive L-selectin clustering.  
When considering clustering, there are two types of clustering that can occur: “outside-
in” and “inside-out”. Outside-in refers to direct clustering of L-selectin as a consequence 
of ligand binding, and inside-out refers to a mechanism that is driven by a pathway 
independent of L-selectin. L-selectin clustering has been reported to coincide with L-
selectin dependent signalling (section 1.11). It is possible that L-selectin clustering 
occurs during TEM, which plays a role in leukocyte exit from the vasculature. 
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This chapter explores the theory that L-selectin is clustered in the pseudopods of 
transmigrating THP-1 cells.  
5.2 EXPERIMENTAL DESIGN 
Clustering is a term that describes a situation where a given set of receptors localise 
together at high densities. Adjacent receptors are brought so close together that they 
can physically interact. Physical protein-protein interactions in vivo can be detected by 
fluorescence lifetime measurement (FLIM) of fluorescence resonance energy transfer 
(FRET) efficiency between GFP- and RFP-tags that are attached to the proteins of 
interest. This technique measures the fluorescence lifetime of a donor fluorophore, in 
this case GFP, after excitation. The donor fluorophore’s lifetime is decreased when it is 
located within 10 nm (100 Å) of an acceptor fluorophore, such as RFP, due to absorption 
of energy by this acceptor, hence the term fluorescence resonance energy transfer (or 
FRET).  Data presented in Chapter 3 describe the generation of THP-1 cell lines stably 
expressing WT L-selectin-GFP. Co-expression of WT L-selectin-RFP in the same cell 
line would allow detection of an interaction between adjacent L-selectin molecules by 
measuring FLIM of FRET between GFP and RFP tags. This would allow detection of L-
selectin clustering during TEM. When generating biosystems for FLIM measurement of 
FRET, the acceptor is commonly present in excess to saturate donor binding. It was 
therefore decided that low expressor THP-1 WT L-selectin-GFP Lo5 would be used so 
that lentivirus particles carrying L-selectin-RFP could be transduced at a higher MOI. 
This resulted in the generation of a “double expressor” THP-1 cell line, termed THP-1 
WT L-selectin-GFP/RFP. Once the cell line was generated, clustering of L-selectin during 
TEM was measured by FLIM analysis and the extent of clustering was expressed as the 
FRET efficiency. Briefly, THP-1 cells were perfused over TNF-α activated HUVEC for 15 
minutes, after which time the cells were fixed with 4% PFA and prepared for FLIM/FRET 
analysis. The fifteen minute time-point was chosen as this was the period at which L-
selectin-GFP spots were seen accumulating in the pseudopods of transmigrating THP-
1 cells (figures 4.7 and 4.8). The FLIM analysis and FRET efficiencies were performed 
and calculated by Dr Maddy Parsons of the Randall Division of Cell and Molecular 
Biophysics at King’s College London. 
Extracellular matrix proteoglycans are known to bind L-selectin [221, 354, 463-466], and 
could potentially cause L-selectin clustering in THP-1 monocyte pseudopods that 
protrude underneath the HUVEC monolayer. Initial data suggesting expression of 
biglycan (dermatan sulphate proteoglycan) by activated HUVEC cells was obtained by 
Dr Aleksandar Ivetic. To further analyse the subcellular distribution of biglycan, 
immunofluorescence experiments were performed. This was to assess whether biglycan 
expression could be specifically detected beneath the HUVEC monolayer.   
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Extracellular and intracellular mutants of L-selectin were also used to address the 
individual and combined roles of the cleavage domain and cytoplasmic serines in 
regulating L-selectin clustering. All newly generated mutant double expressor cell lines 
were FACS sorted to match their total GFP- and RFP-tagged L-selectin levels to that of 
THP-1 WT L-selectin-GFP/RFP cells. Once matched L-selectin expression was ensured, 
all the double expressor cell lines were subjected to 15 minute-long parallel plate flow 
chamber assay and FLIM/FRET analysis of L-selectin clustering during TEM was 
performed.  
The double expressor cell lines were further used to test whether ligation of other 
endogenous CAMs could promote L-selectin clustering in the manner of “inside-out” 
signalling. To this end, an assay was designed where antibodies against extracellular 
domains of PSGL-1, JAM-A, CD43, CD44 and PECAM-1 – which are all known to be 
expressed by THP-1 cells [153, 679-682] – were used to cross-link those CAMs on the 
surface of WT or mutant L-selectin-GFP/RFP expressing THP-1 cells. L-selectin 
clustering was subsequently tested by FLIM measurement of FRET. 
5.3 RESULTS 
5.3.1 Generation of a THP-1 cell line stably expressing GFP- and RFP-tagged WT 
L-selectin 
The pHR´SIN-SEW-L-selectinWT-RFP vector was used to generate lentiviral particles 
carrying WT L-selectin-RFP and is described in more detail in section 3.3.1.1. 
Lentiviruses were generated and titrated as described in sections 3.3.1.2 and 2.11, and 
the obtained titre was 12.56 x 108 i.u./mL (table 2.5). For reasons explained in section 
5.2, low expressor THP-1 WT L-selectin-GFP Lo5 cells were used for transduction. In 
Chapter 3, rigorous biochemical and cell biological testing of THP-1 L-selectin-GFP Hi20 
cells presented with no obvious defects. Although the THP-1 L-selectin-GFP Lo5 were 
not subjected to similar testing, it was reasoned that as they expressed fewer L-selectin 
molecules on the surface, it was unlikely that they would present with any defective 
phenotype. To achieve excess acceptor (RFP-tag) to donor (GFP-tag) ratio, an MOI of 
10 was used to transduce THP-1 L-selectin-GFP Lo5 cells with lentivirus carrying the L-
selectin-RFP transgene. The THP-1 cell transduction method is described in more detail 
in section 2.11.4. The resultant double expressors were subjected to FACS sorting to 
obtain uniform surface expression levels. Fluorescence of both GFP- and RFP-tags was 
used to select cells of low uniform GFP and high uniform RFP expression (figure 5.1). 
As before, the cells displayed characteristic L-selectin membrane localisation seen in 
both GFP and RFP channels. Membrane localisation of L-selectin-RFP suggested that 
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the RFP-tag did not affect L-selectin expression and trafficking to the membrane. Hence, 
the cells were deemed suitable for FLIM/FRET experiments.   
 
Figure 5.1 THP-1 cell line expressing WT L-selectin-GFP and -RFP (THP-1 WT L-selectin 
GFP/RFP).  Representative image showing THP-1 WT L-selectin GFP/RFP cells. Both L-selectin-
GFP and -RFP localise to the cell membrane (arrows). Scale bar: 10 µm.   
 
5.3.2 L-selectin clusters in the pseudopods of transmigrating THP-1 cells 
To investigate if L-selectin clustered during monocyte transendothelial migration, THP-1 
WT L-selectin-GFP/RFP cells were perfused over the TNF-α activated HUVEC 
monolayer in a parallel-plate flow chamber assay (section 2.14.3). Data presented in 
Chapter 4 shows that this type of experiment captures cells in the initial stages of TEM, 
where THP-1 cells extend pseudopods underneath the endothelium (figure 4.6). After 
15 minutes of flow, when L-selectin-GFP spots are known to accumulate (figures 4.7 
and 4.8), the cells were fixed and samples were prepared for FLIM/FRET analysis as 
described in section 2.18.1. The experiment was repeated with THP-1 cells expressing 
L-selectin-GFP only to measure lifetime of the donor in the absence of acceptor. This 
was required to calculate FRET efficiency (ȠFRET). A detailed method of FLIM/FRET data 
analysis is described in section 2.18 of this thesis. Staining with phalloidin-Alexa633 
enabled visualisation of HUVEC actin cables and allowed recognition of non-
transmigrated and transmigrated parts of the same cell, referred to as Top and Bottom 
z-planes, respectively (figure 5.2 A). Analysis revealed that the FRET efficiency was 
highest in the pseudopods of transmigrating THP-1 cells and very little FRET was 
detected in the non-transmigrated parts of the cells (figure 5.2 B). The areas in which 





using a pseudo-colour scale with green through yellow to red, indicating areas of 
progressively shorter lifetime and, therefore, increasing FRET (figure 5.2 B). Blue areas 
represent long lifetimes and no FRET. Calculation of FRET efficiency showed that 
average 4.033% ȠFRET was present in the non-transmigrated parts of the cells, whereas 
ȠFRET in the pseudopods totalled average 9.873% (figure 5.2 C). This suggested that L-
selectin clustered in the pseudopods of transmigrating THP-1 monocytes, and not in the 
non-transmigrated parts. 
 
Figure 5.2 Clustering of L-selecting during transendothelial migration.  THP-1 cells were 
perfused over TNF-α activated HUVEC for 15 minutes (section 2.14.3), fixed with 4% PFA and 
prepared for FLIM/FRET analysis as described in section 2.18.1. FLIM measurement of FRET 
was used to assess the interaction between adjacent L-selectin molecules to determine if L-
selectin clustering had occurred. A)  Left panel: schematic showing typical appearance of a THP-
1 monocyte interacting with HUVEC under flow. Non-transmigrated and transmigrated parts of 
the cells are shown as Top (blue dot) and Bottom (pseudopods, red dots) z-planes, respectively. 
Right panel: Representative wide-field CCD camera image of phalloidin-Alexa633 staining. 
Arrows point out HUVEC actin cables. Blue and red dots indicate z-planes as shown in the 
schematic on the left. Scale bar: 10 µm. B) Representative images showing Top and Bottom z-
planes of a transmigrating THP-1 monocyte. Left panels show images of L-selectin-GFP and the 
right panels show corresponding GFP multi-photon intensity images. Lifetime of fluorescence is 
shown as a pseudo-colour scale of blue (high lifetime) to red (low lifetime). The lower the lifetime 
of fluorescence, the closer the association between the two tagged proteins (more detailed 
explanation of FLIM/FRET measurement and analysis is described in section 2.18). C) 
Quantitation of FRET efficiency between L-selectin-GFP and L-selectin-RFP. Analysis was 











































performed on a total of 15 cells derived from three independent experiments. Mean values are 
shown for each bar. Error bars represent S.E.M. Statistical analysis: Two-tailed, unpaired 
Student’s t-test. ***=p<0.001. 
 
5.3.3. TNF-α activated HUVEC express the L-selectin ligand biglycan 
The above presented results show that L-selectin clusters in the pseudopods of 
transmigrating THP-1 monocytes. L-selectin is known to cluster upon ligand binding 
(section 1.11) and it was hypothesised that discovered L-selectin clustering during TEM 
might be indicative of subendothelial ligand binding. A number of ECM ligands for L-
selectin have now been recognised (section 1.8.3, see summary in table 1.2). The 
majority of such ECM ligands are highly sulphated proteoglycans, and collagen XVIII, 
versican and biglycan are most frequently reported [221, 354, 463, 465, 466]. 
Proteoglycans are commonly produced by endothelial cells, suggesting that the 
observed clustering of L-selectin during TEM could be the result of a proteoglycan 
binding event. Additionally, both collagen XVIII and biglycan have been reported to be 
expressed by the HUVEC monolayer [663, 683]. To investigate whether proteoglycans 
were present in our model, and to assess the effect of TNF-α stimulation on their potential 
expression, Western blotting analysis was performed by Dr Aleksandar Ivetic. The 
results showed that both collagen XVIII and biglycan can be detected in the extracts from 
unstimulated HUVEC (figure 5.3). Collagen XVIII has a molecular weight (MW) of 180-
200 kDa and a faint band was detected migrating at this weight, whereas an abundant 
45 kDa band was detected for biglycan core protein (figure 5.3).  Interestingly, upon 10 
ng/mL TNF-α stimulation – which was a concentration used to stimulate HUVEC for 
parallel-plate flow chamber experiments – collagen XVIII could no longer be detected 
and biglycan expression decreased (figure 5.3).     
 
Figure 5.3 Effect of TNF-α stimulation on HUVEC proteoglycan expression.  Confluent 
HUVEC monolayers were stimulated overnight with 10 ng/mL TNF-α or were left untreated. 
Representative Western blots of proteoglycans detected with anti-collagen XVIII and anti-biglycan 
antibodies. Collagen XVIII migrated at its predicted molecular weight of 180-200 (red arrow), and 













45 kDa was detected in extracts from both stimulated and non-stimulated HUVEC, however TNF-
α treatment decreased its expression. The experiment was performed by Dr Aleksandar Ivetic.    
 
As detection of biglycan core protein was still visible after TNF-α stimulation, it was likely 
that its glycosylated form was secreted by HUVEC and could still have the capacity to 
cluster L-selectin during TEM. A recent report by Yin et al (2013) found that biglycan is 
constitutively secreted by HUVEC, and secretion is greatly potentiated by PMA 
stimulation [663]. Secretion was assumed to take place into the ECM deposited by 
HUVEC but to formally investigate what effect TNF-α stimulation had on the sub-cellular 
distribution of biglycan in HUVEC culture, immunofluorescence analysis was performed. 
Confluent HUVEC cells were stimulated with 10 ng/mL TNF-α overnight or were left 
untreated. Upon fixation with 4% PFA, cells were prepared for confocal microscopy as 
described in section 2.16.2. After z-stack acquisition, Top and Bottom z-planes, as 
shown on a diagram in figure 5.4 A, were compared. Control staining with fluorescently-
conjugated secondary antibody and no anti-biglycan antibody showed minimal 
background staining (figure 5.4 Bottom panel). It has to be noted though that in order to 
fully control for this experiment, additional control, where isotype-matched control 
primary antibody was used, should be performed. Unstimulated cells presented with 
disseminated biglycan staining as well as areas of intense fluorescent signal (figure 5.4 
B Top panel). The areas where the fluorescent signal was most concentrated could 
represent intracellular stores, although this was not formally tested. The majority of 
biglycan was seen as diffuse staining in the Bottom z-plane suggesting that biglycan was 
likely deposited in subendothelial regions (i.e. between the basal surface of the HUVEC 
monolayer and the glass coverslip). After TNF-α stimulation the intense fluorescent 
signal areas were no longer seen (figure 5.4 B Middle panel). If the concentrated signal 
was indeed representing biglycan intracellular stores, it is possible that TNF-α caused 
biglycan secretion, much like what had previously been observed with PMA stimulation 
[663]. The biglycan staining in the Bottom z-plane persisted after TNF-α stimulation, 
however, it was difficult to assess whether the amount of subendothelial biglycan 
decreased, increased or was maintained at the same levels as without treatment. The 
overall biglycan expression was likely to be decreased by TNF-α stimulation as seen by 
Western blotting and lack of the areas of the intense fluorescent signal. Nonetheless, the 
confocal microscopy results indicated that after TNF-α stimulation, biglycan was still 
present in the Bottom z-plane. Altogether the Western blotting and immunostaining 
results suggest that biglycan could be present underneath the HUVEC monolayer during 
the parallel-plate flow chamber experiments. This in turn open the possibility that L-
selectin/biglycan binding could occur during TEM, which could lead to L-selectin 
192 
 
clustering in the pseudopods of transmigrating THP-1 cells. Given time, it would have 
been interesting to perform similar Western blotting and immunofluorescence analysis 































Figure 5.4 Biglycan expression pre- and post-TNF-α stimulation of HUVEC monolayers.  
HUVEC were grown to confluence and stimulated with 10 ng/mL TNF-α overnight or left 
untreated. Cells were then fixed with 4% PFA and prepared for confocal microscopy as described 
in section 2.16.2. A) Schematic showing z-planes in which biglycan expression was analysed. 
B) Representative images of biglycan expression in Top and Bottom z-planes of unstimulated 
HUVEC (Top panel), TNF-α stimulated HUVEC (Middle panel), and unstimulated HUVEC stained 
with secondary antibody (2°ry) only (Bottom panel). Stars indicate areas of concentrated 
fluorescent signal (potential intracellular biglycan “stores”). Scale bar: 25 µm.   
 
5.3.4 Generation of THP-1 cell lines stably expressing GFP- and RFP-tagged ΔM-
N L-selectin 
THP-1 cells expressing shedding resistant (ΔM-N) L-selectin-GFP presented with a 
strikingly different phenotype to WT L-selectin, in that little to no GFP-positive spots were 
observed in the pseudopods of transmigrating cells (figure 4.13). To determine if the 
absence of subendothelial spots in ΔM-N L-selectin could be correlated with a lack of 
subendothelial clustering, a suitable THP-1 cell line, expressing both GFP- and RFP-
tagged forms of ΔM-N L-selectin, was generated. A two-step in vitro site-directed 
mutagenesis – described in section 4.3.7 for pHR´SIN-SEW-L-selectinWT-GFP vector – 
was performed on the pHR´SIN-SEW-L-selectinWT-RFP template vector (for WT L-
selectin cloning into the pHR´SIN-SEW-RFP vector see sections 3.3.1.1 and 2.3). Refer 
to section 2.5 for a detailed method of the site-directed PCR mutagenesis protocol. The 
resultant vector, termed pHR´SIN-SEW-L-selectinΔM-N-RFP, was used to generate 
lentiviral particles as described in sections 3.3.1.2 and 2.11. The lentiviral titre was 
calculated to be 1.87 x 108 i.u./mL (table 2.5). A MOI of 10 was used to transduce THP-
1 ΔM-N L-selectin-GFP Lo5 cell line (described in section 4.3.8) with newly generated 
lentiviral particles carrying the ΔM-N L-selectin-RFP transgene. Double expressors were 
subsequently FACS sorted in to a uniform cell line, named THP-1 ΔM-N L-selectin-
GFP/RFP. When sorting the cells, THP-1 WT L-selectin-GFP/RFP cells were taken to 
the sorting facility and used as a reference population to set both GFP and RFP gates. 
This was to select matching lower-end ΔM-N L-selectin-GFP/RFP expressors, as it had 
been established that transduction with the same MOIs results in higher ΔM-N L-selectin 
than WT L-selectin surface expression (see section 4.3.8.1). In order to measure the 
total surface L-selectin levels upon sorting, cells were labelled with DREG56 anti-L-
selectin antibody followed by RPE-conjugated secondary antibody. The flow cytometer 
used was not equipped to excite or detect fluorescence emitted from RFP, and therefore 
RPE fluorescence intensity was an indication of total (both GFP- and RFP-tagged) L-
selectin levels. Figure 5.5 shows that surface L-selectin expression profiles of THP-1 
WT- and ΔM-N L-selectin-GFP/RFP cells were a close match. A slight shift to the right 
can be seen in the ΔM-N L-selectin histogram as compared to WT L-selectin histogram. 
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This was most probably a result of basal shedding occurring in WT, but not in ΔM-N L-
selectin. 
 
Figure 5.5 Surface WT- and ΔM-N L-selectin-GFP/RFP expression in THP-1 cells.  Flow 
cytometry analysis (section 2.13) of L-selectin expression. THP-1 WT L-selectin-GFP/RFP and 
THP-1 ΔM-N L-selectin-GFP/RFP cells were labelled with anti-L-selectin DREG56 antibody and 
then secondary antibody conjugated to RPE. Representative histograms are shown. A) Dot plot 
showing the population of viable and single THP-1 cells analysed (gate R1). B) The histogram 
depicting total (GFP- and RFP-tagged) surface L-selectin expression in THP-1 cells as measured 
by RPE fluorescence. Gate M1 indicates L-selectin positive cells.  
  
5.3.5 Inhibition of L-selectin shedding completely reverses the subcellular 
distribution of clustered L-selectin in transmigrating cells 
THP-1 ΔM-N L-selectin-GFP/RFP cells were subjected to 15 minute-long parallel plate 
flow chamber assay, fixed and prepared for FLIM/FRET analysis as described in section 
5.3.2. Interestingly, ΔM-N L-selectin clustered in a spatially opposite way to WT L-
selectin. A shown in figure 5.6 A, no appreciable FRET efficiency was detected in the 
pseudopods of transmigrating THP-1monocytes. In contrast, “hot-spots” of FRET were 
seen it the Top z-plane (Top and Bottom z-planes as shown in figure 5.2 A), 
corresponding to the non-transmigrated part of the cells. To further investigate whether 
this reversed phenotype was a result of a lack of L-selectin shedding, THP-1 WT L-
selectin-GFP/RFP cells were pre-incubated with the sheddase inhibitor, Ro-30-9790. 












Figure 5.6 Inhibition of L-selectin shedding reverses the subcellular distribution of L-
selectin clustering during TEM of THP-1 monocytes.   THP-1 cells stably expressing WT or 
ΔM-N L-selectin-GFP/RFP were pretreated with or without Ro-31-9790 (30 minutes at 37°C and 
5% CO2) and perfused over TNF-α activated HUVEC for 15 minutes as described in section 
2.14.3. Specimens were subsequently fixed in 4% PFA and prepared for FLIM/FRET analysis as 
described in section 2.18.1. Relative positions of the Top and Bottom z-planes shown previously 
in a schematic, represented in figure 5.2 A. A) Representative images showing Top and Bottom 
z-planes of transmigrating THP-1 cells. Images show L-selectin-GFP and the corresponding GFP 
multi-photon intensity images. Pseudo-colour scale of blue (high lifetime) to red (low lifetime) is 
used to show lifetime fluorescence. L-selectin clustering occurs where low lifetimes are seen 
(orange to red), whereas high lifetimes indicate areas free of L-selectin clustering (blue). B) 
Quantitation of FRET efficiency between L-selectin-GFP and L-selectin-RFP. Analysis was 
performed on a following number of THP-1 cells: 22 of WT L-selectin-GFP/RFP, 22 of WT L-
selectin-GFP/RFP + Ro-31-9790 and 15 ΔM-N L-selectin-GFP/RFP. Cells were derived from 
















































































Statistical analysis: Two-tailed unpaired Student’s t-test was used to calculate differences 
between Top and Bottom for each cell line. ***=p<0.001. One-way ANOVA followed by Tukey’s 
post-test was used to calculate differences between cell lines in Top (coloured red) and Bottom 
(coloured blue) z -planes. ***=p<0.001  
 
shedding of WT L-selectin from THP-1 cells (figure 3.10). As anticipated, no FRET was 
found in THP-1 cell pseudopods, but L-selectin clustering occurred in the non-
transmigrated parts of the cells (figure 5.6 A). Analysis of FRET efficiency showed that 
significant differences between Top and Bottom z-planes occurred in all cells (figure 5.6 
B). However, when FRET efficiency of WT L-selectin was low at the Top (4.418%) and 
high at the Bottom (11.44%), the FRET efficiency of ΔM-N L-selectin and L-selectin from 
monocytes treated with Ro-30-9790 inhibitor was high at the Top (9.205% and 12.56%, 
respectively) and low at the Bottom (4.405% and 2.3% respectively) (figure 5.6 B). This 
suggested that spatial regulation of L-selectin clustering during TEM was dictated by the 
ability of the ectodomain to undergo shedding. Although ΔM-N L-selectin and WT L-
selectin from THP-1 cells treated with Ro-30-9790 showed the same clustering 
phenotype (high FRET efficiency on Top and low FRET efficiency at the Bottom), ΔM-N 
L-selectin exhibited a more severe phenotype as shown by significantly higher FRET 
efficiency at the Top (figure 5.6 B). This could represent short- versus long-term 
outcome of inhibiting L-selectin shedding (i.e. more ΔM-N L-selectin molecules have 
accumulated at the cell surface than WT L-selectin from monocytes pre-treated with the 
sheddase inhibitor). 
From these results, the most plausible conclusion would be that ectodomain shedding 
regulates the sub-cellular distribution of clustered L-selectin. However, one cannot 
formally exclude the possibility that the intracellular domain plays an active role in this 
process. For example, it is also highly likely that the prolonged presence of L-selectin at 
the cell surface could lead to post-translational modification of the serine residues on the 
L-selectin tail. The next section explores this issue in more detail.  
5.3.6 Serine-to-alanine mutagenesis of the L-selectin tail dramatically alters the 
sub-cellular distribution of clustered M-N L-selectin, but not WT L-selectin, 
during TEM 
As suggested at the end of the section above, it was possible that persistent presence 
of ΔM-N L-selectin at the cell surface could induce modifications to the serine residues 
within the L-selectin tail. Cell activating stimuli are known to cause phosphorylation of 
the L-selectin tail [495, 567] as well as L-selectin shedding [495, 496, 529]. Therefore, 
the link between tail phosphorylation and L-selectin shedding is well recognised, but 
whether phosphorylation occurs before, during or just after shedding is currently not 
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known. If phosphorylation was to occur first, interaction of THP-1 monocytes with TNF-
α activated HUVEC would be likely to cause cell activation and phosphorylation of ΔM-
N L-selectin tail. Hence, it is possible that lack of shedding would maintain this state and 
more ΔM-N L-selectin molecules would become serine-phosphorylated with time. This 
could potentially result in overall “hyperphosphorylation” of L-selectin tail. It could be 
speculated that the movement of clustered L-selectin from the non-transmigrated part of 
the cell to the pseudopods requires linkage to the actin cytoskeleton, for example through 
the ERM proteins that are known to bind to the L-selectin tail [563, 572]. If this was the 
case, perhaps this interaction could become disrupted in the ΔM-N mutant due to the 
hyperphosphorylation. As a result ΔM-N L-selectin clustering in the transmigrated 
pseudopods would be abolished, and clustering would be seen only in the Top z-plane. 
If this was the case, mutating the serines in the cytoplasmic tail of ΔM-N L-selectin into 
non-phosphorylatable alanines could reverse ΔM-N L-selectin clustering phenotype back 
to that seen in WT L-selectin. 
To test this hypothesis constructs were generated, where in vitro PCR site-directed 
mutagenesis was used to introduce two alanine residues in the place of the serine 
residues of the ΔM-N L-selectin cDNA in both pHR´SIN-SEW-L-selectinΔM-N-GFP and 
pHR´SIN-SEW-L-selectinΔM-N-RFP lentiviral vectors. The obtained constructs were 
named pHR´SIN-SEW-L-selectinΔM-NSSAA-GFP and pHR´SIN-SEW-L-selectinΔM-NSSAA-
RFP, respectively. Additionally, to test L-selectin clustering of the SSAA mutant, both 
serine residues in pHR´SIN-SEW-L-selectinWT-RFP construct were replaced with 
alanines, and the construct was termed pHR´SIN-SEW-L-selectinSSAA-RFP. For a 
detailed method describing in vitro PCR site-directed mutagenesis see section 2.5. 
Lentiviruses carrying ΔM-N SSAA L-selectin-GFP or -RFP or SSAA L-selectin-RFP were 
generated and titrated as described in sections 3.3.1.2 and 2.11, and the obtained titres 
are shown in table 2.5. To create double expressor ΔM-N SSAA L-selectin-GFP/RFP or 
SSAA L-selectin-GFP/RFP cells, the same transduction procedure was used as before 
for the WT L-selectin-GFP/RFP cells (section 5.3.1). For detailed method of THP-1 cell 
transduction see section 2.11.4. Once large numbers of newly generated cells were 
obtained, the cells were sorted into uniform populations with the aid of FACS sorter. 
Once again, THP-1 WT L-selectin-GFP/RFP cells were used as a reference population 
on which both GFP and RFP gates were set. Once sorted, the uniform cell lines were 
named THP-1 ΔM-N SSAA L-selectin-GFP/RFP and THP-1 SSAA L-selectin-GFP/RFP. 
Surface expression of both GFP- and RFP-tagged L-selectin was analysed by flow 
cytometry on all newly generated cells. DREG56 staining was used to label all surface 
L-selectin and expression was compared to that of THP-1 WT- and ΔM-N L-selectin-
GFP/RFP cells. As expected, a slight shift towards higher fluorescence was seen in cells 
expressing sheddase resistant forms of L-selectin (ΔM-N and ΔM-N SSAA L-selectin). 
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Additionally, the peak corresponding to SSAA L-selectin was marginally shorter than that 
for WT L-selectin, indicating that there could be slightly less SSAA L-selectin molecules 
at the cell surface. Overall, however, all cell lines were considered to have matched 
surface L-selectin levels (figure 5.7). 
    
 
Figure 5.7 Surface WT and mutant L-selectin-GFP/RFP expression in THP-1 cells.  Flow 
cytometry analysis of L-selectin expression. THP-1 WT and mutant (ΔM-N, ΔM-N SSAA or SSAA) 
L-selectin-GFP/RFP cells were labelled with anti-L-selectin DREG56 antibody and then 
secondary antibody conjugated to RPE. Representative histograms are shown. A) Dot plot 
depicting the population of viable, single THP-1 cells analysed (gate R1). B) Histogram showing 
total (GFP- and RFP-tagged) surface L-selectin expression in THP-1 cells as measured by RPE 
fluorescence. Gate M1 indicates L-selectin positive cells.  
 
Newly generated double expressor cells were subjected to 15 minute-long parallel plate 
flow chamber assay, fixed and prepared for FLIM/FRET analysis as described in section 
5.3.2. FRET results were compared to those obtained earlier for WT L-selectin, ΔM-N L-
selectin and WT L-selectin from THP-1 monocytes pre-treated with Ro-31-9790 
(hereafter referred to as WT Ro-31-9790 L-selectin). Figures 5.8 and 5.9 consolidate all 
the FRET data acquired for all the cell lines.  SSAA L-selectin clustering phenotype 
resembled that of WT L-selectin with high FRET seen at the Bottom and low FRET at 
the Top (figure 5.8 A), but with lower FRET efficiencies (figure 5.8 B). Interestingly, ΔM-












mutant did not entirely reverse the clustering phenotype to WT as anticipated, but rather 
served as an “intermediate” mutant (figure 5.8 A). Analysis of FRET efficiencies showed 
that in all the cell lines significant differences between Top and Bottom occurred, but the 
least difference was found for ΔM-N SSAA L-selectin. This again suggested that the 
clustering phenotype of this mutant placed it half way between two extremes: WT and 













































































































Figure 5.8 Differences in the subcellular distribution of clustered WT and mutant forms of 
L-selectin.  Summary of L-selectin clustering phenotypes observed during transmigration of THP-
1 cells expressing WT and mutant (ΔM-N, ΔM-N SSAA or SSAA) forms of L-selectin-GFP/RFP. 
THP-1 WT L-selectin-GFP/RFP cells were either untreated or pre-treated with Ro-31-9790 
metalloprotease inhibitor. All cell lines were perfused over TNF-α activated HUVEC in a 15 
minute-long parallel plate flow chamber assy as described in section 2.14.3. The cells were then 
fixed and prepared for FLIM/FRET analysis (see section 2.18.1). Top and Bottom z-planes 
correspond to the planes indicated in schematic in figure 5.2 A. A) Representative images 
showing Top and Bottom z-planes of transmigrating THP-1 cells. Images of L-selectin GFP and 
corresponding GFP multi-photon intensity images are shown in all panels. GFP lifetime is shown 
as a pseudocolour scale of blue (high lifetime) to red (low lifetime). L-selectin clustering occurs 
where low lifetimes are seen (orange to red), whereas no clustering occur where high lifetimes 
are seen (blue). B) Quantitation of FRET efficiency between L-selectin-GFP and L-selectin-RFP. 
Analysis was performed on a following number of THP-1 cells: 22 of WT L-selectin-GFP/RFP, 22 
of WT Ro-31-9790 L-selectin-GFP/RFP, 15 ΔM-N L-selectin-GFP/RFP, 18 ΔM-N SSAA L-
selectin-GFP/RFP and 15 SSAA L-selectin-GFP/RFP. Three independent experiments were 
performed for each cell line. Mean values are shown for each bar. Error bars represent S.E.M. 
Statistical analysis: Two-tailed, unpaired Student’s t-test was used to calculate differences 
between Top and Bottom for each cell line. *=p<0.05, ***=p<0.001.  
 
In order to analyse more closely the impact that the various mutations had on L-selectin 
clustering, the FRET efficiencies at the Top (figure 5.9 A) and Bottom (figure 5.9 B) of 
transmigrating cells were collectively subjected to statistical analysis. Analysis of FRET 
efficiencies in the Top z-plane (figure 5.9 A) revealed low ȠFRET values for WT and SSAA 
L-selectin. Since these were the only cell lines where shedding could occur, it suggested 
that L-selectin clustering at the Top, as seen by high ȠFRET of ΔM-N, ΔM-N SSAA and 
WT Ro-31-9790 L-selectin could be a result of lack of shedding. Because ȠFRET of ΔM-
N L-selectin was 12.56% and ȠFRET of ΔM-N SSAA L-selectin was 7.536%, it could be 
speculated that it was the SSAA mutation that decreased ΔM-N L-selectin clustering at 
the Top. Although not statistically significant, slightly lower ȠFRET value of SSAA L-
selectin (2.67%) than WT L-selectin (4.418%) could correspond to a minor difference in 
the peak height seen on the flow cytometry histogram of L-selectin surface expression 
(figure 5.7).  
Analysis of the FRET efficiencies in the pseudopods of transmigrating THP-1 cells 
(Bottom z-plane) (figure 5.9 B) showed that ΔM-N L-selectin and WT Ro-31-9790 L-
selectin had significantly lower ȠFRET values that those calculated for WT, ΔM-N SSAA 
and SSAA L-selectin. Interestingly, the FRET efficiency of ΔM-N SSAA L-selectin – a 
form that also could not undergo shedding – was high and no different to WT L-selectin 
ȠFRET. This suggested that lack of clustering in the pseudopods seen with ΔM-N L-
selectin and WT Ro-31-9790 L-selectin could not be due to lack of shedding. In fact, a 
vast difference in ȠFRET values between ΔM-N and ΔM-N SSAA L-selectin (2.3% versus 
10.3%, respectively), strongly suggests that clustering in the pseudopods is negatively 
regulated by serine phosphorylation. Data from Dr Angela Rey Gallardo (a postdoctoral 
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scientist in Dr Ivetic’s lab) reveals that mutating both serines in the L-selectin tail to 
phospho-mimicking aspartates results in the accumulation of clustered L-selectin 
exclusively to the non-transmigrated part of the cell. This would further support the 
hypothesis that the cytoplasmic serine residues in M-N L-selectin are 
hyperphosphorylated. Interestingly ȠFRET of ΔM-N SSAA L-selectin was not different to 
neither WT nor SSAA L-selectin, but statistical analysis detected difference between WT 
and SSAA L-selectin. One explanation for this could be a delay in FRET of SSAA L-
selectin that would correspond to delay in shedding seen in static transmigration assays 
(figure 4.4). Aleternatively, the difference could be a result of slightly lower surface 
expression of SSAA L-selectin as compared to WT L-selectin (figure 5.7).   
                  
 
Figure 5.9 Statistical analysis of differences between clustering of WT and mutant forms 
of L-selectin during THP-1 cell transmigration.  The graphs display FRET efficiencies as 
shown in figure 5.9 B, but data for Top (A) and Bottom (B) z-planes are dissected into two 
separate panels. Mean values are shown for each bar. Error bars represent S.E.M. Statistical 
analysis: One-way ANOVA followed by Tukey’s post-test was used to calculate differences 
between cell lines in each graph (z-plane). *=p<0.05, **=p<0.001, ***=p<0.0001    
 
5.3.7 ΔM-N SSAA L-selectin appears in large “aggregates” in the pseudopods of 
transmigrating THP-1 cells       
Taken together, it appears that there is a correlation with the spots that are seen in the 
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5.9). For example, both WT L-selectin-GFP spots (as observed using laser scanning 
confocal microscopy) and WT L-selectin-GFP/RFP clusters (as seen with FRET/FLIM 
analysis) accumulate in the pseudopods of transmigrating THP-1 cells. Similarly, the 
subcellular distribution of SSAA L-selectin-GFP was also seen to accumulate in the 
protruding pseudopods, however, the number of GFP-positive spots counted and the 
relative FRET efficiency are both less than the values obtained for WT L-selectin-GFP. 
As shown before, neither GFP spots nor clustering was seen in the protruding 
pseudopods of THP-1 cells stably expressing ΔM-N L-selectin-GFP. The previous 
section revealed that the SSAA ΔM-N L-selectin clustered both in the transmigrated and 
non-transmigrated parts of the cell. Laser scanning confocal microscopy was used to 
further understand whether ΔM-N SSAA L-selectin-GFP also accumulated in the 
protruding pseudopod. THP-1 ΔM-N SSAA L-selectin-GFP/RFP cells were perfused 
over TNF-α activated HUVEC for 15 minutes, fixed and prepared for confocal microscopy 
as described in sections 2.14.3 and 2.16.2, respectively. Single images of Top and 
Bottom z-planes were acquired for GFP and TRITC-phalloidin channels as described in 
section 2.16.4. THP-1 ΔM-N SSAA L-selectin-GFP/RFP cells appeared to have a high 
number of spikes, and hence both spots and spikes were scored as described in 
sections 4.3.9 and 2.16.4. Quantified spots and spikes were compared to corresponding 
values obtained earlier for THP-1 WT, SSAA and ΔM-N-GFP cells (section 4.3.9). 
Cumulative results are presented in figure 5.10. Analysis revealed that ΔM-N SSAA L-
selectin-GFP spots did not accumulate in the pseudopods of transmigrating THP-1 cells 
as average number of spots did not exceed that observed for ΔM-N L-selectin (figure 
5.10 A). Additionally, no significant differences were seen in spikes formation between 
the cell lines, although trend was seen where cells expressing L-selectin whose serines 
were mutated to alanines had slightly more spikes (figure 5.10 B). Interestingly, a new 
form of L-selectin-GFP accumulation was identified in the pseudopods of THP-1 ΔM-N 
SSAA L-selectin-GFP/RFP cells, termed “aggregates”, which were much larger than 
spots (figure 5.11). At this point images of transmigrating THP-1 WT, SSAA and ΔM-N 
L-selectin-GFP cells were re-analysed for the presence of the aggregates. Interestingly, 
very rarely aggregates could be seen in those cells, which explains why they were not 
spotted before. Scoring of the aggregates revealed that, on average, 7 out of 10 cells 
would present with a ΔM-N SSAA L-selectin-GFP aggregate in the pseudopods. On 
average, only 1 out of 10 cells would present with WT, SSAA or ΔM-N L-selectin-GFP 
aggregate (figure 5.10 C), suggesting that relationship between the aggregates and 




Figure 5.10 Quantitation of spots, spikes and “aggregates” of WT, SSAA, ΔM-N and ΔM-N 
SSAA L-selectin-GFP.  THP-1 ΔM-N SSAA L-selectin-GFP/RFP cells were perfused over TNF-
α activated HUVEC for 15 minutes, fixed with 4% PFA and prepared for confocal analysis 
(sections 2.14.3 and 2.16.2). Spots and aggregates of L-selectin-GFP were analysed in the 
pseudopods of transmigrating THP-1 cells. Spikes were quantified using Volocity software and 
aggregates were counted manually. Spikes were counted manually. Analysis of spots and spikes 
of THP-1 WT, SSAA and ΔM-N L-selectin-GFP was performed earlier (figure 4.13) and the 
images were now re-analysed for the presence of aggregates. Graphs presented in this figure 
show consolidated data of spots (A), spikes (B) and aggregates (C) quantitation. For detailed 
method of spots, spikes and aggregates analysis see section 2.16.4. Error bars represent S.E.M. 






































































































































































Figure 5.11 Large ΔM-N SSAA L-selectin-GFP aggregates accumulate in the pseudopods 
of transmigrating THP-1 cells.  THP-1 cells expressing ΔM-N SSAA L-selectin-GFP/RFP were 
perfused over TNF-α activated HUVEC for 15 minutes, fixed with 4% PFA, stained with TRITC-
phalloidin and analysed by confocal microscopy (sections 2.14.3 and 2.16). Representative 
single z-plane confocal images of Top and Bottom z-planes (Top and Bottom as depicted in 
schematic in figure 4.2 A) are shown. L-selectin-GFP spots and aggregates are shown with blue 
and yellow arrows, respectively. Spikes extending from the pseudopods are indicated with red 





















This data shows that even though the ΔM-N SSAA L-selectin-GFP did not accumulate 
in the form of spots, another form of accumulation – big L-selectin-GFP formations 
termed aggregates – were seen in the pseudopods of transmigrating THP-1 cells. The 
nature of these aggregates is not known. Since little aggregates were seen formed by 
WT and SSAA L-selectin that cluster in the transmigrating pseudopods (figure 5.8), it is 
not likely that they correspond to ΔM-N SSAA L-selectin-GFP/RFP clustering that was 
detected in the pseudopods by FRET (figure 5.8). It has to be acknowledged that whilst 
analysis of WT, SSAA and ΔM-N L-selectin-GFP accumulation in the pseudopods of 
transmigrating THP-1 monocytes was performed on cells expressing only GFP-tagged 
L-selectin, accumulation of ΔM-N SSAA L-selectin was performed in the double 
expressor (GFP/RFP) THP-1 cells. As a result it was possible that total levels of ΔM-N 
SSAA L-selectin were not an exact match to the corresponding “single expressors”. 
However, L-selectin-GFP spots and aggregates were analysed using images of the GFP 
channel only. MOI of 5 was used to transduce THP-1 cells with lentiviral particles carrying 
ΔM-N SSAA L-selectin-GFP transgene. Hence, levels of ΔM-N SSAA L-selectin-GFP 
were most probably similar to those on THP-1 ΔM-N L-selectin-GFP Lo5 cells, and thus 
to all the other single expressor cell lines. Therefore, it is believed that analysis of spots 
and aggregates should not be influenced by the fact that additional ΔM-N SSAA L-
selectin-RFP form was also present in the cells. As for examination of spikes, the 
possibly unmatched total ΔM-N SSAA L-selectin levels could skew the analysis. 
Although not statistically significant differences were found between the cell lines, THP-
1 ΔM-N SSAA L-selectin-GFP/RFP cells showed a trend where more spikes were 
present. This could be a result of higher total ΔM-N SSAA L-selectin levels. Notably, a 
trend was also seen where THP-1 SSAA L-selectin-GFP Hi20 cells formed slightly more 
spikes that both THP-1 WT L-selectin-GFP Hi20 and ΔM-N L-selectin-GFP Lo5 cells. 
Thus, it is more likely that the trend was due to SSAA mutation rather than total L-selectin 
levels.  
5.3.8 Clustering of L-selectin is promoted by antibody-mediated cross-linking of 
either CD43 or PECAM-1 
Data presented in the sections above shows that L-selectin clustering occurs during the 
initial stages of TEM, when THP-1 monocytes send pseudopods underneath the HUVEC 
monolayer. L-selectin clustering in the pseudopods could be the result of ECM ligand 
binding, i.e. binding to HUVEC-expressed biglycan (figures 5.3 and 5.4). At the same 
time, other mechanisms of L-selectin clustering could also be in action. One possibility 
is that engagement of other CAMs that are present on the surface of THP-1 monocytes, 
generates intracellular signals that in turn result in clustering of L-selectin. Signals 
generated intracellularly are known to cause upregulation and increase in affinity of 
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leukocyte integrins, and this phenomenon is known as “inside-out” signalling (section 
1.2.4). To test this hypothesis cell adhesion molecules were selected to represent 
proteins that were involved in various stages of the multi-step adhesion cascade: PSGL-
1, JAM-A, CD43, CD44 and PECAM-1. All of these CAMs are known to be expressed in 
THP-1 cells [153, 679-682], and flow cytometry was used to analyse their endogenous 
expression on THP-1 WT L-selectin-GFP/RFP cells. Figure 5.12 shows that although all 
the CAMs were expressed on the THP-1 cells, the expression levels varied between the 
CAMs tested. For example expression of CD43 and CD44 were in the same log scale 
range as L-selectin (around 104), but the expression levels of PSGL-1, PECAM-1 and 




Figure 5.12 Expression levels of THP-1 CAMs.  THP-1 WT L-selectin-GFP/RFP cells were 
labelled with anti-L-selectin, -CD43, -CD4, -PSGL-1, -PECAM-1, -JAM-A or appropriate IgG 
isotype control antibodies and then RPE-conjugated secondary antibodies, and analysed by flow 
cytometry as described in section 2.13. Dot plot in the upper left corner shows gate R1 that was 
used to select single and viable cells only. Histograms show expression levels of indicated CAMs. 
All used antibodies were of the same stock concentration and the same dilution was used for all 












To test whether clustering of any of the CAMs would in turn induce L-selectin clustering 
in a manner of inside-out signalling, the cells were subjected to the cross-linking assay 
described in section 2.19. Briefly, monoclonal antibody was used to specifically label 
PSGL-1, JAM-A, CD43, CD44 or PECAM-1 on the surface of WT L-selectin-GFP/RFP, 
the molecules were cross-linked with relevant secondary antibodies and cells were 
seeded on to ploy-L-lysine (PLL)-coated coverslips. The extent of L-selectin clustering 
was measured by FLIM/FRET. In the control experiments L-selectin was labelled with or 
without DREG56 and cross-linking was promoted with a secondary antibody. All stock 
concentrations of the primary antibodies were matched (table 2.2) and 1:50 dilution was 
used to treat all cells. As expected, cross-linking L-selectin resulted in a dramatic 
increase in FRET efficiency, whereas no FRET was detected in untreated cells (figure 
5.13 A). Remarkably, whilst no FRET was seen when PSGL-1, JAM-A and CD44 were 
cross-linked, cross-linking CD43 or PECAM-1 caused significant clustering of L-selectin 
(figure 5.13 A). Analysis of FRET efficiencies showed that direct L-selectin cross-liking 
resulted in maximal L-selectin clustering. As expected, no clustering was seen in the 
control cells where cross-linking was not performed, implying that the action of seeding 
cells on to PLL did not influence the clustering of L-selectin. Cross-linking of CD43 and 
PECAM-1 caused the same extent of L-selectin clustering as no statistically significant 
differences in ȠFRET values were seen between the two (figure 5.13 B). Interestingly, 
localisation of L-selectin FRET signal and PECAM-1 staining appeared as an exact 
match. CD43 staining was seen in the same areas as L-selectin FRET, but also in other 
areas where L-selectin did not cluster (figure 5.13 A). This could suggest possible 
differences in the way PECAM-1 and CD43 relay their signals to cluster L-selectin. 
The fact that cross-linking CD43 or PECAM-1 did and PSGL-1, CD44 and JAM-A  did 
not cause L-selectin clustering, suggested that the potential of these molecules to cluster 
L-selectin was not necessarily dependent on their relative abundance (figure 5.12). On 
the other hand it had to be appreciated that the relative affinities of the antibodies for 
their ligands were not known. It is possible that this could also have an effect on 
downstream signalling and L-selectin clustering. Although this does not question the fact 
that CD43 and PECAM-1 caused L-selectin clustering, it does not formally exclude the 
possibility that CD44, JAM-A and PSGL-1 could also cluster L-selectin under different 
experimental conditions.  
   
210 
 
   
Figure 5.13 Clustering of L-selectin in response to CD43 and PECAM-1 cross-linking.  THP-
1 WT L-selectin-GFP/RFP cells were labelled with primary antibodies against indicated CAMs 
and, and subsequently cross-linked with relevant Alexa633-conjugated secondary antibodies. 
Alternatively, the cells were incubated with just media (“No X-linking”), and cells were seeded on 
to PLL pre-coated coverslips (for method details see section 2.19). After 5 minutes of binding, 
cells were fixed with 4% PFA and prepared for FLIM/FRET analysis as described in section 
2.18.1. A) In all panels images show L-selectin-GFP (left columns), the GFP multi-photon intensity 
(middle columns) and relevant Alexa633 fluorescent images (right columns). Lifetime of GFP 


















































No Alexa633 image corresponding to JAM-A staining was available. B) Quantified data showing 
FRET efficiency between L-selectin-GFP and L-selectin-RFP. Average 15 cells were analysed for 
each condition per cell line and cells were derived from 3 independent experiments. Error bars 
represent S.E.M.  Statistical analysis: One-way ANOVA followed by Tukey’s post-test. “†” 
represent difference against “No X-link.”, “*” represent indicated differences between cross-linked 
samples. † † †=p<0.001, ***=p<0.001.   
 
5.3.9 Alanine-to-serine mutation of the L-selectin tail is sufficient to block PECAM-
1, but not CD43, mediated clustering of L-selectin  
As described in section 5.3.9 above, cross-linking of both CD43 and PECAM-1 resulted 
in L-selectin clustering. To investigate whether this was dependent on cytoplasmic 
serines and/or L-selectin extracellular cleavage site, it was decided that that THP-1 ΔM-
N, ΔM-N SSAA and SSAA L-selectin-GFP/RFP cells were to be subjected to the same 
cross-linking assay. Expression levels of CD43 and PECAM-1 in WT and mutant L-
selectin double expressing cells were first analysed by flow cytometry. No detectable 
changes in the expression levels of CD43 or PECAM-1 expression were found in any of 
the cell lines tested (figure 5.14).  
 
Figure 5.14 CD43 and PECAM-1 levels are matched in THP-1 cells expressing WT or mutant 
forms of L-selectin-GFP/RFP.  THP-1 cells expressing WT, ΔM-N, ΔM-N SSAA or SSAA L-
selectin-GFP/RFP were labelled with anti-CD43, anti-PECAM-1 or IgG isotype control antibodies. 
Cells were subsequently labelled with RPE-conjugated secondary antibody and analysed by flow 
cytometry (section 2.13). Dot plot in the top panel shows single and viable THP-1 cells (Gate R1) 
selected for analysis. Histograms in the bottom panel show CD43 (left histogram) and PECAM-1 











CD43 or PECAM-1 molecules on THP-1 ΔM-N, ΔM-N SSAA or SSAA L-selectin-
GFP/RFP cells were cross-linked as described in section 5.3.8 (for detailed description 
of the assay see section 2.19), and the cells were prepared for FLIM/FRET analysis 
(section 2.18.1). All results were compared to the previous results obtained for WT L-
selectin (figure 5.12) and cumulative data is represented in figure 5.15. FRET analysis 
showed that all mutants clustered in response to cross-linking with DREG56 antibody. 
Interestingly, the only L-selectin mutant that did not undergo clustering in response to 
either PECAM-1 or CD43 cross-linking was ΔM-N L-selectin. This could be due to the 
possibility that the cytoplasmic tail of ΔM-N is modified in some way (such as 
hyperphosphorylation). In support of this, both ΔM-N SSAA and SSAA L-selectin 
underwent clustering in response to CD43 cross-linking, suggesting that 
hyperphosphorylation of the L-selectin tail may well be the reason for blocking the 
response in ΔM-N L-selectin. The fact that rendering serine residues of ΔM-N L-selectin 
non-phosphorylatable restored L-selectin clustering, would suggest that blocking serine 
phosphorylation is indeed an important requirement for CD43-mediated L-selectin 
clustering. None of the L-selectin mutants clustered in response to PECAM-1 cross-
linking. This result was surprising because of the data obtained for CD43-mediated L-
selectin clustering. Yet, as suggested at the end of section 5.3.8, it is possible that CD43 
and PECAM-1 employ distinct signalling pathways to trigger L-selectin clustering. 
Perhaps PECAM-1-mediated pathway requires both intact L-selectin extracellular 
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Figure 5.15 Clustering of mutant L-selectin in response to CD43 and PECAM1-cross-
linking.  L-selectin, CD43 or PECAM-1 on THP-1 ΔM-N, ΔM-N SSAA or SSAA L-selectin-
GFP/RFP were cross-liked or cells were left untreated, and cells were allowed to bind to PLL-
coated coverslips for 5 minutes at RT (section 2.19). After 4% PFA fixation, cells were prepared 
for FLIM/FRET analysis as described in section 2.18.1. A) In all panels images show L-selectin-
GFP (left columns), the GFP multi-photon intensity (middle columns) and relevant Alexa633 
fluorescent images (right columns). Pseudo-colour scale of blue (high lifetime) to red (low lifetime) 
is used to show lifetime fluorescence.  B) Quantified data showing FRET efficiency between L-
selectin-GFP and L-selectin-RFP. Average 15 cells were analysed for each condition per cell line 
and cells were derived from 3 independent experiments. Error bars represent S.E.M. Statistical 
analysis: One-way ANOVA followed by Dunnett’s post-test against “No X-link.” was performed for 
each cell line. ***=p<0.001.   
  
5.4 DISCUSSION 
5.4.1 Two putative models to explain L-selectin clustering during the leukocyte 
adhesion cascade 
The results presented in this chapter show two major findings: (i) WT L-selectin clusters 
in the pseudopods of transmigrating THP-1 cells (figure 5.2), and (ii) L-selectin clusters 
following antibody-mediated cross-linking of either CD43 or PECAM-1 (figure 5.13). 
Whether there is a relationship between these two events is currently unknown. 
However, given the current knowledge about the role of CD43 and PECAM-1 in the 
leukocyte adhesion cascade, two models for L-selectin clustering can be proposed. The 
first model postulates that engagement of CD43 during rolling drives L-selectin clustering 
and enhances leukocyte recruitment. The second model proposes that PECAM-1 plays 
a role in L-selectin clustering during TEM, which could facilitate binding of ECM ligand 
and/or L-selectin shedding. A schematic summary of the two models is shown in figure 





Figure 5.16 Schematic of two possible models of L-selectin clustering.The findings 
described in this chapter have been used to create two putative models for L-selectin clustering 
during the leukocyte adhesion cascade. I) Engagement of CD43 with endothelial ligand (e.g. E-
selectin) (1) leads to L-selectin clustering (2). This initiates signalling downstream of L-selectin 
tail (3), which promotes leukocyte recruitment. II) Leukocyte PECAM-1 engages with its 
endothelial counterpart (1). This causes or enhances L-selectin clustering and serves to 
translocate clustered L-selectin to the transmigrated pseudopods (2). Clustered L-selectin has 
high affinity for the ECM ligand(s) and binding occurs (3). This triggers signalling downstream of 
L-selectin tail (4), one possible outcome being L-selectin shedding.  
 
Model I 
The role of CD43 during the adhesion cascade is somewhat controversial. It has been 
reported that CD43 is a negative regulator of monocyte, neutrophil and ex vivo (naïve) 
lymphocyte rolling due to its highly negative charge that forms a functional barrier in an 
electrochemically repulsive manner [684, 685].  On the other hand, Mody et al. (2007) 
reported that CD43 has a positive effect on the trafficking of central memory, but not 
naïve, T cells to the LNs [686].  Homing of lymphocytes to LNs is exclusively dependent 
on L-selectin [11, 389-392, 687], and it was possible that CD43 deficiency negatively 
regulated L-selectin expression in the central memory T cells. However, the group did 























marked reduction in their ability to home to the LNs [686]. In the light of results presented 
in this chapter (figure 5.13), it can be hence proposed that during lymphocyte rolling on 
HEV, CD43 acts upstream of L-selectin to enhance recruitment. Since no positive effect 
of CD43 on naïve T cell recruitment has been reported [684, 686], this mechanism might 
be employed solely by the central memory T cells. Upon activation naïve T cells lose 
their L-selectin [386], which prevents them from re-entering the LNs and prompt them to 
home to the sites of inflammation. Upon resolution of the inflammatory response, majority 
of activated T cells undergo apoptosis [688], but some develop into effector memory T 
cells and some into central memory T cells [498]. It is the central memory T cells that re-
express L-selectin and can home to LNs, where they can rapidly respond to re-
stimulation with antigen [387, 498]. Notably, it has been reported that ligation of L-
selectin leads to increased adhesion through β1 and β2 integrins in naïve, but not 
memory T cells [86, 88]. Perhaps central memory T cells acquire different to naïve T 
cells functional requirements, where engagement of CD43 is firstly needed to cluster L-
selectin and initiate signals that promote recruitment to the LNs. It would be of interest 
to perform adoptive transfer experiments in vivo, where the influence of CD43 cross-
linking could be evaluated on naïve versus central memory T cell trafficking.  
Interestingly, it has also been reported that neutrophil and monocyte infiltration into the 
inflamed peritoneum and transmigration across platelet activating factor (PAF)-perfused 
venules of the cremasteric muscle was significantly impaired in CD43 deficient mice 
[685]. This suggests that CD43 might also play a role in leukocyte recruitment to sites of 
inflammation. CD43 is known to bind E-selectin during leukocyte rolling [689-691], and 
hence it is likely that engagement of CD43 clusters L-selectin to increase avidity, reduce 
rolling velocity and aid better recruitment. This could be particularly true in mouse, where, 
unlike in humans, neutrophil L-selectin cannot bind to E-selectin [381]. In such case, 
where direct activation of L-selectin by E-selectin is not possible, CD43 might play a role 
to transduce signalling from E-selectin to L-selectin. For example, it has been shown that 
rolling of human neutrophils on E-selectin and ICAM-1 causes co-clustering of L-selectin 
and PSGL-1, which leads to β2 integrin activation and transition from rolling to arrest 
[413]. Perhaps in mouse it is the binding of CD43 to E-selectin that clusters L-selectin, 
which in turns leads to integrin activation.  
 
Model II 
Leukocyte PECAM-1 is known to mediate transendothelial migration [692], and hence it 
is easy to envisage a mechanism, where engagement of PECAM-1 triggers intracellular 
signals resulting in L-selectin clustering. Leukocyte PECAM-1 is known to rapidly 
redistribute to detergent resistant membranes (DRM) during transmigration [155]. 
GlyCAM-1 binding and antibody-mediated cross-linking of L-selectin have also been 
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shown to drive translocation to DRM [560, 587]. Through casual observations, it seems 
as though PECAM-1 clustering was super-imposed with L-selectin clustering (figure 
5.13). During TEM, leukocyte PECAM-1 makes like-for-like interactions with endothelial 
PECAM-1. As this process ensues, one can imagine that clustering of 
leukocyte/endothelial PECAM-1 at endothelial junctions could potentially serve to 
translocate L-selectin from the non-transmigrated part of the cell to the transmigrating 
pseudopod (figure 5.2). It is therefore possible that once monocyte initiates 
transmigration, PECAM-1 and L-selectin co-localise in cholesterol-rich membrane 
domains, e.g. lipid rafts, where PECAM-1 mediated signalling cause L-selectin 
clustering. Additionally, clustering of L-selectin via PECAM-1 could bring about a 
conformational change that aids binding of multiple sulphated polysaccharide chains 
belonging to an ECM ligand. Clustering of membrane receptors has been proposed as 
a mechanism that modulate the affinity of these receptors for their ligands [693], and lipid 
rafts are known platforms mediating immune cells signalling [588].  Extracellular matrix 
proteoglycans bearing long sulphated polysaccharide chains, i.e. collagen XVIII, 
biglycan and versican, have been shown to bind to L-selectin [221, 354, 463-466]. As 
shown in figures 5.3 and 5.4, biglycan is expressed by TNF-α activated HUVEC and is 
a likely candidate for a subendothelial L-selectin ligand. Remarkably, no research has 
been devoted to investigate the potential signalling triggered by binding of L-selectin to 
sulphated proteoglycans and/or glycolipids. It is likely that this signalling would be of a 
completely different nature to the one evoked by “classic” sLex-epitope bearing ligands. 
Multiple long polysaccharide chains that exhibit a high degree of sulfation could bind L-
selectin in a structurally different way to that of the relatively small sLex  moieties. This 
could in turn result in activation of a distinct signalling pathway downstream of L-selectin 
tail. Notably, Liu and Kiick (2011) analysed the influence of ligand architecture and 
sulphation on L-selectin binding and shedding, and the authors state that sulphation and 
certain ligand density – or spacing between the ligands – needs to be present for the 
binding to induce shedding [678]. It is interesting to note that amid the multitude of cellular 
responses triggered by L-selectin cross-linking, shedding has been reported the most 
frequently [91, 529, 533-536]. Perhaps very densely spaced ligands, such as sulphated 
polysaccharide chains, induce L-selectin clustering in a specific conformation, which 
over time results in L-selectin shedding. It is noteworthy that engagement of PECAM-1 
on human neutrophils has been shown to induce shedding of L-selectin [694]. 
Additionally, ADAM17, a protease that cleaves L-selectin upon cell activation, has been 
reported to cleave its substrates in lipid rafts [695, 696]. Perhaps a certain membrane 
lipid raft environment, where PECAM-1, L-selectin and ADAM-17 co-cluster is formed 
during TEM, which – upon ECM ligand binding – results in L-selectin shedding 
exclusively in the transmigrating pseudopods. Understanding the timing of pseudopod 
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protrusion, its influence from L-selectin-dependent adhesion (with ECM-derived ligands) 
and signalling, and shedding of L-selectin will be important areas of research to explore. 
5.4.2 Cytoplasmic serine residues regulate L-selectin clustering 
Based on long (over 30 minutes to 1 hour) end-point assays, emigrated leukocytes are 
known to have shed their L-selectin [520, 554-556]. Data presented in Chapter 4 shows 
that L-selectin-GFP shedding occurs in the first 20 minutes of TEM under static 
conditions (figure 4.1), which is delayed when the cytoplasmic serine residues are 
mutated into non-phosphorylatable alanines (figure 4.4). Additionally, a correlation was 
identified between L-selectin shedding and accumulation of L-selectin-GFP spots in the 
pseudopods of transmigrating THP-1 cells after 15 minutes of flow (section 4.3.9, figure 
4.13). The results presented within this chapter show that L-selectin clusters in the 
pseudopods of transmigrating THP-1 monocytes after 15 minutes of perfusion (figure 
5.2). A question therefore arose as to a possible relationship between cytoplasmic serine 
phosphorylation, L-selectin shedding and L-selectin clustering during TEM. Interestingly, 
both WT and SSAA L-selectin clustered in protruding pseudopods (figure 5.8), 
suggesting that rendering of the cytoplasmic serine residues non-phosphorylatable does 
not affect L-selectin clustering during monocyte TEM. A decrease in FRET efficiency was 
seen in the SSAA mutant as compared to WT L-selectin, which could correspond to the 
observed delay in shedding seen in the static transmigration assay (figure 4.4).  Most 
interestingly, ΔM-N L-selectin as well as L-selectin from monocytes treated with Ro-31-
9790 metalloprotease inhibitor did not cluster in the pseudopods of transmigrating THP-
1 monocytes (figure 5.6). In fact, a reverse subcellular distribution of clustered L-selectin 
was seen, where L-selectin clustered exclusively in the non-transmigrated parts of the 
cells (Top z-plane) (figure 5.6). This could be interpreted in one of two ways. One 
explanation would be that shedding is required for clustering, and the clustered form is 
L-selectin cleavage product (“stump”). However, this hypothesis does not explain why 
ΔM-N L-selectin clustering was seen in the Top z-plane of the transmigrating cells. Cell 
activating stimuli are known to cause phosphorylation of L-selectin tail as well as induce 
L-selectin shedding [495, 496, 567], but whether those events occur simultaneously or 
one precedes the other is unclear. If tail phosphorylation precedes shedding, both ΔM-
N L-selectin and L-selectin from monocytes treated with Ro-31-9790 might become 
hyperphosphorylated when the cells become activated upon contact with the TNF-α 
activated HUVEC monolayer. Attempts were made to detect phosphorylated serines on 
immunoprecipitated ΔM-N L-selectin, however the antibody used proved unsuccessful. 
Further optimisation of the technique would be needed to address this question. 
However, a hypothesis was formulated where hyperphosphorylation of ΔM-N L-selectin 
uncoupled it from cytoskeleton – perhaps via abrogating interaction with ERM proteins – 
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and caused physical aggregation of L-selectin molecules in the non-transmigrated parts 
of the cells, seen as clustering in the Top z-plane. To test the hypothesis that excessive 
tail phosphorylation prevents L-selectin clustering in monocyte pseudopods during TEM, 
ΔM-N SSAA L-selectin mutant was generated. As expected ΔM-N SSAA clustered in the 
pseudopods of transmigrating THP-1 cells (figure 5.8), suggesting that rendering the 
cytoplasmic serines of ΔM-N L-selectin non-phosphorylatable can restore L-selectin 
clustering in the pseudopods to that seen with WT L-selectin. This also suggests that 
FRET in the pseudopods is a result of full-length, and not “stump” L-selectin clustering. 
Furthermore, it could be proposed that for L-selectin to cluster in the transmigrated 
pseudopods of THP-1 cells, the cytoplasmic serine residues must not be phosphorylated. 
Supportive of this data are results of experiments conducted in the Ivetic laboratory with 
ΔM-N L-selectin mutant whose serine residues were mutated to phospho-mimicking 
aspartates (ΔM-N SSDD). This mutant presented with the same clustering phenotype as 
ΔM-N L-selectin, where no L-selectin clustering was observed in the transmigrated 
pseudopods of THP-1 cells, yet L-selectin FRET was detected in the Top z-plane (Dr 
Angela Rey-Gallardo, unpublished data). Additionally, it can be proposed that the 
clustering in the non-transmigrated parts of the cell, as seen with the sheddase-resistant 
L-selectin mutants, namely ΔM-N, ΔM-N SSAA and ΔM-N SSDD, is non-specific (i.e. 
independent of the serine residues), and could be a result of random interactions 
between L-selectin molecules that are forced to accumulate together at the plasma 
membrane due to lack of shedding.  
WT, SSAA and ΔM-N SSAA L-selectin, but not ΔM-N L-selectin, underwent clustering in 
response to CD43 cross-linking. This suggests that blocking L-selectin phosphorylation 
is needed for CD43-mediated clustering of L-selectin (figure 5.15). Both CD43 and L-
selectin are known to bind ERM proteins [563, 572, 697, 698]. Interestingly, it has been 
shown that mutating serine-76 within cytoplasmic domain of CD43 into a phospho-
mimicking aspartate abolishes binding of CD43 to ezrin [698]. Phosphorylation of the 
same serine residue is thought to mediate CD43 signalling [698]. Perhaps 
phosphorylation of serine-76 on CD43 uncouples the ERM proteins, which can then bind 
to adjacent non-phosphorylated L-selectin tail, and this in turn induces L-selectin 
clustering. This could represent a potential mechanism by which CD43 regulates L-
selectin-mediated trafficking of central memory T cells to the LNs.  Further 
experimentation would be required to formally test this hypothesis. 
That none of the L-selectin mutants underwent clustering in response to PECAM-1 cross-
linking is puzzling (figure 5.15). However, it can be speculated that both extracellular 
cleavage site and intact cytoplasmic serines are required for successful L-selectin 
clustering in response to PECAM-1 cross-linking.  
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CHAPTER 6. MONITORING CELLULAR RESPONSES TO L-
SELECTIN CLUSTERING AND SHEDDING DURING TEM 
6.1 INTRODUCTION 
The leukocyte adhesion cascade is a sequence of highly co-ordinated adhesion and 
activation events that lead to extravasation of the leukocytes into the inflamed tissue 
(section 1.2) [6]. During this process the spherical shape of a circulating leukocyte 
undergoes a series of dramatic changes. Through changes in F-actin reorganisation, 
activated leukocyte acquires anterior-posterior polarity with an extended leading edge 
(the front of the cell) and a rounded back (uropod) [699, 700]. The importance of this 
process is emphasised by the fact that loss of cell polarity abolishes successful 
locomotion of the leukocytes [234, 240, 701]. During the TEM event, leukocytes extend 
their leading edge (i.e. the pseudopods) underneath the endothelium [702, 703]. 
Leukocytes project multiple pseudopods that dynamically protrude and retract [36]. This 
is thought to be a way of “path finding” and exploring of the subendothelial environment. 
Once emigrated, leukocytes migrate through the interstitial ECM, and towards the source 
of inflammation [6, 398, 419, 704]. This process is known as directed cell migration or 
chemotaxis. Chemotaxis is highly dependent on cell polarity, and numerous chemokines 
regulate polarisation [705, 706]. Interestingly, it has been reported that L-selectin null as 
well as “sheddase-resistant” L-selectin murine leukocytes are both able to exit inflamed 
venules but are incapable to migrate through the interstitium towards the 
chemoattractant source [398, 419]. This paradoxical observation suggests that L-selectin 
may have to be shed and then re-expressed on the cell surface for correct chemotaxis 
in to the surrounding tissue. Alternatively the L-selectin “stump” generated upon L-
selectin cleavage may be important for downstream signal propagation resulting in 
successful chemotaxis (as the stump is both absent in the L-selectin knock-out model 
and the sheddase-resistant model). Whether the observed L-selectin-dependent 
chemotaxis defect was due to the compromised leukocyte polarity is not known.   
The Rho family of small GTPases are highly conserved molecular switches that control 
actin cytoskeleton dynamics, thereby affecting cell shape and motility. The Rho GTPases 
are involved in a number of cellular responses during the leukocyte adhesion cascade 
(section 1.5, see summary in table 1.1). The most widely studied members of the family 
are RhoA, Rac1/2 and Cdc42. Expression of dominant active or inactive forms of those 
Rho GTPases, or inhibition of their downstream effectors, severely impair leukocyte 
TEM, polarisation and chemotaxis [118, 234-238, 240, 241, 704]. The Rho GTPases are, 
therefore, the “first suspects” where an altered cell shape is observed. The Rho GTPase 
proteins cycle between an inactive GDP-bound and an active GTP-bound forms, and 
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various methods have been developed to detect the active form. For example, Rho 
GTPase “pull-down assays” are commonly used to quantify the activation of the Rho 
GTPases in cell extracts [707-710].  Additionally, FRET based probes (i.e. the Rho 
GTPase biosensors or the Raichu probes) can be used to monitor the spatio-temporal 
activation of the Rho GTPases in living cells [118, 711-713]. 
The data presented in Chapters 4 and 5 of this thesis describes the results of the 
experiments designed to investigate shedding and clustering of L-selectin during TEM. 
The aim of the work contributing to this chapter is to establish whether L-selectin 
regulates THP-1 monocyte morphology during TEM and if it plays a role in chemotaxis. 
By studying THP-1 cell shape, it is believed that L-selectin plays a role in monocyte 
polarisation during TEM. Additionally, the serine residues within the L-selectin tail are 
shown to be involved in directing THP-1 cell morphology during TEM. The role of the 
serines is still not clear in this process, however the results presented in this chapter 
suggest that preventing their phosphorylation could render the cells less “invasive” during 
TEM.            
6.2 EXPERIMENTAL DESIGN 
Chapter 5 describes the parallel plate flow chamber assays that were used to investigate 
WT and mutant L-selectin clustering during TEM. L-selectin mutants were either 
sheddase-resistant (ΔM-N), had non-phosphorylatable cytoplasmic serines (SSAA), or 
both (ΔM-N SSAA). Those mutants were generated to help understand what role the 
extracellular cleavage site and the cytoplasmic serine residues play in L-selectin 
shedding and clustering during TEM. The assays lasted 15 minutes, which captured cells 
at a moment before L-selectin shedding had reached its peak. All the perfusions were 
recorded with the use of the time-lapse inverted fluorescence microscope, where images 
of the phase contrast and the GFP channel (representing GFP or L-selectin-GFP) were 
acquired into digital video file. The video footages were now re-analysed to examine 
THP-1 cell morphology during the perfusion. The aim of this task was to overlay data for 
THP-1 cell shape change with the existing data acquired for L-selectin shedding and 
clustering during TEM. Pseudopod formation and cell spreading area of THP-1 
monocytes were thus analysed to evaluate the impact of L-selectin expression (and its 
mutants) on cell shape changes during TEM.     
Analysis of the video footage showed striking differences in the cell morphology between 
the cells expressing WT and ΔM-N L-selectin. The Rho family of the small GTPase 
proteins control cytoskeletal dynamics and hence regulate cell shape to aid migration. It 
was shown previously that ligation of L-selectin can activate Rac1 and Rac2 proteins 
[245, 246, 603]. This suggests that morphology of the THP-1 cells during TEM could be 
driven by L-selectin-mediated activation of Rho GTPases. Our laboratory has reported 
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an efficient method for monitoring of the Rho GTPase activation in leukocytes [714].This 
method was employed to investigate the basal levels of Rho GTPases activation in 
resting THP-1 monocytes. This was to investigate whether expression of L-selectin or its 
shedding altered the basal activity of the Rho GTPases.  
FRET-based probes that can visualize local changes in Rho GTPase activity in living 
cells can be used for investigation of the spatio-temporal regulation of these proteins. 
The Rho GTPase biosensors were first reported by Pertz et al. (2006), and were 
designed to monitor RhoA activity during fibroblast migration [711]. The Rho GTPase 
biosensors are built of four domains: the FRET donor (CFP), the FRET acceptor (YFP), 
a Rho GTPase and its “affinity reagent” (binding partner) (figure 6.1). In a non-active 
state, the separation between YFP and CFP results in low FRET efficiency. Upon 
activation, binding of Rho GTPase to its affinity reagent brings CFP into a close proximity 
(<10 nm) of YFP, which increases FRET efficiency. For an explanation of FRET 
phenomenon and FLIM measurement of FRET efficiency see sections 2.18 and 5.2.  
 
Figure 6.1 Schematic of CFP/YFP FRET-based Rho GTPase biosensor.  The Rho GTPase 
biosensor contains the YFP and CFP fluorescent proteins inserted between the Rho GTPase and 
the Rho GTPase “affinity reagent”. When inactive, the probe is in its relaxed form (left diagram), 
where CFP and YFP are wide apart and low FRET efficiency is seen. On stimulation, the GDP 
on Rho GTPase is exchanged for GTP, the active Rho GTPase binds the affinity reagent, and 
high FRET efficiency is detected (right diagram).  Image adapted from Hodgson et al., Methods 
in Cell Biology, 2008 [715]. 
 
RhoA, Rac1 and Cdc42 biosensors in lentiviral vectors were constructed and kindly 
provided by Oliver Pertz (University of Basel, Switzerland). The lentiviral gene delivery 
system that has been used throughout this thesis was again employed to introduce the 
biosensors in to the THP-1 monocytes. Excitation wavelength (λex) of CFP is 433 nm and 
its emission wavelength (λem) is 475 nm. For YFP, λex and λem are 525 nm and 573 nm, 
respectively. Since λex and λem of GFP are 488 and 507, the CFP/YFP biosensors could 
not be introduced in to the described in Chapters 3 and 4 L-selectin-GFP expressing 
cell lines. This was because the GFP-tag would interfere with the FRET signal due to a 













spectral overlap. The probes had to be therefore co-expressed with RFP-tagged L-
selectin. RFP has λex of 584 nm and λem of 607 nm, and hence would not interfere with 
CFP/YFP FRET detection. Generated in Chapter 5 lentiviral particles carrying RFP-
tagged WT or ΔM-N L-selectin were used for transduction. THP-1 cell lines expressing 
CFP/YFP Rho GTPase biosensors and L-selectin-RFP were subjected to the parallel 
plate flow chamber assays. Additionally, grounds were set for a new static assay, where 
WT or ΔM-N L-selectin-RFP was cross-linked and RhoGTPase activation was 
measured. FLIM analysis of FRET between CFP and YFP was performed with the 
collaboration of Dr Maddy Parsons (Randall Division of Cell and Molecular Biophysics, 
King’s College London). 
Analysis of the video footage showed that WT and ΔM-N L-selectin expressing cells had 
different morphology during TEM. A polarisation defect was hypothesised to occur in the 
cells expressing ΔM-N L-selectin. A theory was formed that this could lead to defects in 
subsequent directed cell migration (chemotaxis) of the cells towards a chemoattractant 
source. Transwell assays are commonly used to evaluate chemotaxis of cells, and so 
the transwell chambers were used to monitor THP-1 cell migration. Migration of cells 
across porous filters as well as activated HUVEC monolayers was assessed.   
6.3 RESULTS 
6.3.1 Analysis of pseudopod behaviour during THP-1 monocyte transmigration 
across activated HUVEC under conditions of flow 
6.3.1.1 L-selectin expression promotes pseudopod formation during early phases of 
TEM 
Analysis of the time-lapse video recordings (GFP channel) of THP-1 WT L-selectin-
GFP/RFP cells perfused over TNF-α activated HUVEC showed that the protruding cells 
presented with one, two or multiple (three or more) pseudopods (figure 6.2 A). To 
assess whether the number of protruding pseudopods increased over time, the cells 
were scored half-way through the flow assay (7 minutes), and at the end of the assay 
(15 minutes). The behaviour of the pseudopods over-time is hereafter referred to as 
“pseudopod dynamics”. The scoring assessed the percentage of cells presenting with a 
certain number of pseudopods (one, two or multiple) at the given time-points. The 
percentage was calculated from the total number of cells recruited at any given time-
point (both protruding and non-protruding). The same analysis was performed on THP-
1 GFP Hi20 cells that were subjected to the same 15 minute-long parallel-plate flow 
chamber assay. This was to investigate whether differences existed in pseudopods 
formation between cells expressing fluorescently tagged L-selectin and cells expressing 
GFP protein alone. Using high GFP expressor cell line (Hi20) ensured that any possible 
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differences could be interpreted as resulting from L-selectin expression and not from any 
effects that could be caused by lentiviral gene delivery. The results presented in figure 
6.2 B show that at 7 minutes 41% of L-selectin expressing cells were protruding, 
compared to only 28% for THP-1 cells expressing GFP alone. This analysis broadly 
assessed the total number of protruding cells, irrespective of the number of pseudopods 
they had. When the total numbers of protruding cells were analysed at 15 minutes, no 
differences were seen between the cell lines. Interestingly, the number of the total 
protruding L-selectin expressors did not increase, remaining at 40%, but rather the GFP 
expressing cells reached a similar level of 42% (figure 6.2 B). Next, the number of 
pseudopods the cells were making was analysed. At 7 minutes, the percentages of cells 
having two or multiple pseudopods were significantly increased amongst L-selectin 
expressing cells compared to GFP-expressing cells (figure 6.2 C). This difference 
diminished with time as similar percentages of cells expressing L-selectin and cells 
expressing GFP presented with one, two or multiple pseudopods at 15 minutes (figure 
6.2 D). The pseudopod dynamics was found to be different between the two cell lines. 
The percentage of cells having only one pseudopod increased significantly with time in 
both of the cell lines (13% to 20% for WT L-selectin and 14% to 24% for GFP) (figure 
6.2 E and F). The percentage of cells having two pseudopods did not change much with 
time in either cell line, however, the percentage of L-selectin expressing cells that initially 
had multiple pseudopods decreased significantly with time from 12% to 7% (figure 6.2 
E and F). The fraction of GFP-expressing cells that had multiple pseudopods did not 
change over time. These results suggest that L-selectin overexpression initially renders 
THP-1 monocytes more “invasive”, which manifested in increased percentage of total 
protruding cells and a greater number of cells having more than one pseudopod. This 
effect reduced over time, which presented as a decrease in the number of cells having 
multiple pseudopods and a corresponding increase in the number of cells having a single 
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Figure 6.2 Pseudopod behaviour in THP-1 cells transmigrating across activated HUVEC.  
THP-1 cells expressing wild type L-selectin-GFP/RFP (WT) or GFP alone (GFP) were perfused 
over TNF-α activated HUVEC for 15 minutes (section 2.14.3). The video of the GFP channel was 
used to score the number of pseudopods the cells were making at two different time-points (7 and 
15 minutes). Percentages of cells with a specific number of pseudopods were calculated against 
the total number of cells (protruding and non-protruding) recruited at that given time-point.  A) 
Representative images of cells having one (i), two (ii) or multiple (iii) pseudopods. Scale bar: 10 
µm. B) Total number of protruding cells (irrespective of pseudopod number) were scored at the 7 
and 15 minutes. C) Percentage of cells with one, two or multiple pseudopods at the 7 minutes. D) 
Percentage of cells with one, two or multiple pseudopods at the 15 minutes. E) Time-dependent 
change (dynamics) in the number of THP-1 WT L-selectin-GFP/RFP cells forming one, two or 
multiple pseudopods. F) Pseudopod dynamics of THP-1 GFP Hi20 cells. The video footage was 
derived from three independent experiments. Each experiment was performed in triplicate and 
three separate fields of view were analysed for each replicate. Total 672 THP-1 GFP Hi20 and 
1368 THP-1 WT L-selectin-GFP/RFP cells were analysed. Data represent mean ± S.E.M. 
Statistical analysis: two-tailed, unpaired Student’s t-test. *=p<0.05, ***=p,0.001, ns, not 
statistically significant. 
 
6.3.1.2 Effects of SSAA L-selectin expression on THP-1 cells pseudopod dynamics 
Substitution of the cytoplasmic serines with alanines caused a delay in L-selectin 
shedding in static transmigration assays (figure 4.4), and resulted in decreased L-
selectin clustering in pseudopods of transmigrating THP-1 cells (figures 5.8 and 5.9). 
Analysis of the time-lapse footage of THP-1 SSAA L-selectin-GFP/RFP cells 
transmigrating through TNF-activated HUVEC, showed that those cells had 31% of total 
protruding cells compared to 41% of THP-1 WT L-selectin-GFP/RFP cells (figure 6.3 A). 
This was, however, not statistically significant, most probably due to the variability in the 
number of protruding cells between the experiments. Unlike with the WT L-selectin-
expressing cells (figure 6.2 E), the percentage of SSAA L-selectin-expressing 
monocytes with a given number of pseudopods did not change with time (figure 6.3 B). 
At 7 minutes, the highest number of cells with one pseudopod (16%), moderate number 
of cells with two pseudopods (10%) and low number of cells with one pseudopod (6%) 
were observed, which corresponded to 13%, 8% and 6% at 15 minutes, respectively 
(figure 6.3 B). No differences were detected in the pseudopod formation between SSAA 
L-selectin expressing cells and WT L-selectin expressing cells when the percentages of 
cells with any given pseudopod number was compared. However, a trend was seen 
where THP-1 SSAA L-selectin-GFP/RFP cells had fewer cells with multiple pseudopods 
at 7 minutes (6% versus 12% for WT L-selectin) (figure 6.3 C). Additionally lower fraction 
of SSAA L-selectin expressing cells with one pseudopod was seen at 15 minutes (13% 
versus 20% for WT L-selectin), which was just below statistical significance (p=0.052) 
(figure 6.3 D). This could be a result of a decreased trend in the number of total 
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protruding cells (figure 6.3 A). Overall, these results suggest that rendering of the 
cytoplasmic serines non-phosphorylatable does not have a significant effect on L-
selectin-dependent protrusion dynamics. However, a subtle effect can be seen, where 
SSAA L-selectin expressing cells protrude less that WT L-selectin expressing cells. 
Additionally, the pseudopods seem less dynamic – as seen by lack of time-dependant 
change in the percentages of cells having one, two or multiple pseudopods.      
 
Figure 6.3 Pseudopod dynamics of SSAA L-selectin expressing THP-1 cells.  Time-lapse 
videos of THP-1 SSAA L-selectin-GFP/RFP cells perfused over TNF- activated HUVEC were 
analysed for pseudopod formation as described in figure 6.1. Pseudopod formation was 
compared to that of THP-1 WT L-selectin-GFP/RFP cells. A) Total number of protruding cells at 
7 and 15 minutes. B) Pseudopod dynamics of THP-1 SSAA L-selectin-GFP/RFP cells. 
Percentage of cells having one, two or multiple pseudopods were compared across the two time-
points. C) Comparison of pseudopod formation between WT and SSAA L-selectin expressing 
cells at 7 minutes. D) Corresponding comparison at 15 minutes. The video footage was derived 
from three independent experiments and three separate fields of view were analysed for each 
experiment. Total 2200 THP-1 SSAA L-selectin-GFP/RFP and 1368 THP-1 WT L-selectin-
GFP/RFP cells were analysed. Data represent mean ± S.E.M. Statistical analysis: two-tailed, 
unpaired Student’s t-test. 
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6.3.1.3 Blocking L-selectin shedding promotes the formation of multiple pseudopods 
during TEM that persist over-time 
Blocking L-selectin shedding by rendering the extracellular cleavage site “sheddase-
resistant” (ΔM-N L-selectin), or by treating WT L-selectin expressing cells with Ro-31-
9790 metalloprotease inhibitor abolished L-selectin clustering in the pseudopods of 
transmigrating THP-1 monocytes (figure 5.6). It was hence of interest to investigate 
whether the lack of L-selectin clustering had any effects on THP-1 cells pseudopod 
dynamics. Time-lapse video recordings of the 15 minute-long parallel plate flow chamber 
assays were analysed as described in the sections above. At 7 minutes, the percentage 
of total protruding cells was 33% for the cells expressing ΔM-N L-selectin and 34% for 
the cells expressing WT L-selectin treated with Ro-31-9790 inhibitor, referred to as WT 
Ro-31-9790 L-selectin, which was slightly less compared to to the cells expressing WT 
L-selectin (41%) (figure 6.4 A). This disappeared with time as equal numbers of WT, 
ΔM-N and WT Ro-31-9790 L-selectin expressing cells protruded at 15 minutes (figure 
6.4 A). Strikingly, at 7 minutes not many ΔM-N L-selectin expressing cells formed one 
(7%) or two (6%) pseudopods, but a large number of cells sent multiple pseudopods 
instead (18%) (figure 6.4 B). This phenotype become more severe with time, as at 15 
minutes only 5% and 4% of cells had one and two pseudopods, respectively, whereas 
35% of the cells had multiple pseudopods (figure 6.4 B). Ro-31-9790 treated WT L-
selectin-expressing cells presented with the same pseudopod dynamics, where cells 




Figure 6.4 Pseudopod formation of cells expressing ΔM-N L-selectin or WT L-selectin 
treated with Ro-31-9790 inhibitor.  Time-lapse videos of THP-1 ΔM-N L-selectin-GFP/RFP cells 
or THP-1 WT L-selectin-GFP/RFP cells pre-treated with Ro-31-9790 metalloprotease inhibitor 
(WT + Ro-31-9790) perfused over TNF-α activated HUVEC were scored for pseudopod formation 
as described in figure 6.1. A) Total number of protruding cells at 7 and 15 minutes. The 
percentage is calculated from the total number of cells recruited to the endothelium at given time-
point (protruding and non-protruding). Total number of protruding THP-1 WT L-selectin-GFP/RFP 
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cells is shown for comparison. B) Pseudopod dynamics of THP-1 ΔM-N L-selectin-GFP/RFP 
cells. The graph shows percentage of cells with one, two or multiple pseudopods at 7 and 15 
minutes.  C) Corresponding analysis as in B, but performed on THP-1 WT L-selectin-GFP/RFP 
cells treated with Ro-3197-90. The video footage was derived from three independent 
experiments and three separate fields of view were analysed for each experiment. Total 1826 
THP-1 ΔM-N L-selectin-GFP/RFP cells, 1368 THP-1 WT L-selectin-GFP/RFP cells and 2515 
THP-1 WT L-selectin-GFP/RFP cells pre-treated with Ro-31-9790 were analysed.  Data represent 
mean ± S.E.M. Statistical analysis in A: One-way ANOVA followed by Tukey’s post-test. No 
differences were detected. Statistical analysis in B and C: two-tailed, unpaired Student’s t-test for 
each pair of the time-points. 
 
To more thoroughly analyse the effects of blocking L-selectin shedding on pseudopod 
dynamics, each cell morphotype – morphotype defined by a number of pseudopods – 
was analysed separately at both 7 and 15 minutes. The analysis included cells 
expressing WT, ΔM-N and WT Ro-31-9790 L-selectin and the cumulative data is 
presented in figure 6.5. At 7 minutes, the percentages of WT L-selectin expressing cells 
having one (figure 6.5 A) or two (figure 6.5 B) pseudopods were significantly higher 
than the corresponding percentages of ΔM-N and WT Ro-31-9790 L-selectin expressing 
cells. As for cells having multiple pseudopods, ΔM-N and WT Ro-31-9790 L-selectin 
expressing cells had slightly higher percentages than those cells as compared to WT L-
selectin-expressing cells, but no statistical significant differences were found (figure 6.5 
C). At 15 minutes a high percentage of cells with one pseudopod was found amongst 
WT L-selectin expressing cells, whereas low percentages of such cells were seen for 
both ΔM-N and WT Ro-31-9790 L-selectin expressing cells (figure 6.5 D). When cells 
with two pseudopods were scored, the highest percentage of such cells was found 
amongst WT L-selectin expressing cells and lowest amongst ΔM-N L-selectin expressing 
cells (figure 6.5 E). WT Ro-31-9790 L-selectin-expressing cells had more two-
pseudopod cells than ΔM-N L-selectin cells but less than WT L-selectin expressing cells 
(figure 6.5 E). At 15 minutes, cells sending multiple pseudopods were most abundant 
amongst ΔM-N L-selectin expressing cells, and the lowest percentage of such cells was 
found amongst WT L-selectin-expressing cells (figure 6.5 F). THP-1 monocytes 
expressing WT L-selectin that were pre-treated with Ro-31-9790 had also an increased 
percentage of cells with multiple pseudopods as compared to non-treated cells, but this 
number was not as high as that calculated for cells expressing ΔM-N L-selectin (figure 
6.5 F).      
These results show that, over-time, cells expressing WT L-selectin minimise the fraction 
of cells having multiple pseudopods and maximise the number of cells that have one 
pseudopod. Conversely, the percentage of cells with multiple pseudopods increased 
profoundly with time amongst ΔM-N L-selectin expressing cells and WT Ro-31-9790 L-
selectin cells. Overall, these data suggest that blocking L-selectin shedding promotes 
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multiple pseudopod formation during TEM of THP-1 cells. It is possible that shedding of 
L-selectin is required to retract multiple pseudopods to ultimately consolidate them in to 
a single (or fewer) pseudopod(s).  
 
Figure 6.5 Effects of blocking L-selectin shedding on THP-1 monocyte pseudopod 
behaviour.  THP-1 WT L-selectin-GFP/RFP cells pre-treated with (WT + Ro-31-9790) or without 
Ro-31-9790 metalloprotease inhibitor (WT) or THP-1 ΔM-N L-selectin-GFP/RFP cells were 
perfused over TNF-α activated HUVEC and video recordings of the microscope images were 
analysed for pseudopod formation as described in figure 6.1. Pseudopod formation at 7 minutes 
(A-C) and 15 minutes (D-F) was analysed. Comparison of the number of cells having one 
pseudopod is shown in A and D, two pseudopods in B and E, and multiple pseudopods in C and 
F. The video footage was derived from three independent experiments and three separate fields 
of view were analysed for each experiment. Total 1826 THP-1 ΔM-N L-selectin-GFP/RFP cells, 
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treated with Ro-31-9790 were analysed. Data represent mean ± S.E.M. Statistical analysis: One-
way ANOVA followed by Tukey’s post-test for each graph. *=p<0.05, **=p<0.01, ***=p<0.001. 
 
6.3.1.4 Monitoring the effect of Ro-31-9790 treatment on pseudopod formation by THP-
1 cells expressing GFP alone 
THP-1 monocytes expressing ΔM-N L-selectin and WT Ro-31-9790 L-selectin presented 
with the same pseudopod dynamics. This suggests that WT Ro-31-9790 L-selectin cells 
formed multiple pseudopods as a result of lack of L-selectin shedding. However, Ro-31-
9790 is a broad spectrum metalloprotease inhibitor, and thus it could not be formally 
excluded that blocking of other molecules present on the surface of THP-1 monocytes 
contributed to the observed effect. For example, cleavage of integrins is also known to 
occur during monocyte TEM, which can be blocked by pre-incubation of cells with broad-
spectrum metalloprotease inhibitors [669], such as Ro-31-9790. To investigate whether 
Ro-31-9790 treatment affected pseudopod formation in the absence of L-selectin, THP-
1 GFP Hi20 cells were pre-treaded with Ro-31-9790 and subjected to the 15 minute-long 
parallel plate flow chamber assay. Pseudopods were scored as described above and 
compared to the corresponding values obtained earlier for THP-1 GFP Hi20 cells. Figure 
6.6 shows that no effect of Ro-31-9790 treatment was found on THP-1 cells that were 
expressing just GFP protein. Ro-31-9790 treated and non-treated cells had the same 
number of total protruding cells at 7 minutes (30±2%), and in both cases this number 
increased with time to 42.5±0.5% (figure 6.6 A). Both types of cells presented with the 
same percentage of cells having one, two or multiple pseudopods at both 7 minutes and 
at 15 minutes (figure 6.6 B). This data shows that formation of multiple pseudopods by 
THP-1 WT L-selectin-GFP/RFP cells pre-treated with Ro-31-9790 metalloprotease 




Figure 6.6 Pseudopod formation of THP-1 GFP Hi20 cells pre-treated with Ro-31-9790.  
Time-lapse movies of Ro-31-9790 treated THP-1 GFP Hi20 cells (GFP + Ro-31-9790) perfused 
over TNF-α activated HUVEC were analysed for pseudopod formation as described in figure 6.1. 
Obtained percentages were compared to the corresponding ones calculated earlier for THP-1 
GFP Hi20 cells that were perfused without inhibitor. A) Total number of protruding cells at 7 and 
15 minutes. B) Percentage of cells with one, two or multiple pseudopods at 7 minutes (left panel) 
and 15 minutes (right panel). The video footage was derived from three independent experiments 
and three separate fields of view were analysed for each experiment. Total 672 THP-1 GFP Hi20 
and 830 THP-1 GFP Hi20 cells pre-treated with Ro-31-9790 were analysed. Data represent mean 
± S.E.M. Statistical analysis: two-tailed, unpaired Student’s t-test detected no differences. 
  
6.3.1.5 Effects of ΔM-N SSAA L-selectin expression on THP-1 monocyte pseudopod 
dynamics      
Rendering cytoplasmic serines of ΔM-N L-selectin non-phosphorylatable (ΔM-N SSAA 
L-selectin), promoted L-selectin clustering in the pseudopods of transmigrating THP-1, 










































































































































































































































videos was now performed to investigate whether introducing the SSAA mutation in to 
ΔM-N L-selectin altered pseudopod dynamics. Interestingly, at 7 minutes, THP-1 
monocytes expressing ΔM-N SSAA L-selectin had a similar percentage of total 
protruding cells to that of cells expressing WT L-selectin (43% and 41%, respectively), 
which was slightly higher but not statistically significant than that of cells expressing ΔM-
N L-selectin (33%) (figure 6.7 A). This slight difference was no longer seen at 15 
minutes, where all cell lines had 42.5±2.5% of total protruding cells (figure 6.7 A). At 7 
minutes, amongst the cells expressing ΔM-N SSAA L-selectin, high percentages of cells 
with one pseudopod (16%) and multiple pseudopods (19%) were seen, and a relatively 
low number of cells having two pseudopods was present (8%) (figure 6.7 B). This did 
not change much with time, as the calculated percentages were 19%, 10% and 16% for 
cells having one, two or multiple pseudopods, respectively (figure 6.7 B).   
 
Figure 6.7 Pseudopod formation by THP-1 cells expressing ΔM-N SSAA L-selectin.  Time-
lapse videos of THP-1 ΔM-N SSAA L-selectin-GFP/RFP cells perfused over TNF-α activated 
HUVEC were analysed for pseudopod formation as described in figure 6.1. A) Total number of 
protruding cells at 7 and 15 minutes. Total numbers of protruding cells expressing WT L-selectin 
or ΔM-N L-selectin are shown for comparison. B) Pseudopod dynamics of THP-1 ΔM-N SSAA L-
selectin-GFP/RFP cells. The video footage was derived from three independent experiments and 
three separate fields of view were analysed for each experiment. Total 1826 THP-1 ΔM-N L-
selectin-GFP/RFP cells, 1368 THP-1 WT L-selectin-GFP/RFP cells and 1422 THP-1 ΔM-N SSAA 
L-selectin-GFP/RFP cells were analysed. Data represent mean ± S.E.M. Statistical analysis in A: 
One-way ANOVA followed by Tukey’s post-test. No differences were detected. Statistical analysis 
in B and C: two-tailed, unpaired Student’s t-test for each pair of time-points. No differences were 
detected. 
 
Cells expressing ΔM-N SSAA L-selectin had a relatively high percentage of cells with 
one pseudopod, but also relatively high percentage of cells with multiple pseudopods. 
This suggested that this cell line had pseudopod dynamics that was intermediate 
between those displayed by THP-1 WT L-selectin-GFP/RFP (figure 6.1) and THP-1 ΔM-
N L-selectin-GFP/RFP cells (figure 6.3). To verify this hypothesis, the percentage of 
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cells having one, two or multiple pseudopods were analysed separately at each time-
point. Analysis included cells expressing WT L-selectin, and cells expressing ΔM-N L-
selectin. At 7 minutes there were more cells with one pseudopod amongst cells 
expressing ΔM-N SSAA or WT L-selectin as compared to the cells expressing ΔM-N L-
selectin (figure 6.8 A). Surprisingly, the percentage of cells having two pseudopods was 
similar between cells expressing ΔM-N SSAA (8%) and ΔM-N L-selectin (6%), and this 
was lower than the corresponding percentage calculated for cells expressing WT L-
selectin (15%) (figure 6.8 B). Similar percentage of cells with multiple pseudopods was 
seen amongst all the cell lines at 7 minutes, however cells expressing “sheddase-
resistant” (ΔM-N or ΔM-N SSAA) L-selectin forms had a slightly higher fraction of those 
cells than cells expressing WT L-selectin (18% for ΔM-N, 16% for ΔM-N SSAA and 13% 
for WT L-selectin)  (figure 6.8 C). At 15 minutes, cells expressing ΔM-N SSAA L-selectin 
or WT L-selectin a had much higher proportion of cells with one pseudopod than the cells 
expressing ΔM-N L-selectin (figure 6.8 D). The same was true when cells having two 
pseudopods were analysed (figure 6.8 E). When cells with multiple pseudopods were 
scored, the highest percentage of such cells was found amongst ΔM-N expressing cells, 
and the lowest amongst WT L-selectin expressing cells (figure 6.8 F). Percentage of 
multiple pseudopod-cells amongst cells expressing ΔM-N SSAA L-selectin was higher 
than those amongst WT L-selectin expressing cells but lower than those amongst ΔM-N 
L-selectin expressing cells (figure 6.8 F). These results suggest that rendering 
cytoplasmic serines of ΔM-N L-selectin non-phosphorylatable has a profound effect on 
the number of pseudopods THP-1 cells make during early TEM. The typical multiple 
pseudopod phenotype caused by ΔM-N L-selectin is no longer seen. THP-1 cells 
expressing ΔM-N SSAA L-selectin do have higher fraction of cells with multiple 
pseudopods than the cells expressing WT L-selectin. However, they also have a similar 
number of cells presenting a single pseudopod as cells expressing WT L-selectin. This 
suggests that rendering cytoplasmic serines of ΔM-N L-selectin non-phosphorylatable 
can partially revert the ΔM-N phenotype towards something that resembles a WT 




Figure 6.8 Effects of ΔM-N SSAA L-selectin expression on THP-1 monocyte pseudopod 
dynamics.  THP-1 ΔM-N SAA L-selectin-GFP/RFP cells were perfused over TNF-α activated 
HUVEC and video recordings of the microscope images were analysed for pseudopod formation 
as described in figure 6.1. Calculated values were compared for corresponding ones acquired 
earlier for cells expressing WT L-selectin and cells expressing ΔM-N L-selectin. Pseudopod 
formation at 7 minutes (A-C) and 15 minutes (D-F) is shown. Comparison of number of cells 
having one pseudopod is shown in A and D, two pseudopods in B and E, and multiple 
pseudopods in C and F. The video footage was derived from three independent experiments and 
three separate fields of view were analysed for each experiment. Total 1826 THP-1 ΔM-N L-
selectin-GFP/RFP cells, 1368 THP-1 WT L-selectin-GFP/RFP cells and 1422 THP-1 ΔM-N SSAA 
L-selectin-GFP/RFP cells were analysed. Data represent mean ± S.E.M. Statistical analysis: One-
way ANOVA followed by Tukey’s post-test for each graph. *=p<0.05, **=p<0.01, ***=p<0.001. 
 





















































































































































































6.3.2 Analysis of cell spreading during THP-1 transmigration across activated 
HUVEC under conditions of flow 
Time-lapse video recordings analysed in section 6.3.1 for pseudopod formation, were 
also used to determine the cell spreading area of transmigrating THP-1 monocytes. Still 
images of 7 minutes and then 15 minutes of perfusion were loaded in to ImageJ software 
and cell spreading area was measured as described in section 2.15. As shown in figure 
6.9 A, expression of L-selectin did not influence the cell spreading area as compared to 
overexpression of GFP only. However, cells expressing SSAA L-selectin had a smaller 
spread area than the cells expressing WT L-selectin, which was consistent at both time-
points (figure 6.9 B). This suggested that the SSAA mutation limited cell spreading, but 
whether this was a direct or an indirect effect of L-selectin was not determined.  Blocking 
L-selectin shedding increased THP-1 cell spreading area as compared to WT L-selectin 
expressing cells (figure 6.9 C). A larger spread area was seen in cells expressing ΔM-
N L-selectin at both early (7 minutes) and late (15 minutes) time-points, whereas 
treatment of WT L-selectin expressing cells with Ro-31-9790 resulted in increased cell 
spreading area only at 15 minutes (figure 6.9 C). The increased spread area promoted 
by Ro-31-9790 treatment appeared to be because of a direct effect on blocking L-selectin 
shedding, as no effect on cell spreading was seen when THP-1 GFP Hi20 cells were 
pre-incubated with this inhibitor (figure 6.9 D). Interestingly, when serine residues within 
ΔM-N L-selectin tail were rendered non-phosphorylatable, the cells decreased their 
spreading area to that seen with WT L-selectin expressing cells (figure 6.9 E). These 
results suggested that blocking L-selectin shedding prompted the cells to increase their 
spread area, whilst substituting the cytoplasmic serine residues with non-
phosphorylatable alanines had an opposite effect. The fact that there is a small spreading 
area (figure 6.9 B) as well as decreased shedding in the SSAA L-selectin expressing 
cells (figures 4.3 and 4.4) suggests that the serine residues might play a dominant role 




Figure 6.9 Measuring the cell spreading area of THP-1 monocytes at early and late phases 
of TEM.  Cell spreading areas of THP-1 cells perfused over TNF-α activated HUVEC were 
analysed as described in section 2.15. Analysis was performed at early time-point (7 minutes) 
and late time-point (15 minutes). Following THP-1 cells were analysed: WT L-selectin-GFP/RFP 
expressors pre-treated with or without Ro-319790 metalloprotease inhibitor; GFP Hi20 
expressors pre-treated with or without Ro-319790 metalloprotease inhibitor; SSAA L-selectin-
GFP/RFP expressors, ΔM-N L-selectin-GFP/RFP expressors, ΔM-N SSAA L-selectin-GFP/RFP 
expressors. A) Comparison of cell spreading areas between GFP expressors and WT L-selectin 
expressors. B) The influence of SSAA mutation on the cell spreading area of L-selectin 
expressing cells. C) Effect of blocking L-selectin shedding on cell spreading area. Blocking of L-
selectin shedding was analysed by using “sheddase resistant” (ΔM-N) L-selectin or by treating 
Cell area










































































































































































































































WT L-selectin expressing cells with Ro-31-9790 metalloprotease inhibitor. D) The effect of Ro-
31-9790 metalloprotease inhibitor on spreading area of GFP expressing cells. E) Comparison of 
cell spreading areas between cells expressing WT, ΔM-N and ΔM-N SSAA L-selectin. At least 
270 cells per time-point were analysed for each cell line/condition. Analysed cells were derived 
from three independent experiments. Data represent mean ± S.E.M. Statistical analysis: Two-
way ANOVA followed by Bonferroni post-test. *=p<0.05, **=p<0.01. 
 
6.3.3 THP-1 monocytes expressing GFP, WT L-selectin-GFP or ΔM-N L-selectin-
GFP have comparable levels of RhoGTPase activity when in suspension culture 
The canonical Rho family of small GTPases; RhoA, Rac1 and Cdc42 play a critical role 
in driving leukocyte polarity and motility during various stages of the leukocyte adhesion 
cascade (section 1.5) [118, 234, 237, 238, 240, 241]. The results presented in the 
sections above show that during early phases of TEM, THP-1 monocytes expressing WT 
L-selectin and those expressing ΔM-N L-selectin present with strikingly different 
phenotypes. Whilst cells expressing WT L-selectin tend to polarise with time, as seen by 
majority of cells projecting one or two pseudopods at 15 minutes, ΔM-N L-selectin 
expressing cells project multiple pseudopods that do not retract with time (figures 6.2 
and 6.4 and 6.5). The difference between the two cell lines is further demonstrated by 
an enlarged spread area promoted by ΔM-N L-selectin (figure 6.9 C). These results 
would strongly suggest that the activity of RhoGTPases – the main drivers of cell shape 
change – could be different between the two cell lines. It was possible that expression of 
ΔM-N L-selectin altered the basal activity of Rho GTPases, which could explain, in part, 
the pseudopod retraction defect. To test this hypothesis the activity of RhoA, Rac1 and 
Cdc42 was monitored in resting THP-1 WT L-selectin-GFP Hi20 and THP-1 ΔM-N L-
selectin Lo5 cells using classic pull-down assays. It is noteworthy to mention that all cell 
lines had matched L-selectin expression levels (figure 4.10). To control for the L-
selectin-expressing cell lines, RhoA, Rac1 and Cdc42 activity was monitored in THP-1 
GFP Hi20 cells. This was particularly important as analysis of pseudopod dynamics 
during parallel plate flow chamber assays showed that cells expressing WT L-selectin 
were more “invasive” than cells expressing GFP protein during the first half of the assay 
(7 minutes) (figure 6.1). To analyse the activity of RhoGTPases in resting THP-1 cells, 
glutathione-S-transferase (GST)-fusion GTPase bait proteins were conjugated to 
glutathione sepharose beads, and beads were used in pull-down assays. The bait 
proteins used were of Rho GTPase effector domains and were kindly provided by John 
G. Collard (Netherlands Cancer Institute, Amsterdam, the Netherlands). The following 
bait proteins were used: for RhoA – the Rho-binding domain of Rhotekin (Rhotekin-C21), 
for Rac1 – p21-binding domain of PAK (PAK-PBD) and for Cdc42 – the Cdc42/Rac 
interacting domain (cassette) of the Wiskott-Aldrich syndrome protein (WASP-CRIB-C). 
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The detailed methods of GST-fusion proteins purification and Rho GTPase activation 
assays are described in sections 2.9 and 2.10 of this thesis. As shown in figure 6.10, 
no differences in RhoGTPase activity were found between the tested cell lines. This 
suggested that changes seen in THP-1 monocyte morphology during TEM were not pre-
disposed by altered basal Rho GTPase activity. It was hypothesised that Rho GTPases 
in GFP, WT L-selectin or ΔM-N L-selectin expressing cells could become regulated 
differently upon monocyte activation during parallel plate flow chamber assays.   
   
    
Figure 6.10 Monitoring Rho GTPase activity in THP-1 cells expressing GFP, WT L-selectin-















































































WT L-selectin-GFP or ΔM-N L-selectin-GFP was assessed by the pull down assays using the 
Rhotekin-C21 binding domain for RhoA, the PAK-PBD binding domain for Rac1 or the WASP-
CRIB-C binding domain for Cdc42. The method is described in detail in section 2.10. 
Representative Western blots of RhoA (A), Rac1 (B) and Cdc42 (C) are shown. In each panel, 
the diagrams on the right illustrate the corresponding densitometric analysis of the relative 
activities of RhoA, Rac1, and Cdc42. This is shown as a ratio of GTP-bound GTPase (active) to 
total Rho GTPase protein. Total RhoGTPase levels were normalised against actin. Densitometric 
analysis was performed on Western blottings from three independent experiments. Data 
represent mean ± standard error. One-way ANOVA did not detect any differences in Rho GTPAse 
activity between the cell lines.  
 
6.3.4 Generation of THP-1 cell lines expressing Rho GTPase biosensors 
The Rho GTPase biosensors (figure 6.1) are used to monitor the spatio-temporal activity 
of Rho GTPases in living cells (section 6.2). It was hoped that utilizing such biosensors 
would allow insights in to Rho GTPase activity in THP-1 monocytes undergoing TEM. 
Lentiviral vectors (pLenti CMV Puro DEST (w118-1)) carrying CFP/YFP-based RhoA, 
Rac1 and Cdc42 biosensor constructs were kindly provided by Oliver Pertz (Universty of 
Basel, Switzerland). The vectors were used to produce lentiviral particles as described 
in section 2.11. The titres of generated lentiviruses are presented in table 2.5 of this 
thesis. Moderate MOI of 7 was used to transduce THP-1 cells with lentiviruses carrying 
RhoA, Rac1 or Cdc42 biosensors, yielding polyclonal cell lines, named THP-1 RhoA, 
THP-1 Rac1 or THP-1 Cdc42, respectively. These cell lines were left in culture or were 
further used for transduction with lentiviruses carrying WT L-selectin-RFP or ΔM-N L-
selectin-RFP described in sections 5.3.1 and 5.3.4, respectively. MOI of 20 was used 
for lentiviruses carrying WT L-selectin-RFP and MOI of 5 for lentiviruses carrying ΔM-N 
L-selectin-RFP. These MOIs were previously found to produce matching L-selectin 
levels between the two cell lines (section 4.10).  The method of THP-1 cell transduction 
is described in section 2.11.4. In total, nine polyclonal cell lines were generated. The 
cell lines are outlined in table 6.1. 
CFP/YFP 
Rho GTPase biosensor 
L-selectin-RFP Cell line name 
RhoA - THP-1 RhoA 
RhoA WT THP-1 WT L-selectin-RFP RhoA 
RhoA ΔM-N THP-1 ΔM-N L-selectin-RFP RhoA 
Rac1 - THP-1 Rac1 
Rac1 WT THP-1 WT L-selectin-RFP Rac1 
Rac1 ΔM-N THP-1 ΔM-N L-selectin-RFP Rac1 
Cdc42 - THP-1 Cdc42 
Cdc42 WT THP-1 WT L-selectin-RFP Cdc42 
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Cdc42 ΔM-N THP-1 ΔM-N L-selectin-RFP Cdc42 
Table 6.1 Polyclonal THP-1 cell lines expressing Rho GTPase Raichu probes. THP-1 cells 
were transduced with lentiviruses carrying RhoA, Rac1 or Cdc42 CFP/YFP biosensors. Those 
cell lines were further infected with lentiviruses carrying WT L-selectin-RFP or ΔM-N L-selectin-
RFP. Overall, nine different cell lines were generated and are displayed in this table.  
 
Once generated, the cell lines were analysed by fluorescence microscopy for YFP and 
RFP expression that were indicative of Rho GTPase biosensor and L-selectin 
expression, respectively. All cell lines showed uniform YFP distribution and peripheral 
RFP localisation. This suggested the transgenes were expressed correctly as Rho 
GTPases display general diffuse distribution pattern [716], and L-selectin localises to the 
plasma membrane. Varied expression levels of L-selectin and Rho GTPase biosensors 
were readily observed, which was expected for a polyclonal stable cell lines. 
Representative images of THP-1 WT L-selectin-RFP RhoA cells are shown in figure 
6.11 A. Unfortunately, preliminary parallel-plate flow chamber experiments showed that 
none of the nine cell lines had undergone TEM across activated HUVEC during the 15 
minute period of parallel plate flow chamber assay (data not shown). In other words, the 
adhered cells did not extend pseudopods that were seen to protrude underneath the 
HUVEC. Occasionally, very small pseudopods were formed, that were extending on top 
of the endothelium (as seen by phase-bright appearance). Lentiviruses carrying 
pHR´SIN-SEW-GFP/RFP constructs had been used successfully to deliver transgenes 
throughout this thesis. It was hence hypothesised that it was the pLenti CMV Puro DEST 
(w118-1) construct that had adverse effects, seen as loss of THP-1 transmigratory 
capacity. Alternatively, it was possible that simultaneous expression of the Rho GTPase 
biosensors and the RFP-tagged L-selectin resulted in an overall negative effect on THP-
1 cell behaviour. It is possible that expression of three fluorescent proteins (CFP, YFP 
and RFP) at once was stressful to THP-1 cell function. An attempt was made to select 
for low Rho GTPase biosensor expressors amongst the cell lines, in the hope that the 
low expressors would not be affected by such adverse effects. All nine cell lines were 
subjected to FACS sorting in order to eliminate cells with high Rho GTPase biosensor 
expression. On this occasion, L-selectin expression between cells expressing WT L-
selectin-RFP and cells expressing ΔM-N L-selectin-RFP was monitored to ensure 
continued matched expression. Untransduced THP-1 cells and cells expressing L-
selectin-RFP were used as control populations on which both the YFP and RFP gates 
were set. Representative histograms in figure 6.11 B show THP-1 RhoA cell line pre- 
and post-sorting. The same levels of Rho GTPase biosensor expression was achieved 




Figure 6.11 Expression of Rho GTPase biosensors and L-selectin-RFP in THP-1 
monocytes.  A) Representative images of THP-1 L-selectin-RFP RhoA cells. YFP image shows 
diffuse distribution of RhoA biosensor. The RFP channel shows L-selectin-RFP that localises to 
the plasma membrane (arrows). Scale bar: 10 µm. B) Flow cytometry profiles of unsorted (left 
histogram) and sorted low RhoA biosensor expressors (right histogram) THP-1 RhoA cells. 
Similar histograms exist for THP-1 Rac1, Cdc42, WT L-selectin-RFP RhoA, WT L-selectin-RFP 
Rac1, WT L-selectin-RFP Cdc42, ΔM-N L-selectin-RFP RhoA, ΔM-N L-selectin-RFP Rac1 and 
ΔM-N L-selectin-RFP Cdc42 cells. 
 
Sorted cell lines were subjected to the parallel plate flow chamber assays in the hope 
that the reduced Rho GTPase expression would allow the THP-1 monocytes to form 
pseudopods. Unfortunately, no transmigrating cells were seen after 15 minutes of flow 
in any of the nine sorted cell lines. It was postulated that the cells might be delayed in 
their transmigration ability and so the experiments were repeated where flow was applied 
for 30 minutes. As shown on the representative still images of sorted THP-1 RhoA, THP-
1 WT L-selectin-RFP RhoA or THP-1 ΔM-N L-selectin-RFP RhoA cells, no cells were 
seen undergoing TEM after 30 minutes of flow (figure 6.12 A-C). Again small protrusions 
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stars). Figure 6.12 D shows typical appearance of transmigrating THP-1 cells, where 
large pseudopods can be seen for comparison. This was also true for sorted cell lines 
expressing Rac1 or Cdc42 biosensors. These results show that, unfortunately, the stable 
cell lines were not suitable for investigating of RhoGTPase activity in THP-1 cells 
undergoing TEM. 
 
Figure 6.12 Transmigration defect in THP-1 cells expressing RhoGTPase biosensors.  
Sorted populations of THP-1 RhoA (A) THP-1 WT L-selectin-RFP Rho A (B) or THP-1 ΔM-N L-
selectin-RFP RhoA (C) cells were perfused over TNF-α activated HUVEC for 30 minutes. Time-
lapse footage of the YFP channel and phase contrast was used to generate still images 
corresponding to 15 and 30 minutes of flow. All the cells bound to the endothelial monolayer but 
no protruding pseudopods were formed. Very small pseudopods could be seen forming, but none 
were actually protruding beneath the endothelial monolayer (red stars). Corresponding footage 
exists for the sorted cell lines expressing Rac1 or Cdc42 biosensors, where also no transmigrating 
cells can be seen. D) Transmigrating THP-1 WT L-selectin-GFP Hi20 cells are shown for 
comparison. Prominent pseudopods can be seen extending from the cell bodies. Scale bar: 































6.3.5 Monitoring Rho GTPase activity in THP-1 cells following antibody-mediated 
cross-linking of L-selectin 
As described above, the THP-1 cell lines could not be used to monitor the spatio-
temporal distribution of Rho GTPase activity as the cells failed to undergo TEM. As a 
final attempt, the Rho GTPase activity in cells expressing WT and ΔM-N L-selectin could 
be monitored following cross-linking of L-selectin with monoclonal antibody. If signalling 
downstream of the L-selectin tail regulates Rho GTPases differently between WT and 
ΔM-N L-selectin, this was likely to be seen upon cross-linking. Previous FRET/FLIM 
experiments have clearly shown that L-selectin is monomeric in the plasma membrane 
and can be clustered following cross-linking with the DREG56 monoclonal antibody 
(figure 5.13).L-selectin null cells were left untreated (incubation with media alone) and 
L-selectin on THP-1 cells expressing WT or ΔM-N L-selectin-RFP and RhoA, Rac1 or 
Cdc42 biosensors were labelled with DREG56 antibody and then cross-linked with 
secondary antibody. Alternatively the cells were incubated with just media. The cells 
were subsequently plated on to poly-L-lysine (PLL) coated coverslips, fixed and prepared 
for FRET/FLIM analysis. A detailed description of the assay can be found in section 2.19 
of this thesis. The basal levels of RhoA activity (no antibodies used) seemed comparable 
between the cells, although cells expressing WT L-selectin had slightly more active RhoA 
than the other two cell lines (figure 6.13 A Upper panel and B). Interestingly, a decrease 
in RhoA biosensor FRET efficiency could be seen following WT but not ΔM-N L-selectin 
cross-linking (figure 6.13 B). The basal activity of Rac1 appeared lowest in THP-1 cells 
lacking L-selectin, moderate in THP-1 cells expressing WT L-selectin and highest in cells 
expressing ΔM-N L-selectin (figure 6.13 A Middle panel and B). The same pattern was 
seen in basal Cdc42 activity (figure 6.13 A Lower panel and B). Notably, whilst L-selectin 
cross-linking did not alter Cdc42 activity, decreased Rac1 biosensor FRET efficiency 
was seen upon clustering of ΔM-N but not WT L-selectin (figure 6.13 B). Due to the time 
constraints of this PhD project, the experiment was performed only once. This however 
can serve as a foundation for future investigations of the RhoGTPase activity in L-
selectin expressing cells in our laboratory. At this point however, it has to be appreciated 
that the Rho GTPase biosensor expressing cell lines used in this study were shown to 
fail to extend pseudopods underneath the HUVEC under flow (figure 6.12). To what 
extent the cells were compromised is unknown, and hence the relevance of the results 
obtained in the cross-linking experiments is questionable. It is interesting though that 
previous work in the Ivetic laboratory showed that cross-linking of WT L-selectin on 
300.19 pre-B cells had no effect on Rac1 activity, but led to the downregulation of RhoA 
activity, as measured by active RhoA pull-down assays (Marouan Zarrouk, unpublished 
data). This would suggest that the decreased FRET of RhoA biosensor and no change 
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in FRET of Rac1 biosensor seen upon WT L-selectin cross-linking could be a meaningful 
result, as the Rho GTPase activation pattern followed that seen previously in the pull-
down assays. Perhaps, despite their transmigration defect, the generated cell lines are 
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Figure 6.13 L-selectin-dependent signalling to Rho GTPases in THP-1 cells.  THP-1 cells 
expressing WT or ΔM-N L-selectin-RFP and/or RhoA, Rac1 or Cdc42 biosensors were labelled 
with DREG56 antibody (D56) and cross-liked with secondary antibody. Alternatively, the cells 
were incubated with just media (No. X-link.). For assay details see section 2.19. Cells were plated 
on PLL for 5 minutes before fixation and then prepared for FLIM/FRET analysis as described in 
section 2.18.1. A) The panels show YFP images corresponding to the Rho GTPase biosensors 
(left columns), multiphoton FLIM images of the FRET between CFP and YFP in the Rho GTPase 
biosensor (middle columns) and RFP images corresponding to L-selectin (right columns). 
Additionally Alexa633 images of DREG56 antibody staining are shown where relevant. Pseudo-
colour scale of blue (high lifetime,) to red (low lifetime,) is used to show lifetime fluorescence. 
High lifetime indicates no FRET and non-active Rho GTPase biosensors. Low lifetime indicates 
FRET and the active biosensors. Upper panel: Activity of RhoA, Middle panel: activity of Rac1, 
Lower panel: activity of Cdc42. B) Quantified data showing FRET efficiency between CFP and 
YFP. Average 5 cells were analysed for each condition and the cells were derived from one 
experiment only.   
 
6.3.6 Analysis of THP-1 cell chemotaxis 
L-selectin null leukocytes as well as leukocytes expressing “sheddase-resistant” L-
selectin have been shown to have impaired chemotaxis in vivo [398, 419]. The data 
presented in section 6.3.1 of this chapter show that, during TEM, cells expressing WT 
L-selectin promote a reduction in pseudopods over-time, whereas cells expressing ΔM-
N L-selectin seemed to sustain a multi-pseudopod phenotype (figures 6.2, 6.4 and 6.5). 
It was hence hypothesised that this multi-pseudopod phenotype could result in defective 
chemotaxis. To investigate chemotaxis of L-selectin expressing cells versus L-selectin 
null cells, untransduced THP-1 cells and THP-1 GFP Hi20 cells were chosen. By 
comparing GFP-expressing cells and untransduced cells, one could assess the effect of 
lentiviral transduction and ectopic protein expression on THP-1 cell directed migration. 
Transwell assays are used commonly for studying chemotaxis. Transwell chambers are 
composed of upper and lower compartments that are separated by a porous filter. 
Chemoattractant is added to a lower compartment and the cells are placed in the upper 
compartment, from where they migrate towards the chemotactic source. Monocyte 
chemoattractant protein-1 (MCP-1) is a potent chemotaxis mediator of mononuclear 
cells, capable of causing migration of THP-1 cells in transwell assays [717, 718]. MCP-
1 binds to the C-C chemokine receptor type 2 (CCR2) on the surface of the leukocytes. 
Before transwell assays were perforemed, it was first analysed whether ectopic 
expression of WT or ΔM-N L-selectin had any effects on CCR2 receptor levels. As shown 





Figure 6.14 CCR2 expression on THP-1 cells.  Expression of CCR2 on untransduced THP-1 
cells (UT), THP-1 GFP Hi20 (GFP), THP-1 WT L-selectin-GFP Hi20 (WT L-selectin) and THP-1 
ΔM-N L-selectin Lo5 (ΔM-N L-selectin) cells was monitored by flow cytometry as described in 
section 2.13. Representative histograms are shown. A) Dot plot showing the population of single 
and viable cells that were analysed (gate is shown with the blue line). B) Histogram showing 
CCR2 expression on tested THP-1 cells. 
 
Before transmigration of the cells towards the MCP-1 could be assessed, a technique 
called “checkboard analysis” was used to prove that cell migration is a result of 
chemotaxis and not chemokinesis. Unlike directional chemotaxis, chemokinesis is a 
random, non-directional movement of cells that results from the presence of a stimulant 
in the surrounding environment. Checkboard analysis was performed by adding MCP-1 
(50 ng/mL) to either the bottom compartment, or to both the top and the bottom 
compartments. The first creates a gradient of MCP-1, whereas the second generates 
uniform MCP-1 distribution and hence tests for chemokinesis. For a detailed description 
of the transwell assays see section 2.20.  Checkerboard analysis revealed that THP-1 
cell migration depended on the presence of a MCP-1 gradient across the filter, 
suggesting MCP-1 induced chemotaxis and not chemokinesis (figure 6.15 A). However, 
no differences in the transmigration across the filter was seen between the tested cell 
lines (figure 6.15 A). This suggested that transduction of THP-1 cells with lentiviral 
particles does not influence directed cell migration of those cells. This has also 
suggested that overexpression of L-selectin does not influence THP-1 chemotaxis 
across the filter up the MCP-1 gradient. Furthermore, shedding of L-selectin did not play 
a role in this process either as the same percentage of cells expressing ΔM-N L-selectin 
and cells expressing WT L-selectin had transmigrated. This was rather surprising as 
impaired polarisation of ΔM-N L-selectin expressing cells during TEM (section 6.3.1.3) 
implied that chemotaxis of those cells could be affected. However, a single time point 
was analysed in these studies and it cannot be excluded that any differences in 
transmigration could have been overlooked. Preliminary experiments where 100 or 200 















(data not shown) suggesting that no differences in chemotaxis were likely to occur using 
a higher MCP-1 concentration. However, it could be argued that migration across the 
“naked” filter of the transwell chamber was not representative of transmigration of 
leukocytes crossing an activated endothelial monolayer. The work outlined in this thesis 
so far would postulated that it is the interaction of the THP-1 monocytes with the activated 
HUVECs that triggered L-selectin-dependent pseudopod formation. If this was the case, 
differences in chemotaxis across the activated HUVEC monolayer could be seen 
between WT and ΔM-N L-selectin expressing cells. To test this hypothesis confluent 
HUVEC monolayers were grown on top of the fibronectin-coated transwell filters and 
were activated with TNF-α. Transmigration of untransduced THP-1 cells and cells 
expressing GFP, WT L-selectin-GFP or ΔM-N L-selectin-GFP was analysed. As shown 
in figure 6.15 B, again no differences in the number of transmigrated cells were seen. 
This was unexpected but a possible explanation of this result could be proposed. First of 
all, it was possible that differences could be seen at other time-points that were not tested 
in this study. Secondly, following the rationale that transmigration across the naked filter 
does not resemble TEM across HUVEC, emigrated leukocytes in the lower compartment 
of the transwell assay would not be representative of leukocytes emigrating into the 
interstitial space in vivo. In the transwell chamber, transmigrated leukocytes simply “free 
fall” in the medium of the lower compartment, whereas in vivo they found themselves in 
the thick 3D ECM matrix, which they have to move through to reach the chemoattractant 
source. Therefore, polarity would not play any role in case of the cells that had 
transmigrated into the media, but would be crucial for the cells that emigrated into the 
thick and complex ECM. It is therefore possible that differences could be seen in the 
directed cell migration of GFP, WT and ΔM-N L-selectin expressing cells under different 
experimental conditions. Generation of collagen/matrigel composites is currently being 
optimised in the Ivetic laboratory. Those composites mimic ECM environment and could 
be used to develop more suited chemotaxis assays. For example, an interesting assay 
for studying THP-1 directed cell migration was reported by Cain et al. (2010) [719].  In 
brief, collagen gels were polymerized in transwell filters and HUVEC were grown on top 
of the gels. MCP-1 was added to the lower compartment and THP-1 cells were added 
on top of the activated HUVEC monolayer [719]. After indicated amounts of time the 
samples were fixed and processed by confocal microscopy [719]. Acquired z-stacks 
showed leukocytes migrating in the thick collagen block before reaching the pores of the 
filter and the lower transwell compartment [719].   




Figure 6.15 Chemotaxis of THP-1 cells towards MCP-1.  Untransduced THP-1 cells (UT) and 
cells expressing GFP (GFP), WT L-selectin-GFP (WT) or ΔM-N L-selectin-GFP (ΔM-N) were 
subjected to the transwell assays. All cells were added to the upper compartment. At the end of 
the assay (2 hours and 15 minutes), the transmigrated cells in the bottom compartment were 
collected and the percentage of transmigrated cells was calculated against the input number as 
described in section 2.20. A) Checkboard analysis of THP-1 migration. No MCP-1 was added to 
neither of the compartments in the control experiments (no MCP-1). For analysis of chemokinesis 
MCP-1 (50 ng/mL) was added to both upper and lower compartments (no gradient). For 
chemotaxis analysis MCP-1 was added to the bottom compartment only (gradient).  B) 
Chemotaxis of THP-1 cells across TNF-α activated HUVEC monolayer and towards 50 ng/mL 
MCP-1. Experiments were repeated in triplicates on three independent occasions. Data represent 
mean ± S.E.M. Statistical analysis in A: One-way ANOVA followed by Dunnett’s post-test against 
“No MCP-1” for each cell line and One-way ANOVA followed by Tukey’s post-test for “MCP-1 
gradient” across all cell lines (no difference detected) *=p<0.05, **=p<0.01. Statistical analysis in 
B: One-way ANOVA followed by Tukey’s post-test (no differences detected). 
 
A possibility also existed that effect of MCP-1 could override any effects seen by L-
selectin. In other words that changes in polarity seen between WT and ΔM-N L-selectin 
expressing cells were overridden by the MCP-1 induced chemotaxis. It was possible that 
differences between WT and ΔM-N L-selectin expressing cells could be seen when other 
chemoattractants were used. The in vivo research that identified that L-selectin 
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expression as well as its shedding is important for leukocyte directed migration utilised 
murine keratinocyte chemoattractant (KC) chemokine [398, 419]. Thus, it was possible 
that chemotaxis towards KC could reveal differences in migration of GFP, WT L-selectin 
and ΔM-N L-selectin expressing cells. Although KC is generally considered to be a 
neutrophil chemoattractant, migration of monocytes towards KC, or its human equivalent 
CXCL-1, has been reported [720]. Chemotaxis towards increasing concentration of 
CXCL-1 was thus analysed using the transwell assays. Unfortunately, none of the THP-
1 cell lines responded to CXCL-1 (figure 6.16).  
 
Figure 6.16 THP-1 monocytes do not migrate towards CXCL-1. Untransduced THP-1 cells 
(UT) and cells expressing GFP (GFP), WT L-selectin-GFP (WT) or ΔM-N L-selectin-GFP (ΔM-N) 
were subjected to the transwell assays as described in section 2.20. Indicated concentrations of 
CXCL-1 were used. After a 3-hour long assay, cells that migrated from the upper to lower 
compartments were collected and analysed against the input cells by flow cytometry. Experiments 
were repeated in triplicates on three independent occasions. Data represent mean ± S.E.M.   
  
6.4 DISCUSSION 
6.4.1 L-selectin shedding regulates THP-1 monocyte polarisation during TEM 
The results presented in this chapter show that ectopic expression of L-selectin primes 
the THP-1 cells to be more “invasive” during the first 7 min of flow. When compared to 
cells expressing GFP alone, WT L-selectin-expressing THP-1 cells have a higher fraction 
of total protruding cells, and higher fractions of cells with two or multiple pseudopods 
(figure 6.2). This clearly changes at 15 min, when the pseudopod numbers become 
similar between GFP- and WT L-selectin-expressing cells (figure 6.2). The transition 
from multiple pseudopods to single could be an indicator that shedding of WT L-selectin 
has occurred. Indeed, it is known that blocking L-selectin shedding (either with Ro-31-
9790, or through mutating the cleavage site) dramatically increases pseudopod number 
by the 15 min time point (figure 6.4 and 6.5). It is noteworthy that the peak activity of L-
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selectin shedding during TEM was observed to be 20 min in static TEM assays (figure 
4.1), so, although not formally tested, shedding of L-selectin may be hastened under flow 
conditions. Perhaps a role for L-selectin during monocyte TEM could be to augment the 
initial invasion across the endothelial monolayer. In fact, a role for L-selectin in regulating 
the invasion of trophoblasts during embryo implantation has been speculated before 
[721].  
Interestingly, the spread area of the WT L-selectin-expressing THP-1 cells does not 
decrease over time, but is in fact sustained (figure 6.9). This suggests that multiple 
pseudopods are retracting, but not to an extent that would cause the cells to “round-up”. 
Instead, it would appear that the cells are consolidating their multiple protrusions in to 
one or two pseudopods with a continued commitment towards establishing polarity. 
Again, as suggested above, this may be driven by the actual event of L-selectin 
shedding. When L-selectin shedding is blocked, THP-1 cells form multiple pseudopods 
that do not retract with time (figure 6.4). Additionally, the spread area in THP-1 cells 
expressing ΔM-N L-selectin is much larger than in those cells with an intact cleavage 
site (figure 6.9). This is thought to reflect the area gained by continuous pseudopod 
extension and a lack of multi-pseudopod retraction. These results suggest that L-selectin 
shedding must occur for the THP-1 monocyte to establish polarity during TEM. These 
observations may help understand why ΔM-N L-selectin clusters at the non-
transmigrated part of the cell, which is the total opposite to the WT L-selectin (figure 
5.6). In section 5.3.6 it was hypothesised that the cytoplasmic tail of ΔM-N L-selectin 
could be hyperphosphorylated and that this could block its movement from the non-
transmigrated part of the cell to the transmigrated pseudopod. As ΔM-N L-selectin is 
seen to cluster at the top of the cell (figure 5.6), it is possible that as the pseudopods 
expand beneath the monolayer, more membrane is dedicated to the transmigrated part 
of the cell than the non-transmigrated part. This would create a very limited membrane 
microenvironment for ΔM-N L-selectin to move around in. Furthermore, if indeed ΔM-N 
L-selectin is hyperphosphorylated, it could increase random interactions with other L-
selectin molecules (as they may not be “tethered” to the cortical actin cytoskeleton by 
the interaction with the ERM proteins). This hypothesis is also supported by the 
observations made through mutating the serines to non-phosphorylatable alanines (see 
section 6.4.2) 
The establishment and maintenance of cell polarity is important for successful migration 
of cells, including leukocytes. Leukocytes that have lost their polarity present with 
impaired chemotaxis [234, 237, 238, 243, 247, 710, 722]. Furthermore, leukocytes 
expressing a “sheddase-resistant” form of L-selectin cannot undergo chemotaxis in vivo 
[419]. It was hence hypothesised that the loss of polarity in the THP-1 monocytes 
expressing ΔM-N L-selectin could lead to a defect in chemotaxis. Transwell chambers 
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were used where transmigration of THP-1 cells across HUVEC monolayers towards a 
gradient of MCP-1 was assessed. The assays revealed no differences in transmigration 
between WT and ΔM-N L-selectin expressing cells (figure 6.15). This challenged our 
hypothesis, however it is possible that differences in chemotaxis could be seen at 
different time-points. Additionally, it could be argued that a modified experimental system 
is needed to study the contribution of L-selectin and its shedding to chemotaxis of THP-
1 monocytes. An alternative experiment that was not executed during the course of this 
PhD (due to lack of time) would include a relatively thick ECM-mimicking composite (i.e. 
matrigel and/or collagen block) in which cells could migrate upon transmigration. 
Perhaps L-selectin-driven polarity does not influence transmigration of leukocytes per-
se, but rather prime the cells for subsequent directed cell migration through the ECM. 
Furthermore, it is possible that for L-selectin-dependent chemotaxis to occur, leukocytes 
must be first recruited from flow. L-selectin mediates leukocyte tethering and rolling and 
its outside-in signalling contributes to leukocyte arrest (sections 1.2.4, 1.7.5.1.1 and 
1.11.2). Perhaps it is these early interactions of L-selectin with the endothelium that are 
required for L-selectin to then drive chemotaxis. In support of this theory, transwell 
experiments have shown that L-selectin enhances lymphocyte chemotaxis across 
activated HUVEC only if L-selectin is cross-linked prior to the assay [85, 91].  
Cell motility and polarity is affected by the family of Rho GTPases that regulate 
cytoskeletal dynamics (section 1.5). The initial idea for Rho GTPase-mediated 
polarisation of leukocytes was that the activity of Rac1 and Cdc42 at the leading edge 
promote the formation of the protrusions, whereas protrusions at the back are 
suppressed by high RhoA activity in this area [237, 238, 240, 241]. However, with an 
advent of FRET-based probes that monitor spatio-temporal distribution of Rho GTPase 
activity in real-time, this “black-and-white” model of Rho GTPase function has been 
revised. For example, it has been reported that RhoA is also active at the front of 
transmigrating lymphocytes, where it governs both membrane protrusion and retraction, 
which allows for successful formation of the leading edge [118]. RhoA activity was also 
detected in lymphocyte filopodia extending beneath the HUVEC monolayer [118]. 
Similarly, in migrating epithelial cells and fibroblasts RhoA undergoes cyclic activation 
and deactivation at the leading edge [712, 713]. Specifically, highly localised RhoA 
activation increases and decreases in synchrony with protrusion and retraction, 
respectively [712, 713]. The data regarding L-selectin clustering and Rho GTPase 
activity was obtained in the closing phases of this PhD project and as n=1 only. 
Therefore, only a purely hypothetical model incorporating Rho GTPases and L-selectin-
dependant polarity during TEM can be proposed. According to this model, it could be 
speculated that clustering of L-selectin in the transmigrated pseudopods (figure 5.2) 
could lead to a localised decrease in RhoA activity (figure 6.13), resulting in the possible 
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retraction of some of the projecting pseudopods. The result of this is the extension of a 
single pseudopod (figure 6.2), and correct establishment of a leading edge. The lack of 
such clustering in the pseudopods of cells expressing ΔM-N L-selectin (figure 5.6) leads 
to uncontrolled protrusion of multiple pseudopods (figure 6.4) and loss of polarity. 
Interestingly, the ΔM-N L-selectin only clusters in the non-transmigrated part of the cell, 
so its effects on pseudopod dynamics are likely to be very indirect. The decrease in Rac1 
activity following ΔM-N clustering would suggest that perhaps another Rho GTPase is 
active downstream of ΔM-N L-selectin clustering to promote extensive pseudopod 
formation following clustering of ΔM-N L-selectin (figure 6.13). In short, the results are 
too preliminary to draw any major conclusions and clearly an alternative biosensor is 
required to assess the spatio-temporal resolution of Rho GTPases during TEM. 
The results presented in this chapter and in figures 5.2 and 5.6 (Chapter 5) were used 
to generate a theoretical model that proposes how L-selectin might regulate monocyte 
TEM (figure 6.16). Many migrating cells extend and collapse protrusions at the leading 
edge, which is a way of “path finding” [713]. It is proposed that L-selectin may take part 
in this process.  According to this model L-selectin clusters at the leading edge 
(pseudopods) of the transmigrating cells, which results in local deactivation of RhoA. The 
combined effect of many local RhoA inactivity points results in retraction of some of the 
pseudopods. The overall effect is a transmigrated monocyte that is polarised and is able 
to migrate through the extracellular matrix and towards a chemoattractant source. When 
shedding is blocked, clustering of L-selectin occurs in the non-transmigrated parts and 
no clustering in the pseudopods occurs. As a result, high local RhoA activity at the 
leading edge persists and retraction of the excess pseudopods fails to occur. The 
emigrated monocyte loses its polarity. Such “confused” monocytes are then unable to 
proceed through the ECM and up the chemoattractant gradient. When involvement of L-
selectin shedding in driving monocyte polarity during TEM seems highly likely, the 
proposed involvement of RhoA is purely hypothetical and further experiments would be 





Figure 6.17 Model of L-selectin dependent migration.  Clustering of WT L-selectin occurs at 
the leading edge (pseudopods) of the transmigrating cells, which results in local deactivation of 
RhoA. This leads to retraction of excess pseudopods and contributes to cell polarity. Upon 
transmigration, the polarised monocyte successfully migrates through the extracellular matrix and 
towards the chemoattractant source. “Sheddase-resistant” L-selectin (ΔM-N L-selectin), clusters 
in the non-transmigrated parts of the monocyte, and not in the transmigrating pseudopods. As a 
result RhoA activity and extension of multiple pseudopods is maintained and the emigrated 
monocyte loses its polarity. Lack of polarity prevents the monocyte to successfully respond to the 
chemoattractant gradient and directed migration through the ECM is abolished.    
  
6.4.2 Serine residues within the L-selectin tail regulate THP-1 cell pseudopod 
dynamics 
Mutation of the cytoplasmic serine residues within the L-selectin tail into non-
phosphorylatable alanines (SSAA L-selectin) resulted in a slight decrease in the 
percentage of total protruding cells when compared to the WT L-selectin expressing cells 
(figure 6.3). This was accompanied by decreased dynamics of the pseudopods (figure 
6.3) and reduced cell spreading area (figure 6.9). Therefore, it appears that rendering 
of the L-selectin cytoplasmic serines non-phosphorylatable results in decreased 
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“invasiveness” of the THP-1 monocytes. Perhaps phosphorylation of the tail serines is 
needed for initial dynamic pseudopod extension. This would support the hypothesis that 
the tail of ΔM-N L-selectin might be hyperphosphorylated. The hypothesis, initially 
produced in Chapter 5, assumes that when THP-1 cells become activated upon contact 
with the activated HUVEC monolayer, the L-selectin tail becomes phosphorylated. Lack 
of shedding prevents any further tail modifications and as a result ΔM-N L-selectin 
remains in a hyperphosphorylated state. If tail phosphorylation was driving initial 
pseudopod extension, cells expressing hyperphosphorylated ΔM-N L-selectin would 
become “locked” in this initial phase. This could be seen as increased cell spreading 
area and formation of multiple pseudopods that do not retract with time (figure 6.4 and 
6.9). Future experiments using SSDD mutants may best serve to further unfold this 
mystery. 
The cells that express ΔM-N SSAA L-selectin have the same cell spreading area to that 
of the cells expressing WT L-selectin (figure 6.9). However, the pseudopod dynamics of 
ΔM-N SSAA L-selectin expressing cells lie in between those found in the cells expressing 
WT L-selectin and those found in the cells expressing ΔM-N L-selectin (figure 6.8). On 
one side, the percentage of the polarised cells that form one pseudopod only is similar 
to that amongst the WT L-selectin expressing cells. On the other hand though, the 
percentage of cells with multiple pseudopods does not decrease with time and overall 
more cells with multiple pseudopods are seen at the end of the assay as compared to 
the WT L-selectin expressing cells. The fact that the ΔM-N SSAA L-selectin expressing 
cells show similarities to either WT L-selectin or to the ΔM-N L-selectin expressing cells, 
but not to SSAA L-selectin expressing cells, questions the fact that tail serine 
phosphorylation is important for the initial pseudopod extension. The difference between 
cells expressing SSAA L-selectin and those expressing ΔM-N SSAA L-selectin is that 
the former accumulate L-selectin cleavage product (“stump”) during shedding. Perhaps 
it is the presence of the non-phosphorylatable “stump” at the plasma membrane of SSAA 
L-selectin expressing cells that limits the “invasiveness” of these cells. It is possible that 
a negative feedback loop exists where the dephosphorylated “stump” – that would 
normally be generated later on during the transmigration – affects the extension and the 
dynamics of the pseudopods. Possible future experiments may rest with engineering AD 
and DA mutants to specifically pseudophosphorylate one serine residue and not the 
other. This may help determine the contribution of each serine when phosphorylated. 
The outcome of these results will heavily depend of whether the mutations will radically 
affect the overall structure of the L-selectin tail. 
Although it is difficult to propose the complete theory on how the cytoplasmic serine 
residues within the L-selectin tail influence THP-1 pseudopod dynamics, it can be 
speculated that modification of the L-selectin tail by cyclic 
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phosphotylation/dephosphorylation events are likely to occur. Those modifications are 
proposed to regulate L-selectin ectodomain shedding and L-selectin clustering. This in 
turn regulates signalling downstream of L-selectin and affects formation and dynamics 





















CHAPTER 7. GENERAL DISCUSSION 
The experiments described in the Chapters 3-6 of this thesis were designed to 
investigate the role that L-selectin and its shedding may play during monocyte TEM. To 
this end, THP-1 monocytic cell lines were generated that were expressing WT or 
cytoplasmic/extracellular domain mutants of L-selectin tagged to GFP and/or RFP. The 
first set of experiments to be performed was a rigorous analysis of the expression, 
localisation and function of the GFP-tagged L-selectin, which showed that the fluorescent 
tag did not have any adverse effects on the L-selectin protein behaviour (Chapter 3). 
Thus, a powerful tool was gained that allowed the investigation of the spatio-temporal 
distribution of the L-selectin localisation, shedding and clustering during TEM. More 
importantly, this approach required no monoclonal antibody to visualise L-selectin, which 
could potentially interfere with its function and particularly with respect to clustering. 
Utilisation of such cell lines in a number of carefully designed assays yielded 4 major 
findings: (i) that shedding of L-selectin peaks at 20 minutes when THP-1 monocytes are 
co-cultured with activated HUVEC (Chapter 4); (ii) that prior to the peak of shedding 
activity, L-selectin clusters in the pseudopods of transmigrating monocytes (Chapter 5); 
(iii) that engagement of either endogenous CD43 or PECAM-1 on THP-1 cells may serve 
to drive L-selectin clustering – either independently or in concert with ligand-induced 
clustering (Chapter 5); and (iv) that shedding of L-selectin regulates  monocyte cell 
spreading area and polarisation during TEM (Chapter 6). Furthermore, in all of the 
findings described (i-iv), the L-selectin extracellular cleavage site, the cytoplasmic serine 
residues (S364 and S367), or both, have been identified to play a prominent role in the 
regulation of L-selectin function.    
L-selectin plays a pivotal role during leukocyte tethering, rolling and β1/2 integrin-
mediated adhesion. There is a mounting body of evidence that defines a novel role for 
L-selectin, which is the interstitial locomotion of the emigrated leukocytes (chemotaxis) 
[398, 415-417]. Chemotaxis in vivo has been shown to be dependent on L-selectin 
shedding [419], and emigrated leukocytes have been reported to have shed the majority 
of their L-selectin both in vitro and in vivo [520, 554-556]. Therefore it appears that the 
intraluminal and interstitial activity of L-selectin may be linked through the ectodomain 
shedding that occurs during the TEM event. Due to the limitations of the transmigration 
system used in this study, only the early transmigration stage was examined, whereby 
THP-1 cells extend probing pseudopods underneath the HUVEC monolayer but never 
fully transmigrate. In this experimental system it was found that shedding of L-selectin 
peaks at 20 minutes into the assay (figure 4.1). Monocytes take 10-20 minutes to 
complete transmigration in vitro [56, 669, 723], suggesting that L-selectin shedding is 
likely to occur throughout the whole TEM event. This implies that L-selectin shedding 
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might play a regulatory function during TEM. Additionally, this thesis is the first to show 
that shedding of L-selectin during TEM is dependent on the cytoplasmic serine residues, 
the phosphorylation of which is likely to promote/accelerate shedding (figure 4.4). 
7.1 WHAT IS CURRENTLY KNOWN ABOUT THE SUBCELLULAR DISTRIBUTION 
OF L-SELECTIN? 
The experiments undertaken in this thesis were designed to explore two main aspects 
concerning the subcellular distribution of L-selectin during TEM. The first one is the GFP-
signal, throughout this thesis referred to as the "L-selectin GFP-positive spots”, which 
could be detected using the confocal microscopy. The second one is the distribution of 
L-selectin clustering, which could be seen through FLIM analysis of FRET between L-
selectin-GFP and L-selectin-RFP. 
7.1.1 The subcellular distribution of the L-selectin-GFP spots 
Analysis of the spatio-temporal distribution of the L-selectin-GFP spots during TEM 
revealed that the spots accumulate with time in the transmigrating pseudopods. This is 
reduced in the SSAA L-selectin mutant and is abolished when ΔM-N L-selectin is 
expressed (figures 4.12 and 4.13), suggesting that the observed L-selectin-GFP spots 
accumulation is the L-selectin-GFP “stump” generated during shedding. However, to 
formally test this hypothesis it would be crucial to perform further experiments that could 
verify that the spots lacked the extracellular domain. Simple examination of the GFP 
localisation is not conclusive enough as the GFP-signal could correspond to both full-
length and cleaved L-selectin-GFP. One approach would be to stain the fixed samples 
with LAM1-14 mAb that has now arrived in our laboratory and, unlike DREG56, has the 
ability to recognise L-selectin extracellular domain on fixed samples. Furthermore, it is 
possible that the GFP-positive spots represent internalised L-selectin, whether full-length 
or the “stump”. Unfortunately the approach undertaken in this thesis (EEA1 endosomal 
marker staining) did not prove successful in answering of this question, however other 
experiments can be envisioned for the future. For example, P-selectin is known to cluster 
in clathrin-coated pits before it is internalised [724], and so it would be interesting to 
perform co-localisation studies between L-selectin-GFP and clathrin. Additional staining 
with LAM1-14 could serve to further distinguish between the full-length versus the L-
selectin “stump”.   
Accumulation of the L-selectin-GFP “stump” would mean that shedding of L-selectin 
occurs in the transmigrating pseudopods. This hypothesis is in line with data obtained 
by Miss Abigail Newe, a PhD student in the Ivetic laboratory, who discovered that L-
selectin/CaM interaction can be detected in the pseudopods of transmigrating THP-1 
cells after 7 minutes of perfusion, but the interaction no longer exists after 25 minutes, 
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suggesting that CaM disassociates from L-selectin over time (A. Newe, unpublished 
data, figure 7.1). At the same time, L-selectin/CaM interaction in the non-transmigrated 
parts of the THP-1 monocytes was readily detected at both 7 and 25 minute time-points 
(A. Newe, unpublished data, figure 7.1). As CaM negatively regulates L-selectin 
shedding [559], this could indicate that shedding of L-selectin occurs exclusively in the 
transmigrating pseudopods. The implications of such localised shedding could be 
numerous. For example full-length and cleaved L-selectin could bind different cytosolic 
proteins and could support the assembly of distinct signalling platforms at the L-selectin 
tail. L-selectin is known to mediate intracellular signalling and several different signalling 
complexes have been reported/hypothesised to be associated with the L-selectin tail 
upon stimulation through the extracellular domain [245, 572, 602]. Perhaps the change-
over of the binding partners that occurs just before, during, or shortly after shedding could 
trigger signalling downstream of the L-selectin tail that would be spatially limited to the 
transmigrating pseudopods. On the other hand, L-selectin/CaM interaction and the lack 
of shedding in the non-transmigrated parts of the cell could serve to preserve full-length 
L-selectin at the uropod to support secondary capture of the flowing leukocytes, or for 
any other role it may later play during chemotaxis.  
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Wild type RFP-tagged calmodulin (CaM-RFP) was introduced into THP-1 WT L-selectin-GFP Lo5 
cell line and cells were perfused over TNF-α activated HUVEC monolayer (for the method of the 
parallel plate flow chamber experiments see section 2.14.3). The samples were fixed and 
prepared for FLIM/FRET analysis as described in section 2.18.1. FLIM measurement of FRET 
was used to assess the interaction between L-selectin-GFP and CaM-RFP in the Top and Bottom 
z-planes (Top and Bottom are as shown in figure 5.2 A). The figure shows representative images 
of a transmigrating THP-1 monocytes after 7 (A) or 25 (B) minutes of perfusion. Left panels: 
images of L-selectin-GFP. Middle panels: corresponding GFP multi-photon intensity images. 
Lifetime of fluorescence is shown as a pseudo-colour scale of blue (high lifetime) to red (low 
lifetime). The lower the lifetime of fluorescence, the closer the association between L-selectin-
GFP and CaM-RFP. Right panels: Representative wide-field CCD camera image of CaM-RFP. 
C) Quantitation of FRET efficiency between L-selectin-GFP and CaM-RFP. Analysis was 
performed on a total of 15 cells derived from three independent experiments. Mean values are 
shown for each bar. Error bars represent S.E.M. Statistical analysis: Two-tailed unpaired 
Student’s t-test. **=p<0.01. These unpublished experiments were conducted by Miss Abigail 
Newe (Cardiovascular Division, KCL) and FLIM/FRET analysis was performed by Dr Maddy 
Parsons (the Randall Division of Cell and Molecular Biophysics, KCL).  
 
 
7.1.2 The subcellular distribution of the L-selectin clustering  
In keeping with the hypothesis that L-selectin signalling could be triggered in the 
pseudopods of transmigrating THP-1 cells, this thesis is the first to show that L-selectin 
clusters in the monocyte pseudopods during TEM (figure 5.2). L-selectin is monomeric 
in membranes [579, 580], and clustering is associated with ligand binding and signalling 
downstream of the tail and subsequent cellular responses (table 1.3). Clustering of L-
selectin in the transmigrating pseudopods is abolished when shedding cannot occur 
(figure 5.6), highlighting the importance of shedding for L-selectin-dependent signalling 
during TEM. Interestingly, modification of the cytoplasmic serine residues into non-
phosphorylatable alanines can restore clustering of the sheddase-resistant L-selectin in 
the transmigrating pseudopods (figure 5.8). This suggests that the cytoplasmic serine 
residues have a dominant role over the extracellular cleavage site as far as the clustering 
is concerned. It also implies that the serine residues are likely to be hyperphosphorylated 
in the ΔM-N L-selectin, which in turn prevents clustering. Interestingly, clustering of N-
formyl peptide receptor (FPR) occurs in the absence of receptor phosphorylation, which 
is a pre-requisite for subsequent phosphorylation and FPR internalisation [725]. Although 
FPR and L-selectin are functionally distinct, it is possible that they might share a similar 
clustering mechanism, whereby clustering in the absence of phosphorylation is a 
requirement for subsequent phosphorylation-dependent signalling processes.  
7.2 WHAT COULD BE THE RELATIONSHIP BETWEEN L-SELECTIN CLUSTERING 
AND SHEDDING IN THE TRANSMIGRATING PSEUDOPODS?  
One possibility is that shedding and clustering of L-selectin in the pseudopods are two 
independent events. Perhaps a population of L-selectin molecules clusters in response 
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to the ECM ligand binding, and another population undergoes shedding as a result of 
cellular activation. Proceeding down one of the routes could depend on the membrane 
microenvironment a given L-selectin molecule would be surrounded by. In support of this 
theory, the membrane environment has been shown to regulate L-selectin/CaM/ERM 
interaction [573, 576], and 51±7% of the neutrophil surface L-selectin has been reported 
to reside in lipid rafts under resting conditions, suggesting a pre-existing dichotomy in L-
selectin plasma membrane distribution [726]. Another possibility is that clustering and 
shedding are two consequent stages of the same event. There are several lines of 
evidence to support this hypothesis. First of all, L-selectin cross-linking, and thus 
clustering, has been repeatedly shown to cause L-selectin shedding [529, 533-536]. 
Furthermore, densely-spaced sulfated ligands, the nature of which resembles those of 
the ECM sulfated proteoglycans that bind to L-selectin, have been shown to cause L-
selectin clustering and, ultimately, shedding (figure 7.2) [678, 727]. Expression of 
biglycan (L-selectin ECM ligand) by the TNF-α activated HUVEC monolayers has been 
detected in the experimental set-up employed throughout this study (figures 5.3 and 
5.4). This hypothesis can potentially explain why the ΔM-N SSAA mutant clusters in the 
transmigrating pseudopods, however no accumulation of GFP-positive spots can be 
seen (figures 5.9 and 5.11). If clustering is a pre-requisite for shedding and is dependent 
on the lack of the serine phosphorylation, the ΔM-N SSAA L-selectin can therefore be 
effectively clustered. A lack of the extracellular cleavage site prevents shedding, and 
hence no GFP-positive spots can be seen accumulating. To test whether ECM 
components have the ability to cause L-selectin shedding, THP-1 cells expressing GFP-
tagged L-selectin could be incubated with purified biglycan, versican or collagen XVIII 
and the cell supernatants could be tested for sL-selectin using ELISA. Utilisation of the 
serine mutants in such assays would provide clues as to the role of serine 
phosphorylation in ligand-induced L-selectin shedding. Additionally, cross-linking of 
CD43 or PECAM-1 prior to the assays could help to understand if these molecules play 
a role in the modulation of the extent of the L-selectin shedding. Other experiments to 
consider would be to seed the L-selectin-GFP/RFP double expressor THP-1 cells on to 
purified immobilised ECM ligands (such as biglycan) and determine if L-selectin 
clustering is directly influenced, as assessed by FRET and compared to cells plated on 





Figure 7.2 Relationship between the ligand type and L-selectin clustering and shedding.  
A) Distribution of L-selectin at the plasma membrane when no ligand is bound. B) Engagement 
with densely spaced sulfated ligand causes clustering, conformational changes and shedding of 
L-selectin. C) Engagement with loosely spaced sulfated ligands does not induce conformational 
changes in L-selectin, and as a result shedding does not occur. Image adapted from Liu and Kiick, 
Polym. Chem., 2011 [678].    
 
7.3 HOW IMPORTANT IS INSIDE-OUT SIGNALLING FOR CLUSTERING OF L-
SELECTIN? 
This thesis is the first to report that the engagement of endogenous CD43 or PECAM-1 
causes L-selectin clustering. This discovery sets the foundations for a novel avenue of 
investigation, which would involve: (1) dissecting the signalling pathways between 
CD43/PECAM-1 and L-selectin and (2) analysing the physiological relevance of these 
interactions for leukocyte recruitment. The current study identified that CD43-mediated 
L-selectin clustering occurs in the absence of cytoplasmic tail serine phosphorylation, 
whereas it is hypothesised that PECAM-1-mediated clustering is likely to require dynamic 
phosphorylation/dephosphorylation events on the L-selectin serine residues. This in turn 
suggests that CD43 and PECAM-1 signal to L-selectin at distinct stages during the 
recruitment, which makes sense, given the spatio-temporal difference in the engagement 
of CD43 and PECAM-1 during the leukocyte adhesion cascade (the putative models 
explaining CD43 or PECAM-1-mediated L-selectin clustering during the leukocyte 
adhesion cascade were discussed in more detail in section 5.4.1). As mentioned above, 
a role of CD43/PECAM-1-induced L-selectin clustering in L-selectin shedding could be 
explored, however it would be also interesting to investigate what proteins bind to the L-
selectin tail in response to CD43/PECAM-1 signalling. A possible experiment could 
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chromatography, using the 17 C-terminal amino acids of the L-selectin tail as “bait”. Such 
column has been successfully used in the past for the identification of the L-selectin 
binding partners in the lysates from the PMA-stimulated lymphocytes [563]. Once 
identified, the binding partners could be tagged to RFP and introduced to the L-selectin-
GFP expressing THP-1 cell lines and FRET between the two could be measured during 
TEM over a series of time points.   
7.4 WHAT IS THE BIOLOGICAL SIGNIFICANCE OF L-SELECTIN’S ACTIVITY 
DURING TEM? 
Chapter 6 of this thesis is the first to demonstrate that L-selectin influences monocyte 
morphology and pseudopod dynamics during TEM. The data presented suggest that 
expression of L-selectin renders the cells more invasive in the very early stages of TEM 
as compared to monocytes expressing GFP alone (figure 6.1). This finding could have 
potentially important therapeutic implications, given the prominent role of monocyte 
recruitment in chronic inflammatory diseases such as atherosclerosis. With time this pro-
invasive advantage is lost, a phenomenon that could be potentially explained by L-
selectin shedding occurring in the pseudopods. In keeping with this, transmigrating 
monocytes expressing WT L-selectin consolidate their multiple “invasive” pseudopods 
into one or two as the time progresses, which is thought to occur by “channelling” of the 
available membrane area into the dominant pseudopods without overall reduction in the 
cell spreading area (figure 6.9). This allows the monocytes to acquire a polarised 
phenotype. In the absence of L-selectin shedding no pseudopod rearrangement seems 
to occur, multiple pseudopods are maintained and the cell loses polarity (figures 6.4 and 
6.5). Interestingly, pseudopod dynamics and polarity appears to be also regulated by the 
cytoplasmic serine residues, as the SSAA mutation of the ΔM-N L-selectin tail can 
partially restore the dynamics seen with WT L-selectin (figure 6.8). This highlights the 
importance of the non-phosphorylated state of the serines required for L-selectin 
clustering in the pseudopods (Chapter 5), and suggests a link between clustering, 
shedding and monocyte polarisation. If the two-step model of L-selectin shedding in the 
pseudopods is true, then it is possible that the serine residues regulate L-selectin 
clustering and induce signalling necessary for the shedding response.  
Although the morphology of fully transmigrated cells could not be analysed in this study, 
it is tempting to speculate that emigrated monocytes would present with a polarised 
appearance, where the cell front would be devoid of full-length L-selectin. In support of 
this theory, preliminary experiments from the Ivetic laboratory show that when PBMCs 
are labelled with fluorescently tagged LAM1-14 mAb and subsequently perfused over 
activated endothelial cells, around 30-50% of them retain L-selectin expression at the 
uropod following TEM (Dr A. Ivetic, unpublished data). Why the remaining population 
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lose their L-selectin is unknown, and also it is not known whether the THP-1 cells studied 
in this project truly represent the monocytes that retain their L-selectin expression 
following TEM. One way to investigate this question in the THP-1 cell model would be to 
grow HUVEC on the thick collagen/matrigel substrates, allow the monocytes to 
transmigrate fully and monitor their fate beyond the endothelial barrier and in to the ECM. 
Yet again, the non-function blocking anti-L-selectin antibody LAM1-14 would prove 
useful, to label L-selectin prior to the assay or in the fixed samples. Such experiments 
are currently underway in the Ivetic laboratory in a new PhD project.  
7.5 A PUTATIVE MODEL FOR THE ROLE OF L-SELECTIN DURING TEM AND 
BEYOND   
The above has described four major findings of this PhD project were used to generate 
a hypothetical model explaining the involvement and implications of L-selectin’s activity 
during TEM. The graphical summary of the model is presented in figure 7.3, and the 
model is discussed in more detail below. It is proposed that during the resting state and 
the early stages of the leukocyte adhesion cascade, the tail of L-selectin is cyclically 
phosphorylated/dephosphorylated. This might involve stages, where only one of the 
serines (S364 or S367) is phosphorylated, two serines are phosphorylated or none is 
phosphorylated. Such regulation is likely to be very dynamic and allow for regulation of 
L-selectin function, e.g. modulation of the tail interaction with CaM, ERM and the inner 
leaflet of the plasma membrane, regulation of basal L-selectin shedding, ligand binding 
during tethering and rolling or clustering in response to CD43 engagement. Based on 
the data presented in this thesis, it is likely that the serines may play a redundant role, 
which is why mutating both serines will lead to an observed phenotype. During 
transmigration, L-selectin is exposed to the ECM environment, where it can bind to its 
sulfated ligands. It is proposed that the cytoplasmic serine residues must not be 
phosphorylated for ligand-induced clustering to occur. Furthermore, the binding could be 
facilitated by the CD43/PECAM-1-mediated L-selectin clustering. CD43/PECAM-1-
induced clustering of L-selectin could bring about a conformational change that would 
increase the avidity of L-selectin for the ECM ligand. Inside-out signalling evoked by 
stimulation of leukocytes with lineage specific stimuli has been reported to improve the 
affinity of L-selectin for PPME ligand mimetic before [728]. Additionally, due to its 
prominent role in TEM and leukocyte/EC junction interaction, PECAM-1 could serve to 
translocate clustered L-selectin from the non-transmigrated to transmigrated 
(pseudopod) part of the cell. Alternatively, L-selectin/ligand binding could occur first, and 
CD43/PECAM-1-induced inside-out signalling could modulate the avidity of this complex. 
It is further hypothesised that specific conformation of clustered L-selectin, induced by 
ECM ligand binding and/or inside-out CD43/PECAM-1-mediated signalling triggers 
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shedding of L-selectin. This event is thought to be limited to the transmigrating 
pseudopods only. Shedding of L-selectin has been reported to be mediated by p38 
MAPK [496, 531], and activation of p38 MAPK downstream of L-selectin clustering has 
been reported [589]. This opens up a possibility that engagement of L-selectin 
ectodomain could lead to L-selectin shedding in a p38 MAPK-dependent manner. 
Interestingly, p38 MAPK inhibitors have been shown to have no influence on leukocyte 
rolling or adhesion but caused chemotaxis defects parallel to those seen in L-selectin 
deficient mice [729]. This could imply a role for p38 MAPK-mediated shedding of L-
selectin during TEM as a pre-requisite for chemotaxis. It is further postulated that 
clustering and shedding of L-selectin are important for the establishment of cell polarity 
during TEM. It is proposed that signalling downstream of clustered or cleaved (“stump”) 
L-selectin could drive the retraction of competing pseudopods and could stimulate 
extension of the dominant pseudopod. It is tempting to speculate that the signalling 
pathway involves activation/deactivation of certain Rho GTPases, although the data 
presented in this thesis is currently too preliminary to draw any meaningful conclusions. 
It is hypothesised that due to L-selectin clustering and shedding, emigrated leukocytes 
would have an established polarity and would therefore be primed for directional 
migration in the extravascular space. It is also possible that the L-selectin “stump” could 





Figure 7.3 Schematic model representing the possible role of L-selectin clustering and 
shedding in TEM and chemotaxis.  This model was produced based on the four major findings 
of this PhD thesis and currently available literature. It is proposed that the L-selectin tail is 
cyclically modified by phosphorylation/dephosphorylation events that regulate basal shedding, 
ligand binding during tethering and rolling, as well as the interaction of L-selectin with CaM, ERM 
and the plasma membrane (1). During TEM, L-selectin clusters upon ECM ligand binding, which 
could be modulated by CD43/PECAM-1-mediated inside-out signaling (2). Clustering is likely to 
involve CaM/ERM interaction in cis, binding of K-Ras to SOS (not shown on the schematic, see 
text below and figure 7.4) (2). Clustering results in L-selectin shedding (3). Pseudopod-specific 
clustering and shedding of L-selectin leads to retraction of multiple pseudopods, dedication of the 
plasma membrane towards one or two dominant pseudopods and leukocyte polarisation (4). 
Transmigrated leukocyte is polarised with full-length L-selectin at the uropod and L-selectin 




























7.6 HOW DOES THIS WORK FIT WITH THE PREVIOUS OBSERVATIONS MADE IN 
THE IVETIC LABORATORY? 
Not much is currently known about the molecular players that could be involved in the 
initiation of the signalling postulated in this thesis. However, Killock et al. (2009) has 
proposed that under resting conditions each L-selectin molecule forms an independent 
1:1:1 heterotrimeric complex with CaM and ERM, where CaM associates with K-Ras and 
ERM associates with SOS (son of sevenless, GEF for Ras) (figure 7.4) [572]. Clustering 
of L-selectin was proposed to bring CaM, ERM, as well as their respective binding 
partners, from the adjacent L-selectin tails close together, which allows K-Ras to SOS 
binding (figure 7.4) [572]. This in turn could create a signalling platform capable of signal 
initiation downstream of the L-selectin tail [572]. Interestingly both K-Ras and SOS have 
been shown to activate p38 MAPK [730, 731], and engagement of L-selectin ectodomain 
stimulates the Ras pathway through SOS [245]. Additionally, Ras has been shown to 
mediate lamellipodia extension during cancer cell migration [732] and SOS has been 
seen accumulating at the leading edge of the migrating fibroblasts and COS cells [733]. 
It is hence possible that L-selectin clustering in the pseudopods results in CaM/ERM 
interaction in cis, association of K-Ras and SOS and recruitment of p38 MAPK to the 
complex. The SOS/K-Ras interaction could drive membrane extension, which could be 
subsequently modulated by p38 MAPK-induced shedding of L-selectin. It would be 
interesting to generate cell lines where L-selectin-GFP would be complimented with 
SOS-RFP or Ras-RFP and FRET could be measured between these molecules during 
TEM. Alternatively, as a more simple approach, L-selectin could be cross-linked and 
techniques like immunoprecipitation or affinity chromatography could be used to 
investigate proteins that associate with clustered L-selectin. Additionally, mutations of 
the serine residues within the L-selectin tail could help to understand if these amino acids 


















Figure 7.4 Clustering of L-selectin prompts interaction between CaM and ERM in cis.  In 
resting cells, L-selectin, ERM and CaM form a heterotrimeric complex. Within the complex, ERM 
and CaM hold proteins involved in initiation of signalling, such as SOS and K-Ras, sufficiently far 
apart to prevent signal propagation. Clustering of L-selectin (as might occur in the transmigrating 
pseudopods) brings ERM and CaM together in cis, leading to binding of SOS to K-Ras, and 
subsequent signalling. Image was generated by Dr D. Killock as an adaptation from Killock et al., 
J. Biol. Chem., 2009 [572].  
 
7.7 ARE THERE ANY OTHER POTENTIAL PLAYERS THAT COULD BE INVOLVED 
IN L-SELECTIN-DEPENDENT SIGNALLING DURING TEM OR CHEMOTAXIS? 
L-selectin clustering through ligand binding has been shown to upregulate CXCR4 
chemokine receptor and maintain receptor expression at the cell surface [85, 90]. This 
was dependent on the activation of the Src kinases [90], and another report has shown 
that the Src kinase family member p56lck becomes activated downstream of L-selectin 
clustering in lymphocytes [245, 602]. It would be interesting to establish whether Src 
kinases are activated downstream of L-selectin in THP-1 cells, as the Src kinases have 
been reported to play a role in monocyte chemotaxis [734]. It would be especially 
interesting to investigate whether the Src kinases could bind to the full-length L-selectin 
or to the L-selectin “stump” generated during shedding. 
Interestingly, infiltration of monocytes to the synovium of patients with rheumatoid 
arthritis was found to be dependent on Src/Ras/p38 MAPK pathway [734]. Even more 
interestingly, the chemoattractant in this case was found to be the soluble E-selectin 
[734], which is an L-selectin ligand for human neutrophils [381]. This highlights the 
importance of the signalling through Src kinases, p38 MAPK and Ras for monocyte 
chemotaxis, and further supports the hypothesis that these signalling molecules could 
be involved in the regulation of L-selectin-dependent signalling pathways during TEM 
and chemotaxis. It would be of interest to investigate if L-selectin from human monocytes 
can bind E-selectin, or if CD43/E-selectin binding on would lead to L-selectin clustering 
and/or shedding. 
Although the work presented in this thesis goes some way to advance our understanding 
of the role of L-selectin in the leukocyte recruitment, a number of questions still remains 
to be answered and also new questions arise, what with the discoveries made in this 
thesis. It will be important to understand where L-selectin fits between other CAMs that 
can also be clustered, can transmit signalling and can be shed. It is now clear that L-
selectin functions not only during leukocyte tethering and rolling, but also plays a role in 
leukocyte polarisation during TEM (this thesis) and mediates chemotaxis (sections 
1.7.5.1.2 and 1.11.3). To understand how L-selectin can perform its multiple functions 
would be crucial in the design of novel anti-inflammatory drugs and therapies. It is 
plausible that interference with L-selectin shedding, modulation of the L-selectin tail 
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phosphorylation by specific kinase inhibitors or blocking of upstream or downstream L-
selectin effectors could prove to be effective strategies for treatment of some of the 
chronic inflammatory diseases. Understanding what signalling platforms are being 
assembled at the L-selectin tail and how and when shifts in L-selectin signalling occur, 
would prove useful to interfere with specific stages of the leukocyte adhesion cascade 
without disruption of the others.            
7.8 CONCLUDING REMARKS 
In summary, this research project has identified a possible role for L-selectin during 
monocyte TEM. The results presented in this thesis suggest that L-selectin clusters and 
is most probably shed exclusively in the transmigrating pseudopods. This in turn results 
in the establishment of cell polarity, which is understood to play a crucial role in the 
interstitial migration of leukocytes. Hence, this thesis contributes to the current 
understanding of L-selectin’s function by possibly bridging the gap between the role of 
L-selectin inside the vasculature and the role of L-selectin outside the vasculature. This 
could have potentially powerful therapeutic implications, especially with regard to chronic 
inflammatory diseases that are mediated by monocytes. However, more research is 
needed to fully understand the mechanisms involved in the clustering, shedding and 
signalling of L-selectin during TEM as well as L-selectin’s relationship with other CAMs 
involved in the leukocyte adhesion cascade. Further assessment of full length versus 
cleaved L-selectin with respect to interstitial migration would be of great importance in 
the near future. Finally, this work has been entirely dedicated to monocytes. An important 
future aim would be to determine if these observations are specific to monocytes, or 
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